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The brain of most mammals is capable of producing newly born neurons during 
the whole life, including postnatal and adult periods, throughout a process called adult 
neurogenesis. It is now well-established that the core cells that fundament the whole 
adult neurogenic process are adult neural stem cells (NSCs). These cells give birth to 
neurons that integrate into the existent circuitry in at least two regions of the brain; the 
subventricular zone (SVZ) of the lateral ventricles (LVs) and the subgranular zone 
(SGZ) of the dentate gyrus (DG). The DG is part of the hippocampal formation (HPF) 
and therefore, the neurogenic process here is termed adult hippocampal neurogenesis 
(AHN).  
In mice, it was described that the AHN diminishes over time. Indeed, a dramatic 
neurogenic decline is associated with aging and it has been proposed to occur mainly 
because of NSC depletion, due to the ultimate astrocytic or neuronal differentiation of 
those NSCs that enter the cell cycle (“get activated”) to generate neuronal precursors. 
Although self-replication of NSCs is possible in the adult SGZ it is not enough to 
outpower the progressive depletion of the NSC population. Therefore, the total 
neurogenic capacity of an individual will be determined by the initial number of NSCs. 
Although the origin of adult NSCs is not well known, the generally accepted view in the 
field is that they, as well as the process of AHN, are a remnant from the embryonic 
hippocampal development. 
In humans, the actual occurrence and extent of AHN has been historically 
subject of fierce debate. Recently, the debate got rekindled due to a controversial work 
reporting the absence of AHN from childhood onwards. However, other authors have 
reported the presence of doublecortin (DCX)-expressing cells in the SGZ of the adult 
DG, inferring thus the presence of AHN. The two opposing views remain under debate 
up to this day. 
In the first part of this thesis, we address the developmental origin of adult 
NSCs. For that, we studied the postnatal development of the DG in a knock-out mouse 
for cyclin D2 (cD2) crossed with a Nestin-Green fluorescent protein (GFP) transgenic 
line of mice in which NSCs are readily visualized. We also used region-targeted 
retroviral infections to permanently label dividing cells and their progeny in different 
regions of the postnatal brain. The results indicated that the adult population of NSCs is 
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generated on-site in the DG around postnatal days 2-7 through a cD2 dependent 
process. This suggests that adult NSCs comprise a separated population from 
developmental progenitors, being generated postnatally in an independent manner. 
Therefore, the process of postnatal and AHN is not a mere continuation of the 
embryonic development. These results are also supported by the differential 
expression of a biomarker that is not present in developmental NSCs. Using the 
transgenic lysophosphatidic acid receptor 1 (LPA1)-Enhanced green fluorescent protein 
(EGFP) mouse model, we observed that LPA1 starts to be expressed in NSCs only 
from postnatal day 10-14 (P10-P14) onwards, and then its expression remains 
throughout adulthood in hippocampal NSCs.  
As mentioned, the existence of AHN in humans recently became a hot topic in 
the field with strongly controversial results being reported. Addressing the issue from a 
developmental point of view, we described that human and mouse developmental 
processes may follow different temporal dynamics, although sharing similar formation 
patterns. In contrast to mouse, where the DG develops mainly postnatally, in humans it 
is almost completely formed by mid-gestation. However, radial glia cell (RGC) 
populations are still present early after birth. Indeed, the existence of a population of 
NSCs in the human DG after birth (independent on the temporal extent) could be of 
great importance in pathological conditions.  
The loss, disruption or alteration of the hippocampal neurogenic niche arguably 
results in the impairment of all the related tasks such as learning, memory, pattern 
separation, axiety, etc. In fact, the pathological alteration of AHN has been related to 
different neurodegenerative diseases such as epilepsy, Parkinson’s, Alzheimer’s, 
Huntington’s or dementia. In all these pathologies at least part of the symptoms could 
be potentially caused or favored by reduced or altered AHN. Indeed, my host 
laboratory has recently shown how seizure-induced neuronal hyperactivity induces 
NSCs to become reactive NSCs (React-NSCs), drastically changing their mitotic and 
morphological properties and ultimately generating reactive astrocytes at the almost 
complete expense of neurogenesis.  
In the second part of this thesis, using a model of mesial temporal lobe epilepsy 
(MTLE) in which a single injection of kainic acid (KA) is delivered into the HPF, we 
studied the role of the epidermal growth factor receptor (EGFR) signaling pathway in 
the onset of the neurogenic niche pathological response to seizures. EGFR is 
upregulated in NSCs early after seizures, and using the reversible EGFR inhibitor 
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Gefitinib (used for the treatment of glioma) after MTLE induction, we show that the 
massive proliferating activity and React-NSC induction is significantly ameliorated, 
suggesting a major role of the pathway in this process. Importantly, neurogenesis, 
measured by the presence of DCX-expressing immature neurons is recovered in the 
MTLE mice that were administered with Gefitinib. Furthermore, we demonstrate that 
the increased release of zinc (Zn+2) after seizures also contributes to the induction of 
React-NSCs, either by direct stimulation of EGFR or by potentially promoting the 
cleavage of membrane-bound heparin binding-epidermal growth factor (HB-EGF), a 
































3.1. Hippocampal formation (HPF): The brain seahorse 
3.1.1. Anatomy and circuitry 
It was 1587 when the anatomist Giulio Cesare Arantius found deep inside the 
medial temporal lobe of the human brain a curious structure that strongly resembled a 
seahorse. Acknowledging this similarity he took the Greek word for this sea creature 
and named the region “hippocampus” (HP) (Arantius, 1587). Since then, this 
archicortical structure has been continuously raising the interest of uncountable 
researchers that have worked to unravel its morphological and functional properties. 
Nowadays, the term HP refers to a structure that was also termed “cornu ammonis” 
(CA) or “ammon’s horn” due to its similarity to a ram horn and after the Egyptian god 
Amun Knepth, whose symbol was a ram (de Garengeot, 1742). Curiously, the CA 
nomenclature was thereafter maintained to define the subfields of the HP (CA1, CA2, 
CA3 and CA4) (Figure I1 A). 
The HP is functionally connected to related brain regions that together comprise 
the HPF, first represented by Camillo Golgi (Golgi, 1886) and thoroughly described by 
Santiago Ramón y Cajal (Ramón y Cajal, 1893, 1911) and his student Raphael Lorente 
de Nó (Lorente de Nó, 1934). Based on their studies, we nowadays know that the HPF 
is formed by different structures other than HP, that include the subiculum, 
presubiculum, parasubiculum, entorhinal cortex (EC), alveolus, hippocampal fissure 
(HF), hippocampal tail, HP-amygdala transition area (HATA) and also the dentate 
gyrus (DG) (Iglesias et al., 2015) (Figure I1 A). These structures, although varying in 
size, are present in all mammals from rodents to humans (Figure I1 B). 
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Figure I1. A) Different subfields of the HPF. B) HPF of rat, monkey and human (modified from Iglesias et 
al., 2015 and Savage et al., 2013). 
The studies performed by Theodore Wilhelm Blackstad and colleagues on the 
60s shed light on the HPF circuitry. They described how the different structures are 
linked mostly by unidirectional connections (Blackstad, 1956, 1958; Blackstad et al., 
1970) and portrayed the main circuit of the HPF, the so-called “trisynaptic circuit” 
(Andersen et al., 1966). Stellate and pyramidal neurons from the EC project their 
output to the dendrites of the DG excitatory granule cells (GCs) through the perforant 
path (PP). GCs extend their axons, the mossy fibers (MFs), to CA3, where Schaffer 
collateral axons send the major input to CA1 field (Andersen et al., 1966; Steward and 
Scoville, 1976). Moreover, CA1 neurons project back to EC deep layers and to the 
subiculum, which in turn close the loop connecting to the cortical areas that originally 
projected to the HPF (Köhler, 1985a) (Figure I2). More recently, it was described a 
disynaptic circuit where EC excitatory inputs directly reach CA2 neurons, which in turn 
send strong output to CA1 (Chevaleyre and Siegelbaum, 2010). Also, the subiculum 
has been shown to be a modulator of the neurotransmission along the PP (Köhler, 
1985b; Shipley, 1975). 
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Figure I2. The hippocampal circuitry first performed by Santiago Ramón y Cajal (1909) visualizing neurons 
using Golgi. Later, Theodore Blackstad and colleagues will further describe these connections (see inset) 
(Blackstad, 1956, 1958; Blackstad et al., 1970) and Per Andersen will baptized them as the “trisynaptic 
circuit”.  
Following the concept of trisynaptic circuit, Per Andersen and its collaborators 
postulated that hippocampal circuitry exists in a transversal way, repeating along the 
septotemporal axis and creating slices, or lamella, of interconnected regions. They 
called this theory “the lamellar hypothesis of the hippocampal connectivity” (Andersen 
et al., 1971). Although this hypothesis supposed one of the first important steps in the 
way to define hippocampal connectivity, years later several studies demonstrated that 
this was an extremely simple theory and that the HPF showed both internal regional 
complex connectivity patterns and external connections to other brain regions such as 
the septum, hypothalamus, amygdala and neocortex (Sloviter and Lømo, 2012). 
During the early 2000s, the field of hippocampal neuroanatomy took a huge 
step forward by combining genomic and neuroanatomical experiments such as 
microarray analysis and microdissection techniques. Hence, several authors provided 
molecular basis for the previously defined anatomic hippocampal subfields, revealing 
differential region-specific molecular expression between and within the adult mouse 
hippocampal subfields (Datson et al., 2001, 2004; Lein et al., 2004, 2005, 2007; Zhao 
et al., 2001). Furthermore, this heterogeneity on the molecular expression has been 
demonstrated also along the septotemporal axis (Leonardo et al., 2006; Thompson et 
al., 2008). These discoveries were crucial to facilitate functional studies on the different 
structures and neuronal subtypes of the HPF. 
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3.1.2. Cognitive functions 
The HPF is involved in important cognitive functions, as it has been shown 
through animal and human studies. After Alf Brodal questioned for the first time the 
widely held view that the HPF was a specific part of the olfactory system (Brodal, 
1947), important advances were made underlying its role in learning and memory. In 
1957, William Beecher Scoville and Brenda Milner studied patients who underwent 
bilateral surgery to remove both hippocampi as a solution to their psychosis or, in the 
famous case of H.M., constant seizures caused by epilepsy. They reported severe loss 
of recent memory consequent to hippocampal extraction (Scoville and Milner, 2000). 
Since then, the importance of the HPF in these cognitive processes has been long 
addressed in rodents and humans and it is a widely accepted concept nowadays 
(Jarrard, 1993; Moscovitch et al., 2005). Nevertheless, spatial representation and 
anxiety has also been reported to be dependent on the HPF functionality (McNaughton 
and Gray, 2000; Moser et al., 2017). Specifically, the ventral HPF (vHPF) has been 
reported to participate in anxiety-related behaviors while the dorsal HPF (dHPF)  
relates more to memory and learning processes (Bannerman et al., 2004). 
3.1.3. DG: The complex gate 
The DG is the most medial area of the HPF (Medina and Abellán, 2009; 
Puelles, 2001) and its main input region. As part of the archicortex, it is a structure 
divided in three layers and comprised by a principal layer called granule cell layer 
(GCL), formed by a dense population of excitatory GCs and also inhibitory pyramidal 
basket cells located at the border between GCL and the next layer of the DG; a 
polymorphic layer named hilus, mainly populated by mossy cells (inhibitory) and 
excitatory neurons, that serves as a connecting region for CA and DG; and the 
molecular layer (ML), a relatively cell-free layer mainly populated by the GC dendrites, 
PP fibers and few interneurons, as well as glial cells (Amaral et al., 2007; Lorente de 
Nó, 1934) (Figure I3). Thus, the DG is a complex structure in which the functionality of 
the HPF highly relies. Several authors have described the DG as the gate of the HPF, 
where incoming inputs get filtered by the dentate-hilar complex, therefore modulating 
pattern separation and specific memory creation (Acsády and Káli, 2007; Hsu, 2007). 
When a stimulus reaches the DG, GCs activate following a sparse coding. A small 
number of cells get activated each time, thus enabling a sensitive pattern separation 
capacity both in rodents and humans (Bakker et al., 2008; Chawla et al., 2005; Leutgeb 
et al., 2007). 
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Figure I3. Different neuronal types in the DG (modified from Amaral et al., 2007). 
One of the main characteristics that distinguish the DG as a unique structure in 
mammalian brain is the capacity to generate newborn neurons during the whole life. 
Thus, neurons are added continuously to the already existing circuit in a process 
known as adult hippocampal neurogenesis (AHN), modulating several brain functions 
in the normal and pathological brain. However, a role for newborn neuron generation in 
the adult brain was not first described in mammals but in birds. The pioneering studies 
of Fernando Nottebohm and colleagues were the first step on the study of the 
involvement of adult neurogenesis in learning and memory associated with spatial 
information. The formation of new neurons in the high vocal center (HVC) of avian 
brain was demonstrated to be related to hormonal patterns, seasonal and sex 
differences and also complex experiences that affect song learning (Goldman and 
Nottebohm, 1983; Nottebohm, 2004). 
Over the last two decades AHN has been associated with memory and learning. 
The generation and integration of new neurons in the hippocampal circuit have been 
suggested to help weakening old memories, strengthening the capacity to learn new 
things and acquire new information (Abrous and Wojtowicz, 2015; Akers et al., 2014; 
Drew et al., 2013; Gould et al., 1999a; Shors et al., 2001; Treves et al., 2008; Vivar and 
van Praag, 2013). Also, it has been long related the relevance of AHN for pattern 
separation, facilitating the spatial and temporal contextual memory (Deng et al., 2010; 
Vivar et al., 2016) and encoding temporally related memories (Aimone et al., 2006; 
Becker and Wojtowicz, 2007; Clemenson et al., 2015). However, this idea has recently 
been discussed (Becker, 2017). In fact, there is controversy between rodent studies 
that relate, or do not, AHN to different cognitive functions. Therefore, the variability 
between studies makes it difficult to draw conclusions on the specific role of AHN, 
though it seems safe to claim its relation to learning and memory in general terms. 
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3.2. History of adult neurogenesis: 50 years to acceptance 
In 1958, Bernard Messier and colleagues discovered clusters of dividing cells 
underlying the ependyma of the lateral ventricle (LV) in mice (Messier et al., 1958), and 
these cells were further suggested to be a continuous source of glia in rats (Bryans, 
1959). Later, Ian Smart and Charles Phillipe Leblond continued these studies in mice 
reporting that subependymal cells did divide, although they did not add a significant 
population of new cells to the adult brain, possibly balanced by cell death (Smart and 
Leblond, 1961). However, even though their discoveries were fundamental for the 
posterior research and findings, they failed to find adult newborn neurons and they did 
not report any cell division in the DG. 
It was not until the 60-70s when the generation of newborn cells in the adult 
brain, which nobody considered it possible until then, appeared on the spotlight of the 
neuroscience field, with Joseph Altman as the visible head of several studies that laid 
the groundwork of adult neurogenesis. Using thymidine labeled with tritium (a 
radioactive isotope of hydrogen; ([3H]-TdR) he studied brain lesions in rats and found 
neuronal cells in the DG that unequivocally retained this radiolabelled signal. This 
finding led him to wonder for the first time about the possibility of new neuronal 
production in the adult HPF and brain in general (Altman, 1962a, 1962b). He quickly 
performed another study in adult rats and cats in which he found high rates of 
ependymal cell multiplications in the LVs and frequent labeling of GCs in the DG 
(Altman, 1963). During the following decade, combining [3H]-TdR and histological 
analyzes, he and his collaborators described that effectively the observed dividing cells 
were generating new neurons in the LVs, from where they migrated to the olfactory 
bulb (OB) to supply with new neuronal populations (Altman, 1969a; Altman and Das, 
1965). They also described adult neurogenesis happening in the caudate nucleus and 
cerebellum of rats (Altman, 1969b; Das and Altman, 1971). Finally, in collaboration with 
his colleague Gopal Das, they found adult neurogenesis in the DG of rats, cats, and 
guinea pigs (Altman and Das, 1965, 1967).  
Subsequent studies using previous [3H]-TdR techniques combined to electron 
microscopy (EM) supported the idea that the [3H]-TdR labeled cells in the adult rat DG 
and OB were in fact young neurons and not any other cell type (Kaplan and Hinds, 
1977). Moreover, additional evidence was provided by Kaplan and colleagues when 
they found adult neurogenesis in the visual cortex (Kaplan, 1981) and in the DG of 9-
month old rats (Kaplan and Bell, 1983), being product of dividing neuroblasts (NBs) 
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(Kaplan and Bell, 1984). More importantly, it was later demonstrated the existence of 
adult neurogenesis in higher vertebrates, after finding dividing cells in the 
subependymal layer of the LVs in rhesus monkey (Kaplan, 1983).  
However, adult neurogenesis was yet to find several setbacks on its way to 
acceptance. The skepticism of the field was well represented first in the book published 
by Hubert Korr in which against the evidence of newborn neuron generation in the adult 
rodent brain he reviewed previous works where adult neurogenesis was indeed not 
found and posed under doubt the interpretation about [3H]-TdR labeled cells being 
neurons (Korr, 1980). Moreover, Pasko Rakic reported the non-existence of adult 
neurogenesis in higher vertebrates. He analyzed the HPF of rhesus monkey and 
described how only a few cells divided in the DG after birth, doing so only during the 
first postnatal months and not in the adult life (Eckenhoff and Rakic, 1988; Rakic, 
1985). He reported the absence of adult-born neurons in any other brain region and 
charged against the previous study of Michael Kaplan, also in rhesus monkey, arguing 
misinterpretation of the nature of the dividing cells. He claimed that glial cells had been 
taken for neurons and damaged cells for dividing cells (as during the mechanism of 
deoxyribonucleic acid (DNA) reparation, damaged cells remove the damaged 
nucleotide and insert the correct one, or in this case [3H]-TdR, without implying mitotic 
process) (Rakic, 1985). That same year, Kaplan published a work defending his 
method based on ultrastuctural analysis through EM as the only valid method for the 
assessment of the neuronal nature of an adult-born cell and therefore discrediting the 
absence of adult neurogenesis claimed by Rakic (Kaplan, 1985). The field was 
polarized and immersed in a fierce debate and adult neurogenesis would have to wait 
many more years to become widely accepted.  
One of the main findings that allowed important discoveries in the field was the 
development of a monoclonal antibody directed against 5-bromo-2'-deoxyuridine 
(BrdU), a synthetic nucleoside analog of thymidine, allowing immunohistochemical 
staining of cells which have incorporated this compound into their DNA during 
replication (Gratzner et al., 1982). The use of BrdU was introduced and adapted by 
Miller and Nowakowski for studying cell proliferation, migration and time of origin of 
cells in the developing brain (Miller and Nowakowski, 1988). A year later, they used 
BrdU labeling to successfully find AHN in juvenile rodent brains, although they 
interpreted their results as hilar proliferation during the development of the DG without 
linking it to adult neurogenesis (Nowakowski et al., 1989).  
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During the 90s, BrdU was successfully employed to demonstrate the existence 
of adult neurogenesis in rodents in both the subventricular zone (SVZ) of the LV 
(Corotto et al., 1993) and subgranular zone (SGZ) of the DG (Cameron et al., 1993; 
Kuhn et al., 1996; Seki and Arai, 1993) (Figure I4). More importantly, towards the end 
of the decade Elizabeth Gould et al. published several works using BrdU and showing 
the existence of AHN in treeshrews and old world monkeys (Gould et al., 1997, 1999b, 
1999a) and in the SVZ of macaques (Gould et al., 1999c). This time, the discoveries 
were supported by other authors, including Pasko Rakic and colleagues (Kornack and 
Rakic, 1999, 2001; Pencea et al., 2001), although they reported that AHN in old world 
monkeys was, relatively, ten times lower than in rodent studies (Kornack and Rakic, 
1999). Thus, in spite of the unsettled opinion about the correct usage and interpretation 
of BrdU during the next years (Nowakowski, 2000), almost half a century after Altman’s 
discoveries the concept of adult neurogenesis in the mammalian SVZ and SGZ got 
fully accepted and started to be intensely studied. After 50 years struggling to outweigh 
the heavy power of an already established idea; the “everything may die, nothing may 
be regenerated” dogma was dead (Gross, 2000). 
 
Figure I4. Adult neurogenic niches in the SVZ of the LV wall and SGZ of the hippocampal DG. 
3.3. Adult hippocampal neurogenic cascade 
The discovery of the in vitro neurogenic capabilities of cells residing in the adult 
SVZ and the DG (Palmer et al., 1997; Reynolds and Weiss, 1992; Richards et al., 
1992) rapidly brought discussion over the existence of undifferentiated, multipotent 
stem cells (SCs) (potentially producing neurons, astrocytes and oligodendrocytes) with 
endless or prolonged self-renewing capacity along the entire life of an individual 
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(McKay, 1997; Seaberg and Van Der Kooy, 2003; Watt and Hogan, 2000; Weiss et al., 
1996). SCs are able to divide both symmetrically, producing two cells committed to the 
same fate, or asymmetrically, giving two distinct cell types. The intermediate cell type 
between the SC and the finally differentiated cell is called progenitor. Opposing SC 
properties, progenitors are unipotent and have limited self-renewal capacity. From a 
functional perspective, they serve to amplify the final progeny and allow SCs to keep 
their multipotent nature (Watt and Hogan, 2000; Weiss et al., 1996). 
3.3.1. From neural stem cells (NSCs) to newborn neurons 
In the adult DG, radial glia cells (RGCs) expressing the glial fibrillary acid 
protein (GFAP) (Kosaka and Hama, 1986; Rickmann et al., 1987) were found to be 
capable of dividing, although this proliferating capacity was initially related to 
gliogenesis (Cameron et al., 1993; Kaplan and Bell, 1984). However, years later Arturo 
Alvarez-Buylla and colleagues described for the first time, using BrdU to label and trace 
mitotic cells, that GFAP-positive radial astrocytes acted as SCs and were indeed 
generating newborn neurons in the SGZ of the adult DG (Seri et al., 2001). 
Shortly after, transgenic lines of mice in which NSCs could be labeled based on 
the expression of the specific neuroepithelial SC marker neuroectodermal stem cell 
intermediate marker (Nestin) were developed (Lendahl et al., 1990). These new 
transgenic mice allowed for a detailed characterization of the SGZ radial astrocytes 
that immunostaining alone could not provide. Thus, the neurogenic radial astrocytes 
that represented the first step of the adult neurogenic cascade were called type-1 cells 
(Filippov et al., 2003; Kronenberg et al., 2003). They were defined as those cells 
showing a characteristic morphology, with the soma located in the SGZ and a process 
extending towards the ML that branched once reaching the outer region of the GCL, 
creating a broccoli-like crown (Filippov et al., 2003; Mignone et al., 2004) (Figure I5 A). 
In addition to GFAP and Nestin, they have been described to show expression of other 
markers such as Vimentin, Brain Lipid-Binding Protein (BLBP) and Sex determining 
region Y box 2 (Sox2), as well as to lack expression of the mature astrocyte marker 
S100 (Encinas and Enikolopov, 2008; Filippov et al., 2003; Gould et al., 1992; 
Yamaguchi et al., 2000). These cells have also been referred to as quiescent neural 
progenitors, as at the population level they are mainly quiescent, with only the 2-5% of 
them dividing in a given moment (Encinas et al., 2011a). The term progenitor was also 
preferred because it had been only demonstrated that they gave rise to neurons and 
not other cell type and therefore they did not comply with the definition of SC. 
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Currently, they are generally accepted as bona fide NSCs (and this is the way we will 
refer to them from now on) as they are considered to be multipotent and can self-
renew. Nonetheless, their SC nature is still discussed, as we will later address.  
The mechanisms and dynamics by which NSCs divide have been long 
addressed by the scientific community, aiming to unravel the cell division patterns in 
the adult SGZ. Using inducible lineage tracing combined with BrdU labeling and later 
two-photon in vivo imaging, it has been reported that once activated, NSCs divide an 
average of 3 times (Encinas et al., 2011a; Pilz et al., 2018), giving birth (asymmetrically 
in most occasions) to a copy of themselves and a rounded daughter cell lacking GFAP 
and Vimentin expression (Encinas et al., 2006; Kempermann et al., 2004; Kronenberg 
et al., 2003; Seki et al., 2007). While the fate of this progenitors is neurogenic, 
activated NSCs finally differentiate into astrocytes thereby losing their neurogenic 
capabilities (Encinas et al., 2011a) (Figure I5 B). Depletion of activated NSCs by 
neurogenic symmetric division is also possible (Pilz et al., 2018) and in fact it has been 
suggested using mathematical modeling that the astrocytic differentiation of NSCs 
might not account for all the depletion of the NSC pool (Ziebell et al., 2018). This study 
also supported that the oscillation between quiescence and activation would better 
explain the maintenance and exhaustion of the NSC pool. However the in vivo data by 
(Encinas et al., 2011a; Pilz et al., 2018) support the contrary. Once activated the vast 
majority of NSCs will divide several times consecutively and then exit the NSC pool 
through astrocytic or neurogenic differentiation. Nonetheless, the dynamics of NSC 
activation and depletion can change with age. NSCs could become more quiescent 
overtime and therefore their exhaustion would be slowed down (Kalamakis et al., 2019; 
Martín-Suárez et al., 2019) so that even in the aged brain NSCs, and neurogenesis, 
remain. Different mechanisms are involved in this change of behaviour, ranging from 
the increase in neuroinflammatory modulators (Kalamakis et al., 2019; Martín-Suárez 
et al., 2019) to age-related increase of glucocorticoid receptors by NSCs (Schouten et 
al., 2019). 
In any case, the modulation of the activation of NSCs will determine the level of 
neurogenesis in a given time point but also have consequences in the long term. 
Understanding the mechanisms underlying NSC activation will also be of special 
relevance in those pathological situations in which NSC activation is abnormally 
increased. According to previous findings Achaete-Scute Family BHLH Transcription 
Factor 1 (Ascl1) is essential for the regulation of cell cycle in NSCs, showing a dynamic 
expression along the different cell stages of the hippocampal neurogenic cascade (Kim 
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et al., 2011). The induction of Ascl1 expression when NSCs receive activating signals 
provokes the subsequent entrance into a proliferating state. Moreover, blockage of 
Ascl1 renders NSCs unresponsive to activating stimuli (Andersen et al., 2014) and the 
destabilization of Ascl1 by the E3 ubiquitin ligase Huwe1 provokes the return of NSCs 
to a quiescent state (Urbán et al., 2016). In addition, the level of activated Notch1 plays 
a fundamental role in the NSC choice to remain quiescent or divide. Low levels of 
activated Notch1 promote NSC activation, although the complete ablation of Notch1 
also provokes the transition of NSCs to an intermediate progenitor or neuronal state 
(Breunig et al., 2007a; Guentchev and McKay, 2006). Bone Morphogenetic Proteins 
(BMPs) are also involved in the maintenance of NSCs quiescence, preventing them 
from getting activated and preserving the neurogenic capacity of the niche (Mira et al., 
2010), as well as gamma-aminobutyric acid (GABA), which is also important as a niche 
signal to maintain adult NSCs quiescence (Song et al., 2012). Interestingly, epidermal 
growth factor receptor (EGFR) has been shown to be expressed in activated NSCs 
(Jhaveri et al., 2015; Okano et al., 1996; Walker et al., 2016) and since its ligand 
epidermal growth factor (EGF) can modulate the proliferation of NSCs in the SVZ 
(Craig et al., 1996; Reynolds and Weiss, 1992), it seems logic to conclude that EGFR 
signaling pathway may play a role in the activation of hippocampal NSCs as it will be 
discussed in detail later.  
After NSCs enter mitosis, they give birth to intermediate progenitors known as 
amplifying neural progenitors (ANPs), also called type-2 cells (Filippov et al., 2003), 
that expand themselves through symmetric divisions actively dividing around 2-5 times 
at a population level (Encinas et al., 2011a; Pilz et al., 2018). ANPs, modulated by 
GABA-induced excitatory tonic input (Tozuka et al., 2005), exit cell cycle to differentiate 
into doublecortin (DCX) and polysialic acid neural cell adhesion molecule (PSA-NCAM) 
expressing type-3 NBs. These NBs also start to express markers that will retain as 
mature neurons, such as Prox1 (particular to GCs) and NeuN (Encinas et al., 2006; 
Filippov et al., 2003; Kempermann et al., 2004; Seri et al., 2004). Importantly, around 
two thirds of cells transitioning from ANP to NB undergo apoptosis, being efficiently 
phagocytosed by microglia in a process critical for AHN (Sierra et al., 2010, 2014). The 
surviving newborn neurons undergo several morphological changes during the 
posterior three weeks. They evolve from being a round cell with short processes to a 
multipolar cell with multiple neurites, to finally extend an apical dendrite until it 
branches in the ML and the axon towards CA3 (Seri et al., 2004; Stanfield and Trice, 
1988; Zhao et al., 2006a). Thus, together with the onset of glutamatergic input, new 
INTRODUCTION 




GCs get integrated into the already existing hippocampal circuit (Van Praag et al., 
2002) (Figure I5 B). 
The different steps of the neurogenic cascade have been assessed also at 
transcriptomic level by the use of single cell ribonucleic acid-sequencing (scRNA-seq). 
First, it was described that quiescent NSCs display a different molecular program once 
activated, decreasing their extrinsic signaling capacity and therefore becoming less 
responsive to environmental input (Shin et al., 2015). Further studies showed specific 
molecular changes across the different steps of the neurogenic cascade from 
quiescent NSCs to mature neurons, supporting the transition across each of the 
cellular types previously described (Artegiani et al., 2017; Hochgerner et al., 2018). 
 
 
Figure I5. A) Nestin (green)- and GFAP (red)-expressing NSC with the soma located in the SGZ and the 
process extending towards the ML, where it arborizes forming a broccoli-like crown. B) Hippocampal 
neurogenic cascade. NSCs, with radial morphology, are mostly quiescent, but once activated they divide 
several times consecutively asymmetrically to give rise to ANPs that either die by apoptosis or slowly 
differentiate into mature granule cells (modified from Encinas et al., 2011 and Encinas and Sierra 2012). 
3.3.2. NSCs: SCs? 
As mentioned, the multipotency of the SGZ NSCs remains an opened debate in 
the field. NSCs have been shown to generate both neurons and astrocytes (Bonaguidi 
et al., 2011; Encinas et al., 2011b) and some authors have claimed that they possess 
self-renewing capabilities (Bonaguidi et al., 2011). Moreover, some studies were able 
to artificially induce oligodendrocytes from SGZ neural stem and progenitor cells 
(NSPCs) either by overexpression of Ascl1, Olig2 and Sox10 (Braun et al., 2015) or 
inactivation of Neurofibromin 1 (Sun et al., 2015), being remarkable their functional 
capability to remyelinate cells (Braun et al., 2015). However, this multipotency has 
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been opposed by studies indicating that SGZ NSCs are not able to give 
oligodendrocytes in several different in vitro conditions, and that they only undergo self-
renewal when co-culturing with embryonic tissue, being influenced by developmental 
niche inputs that modulate them (Clarke and Van Der Kooy, 2011; Seaberg and Van 
der Kooy, 2002; Seaberg and Van Der Kooy, 2003). 
Michael Bonaguidi et al. interpreted their results that self-renewal of NSCs took 
place in the DG based on the close proximity of clonally labeled NSCs. By minimal 
sparse labeling of NSCs in inducible Nestin-GFP transgenic mice (labeling initially just 
one or two cells per DG) they concluded that two NSCs located proximal to each other 
could only came from the same precursor cell and therefore that NSCs have the 
capacity to symmetrically divide generating two copies of them. However, since NSC 
show a natural cluster organization (Mineyeva et al., 2018), this conclusion seems to 
be premature and it calls for further research. Even more if we take into account that 
other studies have reported the absence of NSC self-renewal (Encinas et al., 2011a). 
More recently, chronic in vivo imaging has shown that NSCs are capable to 
symmetrically divide and expand themselves, although the majority of divisions are 
asymmetric. Nonetheless, NSCs do not return to quiescence once they get activated 
(Pilz et al., 2018), meaning that the natural progressive depletion cannot be 
counterbalanced by symmetric division of NSCs.  
We understand that the SC nature of SGZ NSCs implies more than a semantic 
issue, significantly affecting the way we investigate and draw conclusions regarding 
these cells. Establishing whether they are life-long SCs or on the contrary a 
differentiated cell type with neurogenic capabilities will be important for addressing 
future investigations from the correct scope. 
3.3.3. Modulating factors of AHN 
The hippocampal neurogenic cascade can be modulated by multitude of 
factors, either augmenting or reducing the generation of newborn neurons. Among the 
stimuli that promotes AHN there are dietary restriction (Lee et al., 2000a), enriched 
environment (Kempermann et al., 1998; Nilsson et al., 1999), hippocampal-dependent 
learning-tasks (Gould et al., 1999a; Lemaire et al., 2000), physical exercise (Hodge et 
al., 2008; Kronenberg et al., 2003; Van Praag et al., 1999), Fluoxetine (Encinas et al., 
2006) and deep brain stimulation (Encinas et al., 2011b). Also, any stimulus causing 
neuronal hyperactivity will lead to an increase in cell proliferation and neurogenesis 
(Deisseroth et al., 2004). Normally, the increase in AHN happens by an effect upon 
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ANPs, thereby preserving quiescent NSCs intact and the neurogenic reservoir 
conserved.  
On the contrary, several drugs (alcohol, nicotine, opiates) have been associated 
with decrease in AHN. Likewise, stressful experiences have been reported to reduce 
AHN as well (Gould et al., 1998, 1999b; Tanapat et al., 2013), relating this effect to the 
release of glucocorticoids in response to stressors (Gould and Gross, 2002). However, 
one of the most studied phenomenon provoking a decrease in AHN is the age itself 
(Altman and Das, 1965; Barker et al., 2005; Beccari et al., 2017; Encinas et al., 2011a; 
Kalamakis et al., 2019; Kempermann et al., 1998; Seki and Arai, 1995) (Figure I6). As 
it was previously mentioned, once activated NSCs divide and end up losing their 
neurogenic capabilities by ultimately differentiating into astrocytes or neurogenic 
progenitors. Taking into account that the proportion of active NSCs remains constant 
over time, the continuous and exponential depletion of NSCs is the main driving force 
underlying the age-related decline in AHN (Encinas and Sierra, 2012; Encinas et al., 
2011a). Despite the potential NSC ability to self-renew, previously discussed, it is not 
enough to overcome the NSC loss at a population level (Bonaguidi et al., 2011; 
Encinas et al., 2011a; Pilz et al., 2018). Altogether, these dynamics suggest the 
importance of the initial number of NSCs, as they will determine the total hippocampal 
neurogenic output in the life of an individual. It is therefore crucial to shed light upon a 
fundamental question that has been intriguing the field during several decades. When 
and how are adult hippocampal NSCs generated? 
 
 
 Previous page. Figure I6. Depletion of NSC population with age. A) Young DG full of NSCs along the 
SGZ. B) Elderly DG in which there are only few remaining NSCs. C-D) Close confocal pictures of the GCL 
of young (C) and old (D) mice (taken from Encinas et al., 2011). 
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3.4. Adult hippocampal neurogenic niche: Development in rodents 
3.4.1. Cortical hem (CH): First steps towards the HPF 
During telencephalon development, the dorsal midline region invaginates at 
embryonic day 8.5 (E8.5) to give rise to paired telencephalic vesicles. Concomitantly, 
the dorsal telencephalon is subdivided along the medial-lateral axis into three regions. 
The most lateral region, called cortical neuroepithelium forms the cerebral cortex. The 
medial tissue becomes reorganized and subdivided into the most medial part, the 
choroid plexus epithelium and a longitudinal strip of neuroepithelium generated in the 
intermediate part, termed the CH by Elizabeth Grove and colleagues. The medial 
location of the CH is defined by its rich expression of proteins from the two main 
superfamilies related to axis generation and SC proliferation during embryonic 
development: The protein families of Wingless-related integration site (Wnt) and 
transforming growth factor ß (Tgfß), to which BMPs belong. Hence, CH is a 
fundamental region to provide patterning cues to the adjacent developing HPF (Furuta 
et al., 1997; Grove et al., 1998) (Figure I7). 
 
Figure I7. A-B) At E9, the roof plate starts to invaginate in response to Wnt and BMP signalization (Furuta 
et al., 1997; Grove et al., 1998). C) At E11, the different regions of the medial telencephalon are already 
observable, including the CH (modified from Grove et al., 1998). 
The instrumental role of the CH on normal hippocampal development was 
proven by studies using different mutant mice for the Wnt signaling pathway, in which 
HPF failed to normally develop (Galceran et al., 2000; Lee et al., 2000c; Zhou et al., 
2004). Moreover, in another study where the CH was completely ablated basing on the 
Wnt3a and empty spiracles homeobox 1 (Emx1) co-expression (restricted to CH in the 
telencephalon), the HPF was also absent at mid gestation. These results showed that 
the CH comprises the first step in the HPF development (Yoshida et al., 2006). 
Moreover, the activation of Wnt signaling outside the prospective HPF, as in the 
cortical neuroepithelium, causes the appearance of hippocampal phenotypes in 
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neocortical territory, with upregulated subset of hippocampal markers (Machon et al., 
2007). 
BMP has also been reported to be a critical regulator of CH activity working as a 
suppressor of different Wnt-inhibiting signals such as fibroblast growth factor 8 (Fgf8) 
or LIM homeobox 2 (Lhx2), and therefore conserving the CH identity (Monuki et al., 
2001; Shimogori et al., 2004). In fact, Lhx2 expression is restricted to the cortical 
neuroepithelium cells, and not CH. In its absence, the CH expands at the expense of 
the cortical neuroepithelium, causing detailed hippocampal field specification in the 
neocortex (Bulchand et al., 2001; Mangale et al., 2008). Similar effects were described 
in the absence of forkhead box G1 (Foxg1), where mice showed an expanded CH 
(Muzio and Mallamaci, 2005). These findings strongly support the role of the CH as 
hippocampal organizer. 
The CH is also a source for Cajal-Retzius (CR) cells that migrate to cortical 
regions to form a neuronal layer critical for the laminar organization of the neocortex 
(García-Moreno et al., 2007; Takiguchi-Hayashi et al., 2004; Yoshida et al., 2006; Zhao 
et al., 2006b). Interestingly, CR cells were described to be present in the HPF and 
more specifically in the prospective ML of the developing DG (Del Río et al., 1995; 
Soriano et al., 1994). From this strategic location, they orchestrate the development of 
the DG via reelin (Brunne et al., 2014; Förster et al., 2002; Frotscher et al., 2003; Sibbe 
et al., 2009; Stanfield and Cowan, 1979; Wang et al., 2018; Zhao et al., 2004), p73 
(Meyer et al., 2004) and stromal cell-derived factor 1 (SDF1) (Berger et al., 2006; Li et 
al., 2009) and also play a role in hippocampal synaptogenesis (Borrell et al., 1999; Del 
Rio et al., 1997; Del Río et al., 1996) 
3.4.2. Building the DG 
Several authors, including Joseph Altman himself, performed pioneering studies 
to describe the development of the DG. It was described how neurons travel from the 
LV wall into the DG following a migration route along the fimbria. However, it was under 
debate whether those migrating neurons divided or not along the way (Altman and Das, 
1965, 1966, 1966; Schlessinger et al., 1975; Stanfield and Cowan, 1979). It was not 
until the early 90s that Joseph Altman and Shirley Bayer described thoroughly the 
origin, migration and settling of the principal cells comprising the HPF, with special 
emphasis on the DG (Altman and Bayer, 1990a, 1990b). Thus, they established the 
basis for future research on the topic. 
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Dorsal to the CH, the ventricular region gets defined by two morphogenetically 
distinct components. The dentate neuroepithelium (DNe) originates from a ventricular 
indentation called the dentate notch. Here is where the first progenitor pool that will 
generate GCs arises, also known as the primary dentate matrix (Altman and Bayer, 
1990c; Nakahira and Yuasa, 2005; Seki et al., 2014). Following the ventricle dorsally, 
the ammonic neuroepithelium will give rise to the pyramidal neurons of CA in a process 
that will end before birth. Also, the CH will develop into the fimbrial glioepithelium, 
giving rise to glial cells of the fimbria. Together, these three structures form the 
hippocampal neuroepithelium (HNe) from which the majority of HPF arises (Altman and 
Bayer, 1990c) (Figure I8). 
 
Figure I8. The three different regions of the HNe as were first described by Joseph Altman: Ammonic 
neuroepithelium, DNe and fimbrial neuroepithelium (modified from Altman and Bayer 1990). ah: Ammonic 
neuroepithelium. AHm: Ammonic migration. dgp: primary dentate neuroepithelium. DH: Dentate hilus cells. 
dn: Dentate notch. fg: fimbrial glioepithelium. SU: Subiculum. su: Subicular neuroepithelium. 
From the ventricular zone (VZ) of the DNe developmental NSCs (dNSCs) exit 
the contact with the ventricle, forming a migration route along the subpial region 
towards the prospective DG known as dentate migratory stream (DMS). These dNSCs 
constitute the secondary dentate matrix (Altman and Bayer, 1990a; Hodge et al., 2013; 
Li et al., 2009; Nakahira and Yuasa, 2005; Seki et al., 2014) (Figure I9 A-B). They 
proliferate all the way until they reach the HF. Once there, they form a transient 
neurogenic niche that will generate the first GCs. These primitive neurons will allocate 
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in the outer layer of the GCL comprising the skeleton of the structure (Hodge et al., 
2013; Li et al., 2009; Seki et al., 2014). 
Around birth, a second migration route takes place, where dNSCs exit the 
subpial region at the fimbrio-dentate junction (FDJ) level to enter the hilus and form the 
so-called tertiary dentate matrix (Figure I9 C-D). As the secondary dentate matrix gets 
depleted, this new dNSC pool will give rise to the neurons that will build the GCL from 
superficial (outer) to deeper (inner) layers (Altman and Bayer, 1990a; Hodge et al., 
2013; Nakahira and Yuasa, 2005; Namba et al., 2005, 2007, 2011; Seki et al., 2014; 
Sugiyama et al., 2013). Still, the role of the secondary matrix during the early postnatal 
period remains under debate. It is not clear whether it remains active giving birth to 
GCs or on the contrary acts as a mere source from which tertiary matrix dNSCs arise. 
As a final step in the GCL formation, it has been reported that immature 
neurons migrate tangentially from the tertiary matrix to find their right position into the 
GCL (Namba et al., 2007, 2019). However, the main mechanism by which they reach 
the GCL is radial migration (Nakahira and Yuasa, 2005; Namba et al., 2019), guided by 
elongated RGCs that describe the path for the migrating cells. As the postnatal 
development proceeds, the tertiary matrix disappears from the hilus, and a layer of 
neuronal precursors gets restricted to the SGZ under the GCL, being responsible for 
neurogenesis throughout the adulthood (Altman and Bayer, 1990a; Hodge et al., 2013; 
Li et al., 2009; Namba et al., 2005; Nicola et al., 2015; Seki et al., 2014; Sugiyama et 
al., 2013).  
 
Figure I9. A-D) Temporal evolution of the different progenitor matrixes that form the DG. The primary 
matrix (in blue) arises from the DNe and gives rise to the secondary matrix (in green) that extends along 
the fimbria and connects to the DG, forming the DMS. Inside the DG, the tertiary matrix (in yellow) of 
progenitors ends the formation of the DG postnatally (modified from Sugiyama et al. 2013). 
Thus, while the majority of neurons that form the HPF are generated during 
embryonic gestation, the vast majority of the GCL neurons are born after birth 
(Angevine, 1965; Bayer, 1980; Bayer and Altman, 1974). Postnatal neurogenesis 
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follows a sharp peak early after birth and then it drops off later by the second week 
(Bayer and Altman, 1974), being crucial for the formation of the initial connections 
between MFs and CA3 neurons (Amaral and Dent, 1981; Gaarskjaer, 1985). 
Interestingly, the sequence of neuron formation in the GCL is unique and contrary to 
any other cortical area or layer, following three distinct morphogenetic gradients. First, 
neurons populate the GCL in an “outside-in” pattern where the superficial neurons are 
formed earlier than the deeper ones (Angevine, 1965; Schlessinger et al., 1975). 
Second, GCs at the tip of suprapyramidal layer of the GCL are the first ones to get 
generated, following a dorsal to ventral gradient in the generation of the GCL. Finally, 
caudal (or temporal) regions are formed earlier than rostral (or septal) ones (Bayer, 
1980; Schlessinger et al., 1975).  
The neuronal migration described during the DG development, with progenitor 
pools forming different germinal matrixes fixes spatio-temporally with the formation of 
glial scaffolds described by Cowan and colleagues (Rickmann et al., 1987). They and 
others described how a primary RGC scaffold arise from the DNe to the subpial zone 
(SPZ) and contact the HF invagination point earlier than the first GCs start to migrate. 
This serves as a tangential migration scaffold for the dNSCs that form the secondary 
germinal matrix after detaching from the neuroepithelium (Nakahira and Yuasa, 2005; 
Rickmann et al., 1987; Sievers et al., 1992). 
Together with neuronal precursors, glial precursors migrate from the VZ along 
the DMS, giving rise to the secondary RGC scaffold that appears fanning out in the 
hilus from the FDJ, extending towards the GCL in a suprapyramidal to infrapyramidal 
pattern (Yuasa, 2001). This allows new GCs of the tertiary matrix to reach the GCL. 
Interestingly, it has been suggested a mechanism whereby RGC fibers get 
“unattractive” while they get old, explaining the suprapyramidal to infrapyramidal 
formation pattern of the GCL and why neurons follow secondary rather than primary 
RGC scaffold postnatally (Eckenhoff and Rakic, 1984; Rickmann et al., 1987; Sievers 
et al., 1992). 
3.4.3. Origin of adult NSCs 
In the rodent SVZ neurogenic niche, adult NSCs are originated from neuronal 
precursors during the early development. Around E14 RGCs proliferate generating 
glutamatergic neurons that allocate in cortical, septal and striatal regions. RGCs enter 
quiescence after several divisions, acquiring a dormant state until they get re-activated 
at postnatal or adult stages when they give rise to GABAergic OB neurons. Arturo 
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Alvarez-Buylla et al. named this process the “set-aside” model in which embryonic 
progenitors stop their cell cycle and activate again after a long period generating a 
completely different type of neuron (Fuentealba et al., 2015; Furutachi et al., 2015). 
Despite the considerable advances done on the origin of SVZ adult NSCs, this same 
topic remains one of the most intriguing unresolved aspects of DG development. 
3.4.3.1. Embryonic origin of NSCs 
The DG comprises a neurogenic niche with a remarkable difference compared 
to the SVZ. It is located far from the ventricle. In fact, the adult SGZ of the DG remains 
completely dissociated from its embryonic germinative zone (Altman and Bayer, 
1990a). When the DG development started to be described, it was published that adult 
hippocampal NSCs were generated from precursors residing in the DNe during 
development, either by direct translocation (Eckenhoff and Rakic, 1984) or indirectly 
following the above described DG-forming migration processes (Altman and Bayer, 
1990a) until they end up located in the SGZ of the DG postnatally (Nicola et al., 2015; 
Sugiyama et al., 2013). Thus, it has been the generally accepted view in the field, as 
stated by Gage and collaborators (Gonçalves et al., 2016), that adult NSCs and 
neurogenesis are a remnant from the embryonic development of the HPF. 
Supporting this view, it has been described how GFAP is expressed by spindle-
shaped neuronal precursors along the different germinal matrixes that form the DG 
during embryonic and postnatal development. Thus, it was suggested that these 
astrocyte-like cells migrate from the DNe to the SGZ, comprising the precursor 
population that generates GCs throughout the whole life (Matsue et al., 2018; Seki et 
al., 2014). However, BLBP has been referred as a differential factor between prenatal 
and postnatal dNSCs. After birth, neuronal precursors acquire BLBP expression before 
getting established in the SGZ (Matsue et al., 2018; Nicola et al., 2015; Seki et al., 
2014). This finding could mean either that migrating dNSCs acquire new characteristics 
before getting established in the SGZ, or on the contrary that a new subpopulation of 
NSCs arises from the embryonic dNSCs postnatally. 
Further studies have identified the putative dNSCs migrating from DNe to SGZ 
using other markers and transgenic mouse models: Nestin, the intermediate precursor 
marker eomesodermin, also known as T-box brain protein 2 (Tbr2) (Hodge et al., 2008, 
2012) and neurogenin-2 (Ngn2) have been described to label neuronal precursors 
across all the dentate germinal matrixes (Galichet et al., 2008; Hodge et al., 2013; Li et 
al., 2009). In this line, Samuel Pleasure and colleagues suggested that some of them 
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migrate from the DNe, maintaining their undifferentiated state due to neurogenic 
inhibiting signals, until they reach the SGZ at postnatal stages and remain there during 
adulthood (Pleasure et al., 2000a). Moreover, they described that dNSCs dwell in a 
transient neurogenic zone located in the SPZ between the HF and the FDJ for at least 
one week before establishing in the SGZ (Li et al., 2009) (Figure I10). In the absence 
of Ngn2 (Galichet et al., 2008) reelin or chemokine ligand 12/chemokine receptor 4 
(Cxcl12/Cxcr4) signaling (Brunne et al., 2014; Hodge et al., 2013; Li et al., 2009) the 
SPZ to SGZ NSC transition was not completed, triggering an excessive accumulation 
of precursors in the subpial region and the absence of adult NSC pool. Also, using a 
knock-out mouse model for Tbr2 it was shown that its expression in CR cells is 
necessary for their establishment surrounding the outer edge of the forming GCL. From 
this strategic location, Tbr2-positive CR cells contribute to the RGC scaffold 
establishment, dNSC guidance and adult NSC pool generation (Hodge et al., 2013) 
(Figure I10). 
 
Figure I10. A-C) Guided by CR cells located in the SPZ along the HF, the precursors of adult NSCs 
migrate from the DNe into the DG until they allocate along the SGZ forming the adult NSC population 
(modified from Hodge et al., 2013). 
Homeodomain protein box (Hopx) is expressed in DG adult NSCs (Shin et al., 
2015) and distinguishes them from SVZ NSCs. Also, a role for Hopx in the regulation of 
AHN was suggested through interaction with Notch signaling (Li et al., 2015). Recently, 
Daniel Berg et al. reported that Hopx-positive dNSCs migrate from the DNe to the SGZ, 
contributing to the formation of the DG throughout the embryonic and postnatal 
development to later become quiescent and constitute the adult NSC population. More 
importantly, they claimed that Hopx-positive progenitors generate GCs exclusively, 
highlighting their specificity and bias to this particular neuronal lineage. Basing on 
these results, they supported the notion that AHN is the lifelong extension of the 
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embryonic and postnatal development, defending a “continuous” model in which Hopx-
positive NSCs give GCs throughout the whole life, from development to adulthood 
(Berg et al., 2019). 
Regarding the spatial origin of the adult NSCs, the work of Samuel Pleasure 
and colleagues reporting a new temporo-septal progenitor migratory stream came as a 
challenging idea to the field. They described that adult NSC precursors migrate from 
the VZ close to the ventral DG towards the dorsal DG at embryonic and perinatal 
stages, getting established in the SGZ postnatally. They migrate in a sonic hedgehog 
(Shh)-reponsive manner, as indicated by the impaired formation of adult NSC pool in 
the absence (or defects in regulators) of this signaling pathway (Li et al., 2013). Shh is 
a well known member of the hedhehog (Hh) family and it has been shown to be highly 
implicated in the growth and development of the neocortex promoting RGC and 
progenitor expansion, but the work of Samuel Pleasure and colleagues brought the 
signaling pathway into the focus of hippocampal development. In fact, they opposed 
the general view of the field and suggested that DNe progenitors contribute only to the 
formation of the outer GCL shell, the initial one, while the inner shell and adult NSC 
population originate from dNSCs migrating from the ventral DG in a Shh-reponsive 
way. They propose a model in which both streams connect perinatally in the FDJ of the 
DG, opening the possibility for different spatial origins for adult NSCs (Li et al., 2013). 
3.4.3.2. Postnatal proliferation: generating adult NSCs 
Regardless of their embryonic origin, postnatal proliferation has been 
demonstrated to be critical for the formation of the adult NSC pool in the DG. Using 
BrdU it was reported that although some dNSCs divide embryonically and then enter 
quiescence until adulthood, the majority of them divide at early postnatal stages before 
acquiring adult characteristics between P7-P14 (Mathews et al., 2010). Furthermore, 
using dual birth-dating methods it was reported that adult NSC precursors have a 
proliferation peak towards the end of the first postnatal week, suggesting that this time 
is a key period for the generation of adult NSCs (Ortega-Martínez and Trejo, 2015). 
Indeed, it was described that in rats, adult NSCs arise from dividing non-radial 
precursors located in the hilus at postnatal day 5 (P5) (Brunne et al., 2010; Namba et 
al., 2005, 2011). Using intrahippocampal retroviral infections, Takashi Namba and 
colleagues defined that hilar GFAP-expressing dNSCs generate neurons, astrocytes 
and also adult NSCs dividing in symmetric and asymmetric patterns (Namba et al., 
2005, 2011). Complementing the previous studies, it was also reported using retroviral 
infections that dividing dNSCs from the hippocampal VZ, the postnatal region derived 
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from the DNe, contribute to the formation of the DG with neurons, astrocytes and also 
adult NSCs at P5 (Navarro-Quiroga et al., 2006). However, this result was controversial 
since other authors described that the postnatal hippocampal VZ does not contribute to 
the adult NSC population, and instead adult NSC precursors migrate from the DNe into 
the hilus during the embryonic period (Clarke and Van Der Kooy, 2011). Also, a recent 
report described that during early postnatal stages, adult NSC precursors divide to 
expand themselves in a Shh-depending way before becoming quiescent to form the 
adult NSC pool (Noguchi et al., 2019). Together, these results suggest that blocking 
proliferation at early postnatal stages would signify the loss of adult NSC population, 
directly acting on their generation window. 
However, several studies have reported reversible effects upon GC production 
after proliferation blocking insults during the postnatal period, such as low irradiation 
(although the obtained results could be biased by the proneurogenic physical activity to 
which the treated animals are subjected) (Naylor et al., 2008), administration of the cell 
proliferation suppresser methylazoxymethanol (MAM) (Ciaroni et al., 2002) or an 
induced transitory hypothyroidism model (Zhang et al., 2009). These results showed 
postnatal reduction of GC production, but AHN was not impaired at long-term, 
suggesting that a unique or transitory proliferation blockage is not enough to affect the 
adult NSC pool generation and long-term neurogenic capacity. On the other hand, a 
recent study suggested that pharmacogenetic ablation of proliferating GFAP-
expressing cells during the first postnatal week has devastating effects upon adult 
NSC. Incapable to divide, dNSCs do not fully form the adult NSC population, provoking 
the lack of neurogenic capacity during adulthood. Interestingly, when proliferating 
GFAP-positive cells were ablated during the third postnatal week there was no effect 
over the number of adult NSCs, although they became less neurogenic both at short- 
and long-term (Youssef et al., 2019). The authors argued that progenitors are more 
proliferative at P0-P7 than at P14-P21 and therefore the effect on ablated progenitors 
is stronger during that period. However, they might be affecting different populations in 
their two paradigms (dNSCs vs adult NSCs), which would explain their differential 
outcomes. Besides, they do not provide any spatial resolution about the progenitors 
they are affecting. Nonetheless, this work provides basis for the need of a sustained 
proliferation blockage during postnatal development to significantly impact on the adult 
NSC generation, leading us to hypothesize that they might be generated in a gradual 
way. 
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3.4.3.3. Dividing mechanisms of adult NSC precursors: Cyclin D2 (cD2) 
The mechanisms by which dNSCs divide and give birth to adult NSCs remain 
unknown. It has been previously suggested that Shh signaling pathway is involved in 
the postnatal proliferation of precursors that will form the DG as well as the adult NSC 
pool. Smoothened (Smo) and Supressor of Fused (SuFu) regulate Shh activity 
controlling dNSC proliferation. Deregulation of this signaling pathway leads to a 
premature entrance into quiescence of the dNSCs, failing to expand and triggering a 
reduced adult NSC pool and a smaller GCL (Han et al., 2008; Noguchi et al., 2019). 
Other factors such as GABA or BMP have been explored as quiescence regulators in 
the adult mouse brain, whereas their role upon postnatal proliferation remains 
unexplored (Mira et al., 2010; Song et al., 2012). 
The D-type cyclins (D1, D2 and D3) govern the G1 to S phase transition of the 
mammalian cell cycle, a step largely involved in controlling cell proliferation and 
differentiation (Figure I11). Specifically, D-type cyclin activation is the first response 
after a cell receives mitogenic stimulus to leave quiescent state, triggering the 
activation of cyclin-dependent kinase 4 and 6 (CDK4 and CDK6) (Pardee, 1989). 
Interestingly, D-type cyclins have been described to be quite redundant and highly 
compensatory. Thus, mice lacking one of the three show normal embryogenesis, 
although there are specific phenotypes associated to older ages (Ekholm and Reed, 
2000; Sherr, 1995; Sherr and Roberts, 2004). In fact, even the lack of all D-type cyclins 
was described to be irrelevant for mouse embryogenesis up to E16.5, meaning that 
embryonic cell cycle progression happens, or can happen, in a cyclin D-independent 
way (Kozar et al., 2004). 
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Figure I11. The role of the different cyclins in the regulation of the different phases of cell cycle. Cyclin D1, 
D2 and D3 in combination with CDK4 and CDK6 regulate the transition from G1 to S phase (Modified from 
van den Heuvel, 2005). 
In the mammalian brain, cD2 has been shown to be involved in the correct 
development of the cerebellum. In its absence, reduced proliferation and increased 
apoptosis processes trigger a diminished GC and interneuron population by the second 
postnatal week (Huard et al., 1999). Likewise, the neocortex shows aberrant 
development in cD2 knock-out mice (cD2KO), showing lengthening of G1 phase, 
shortening of S phase and premature cell cycle-exit of the embryonic progenitors, 
triggering their early differentiation into neurons (Glickstein et al., 2007a, 2009). 
Likewise, cD2 was described to pay a role in the apical progenitor maintenance during 
neocortex development. After asymmetric divisions, cD2 would be inherited by one of 
the daughter cells thereby keeping the apical progenitor fate (Tsunekawa et al., 2012). 
In addition, posterior work showed that cD2 activity during neocortex development is at 
least in part regulated by Smo, critical regulator of the Shh pathway. In Smo absence, 
cD2 is down-regulated leading to progenitor expansion failure and neocortical 
development defects (Komada et al., 2013). Together, these results highlight the role of 
cD2 to maintain the undifferentiated state and guide the expansion of progenitors 
during neocortex development and open the possibility for similar regulation 
mechanisms in the DG. 
INTRODUCTION 




In the developing DG, cD2 appears expressed especially along the DMS and 
around the HF, while cD1 shows stronger expression in the secondary and tertiary 
germinal matrixes. Postnatally, both cD1 and cD2 show expression in the tertiary 
matrix, getting restricted to the SGZ with DG maturation (Glickstein et al., 2007b). 
Interestingly, at early postnatal stages cD2KO transgenic mice show similar levels of 
proliferating cells in the DG than WT animals (Kowalczyk et al., 2004). However, and 
despite the expression of cD1 in the SGZ (Glickstein et al., 2007b), AHN has been 
reported to be almost absent in the cD2 deficient mice (Ansorg et al., 2012; Kowalczyk 
et al., 2004) (Figure I12). It remains unresolved whether this lack of neurogenic 
capacity is due to the inability of adult NSCs to generate newborn neurons or on the 
contrary, consequence of a developmental failure in the postnatal expansion of dNSCs 
and posterior generation of adult NSC pool. 
 
Figure I12. In the absence of cD2, proliferation in the DG starts to decay during the first postnatal two 
weeks, and AHN is absent at P28 (modified from Ansorg et al. 2012). Dots show dividing cells that have 
incorporated BrdU. 
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3.4.3.4. Adult NSCs vs dNSCs 
Shedding light upon the origin of adult DG NSCs will help to solve one of the 
main questions remaining in the field: Is AHN a remnant from the developmental 
neurogenesis forming the DG or is it an independent process built as a unique 
biological phenomenon? Addressing this question could be essential to understand the 
functions of the AHN and its role in several normal and pathological conditions. 
The postnatal appearance of a new structure away from the ventricle and 
capable to persist giving newborn neurons during the whole life have led some authors 
to pinpoint the principal differences between the developmental and adult neurogenesis 
(Nicola et al., 2015). However, since the SGZ is the endpoint of the whole plethora of 
developmental processes and structures to form the DG, it is the current accepted view 
in the field that AHN is the last remaining step in the formation of the DG. In other 
words, a continuation of the developmental neurogenesis program (Berg et al., 2019; 
Matsue et al., 2018; Nicola et al., 2015; Seki et al., 2014). 
A recent work using powerful technology as scRNA-seq described that the 
neurogenic process follows similar paths both in adult and developmental scenarios. In 
other words, ANPs, NBs and immature neurons are molecularly highly similar at 
embryonic, perinatal and adult stages (Hochgerner et al., 2018). These results have 
been used to support the idea of AHN being a remnant from development (Berg et al., 
2019). However, Sten Linnarson and colleagues also identified a switch in the 
molecular properties of the NSCs from embryonic to postnatal/adult age. They 
described that coinciding with NSCs getting established in the SGZ, they undergo 
molecular changes (higher quiescence and switch on marker expression) becoming 
clearly distinguishable from dNSCs (Hochgerner et al., 2018). Supporting this, Jennifer 
Gilley et al. found cell-autonomous changes from early postnatal to young/adult mice, 
observing different transcriptional profiles between both ages (Gilley et al., 2011). 
Altogether, these results lead us to think about adult and developmental neurogenesis 
being different processes, at least at NSC level. 
The main issue when addressing the dNSC transition from developmental to 
adult is the lack of valid specific markers to differentiate both populations. Several 
works have shown that BLBP expression switches from embryonic to postnatal stages, 
where progenitors start to express it (Matsue et al., 2018; Nicola et al., 2015; Seki et 
al., 2014), although the differential expression between early postnatal dNSCs and 
adult NSCs remains unclear. Sten Linnarson et al. showed in their scRNA-seq data 
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that some markers were specific among quiescent NSCs compared to the active ones 
(Hochgerner et al., 2018). As quiescence has been described to be a hallmark of adult 
NSCs, we hypothesize that these markers could be differentiating adult NSCs from 
developmental precursors. Interestingly, Lysophosphatidic acid receptor 1 (LPA1) was 
one of those markers (Hochgerner et al., 2018), which has been reported to specifically 
label NSCs in the adult DG using the LPA1-Enhanced green fluorescent protein (EGFP) 
mouse model (Valcárcel-Martín et al., 2020; Walker et al., 2016) (Figure I13). Although 
its role in adult NSC function remains mostly unknown, LPA1 deletion has been shown 
to reduce AHN in normal conditions (Matas-Rico et al., 2008) and the massive 
activation of NSCs after seizures (Valcárcel-Martín et al., 2020). Furthermore, during 
embryonic development, LPA1 has been involved in cortical neural progenitor 
proliferation, cell migration and survival (Estivill-Torrús et al., 2008). For all these 
reasons, LPA1 seems to be a good candidate to specifically label NSCs ones they 
acquire quiescence at a population level and become adult. 
 
Figure I13. A) Using the LPA1-EGFP transgenic mouse model, LPA1 expression can be observed both in 
the SVZ of the LV and in the DG. B-C) LPA1 specifically labels NSCs in the adult DG, both in the absence 
(B) and presence of an anti-GFP antibody (modified from Walker et al. 2015). 
3.5. The hippocampal neurogenic niche in humans 
Animal models, including rodents, represent a well-known system to address 
the formation and development of the HPF during the entire (animal) life. However, 
what happens in humans? With the objective to translate all the information from rodent 
models into our knowledge about our own brain, it is fundamental to search for the 
similarities and differences that both share. One of the major differences of the HPF 
between rodents and higher mammals, worth to bear in mind when comparing both 
systems, resides in its spatial location. In contrast to rodents, the human HPF develops 
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along the ventral midline of the hemisphere (Abraham et al., 2004; Kier et al., 1997; 
Strange et al., 2014; West, 1990) (Figure I14). Dorsally, the prospective HPF fades at 
early prenatal stages due to the emergence and progressive growth of the corpus 
callosum, remaining in the adulthood as an atrophic remnant called the induseum 
griseum (Meyer et al., 2019; Rakic and Yakovlev, 1968). Thus, the vHPF is the one 
that develops into the well-known functional structure of the adult brain (Abraham et al., 
2004; Kier et al., 1997; Meyer et al., 2019). However, the different stages in the 
development of the human HPF remain largely unexplored. 
 
Figure I14. Picture of the human HPF after the removal of the overlaying cortex. It is observable (coloured 
in gray in the schematic of the right) that the HPF is more prominent in the ventromedial position (modified 
from West, 1990). 
3.5.1. Development of the human hippocampal neurogenic niche 
The CH serves as embryonic signaling center for the formation of rodent HPF 
and it is defined by the expression of Bmp and Wnt family proteins (Grove et al., 1998; 
Lee et al., 2000c). Likewise, a CH-like structure was identified during early 
development of human fetuses by the overlapping expression of Bmp7 and Wnt2b in a 
dorsal region close to the ventricle, suggesting that the major patterning cues seen in 
rodents were conserved also in humans (Abu-Khaklil et al., 2004). Later on, this 
structure was also ventrally observed, and it was described to be the source of CR 
cells that will help in the formation of the primary ammonic and dentate structures 
(Abraham et al., 2004). Importantly, this ventral CH has not been identified in rodents 
(where it exists only dorsally), suggesting the uniqueness and relevance of this 
structure in humans compared to mammals with more prominent dHPF (Abraham et 
al., 2004). 
One of the most important events of the early human hippocampal development 
is the appearance of a slight inward curve in the ventromedial region around 
gestational week 11/12 (GW11/12) that will represent the HF. At this stage, ammonic 
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and subiculum plates already express layer specific markers and the EC is also 
discernible (Cipriani et al., 2016; Humphrey, 1967; Meyer et al., 2019). At GW13/14, 
the wide-opened prospective HF thickens to form a “diffuse zone” (Humphrey, 1967) 
mainly populated by CR cells coming from the CH (Abraham et al., 2004). At this stage, 
the unfolded HPF surrounds the HF, formed by now clearly discernible 
cytoarchitectonic regions and a distinguished cell layer of pyramidal neurons forming 
the primordial CA (Arnold and Trojanowski, 1996; Kier et al., 1997). During the 
following weeks, the DG and CA fold into the temporal lobe (Kier et al., 1997) and the 
two structures and subiculum approximate each other across the HF, that gets fused 
(Humphrey, 1967; Kier et al., 1997) (Figure I15). At GW16 CA fields start to clearly 
differentiate from each other (Kier et al., 1997; Kostović et al., 1989) and by GW24 the 
HPF already resembles the adult structure (Arnold and Trojanowski, 1996; Humphrey, 
1967; Kier et al., 1997; Seress et al., 2001) and has established both septal (fimbria-
fornix) and entorhinal (PP) synaptic connections (Kostović, 1986; Kostović et al., 1989). 
 
Figure I15. At early fetal stages (GW11/12), the HPF starts to fold from the region between DG and CA 
(large arrow) and the HF is generated (small arrow) at GW13/14. Later, at GW18, the HF gets obliterated 
and the HPF adopts the form that will maintain during the adulthood (modified from Kier et al., 1997). 
The DG follows unique and differentiated patterns from the rest of the HPF. At 
GW9, proliferating progenitors form the primary dentate matrix next to the CH, although 
the distinction between the ammonic neuroepithelium and the DNe has not been 
clearly established yet at this early time point. Around GW11/12, a non-proliferative 
neuronal layer appears in the prospective DG, so-called the “dentate plate” (Abraham 
et al., 2004; Cipriani et al., 2017). Interestingly, although the dentate plate has been 
demonstrated in the developing HPF of monkeys (Eckenhoff and Rakic, 1984) it has 
never been described in rodents. Then, Vimentin- and Nestin-positive RGC fibers from 
the primary dentate matrix extend into the SPZ below the HF, crossing the forming 
GCL and contacting the dentate plate. Thus, the primary glial scaffold gets established, 
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coinciding with the appearance of the secondary dentate matrix adjacent to the DNe, 
composed of Pax6- and Tbr2-expressing proliferative progenitors. At GW13/14, the 
secondary dentate matrix progenitors start to migrate and form the DMS. Proliferating 
cells extend from the DNe towards the SPZ and populate the hilus of the prospective 
DG (Abraham et al., 2004; Cipriani et al., 2017, 2018; Seress et al., 2001; Sorrells et 
al., 2018). At this stage, the DG reaches the peak of neurogenesis (Yang et al., 2014). 
Later at GW17/18 a more condensed GCL starts to be distinguishable and the tertiary 
dentate matrix gets formed in the hilar region of the DG. By GW22, proliferation 
disappears from the DNe and DMS and is almost entirely restricted to the hilus 
(Sorrells et al., 2018). 
Like in rodents, human DG is the last hippocampal region to get formed and 
GCs are added to the GCL from GW30 on and at least until early after birth (Arnold and 
Trojanowski, 1996; Humphrey, 1967; Seress et al., 2001), with remaining Nestin-
expressing cells populating the hilus and GCL (Cipriani et al., 2018; Sorrells et al., 
2018) and the last waves of NB migration to the GCL taking place during the first 
postnatal eight months (Seress, 1988; Seress et al., 1992). Nonetheless, the formation 
of GCL is considered to be practically completed by mid-gestation and cell proliferation 
occurring during the second half of gestation and at postnatal stages is not especially 
prominent (Arnold and Trojanowski, 1996; Humphrey, 1967; Seress et al., 2001; 
Sorrells et al., 2018). The existence of a postnatal neurogenic niche has always 
attracted scientific attention and many authors have tried to unravel the extent and 
relevance of postnatal human AHN (hAHN), seduced by the implication of its 
therapeutic potential. 
3.5.2. hAHN: To be or not to be 
The development and formation of an adult neurogenic niche in the mammalian 
DG has been of great interest for the scientific community. However, it was not until 
1998 that the first evidence of hAHN appeared. In their seminal study, Peter Erikson et 
al. analyzed postmortem hippocampal samples of cancer patients (average age of 64.4 
± 2.9 years) to whom BrdU had been intravenously administered to label proliferative 
tumor cells. Unexpectedly, they found BrdU-positive cells in the GCL of the DG, with a 
substantial part of them co-staining for neuronal markers. With this appealing results, 
they claimed that new neurons were generated in this region during the whole human 
life (Eriksson et al., 1998). During the following years opposite results were reported, 
showing a residual expression of MKI67 (the gene that encodes nuclear protein Ki67, 
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necessary for cellular proliferation) in the SGZ of adult epileptic patients (Del Bigio, 
1999). In spite of this, the work of Erikson and colleagues was gladly received in the 
community and became the milestone for the animal studies of the following decade. In 
addition, several in vitro studies supported the presence of neural progenitors in the 
human DG capable to generate neurons (Coras et al., 2010; Hermann et al., 2006; 
Moe et al., 2005; Palmer et al., 2001; Roy et al., 2000).  
At the beginning of this last decade, Rolf Knoth and collaborators characterized 
the pattern of expression of the immature neuronal precursor marker DCX throughout 
the human adulthood. They found that DCX expression was present in the GCL across 
different adult ages, although it progressively decreased over time. The unusual 
localization of DCX to the nucleus of the labeled cells, however, raised concerns about 
the specificity of the immunodetection. Based on their findings, Knoth et al. speculated 
about the similitude of the neurogenic patterns between rodents and humans, although 
they were unable to find any radially-oriented glia cell in the SGZ (Knoth et al., 2010). 
Another study led by Kathryn Mathews et al. supported their conclusions after the 
characterization of the levels of messenger ribonucleic acid (mRNA) of both DCX and 
MKI67 genes at different time-points across the life, showing its age-related 
downregulation (Mathews et al., 2017). However, it was not until 2013 that one of the 
most important works regarding hAHN came out. Kirsty Spalding et al. assessed the 
generation of hippocampal cells in humans by taking advantage of the atmospheric 
carbon 14 (14C) released from the cold-war rising nuclear-bomb tests and its integration 
in genomic DNA. They presented an integrated model reporting that 700 neurons are 
added per day in the adult human DG with a modest decline with aging, corroborating 
the previous studies and establishing solid grounds on the existence of hAHN 
(Spalding et al., 2013). The adequacy of the modeling has however been challenged 
and a corrected curve with much sharper decline, more in agreement with animal data, 
has been proposed (Lipp and Bonfanti, 2016). 
Recently, when hAHN seemed well-rooted and almost undoubted, new works 
have claimed the lack of such process, stirring the scientific community and raising new 
questions in the field. The first one was based on immunohistochemistry (IHC) results 
reporting that after 3 years of age, microglia is the only proliferating cell type in the 
human DG (Dennis et al., 2017). These results brought disbelief and controversy to the 
field (Dennis et al., 2017; Marucci, 2017), although the community was not truly shaken 
until the appearance of the work of Arturo Álvarez-Buylla and colleagues. Analyzing 
both light and EM images of samples from different fetal, perinatal and adult ages, they 
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described a huge decline of DCX-positive cells from fetal stages to first years of life, 
with negligible amounts of DCX cells remaining by 7-13 years of age (Sorrells et al., 
2018) (Figure I16 A). They did not observe progenitors adjacent to the GCL during 
adulthood, nor a dense layer similar to the rodent SGZ. Thus, they concluded that 
“neurogenesis in the DG does not continue, or is extremely rare, in adult humans” 
(Sorrells et al., 2018). Furthermore, another work came out same year claiming that 
although morphologically, antigenically and topographically diverse progenitor pools 
are present in the human DG from development to adulthood, their neurogenic 
potential is minimal, indicated by the very few DCX-positive cells being present in the 
adult DG (Cipriani et al., 2018). Reacting to these studies, a big part of the community 
focused on reminding that “the absence of evidence is not evidence of absence” and 
giving relevance to the strong evidence showed in the past (Kempermann et al., 2018; 
Lee and Thuret, 2018). On the other side of the coin, new criticism arouse about the 
existence of hAHN, also pointing to the previous groundbreaking works (Eriksson et al., 
1998; Spalding et al., 2013) and their possible technical issues that misled to a wrong 
conclusion (Duque and Spector, 2019). The lack of evidence for NSCs in the adult 
human DG, the high variability between samples and the fact that, as explained by 
previous studies (Breunig et al., 2007b), cells could incorporate BrdU by processes not 
associated with cell division (by cell damage for instance) were argued against the 
well-established idea of hAHN (Duque and Spector, 2019; Sorrells et al., 2018). In fact, 
some authors (Dennis et al., 2016) indicated that even the studies arguing in favor of 
hAHN (Knoth et al., 2010; Spalding et al., 2013) reported low levels of new added 
neurons, even 10-times lower than in laboratory animals (Spalding et al., 2013). It was 
the start of another chapter (perhaps the last) on the story of the controversy of adult 
neurogenesis. 
Soon after Sorrells et al. claimed absence of hAHN, a publication came out 
reporting that neurogenesis does actually persist in the adult DG. They showed 
presence of dividing progenitor cells using Ki67 in combination with Nestin and Sox2 
markers, and also DCX- and PSA-NCAM-positive cells that could potentially be 
immature neurons (Boldrini et al., 2018). Hence, Maura Boldrini et al. and others 
defended the evidence of hAHN and attributed the contradictory results with Alvarez-
Buylla and colleagues (Sorrells et al., 2018) to variations between both studies in 
duration of postmortem delay, fixation and sample preservation methods and staining 
protocols. They also criticized the absence of case information in Alvarez-Buylla’s 
work, arguing that pathological circumstances could be affecting their results 
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(Kempermann et al., 2018; Kuhn et al., 2018; Tartt et al., 2018). The debate was 
opened, and Alvarez-Buylla and colleagues quickly followed-up calling into question 
some of the labeling from Boldrini’s paper and highlighting the outside-GCL location of 
the Nestin/Sox2-positive cells. They also pointed out the importance of doing correct 
interpretations of the obtained results, suggesting that apart from the specific antibody 
expression, parameters like morphology or location should be taken into account when 
categorizing a neuron as mature or immature (Paredes et al., 2018).  
In this scenario, a new paper got the focus of the community, reporting 
abundant hAHN in adult cases up to the ninth decade of life. They based their work on 
DCX and Calretinin (another immature neuron marker) expression and claimed the 
presence of newborn neurons in a methodologically thorough work in which fixation 
protocols were tightly controlled (Moreno-Jiménez et al., 2019) (Figure I16 B). They 
tried different antibodies for DCX and several fixation times getting a really complete 
IHC method that they published in an extended way short after (Flor-García et al., 
2020). Meanwhile, another report supported these results finding DCX-expressing cells 
spread in the GCL throughout the dorsal-ventral axis in elderly individuals. Also, they 
reported the presence of Sox2 and Nestin-positive cells, which they claim to be 
progenitors, although Nestin was restricted exclusively to the anterior DG (Tobin et al., 
2019). These new findings brought again strong belief into the hAHN occurrence and 
its potential role in normal and pathological conditions. Some authors like Paul 
Lucassen et al. defended the massive evidence showing its existence over the reports 
claiming its absence (Lucassen et al., 2020), while others highlighted that the scientific 
community “should not let questions about the extent of adult neurogenesis once again 
impede our progress toward understanding the phenomenon and how it might be 
harnessed to improve human health" (Snyder and Drew, 2020).  
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Figure I16. A) Decline of proliferating cells and immature neurons from childhood to adulthood suggesting 
the absence of adult neurogenesis in humans, as reported by Sorrells et al. (2018). B) Presence of DCX –
expressing cells (in red) in the GCL of adult humans (47-83 year old), colocalizing with DAPI (blue) and 
NeuN (green) staining. These results suggest the presence of immature neurons in the GCL, as reported 
by Moreno-Jiménez et al. (2019) (modified from Sorrells et al., 2018 and Moreno-Jiménez et al., 2019). 
GCL: Granule cell layer. ML: Molecular layer. 
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On the other hand, other authors chose a different view, focusing on the 
limitations to overcome in future studies when addressing hAHN. David Petrik and 
Juan Manuel Encinas, for instance, stressed that Sox2 and Nestin may not be the best 
candidates for the detection of NSCs due to their wide expression in other cell types 
like oligodendrocyte precursor cells (OPCs) or astrocytes (Clarke and Van Der Kooy, 
2011; Encinas et al., 2011a; Komitova and Eriksson, 2004; Petrik and Encinas, 2019). 
Thus, new specific markers should be necessary to define a given cell as a NSC in the 
adult human DG. Regarding immature neuronal markers, Gerd Kempermann and 
colleagues already showed concern years ago when they reported DCX-expressing 
cells to be present in the adult DG and cautiously conclude that “Such data would not 
offer proof of adult neurogenesis in humans, because it is based on the assumption 
that humans and rodents share marker expression patterns in adult neurogenesis” 
(Knoth et al., 2010). In agreement, a recent paper showed high levels of PSA-NCAM-
positive cells in adult control and epileptic cases, although few DCX-, HTLV-I U5RE 
binding protein (HuB; another immature neuron marker)- and Ki67- expressing cells 
were observed. Hence, authors suggested that PSA-NCAM-expressing immature-type 
neurons were not recently generated neurons and that hAHN is indeed sparse, so they 
enforced the need of different interpretations of IHC results between rodents and 
humans (Seki et al., 2019). Furthermore, DCX have been reported to be expressed in 
glial cells, such as microglia or astrocytes, in different conditions (Liu et al., 2018; 
Verwer et al., 2007; Zhang et al., 2014) and to be re-expressed by already mature 
neurons by neural excitation or drug administration, being therefore independent of 
hAHN process (Hagihara et al., 2019). Also, the presence of DCX-positive cells does 
not assure that neurogenesis takes place, as these could be cells generated even 
during development that maintain the expression of DCX. They might undergo very 
long periods of maturation and integration as it has been demonstrated in the brain of 
rodents and sheep (Piumatti et al., 2018; La Rosa et al., 2019; Benedetti et al. 2019). 
Despite all the controversy, there is agreement over a certain postnatal period 
in which neurogenesis still happens in the human DG (Cipriani et al., 2018; Knoth et 
al., 2010; Sorrells et al., 2018), and unlike in the adulthood, early life exposures to 
social and chemical stress have been shown to produce long-lasting effects on brain 
function, potentially including hippocampal disfunction (Cooper et al., 2015; Dorn et al., 
2014; Rees and Inder, 2005). This suggests a neonatal temporal window when 
pathological insults could irreversibly affect a yet unformed HPF. In fact, opposing the 
results observed in adult epileptic conditions (Fahrner et al., 2007; Seki et al., 2019), 
INTRODUCTION 




evidence was provided for increased neurogenesis in pediatric patients with early onset 
of temporal lobe epilepsy (TLE) (Blümcke et al., 2001), possibly derived from Nestin-
expressing astroglial cells remaining from fetal development (Cipriani et al., 2018; 
Kruglyakova et al., 2005; Sorrells et al., 2018). 
In TLE, despite the demonstration of no enhanced hAHN (Fahrner et al., 2007; 
Seki et al., 2019) reorganization of neurons (Seki et al., 2019) and astroglial 
populations (Crespel et al., 2005; Liu et al., 2018; Verwer et al., 2015) have been 
shown. Indeed, in rodent models NSCs have been reported to actively contribute to 
gliosis after seizures (Muro-García et al., 2019; Sierra et al., 2015). All the above 
indicates the relevance of shedding light into human DG development to understand 
how different neuronal and glial populations are arranged during initial formation, 
regardless of the neurogenic capacity of the adult niche. Likewise, understanding of 
pathological mechanisms closely related to hippocampal functionality such as TLE and 
their effect on different cell populations of the DG will help to unravel functional 
properties associated to this structure. 
3.6. Adult hippocampal neurogenic niche in pathology: Epilepsy 
To describe such a complex pathology like epilepsy, it is worth to start by its 
definition. Scientific history tells us how difficult it is to get a consensus when defining 
something and it is not different in this case. A conceptual definition of epilepsy was 
provided by the “international league against epilepsy” (ILAE) in 2005 for the first time, 
as a “disorder of the brain characterized by an enduring predisposition to generate 
epileptic seizures and by its psychosocial consequences”. For a condition to be 
considered and treated as epilepsy, two unprovoked seizures had to be reported more 
than 24 h apart (Fisher et al., 2005). However, this definition was revisited in 2014 and 
the ILAE started to consider epilepsy a brain disease, in which either two unprovoked 
seizures occurred more than 24 h apart, the risk of further seizures after one 
unprovoked seizure was higher than 60% or an epilepsy syndrome was diagnosed 
(Fisher et al., 2014). 
This widened definition brought controversy into the field, mainly focused on the 
treatment of epilepsy as a disease rather than a disorder. On behalf of ILAE, Robert 
Fisher explained that the disease word can be misunderstood to reflect contagiousness 
and might carry more stigma than it does a disorder, but ILAE interpreted that ‘disease’ 
better conveyed the gravity of epilepsy (Fisher, 2015). Still, part of the community was 
not convinced. Adam Noble et al. carried out a survey in which they questioned several 
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epileptic patients and reported that the significant majority of them preferred other 
terms rather than ‘disease’. Thus, they concluded that ILAE was at odds with what 
patients want and discussed the implications of it (Noble et al., 2017). However, the 
definition provided by ILAE (Fisher et al., 2014) is the one that currently stands as the 
official one.  
However it is defined, epilepsy imposes a substantial public health burden with 
an estimated number of 65 million people affected worldwide, being the developing 
countries the most impacted areas (Ngugi et al., 2010). Besides its prevalence, side 
effects and more importantly comorbidities such as cognitive impairment, depression or 
psychiatric disorders make epilepsy a major health concern (Gaitatzis et al., 2004; 
LaFrance et al., 2008). It is worth to mention that the risk of suicide has been 
demonstrated to be increased in most of people with epilepsy (Bell et al., 2009). The 
probability of premature death is 10 times higher in people with epilepsy than in the 
general population (Fazel et al., 2013). Furthermore, some studies have shown that 
between 30-40% of patients become resistant to antiepileptic drugs (Kwan and Brodie, 
2000). Despite a tremendous increase in the number of new drugs developed for 
epilepsy in the last decades, the efficacy of the treatment has not improved in the last 
70 years. 
Regarding the mechanisms underlying epilepsy, it is well-known that it is the 
result of synchronized increased neuronal activity. This hyperactivity is provoked by an 
imbalance wherein excitatory neurotransmission, mostly through glutamatergic 
signaling, is increased or the inhibitory neurotransmission, through GABAergic 
signaling, is decreased (Dalby and Mody, 2001; Isokawa et al., 1997; Sharma et al., 
2007a). Thus, a seizure, the defining event of epilepsy, was described as “a transient 
occurrence of signs and/or symptoms due to abnormal excessive or synchronous 
neuronal activity in the brain” (Fisher et al., 2005). Nonetheless, there are different 
types of seizures, which lead to different types of epilepsy.  
Since the first modern classification was proposed in 1964 (Gastaut and Poirier, 
1964), seizures have been classified according to different standards for many years. 
In 2015, ILAE made a new classification both for seizure (Fisher et al., 2017) and types 
of epilepsy (Scheffer et al., 2017). Thus, they classed them depending on parameters 
such as the type: Focal, generalized, both focal and generalized or unknown, and the 
region where seizures take place (Fisher et al., 2017; Scheffer et al., 2017). Again, 
some authors manifested their disagreement with the ILAE criteria of classification 
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(Lüders et al., 2019), which again was addressed by Robert Fisher. Indeed, he faced 
the debate stating that “controversy about seizure classifications will continue until 
science explains why there are different types of seizures. Until then, every 
classification is a compromise, reflecting consensus and pragmatism”. 
One of the few consensuses in the scientific community is that TLE is the most 
common subtype of focal epilepsy in human patients and the most likely to be resistant 
to drug treatment. Importantly, it is closely associated to the HPF and related structures 
(Falconer et al., 1964; Savage, 2014; Wiebe, 2000). 
3.6.1. Mesial temporal lobe epilepsy (MTLE) 
Different subclassifications of focal seizures arising from the temporal lobe have 
been proposed, finally leading to the distinction between two types of TLE depending 
on their site of origin: The lateral neocortical type and the medio-basal type, also known 
as MTLE (Yu et al., 2003). Although symptomatology commonly overlaps and spreads 
from lateral to mesial cortex (and vice versa), this is a useful distinction. MTLE arises 
from HPF or related structures in the majority of the cases and is mostly associated 
with specific memory impairment, although general intellectual impairment can often be 
discerned (Hermann et al., 1997). In most cases, MTLE associated seizures consist of 
non-lateralized manifestations such as oral automatisms, papillary dilatation, impaired 
consciousness and generalized rigidity (Williamson et al., 1993). 
MTLE is the most pharmacoresistant among the different subtypes of epilepsy 
and therefore many patients (up to 30%) undergo surgery to resect the HPF and in 
most instances also the anterior parahippocampal gyrus (Wieser, 2004). However, this 
intervention is expensive and not always practicable. Furthermore, even though 
surgery can control seizures and improve quality of life in appropriately selected 
patients (Arruda et al., 1996; Garcia et al., 1994; Jeha et al., 2006; McIntosh et al., 
2004; Quirico-Santos et al., 2013), there are still cases that do not respond to neither 
medical nor surgical treatment and are classed as “intractable epilepsy”. In these 
cases, comprehensive care is required to address the adverse effects of medical 
treatment, quality of life issues and comorbid disorders (Schuele and Lüders, 2008). 
The pathological evolution of MTLE is comprised by three different critical stages: 
Status epilepticus (SE), the latent period and the chronic period (Figure I17 A). The SE 
is the initial phase in which a precipitant injury afflicting the HPF or related areas leads 
to seizure activity lasting more than 5 minutes during which full consciousness does not 
recover (Figure I17 B). It is divided in two different phases; A first one characterized by 
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generalized convulsive tonic-clonic seizures and a second one associated to minor 
behavioral symptoms concomitant to continuous electrical discharges, increase in 
intracranial pressure and decrease in cerebral blood flow recover (Lowenstein, 1999; 
Seinfield et al., 2016). The latent period is the seizure-free time between the SE and 
the clinical manifestation of the first spontaneous seizure, characterized by strong 
presence of interictal spikes in electroencephalograph (EEG) recordings (Chauvière et 
al., 2012; Wang et al., 2019; White et al., 2010). Finally, patients start to show chronic 
occurrence of clusters of seizures that can happen many times a day over multiple 
consecutive days, known as spontaneous recurrent seizures (Figure I17 C) (Haut, 
2006; Williams et al., 2009). The study of MTLE in human tissue, as for any other 
pathological condition, is limited. Therefore, different animal models have been 
developed to reproduce the electroencephalographic, behavioral and neuropathological 
features of this disease (Kandratavicius et al., 2014; Lévesque et al., 2016). 
 
Figure I17. A) The pathological evolution of MTLE in rodents. After the SE induced by kainic acid (KA) 
administration, a seizure-free latent period lasts around one week until the first spontaneous seizure 
appears, leading to the chronic period in which spontaneous recurrent seizures take place. B) KA-induced 
seizures during the SE. Electrographic spikes were continuous, but decreased in frequency from 1h to 8h 
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following KA treatment. C) Electrographic spikes of a spontaneous seizure recorded 12 weeks after SE 
(modified from White et al., 2009 and Williams et al., 2010). 
3.6.1.1. Rodent models of MTLE 
The most widely used models to reproduce MTLE in rodents are administration 
of pilocarpine or KA. In both models, in the first days after intraperitoneal or 
intracerebral injection of the chemoconvulsants animals alternate between seizure-free 
periods and high-seizure rates (Arida et al., 1999; Babb et al., 1995; Bouilleret et al., 
1999; Cavalheiro, 1995; Goffin et al., 2007; Williams et al., 2009). 
Pilocarpine is a cholinergic muscarinic receptor agonist that in 1983 was 
showed to induce SE in rodents after systemic intraperitoneal administration. It affects 
several regions including the olfactory cortex, amygdale, thalamus, neocortex, 
substantia nigra and also the HPF. Approximately 2 weeks after the initial SE, animals 
suffer spontaneous seizures (Turski et al., 1983). Although pilocarpine has been mainly 
used intraperitoneally in rats (Arida et al., 1999; Cavalheiro, 1995; Goffin et al., 2007; 
Parent et al., 1997, 2006), it has been also administered intrahippocampally (De 
Furtado et al., 2002). 
KA is a cyclic analog of L-glutamate and an agonist of the ionotropic KA 
receptor. Ben Ari and colleagues used its administration as the first MTLE model in rats 
(Ben-Ari et al., 1979). They reported SE after an intraamygdalar KA injection and 
appearance of spontaneous seizures thereafter. Similar results were obtained using an 
intrahippocampal injection model (Cavalheiro et al., 1982) and also intraperitoneal 
systemic injections, although the brain damage was more generalized in the latter 
(Babb et al., 1995). Later, the intrahippocampal method was thoroughly implemented 
for the study of MTLE in mice, replicating human EEG features, cell death and 
inflammation (Abiega et al., 2016; Bouilleret et al., 1999; Sierra et al., 2015). In mice, 
the intraamygdalar injection of KA replicates the effects of the intrahippocampal 
injection of KA on the DG and the observations in the DG and neurogenic niche of 
MTLE patients (Muro-García et al., 2019).  
Both models (Pilocarpine and KA) and their different experimental applications 
(intraperitoneal, intraamygdaloid or intrahippocampal) represent valid methods for 
human MTLE replication in rodents. However, the KA intrahippocampal injection model 
has been described to be the one that more reliably reproduces human MTLE and 
consequent hippocampal sclerosis (HS) in mice, mimicking the effect of hippocampal 
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focal seizures and their extended damage over related healthy tissue (Lévesque and 
Avoli, 2013). 
3.6.1.2. MTLE-HS 
MTLE is highly associated with a pathology termed HS, characterized by 
hardening of the HPF (Blümcke et al., 2013; Thom, 2014). In 1880, Wilhelm Sommer 
reviewed the accumulating data and published a landmark paper recognizing the 
relevance of this lesion in the tissue. He highlighted neuronal loss in CA as the main 
observation (Sommer, 1880). In the following decades this concept was extended with 
new reported forms of HS with neuronal loss and gliosis affecting also the DG 
(Margerison and Corsellis, 1966; Spielmeyer, 1927). Currently, there is a classification 
of different HS types (Blümcke et al., 2013; Thom, 2014) (Figure I18) and it is studied 
with high interest, as its exact relation with seizures (cause or consequence) remains 
intriguingly unknown (Blümcke et al., 2002; Cendes et al., 2014; Sano and Malamud, 
1953; Thom, 2014).  
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Figure I18. Classification of the different types of HS (modified from Thom, 2014). 
The most obvious and classically studied change that occurs with HS is 
neuronal loss in different regions of the HPF, specially CA subfields and DG. Pyramidal 
cells, excitatory mossy cells and interneurons undergo cell death at variable degrees 
depending on the case and the HS type (Blumcke et al., 2000; de Lanerolle et al., 
1989; Mathern et al., 1996; Steve et al., 2014; Thom et al., 2002). Together with 
neuronal loss, GCL dispersion (GCD) (Houser, 1990; Kobow et al., 2009; Lurton et al., 
1998), MF sprouting and synaptic reorganization are key neuropathological aspects of 
HS (Malmgren and Thom, 2012; Sutula et al., 1989). Focusing on these neuronal 
effects, most antiepileptic drugs produce their therapeutic effect either by reducing 
neuronal excitation or potentiating neuronal inhibition (Rogawski and Löscher, 2004). 
However, the neuronal approach is not always effective and the patient can become 
medically refractory (Kwan and Brodie, 2006; Schuele and Lüders, 2008). Therefore 
several authors have highlighted the importance of new approaches focusing on 
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reactive astrogliosis, another critical pathological consequence of HS and MTLE 
(Binder and Steinhäuser, 2006; Rassendren and Audinat, 2016; Wilcox et al., 2015). 
Proliferation and hypertrophy of astrocytes that form the glial scar has been 
highly studied as one of the hallmarks of MTLE (Binder and Steinhäuser, 2006; 
Rassendren and Audinat, 2016; Wilcox et al., 2015). In control conditions, astrocytes 
can release calcium from internal stores following activation of a variety of G-coupled 
receptors. This triggers the release of different factors that can modulate neuronal 
signaling, such as glutamate, d-serine and adenosine triphosphate (ATP) (Halassa et 
al., 2007). In epileptic conditions, changes in astrocyte numbers and densities have 
long been reported, with high increase especially in the DG (Briellmann et al., 2002). 
Moreover, they undergo morphological changes like process thickening and increase 
their expression of intermediate filament proteins such as GFAP, (Wilhelmsson et al., 
2006) both characteristics of reactive astrocytes (Sofroniew, 2009) (Figure I19). 
Following reactivation, glutamate transport currents are altered (Takahashi et al., 2010) 
and they decrease glutamine synthetase expression (Eid et al., 2019), which leads to 
an excessive release of extracellular glutamate, causing general neuronal 
hyperexcitation. Also, in seizure-related pathologies their domain organization gets 
disrupted (Oberheim et al., 2008) and water and potassium homeostasis dysregulated 
(Lee et al., 2012). Interestingly, soon after KA-induced SE, astrocytes start to express a 
number of specific subunits of KA receptors (Vargas et al., 2013). 
The exact role of astrocytes in the development of epilepsy has been long 
discussed in the last decades (Gibbons et al., 2013). In fact, it has been proposed not 
only that they have fundamental roles in modulating seizures by altering the electrical 
excitability and excitotoxic levels of the epileptogenic focus (de Lanerolle and Lee, 
2005), but also that they may contribute in the genesis of epilepsy and seizures, as well 
as in the pathways targeted by antiepileptic drugs (Lee et al., 2012; Tian et al., 2005). 
However, the assessment of astrogliosis contribution needs to be carefully done, as it 
is not a single-or-none response (Sofroniew, 2009). Astrogliosis should be regarded as 
a complex process in which numerous subtle and reversible changes take place in a 
continuous way. Moreover, depending on the circumstances reactive astrocytes can 
mediate beneficial functions that include protecting neurons or restricting the spread of 
inflammation and infection (Sofroniew, 2009). 
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Figure I19. Morphological changes of GFAP-expressing astrocytes in the mouse neocortex. Compared to 
healthy conditions, astrocytes show process thickening and stronger expression of GFAP in conditions of 
moderate astrogliosis. They form a glial scar around the inflamed area when the astrogliosis is severe 
(taken from Sofroniew, 2009). 
3.6.1.3. MTLE and NSCs 
Adult hippocampal NSCs have been shown to get activated in different animal 
models in which seizures were provoked and neuronal activity enhanced (Gray and 
Sundstrom, 1998; Hüttmann et al., 2003; Lugert et al., 2010; Segi-Nishida et al., 2008; 
Sierra et al., 2015). In fact, it has been proposed that neuronal activity and NSC 
proliferation are coupled, the first triggering the latter (Deisseroth et al., 2004). 
Likewise, tonic GABA promotes quiescence of NSCs and its reduction favors their 
activation (Song et al., 2012). In rats to which pilocarpine was intraperitoneally 
administered following systemic injections, seizure induced SGZ proliferation has been 
associated with increased newborn neuron generation at short-term (Hattiangady et al., 
2004; Parent et al., 1997). Moreover, these neurons have been reported to accelerate 
their morphological development and abnormally migrate into ectopic locations, mainly 
ML and hilus (Overstreet-Wadiche et al., 2006). Their aberrant integration into the 
existent circuit contributes to increased synapses in the hippocampal circuit that trigger 
cognitive impairment (Althaus et al., 2019; Jessberger et al., 2005, 2007; Parent et al., 
1997, 2006; Scharfman et al., 2000). However, these enhanced neurogenesis is driven 
by effects upon DCX-positive migrating late-stage progenitors rather than NSC 
activation itself (Jessberger et al., 2005). Indeed, the increased neurogenesis observed 
shortly after acute seizures returns to baseline levels by about 2 months after the initial 
seizure episode in rats (Jessberger et al., 2007), although slightly augmented 
neurogenesis has also been reported to be maintained after spontaneous recurrent 
seizures (Cha et al., 2004). 
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On the contrary, it has been reported that chronic epileptic seizures impair AHN 
rather than stimulating it (Hattiangady et al., 2004; Heinrich et al., 2006; Kralic et al., 
2005; Sierra et al., 2015). In both intraventricular and intraperitoneal KA injections in 
rats, after an initial burst of progenitor cells proliferation, neurogenesis becomes absent 
at long-term (Hattiangady et al., 2004). In addition, given that the authors failed to 
observe a decrease in Sox2 or Vimentin-expressing NSCs in the SGZ of chronically 
epileptic animals, the decrease in the neurogenic capacity was attributed to a change 
of the neurogenic niche towards a hostile environment for the NSCs (Kuruba and 
Shetty, 2007). 
In mouse models in which KA was injected intrahippocampally, more 
characteristics of MTLE and HS were reproduced: 1) The mitotic activity following injury 
was indeed not neurogenic, contributing to previously reported microgliosis and 
astrocytosis (Heinrich et al., 2006; Kralic et al., 2005; Lee et al., 2003). 2) The 
production of newborn neurons sharply decreased in a disrupted neurogenic niche, at 
that time explained as “induced quiescence of NSCs” (Kralic et al., 2005). 3) In 
previous studies of my host lab, Juan Manuel Encinas and colleagues applied this 
intrahippocampal model using constitutive and inducible Nestin-GFP transgenic mice, 
corroborating the massive activation of NSCs and a drastic alteration of their 
neurogenic program. After seizures affecting the HPF and adjacent areas, NSCs 
undergo a dramatic shift in their morphology, acquiring a reactive phenotype 
(hypertrophic and multibranched) and switching from neurogenic state to a gliogenic 
one. Indeed, reactive NSCs (React-NSCs) tend to divide symmetrically generating 
more copies of them, which finally differentiate into reactive astrocytes by division or 
direct transformation. Therefore, the transformation of NSCs into React-NSCs 
contributes to the hippocampal gliosis and leads to the long-term impairment of 
neurogenesis (Muro-García et al., 2019; Sierra et al., 2015; Valcárcel-Martín et al., 
2020) (Figure I20). 
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Figure I20. 150 days after KA-induced MTLE, the hippocampal neurogenic niche gets completely 
disrupted. NSCs get massively activated, producing React-NSCs and contributing to the gliosis in the GCL 
(modified from Sierra et al., 2015). 
Despite the importance of the NSC pool disruption and its potential contribution 
to the pathological consequences in chronic epilepsy, the mechanisms underlying 
these alterations remain unknown. Alternatively, growth factors have been long known 
to regulate the formation of new neurons by modulating SC and progenitor proliferation, 
differentiation and survival (Calof, 1995). Moreover, seizure-induced expression of 
trophic factors by surrounding tissue, such as brain-derived neurotrophic factor 
(BDNF), vascular endothelial growth factor (VEGF) and others could indirectly induce 
NSC proliferation (Gall, 1993; Gall et al., 1991). 
3.6.2. Possible mechanisms in MTLE-HS 
EGF was long ago reported to be mitogenic on cultured astrocytes (Simpson et 
al., 1982). Later, both EGF and fibroblast growth factor 2 (FGF2) were shown to 
stimulate proliferation of cultured embryonic SC and progenitors (Reynolds et al., 1992; 
Tropepe et al., 1999) and several studies reported also the mitogenic effect of both 
factors in NSCs derived from the adult rodent brain (Kuhn et al., 1997; Palmer et al., 
1995). Importantly, EGF also provokes the expansion of SVZ NSCs after its in vivo 
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administration (Craig et al., 1996). Altogether, these results suggest a possible role for 
these factors and their signalization pathway in the activation of NSCs and astrocytes, 
thereby being potentially relevant in the context of epilepsy. 
3.6.2.1. Fibroblast growth factor receptor (FGFR) 
FGF2 is part of a bigger family of growth factors composed by 18 different FGFs 
forming different subfamilies. Although they share a 30-60% homology, different N- and 
C-terminals regulate their specific receptor binding (Beenken and Mohammadi, 2009). 
FGFs have been reported to bind four different FGFRs: FGFR1, FGFR2 (Dionne et al., 
1990), FGFR3 (Keegan et al., 1991) and FGFR4 (Partanen et al., 1991; Stark et al., 
1991). All of them consist of an extracellular ligand binding region containing three 
immunoglobulin-like domains and an intracellular split tyrosine kinase domain. FGFR1 
and FGFR2 are the ones with higher affinity to FGF2 (Dionne et al., 1990; Johnson et 
al., 1990), while FGFR3 has lower affinity for it (Keegan et al., 1991) and FGFR4 binds 
to FGF1 but not to FGF2 (Partanen et al., 1991). Importantly, FGF2 needs to 
previously bind to heparan sulfate to properly bind to FGFRs (Rapraeger et al., 1991). 
FGF2 has been long demonstrated to be increased after seizures in different 
rodent models. Following a focal electrolytic lesion in the hilus that triggered seizures, 
FGF2 was shown to be increased in several brain regions, including DG. Interestingly, 
although the majority of cells showing FGF2 expression were astroglia, GCs also 
showed increased expression of FGF2 (Gall et al., 1994). In this line, within the first 24 
h after an intraperitoneal KA injection FGF2 was augmented in astrocytes and neuronal 
populations of the DG (Gómez-Pinilla et al., 1995a; Riva et al., 1994; Van Der Wal et 
al., 1994). Moreover, FGFR1 was also increased especially in astroglial populations, 
suggesting an interplay between FGF2 and FGFR1 in the seizure-mediated glial 
response (Gómez-Pinilla et al., 1995b; Van Der Wal et al., 1994). Supporting these 
observations, cultured astrocytes showed increased FGF2 and FGFR1 levels in the 
presence of glutamate (Pecháň et al., 1993), which is known to be abnormally released 
into the extracellular medium after seizures (Eid et al., 2019; Meldrum et al., 1999). 
Indeed, FGF2 and FGFR1 have been shown to be involved in the reactivity of 
astrocytes after a focal injury in rodents (Gómez-Pinilla et al., 1995b). Also, after its 
subcutaneous administration FGF2 promotes neurogenesis in the postnatal rat 
cerebellum (Tao et al., 1996) and in the HPF and SVZ both at postnatal and adult 
stages (Wagner et al., 1999). In fact, when administered intraventricularly, FGF2 
promotes expansion of the progenitor population, enhancing neurogenesis and 
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newborn neurons in the OB (Kuhn et al., 1997). Therefore, it seems fair to hypothesize 
that FGFR1 stimulation could be playing a role in the aberrant neurogenesis and 
reactive astrogliosis that occurs after seizures (Sierra et al., 2015). Interestingly, FGF2 
has been described to induce responsiveness to EGF during embryonic development, 
possibly mediated by induced EGFR expression (Ciccolini and Svendsen, 1998). 
3.6.2.2. EGFR 
EGFR (Also known as HER or ErbB1) is the first receptor of the ErbB family, 
also comprised by three more transmembrane receptor kinases that were described as 
related to EGFR: ErbB2 (Semba et al., 1985), ErbB3 (Kraus et al., 1989; Plowman et 
al., 1990) and ErbB4 (Plowman 1993). EGFR was discovered in 1978 by Graham 
Carpenter and colleagues. Using a cell-free membrane preparation, they reported for 
the first time a receptor tyrosine kinase that was bound to EGF, triggering  
phosphorylation of endogenous and exogenous proteins (Carpenter et al., 1978). Later, 
the complete amino acid sequence of the receptor was presented, opening a new way 
for further research on its cellular role and signaling pathway (Ullrich et al., 1984).  
Each of the ErbB receptor kinases are single chain transmembrane polypeptide 
proteins that have three different domains: 1) A cysteine-rich extracellular domain that 
acts as binding site for the ligands that will trigger the receptor activation, 2) a 
transmembrane domain involved in the dimerization between receptors after ligand 
stimulation and 3) a large cytoplasmic tyrosine kinase domain that phosphorylates 
tyrosine residues on substrate proteins, triggering the correspondent signaling pathway 
that will end up provoking the cellular outcome (Bessman et al., 2014; Herbst, 2004; 
Riese and Stern, 1998; Yarden and Sliwkowski, 2001) (Figure I21).  
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Figure I21. The structure of EGFR before and after binding to a ligand. The four different domains that 
comprise the extracellular module form a dimer (as it will be later explained) in order to bind to the ligand. 
Then, the transmembrane domain and the juxtamembrane segment trigger the activation of the tyrosine 
kinase domain (Intracellular module) activating different downstream signaling pathways (modified from 
Kovacs et al., 2015). 
ErbB receptors can be activated by multiple ligands, with the exception of 
ErbB2 that is considered an orphan receptor and thus, its action is restrained to 
heterodimerization with the other receptors of the family. All ligands are synthesized 
from one transmembrane precursor and once expressed at the plasma membrane they 
are subjected to the proteolytic cleavage of their ectodomain. Thus, the soluble growth 
factor that will trigger the whole cellular response is generated (Carpenter, 2000). 
EGFR in particular can be activated by seven different growth factors that are classified 
in two different subtypes. The high-affinity ligands are EGF, transforming growth factor 
alfa (TGFα), heparin-binding EGF-like growth factor (HB-EGF) and betacellulin (BTC), 
while the low-affinity ligands are epiregulin (EPR), epigen (EPGN) and amphiregulin 
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(AREG) (Harris et al., 2003; Jones et al., 1999; Riese and Stern, 1998). The affinity of 
the ligands to EGFR is not exclusive and differs between them. For example, BTC also 
shows high-affinity to ErbB4, whereas EGF, TGFα and HB-EGF have narrow specificity 
to EGFR (Jones et al., 1999). However, ligand affinities get more complex considering 
one fundamental characteristic for the functionality of ErbB receptors: Dimerization. 
Before being stimulated by a ligand, ErbB receptors remain as tethered 
monomers. When a ligand activates them they bind together, forming dimers that are 
essential to trigger the whole intracellular signaling thereafter (Bessman et al., 2014; 
Herbst, 2004; Riese and Stern, 1998; Yarden and Sliwkowski, 2001). In this process, 
receptors can bind to their equals, forming homogeneous dimers or homodimers. 
Nonetheless, the capacity of the receptors to cross-talk and generate heterodimers 
with different receptors of the family has been long studied (Earp et al., 1995; 
Karunagaran et al., 1996; Tzahar et al., 1996). This interplay is not meaningless for the 
resulting cellular dynamics since it affects the tyrosine phosphorilation sites and hence 
which signaling proteins are engaged. For instance, even though ErbB2 cannot bind to 
any ligand, it has the capacity to form heterodimers with the rest of the receptors after 
they are activated, provoking strong responses (King et al., 1988; Stern and Kamps, 
1988; Wada et al., 1990). Indeed, it has been described that homodimeric receptor 
combinations are the less mitogenic and transforming ones, being the heterodimers the 
most potent complexes to elicit this cellular output (Pinkas-Kramarski et al., 1996). In 
adittion, different receptor combinations can affect the binding preference of a ligand, 
modifying the whole cellular functions (Jones et al., 1999). 
Once the intracellular machinery has started, the different ErbB family members 
possess distinct complements of tyrosine phosphorylation sites that make them elicit 
diverse, although sometimes overlapping, sets of responses (Jones et al., 2006). 
Nonetheless, similar to the non-existent capacity of ErbB2 to bind to any ligand, ErbB3 
has lost robust kinase activity over the evolutionary course, remaining catalytically 
inactive (Jura et al., 2009). Thus, its signalization capacity is also restricted to 
heterodimerization. Soon after the discovery of EGFR (Carpenter et al., 1978) several 
tyrosine residues were described in the intracellular carboxyl-terminal tail of the 
receptor, identified as autophosphorylation sites in the activated EGFR (Carpenter, 
1983). During the following years, these autophosphorylation sites were further 
described (Y992, Y1068, Y1086, Y148 and Y1173)(Downward et al., 1984; Margolis et 
al., 1989; Walton et al., 1990) and it was also reported the existence of specific tyrosine 
residues (Y845, Y891, Y920 and Y1101) that despite not being able to 
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autophosphorylate, they had the capacity to be trans-phosphorylated by other kinases 
(Biscardi et al., 1999; Stover et al., 1995). Moreover, phosphorylation of serine (S967, 
S971 and S1002) and threonine (T654 and T669) residues were also found in EGFR 
(Heisermann and Gill, 1988; Hunter et al., 1984; Kuppuswamy et al., 1993). 
Interestingly, apart from direct ligand binding ErbB receptors can also get 
indirectly activated. G protein-coupled receptors (GPCRs) can get activated and 
indirectly promote phosphorylation of specific tyrosines on ErbB receptors (Carpenter, 
1999, 2000; Gschwind et al., 2001). After GPCR activation, the non-receptor tyrosine 
kinase Src was described to directly associate and phosphorylate EGFR tyrosine 
kinases (Thomas and Brugge, 1997). Furthermore, it was demonstrated that 
angiotensin II (Eguchi et al., 1998) or LPA (Luttrell et al., 1996) were able to quickly 
increase the detected amount of Src coprecipitated with EGFR. Indeed, this GPCR-
derived EGFR tyrosine phosphorylation was decreased by overexpression of either a 
dominant-negative Src construct or C-terminal Src kinase (CSK), a regulatory kinase 
that inhibits Src function (Luttrell et al., 1996). Therefore, the Src-EGFR complexes 
provoked by GPCR activation were defined as a mechanism for EGFR trans-activation. 
This process was initially thought to occur only in an intracellular ligand-independent 
manner due to its rapid onset (Carpenter, 1999). However, it was later described that 
trans-activation can indeed be mediated by ligand induction (Carpenter, 2000; 
Gschwind et al., 2001). In a pair of groundbreaking works, Norbert Prenzel and 
colleagues reported that after GPCR agonist binding, mettalloproteinases get quickly 
stimulated and cleavage the HB-EGF precursor protein (pro-HB-EGF), ultimately 
leading to EGFR activation by the soluble HB-EGF and the consequent biological 
outcome (Gschwind et al., 2002; Prenzel et al., 1999). This process was termed triple 
membrane passing signal event (Prenzel et al., 1999). 
EGFR dimerization and ligand activation can trigger a plethora of intracellular 
responses in an extensive downstream signaling pathway. The described tyrosine 
phosphorylation sites act as docking sites for several signaling molecules containing a 
phosphotyrosine-binding sequence, such as Src homology 2 (SH2) or 
phosphotyrosine-binding domains (PBD) (Olayioye, 2000; Shoelson, 1997). Next, 
depending on the receptor stimulation process, different downstream signaling 
pathways will activate.  
The most important and studied one is possibly the mitogen-activated protein 
kinases (MAPK) pathway (Figure I22 A). This well-known signaling pathway starts with 
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the activation of RAS proteins that lead to the phosphorylation of RAF kinases, which in 
turn phosphorylate MAPK/extracellular signal regulated kinases (ERK) (MEK). Finally, 
MEK induces ERK1/2 activation leading to the production of several cell-cycle 
associated transcription factors and the accumulation of cD catalyzing the division of 
the cell (Downward, 2003). Moreover, ERK1/2 phosphorylate a wide number of 
substrates and translocate them to the nucleus, where they modulate the action of 
multiple proteins and transcription factors that play critical roles in the regulation of 
proliferation, survival and cell metabolism (Deschênes-Simard et al., 2014; Lewis et al., 
1998; Morrison, 2012). 
Another pathway among the downstream signaling of EGFR is the Akt (Figure 
I22 A), also known as protein kinase B (PKB), signaling pathway. In this case, 
phosphoinositide 3-kinase (PI3K) docks to a phosphorylated kinase in EGFR and 
stimulates the generation of phosphatidylinositol-3,4,5-triphosphate (PIP-3), which in 
turn promotes the activation of Akt (Cully et al., 2006). Thus, Akt modulates cell 
survival through suppression of apoptosis and can participate in other cellular 
processes such as proliferation, metabolism, cell growth and motility (Dibble and 
Cantley, 2015; Morgensztern and McLeod, 2005).  
The family of signal transducers and activator of transcription proteins (STATs) 
(Figure I22 B) has been also shown to be part of the EGFR downstream signaling 
(David et al., 1996). Particularly, STAT3 can bind to multiple tyrosine residues of EGFR 
and get phoshporylated (Park et al., 1996; Zhong et al., 1994). Once activated, STAT3 
forms a dimer with another STAT3 protein and gets internalized. Interestingly, it has 
been reported to play a role in the proliferative capacity and reactivity of astrocytes in 
different conditions (De La Iglesia et al., 2008; Priego et al., 2018). Furthermore, 
STAT3 can also be activated through Akt signaling pathway (Kim et al., 2013), 
suggesting that the interplay between different signaling pathways can be critical for 
the final cellular outcome. 
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Figure I22. Downstream signaling pathways of EGFR. A) A simplified version of the Akt and ERK1/2 
downstream signaling pathways that mostly lead to cell proliferation, migration and survival. B) The STAT3 
downstream signaling pathway that after being activated forms a dimer with another STAT3 and plays a 
role in cellular processes such as survival (modified from Yamashita et al., 2017; Zulkifli et al., 2017). 
EGFR was reported to be ubiquitous in the mammal brain, starting to be 
expressed in astroglia at P16 and reaching its maximum immunoreactive expression at 
P19, while it becomes much weaker or almost absent thereafter (Gómez-Pinilla et al., 
1988; Nieto-Sampedro et al., 1988). On the contrary, in adult and aged rats and also in 
humans, strong EGFR signal was reported in cortical neurons, being abundant in the 
cingulate, frontal, frontoparietal and striate cortical regions (Gómez-Pinilla et al., 1988; 
Werner et al., 1988). However, even if the expression of EGFR in glial cells is 
negligible in normal conditions, the situation changes in pathological conditions. 
EGFR has been highly studied in the context of cancer diseases. Its 
overexpression has been reported in several types of human tumors, including head 
and neck, breast, ovarian, prostate, bladder, non-small-cell lung cancer, pancreatic an 
renal cell carcinomas and squamous carcinomas (Arteaga, 2011; Nicholson et al., 
2001; Salomon et al., 1995; Sasaki et al., 2009; Sharma et al., 2007b). In addition, the 
EGFR amplification has been demonstrated to be highly important in glioblastomas 
(Lee et al., 2006; Libermann et al., 1985; Vivanco et al., 2012). Taking this into 
account, it seems that the relevance of EGFR for cellular proliferation and reactivity in 
pathologic conditions could be applied to the understanding of MTLE. However, not 
much is known about the role of EGFR in this disease. Juan Manuel Encinas and 
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colleagues performed gene expression (whole genome arrays) analysis and showed 
that three days after an intrahippocampal KA injection 46 different signaling pathways 
were upregulated in the mouse HPF. Interestingly, the ErbB signaling pathway, to 
which EGFR belongs, was one of them (Sierra et al., 2015). Nonetheless, one of the 
hallmarks of MTLE, which is the massive extracellular release of glutamate that causes 
neuronal hyperexcitation (Eid et al., 2019; Meldrum et al., 1999), could affect EGFR 
expression. In glioblastoma-derived glial cells glutamate induces a significant increase 
of EGFR mRNA and protein levels, while treatment with EGFR inhibitors such as 
Gefitinib reversed the effect of glutamate on cell proliferation (Schunemann et al., 
2010). In hypothalamic astrocytes activation of metabotropic or AMPA glutamate 
receptors causes the recruitment of ErbB receptors to the cell membrane, trans-
activating them and increasing their cellular expression (Dziedzic et al., 2003). 
Likewise, in cultured rat cortical astrocytes, the glutamate receptor mGluR5, when 
activated, forms a signaling complex with EGFR and together induce the activation of 
ERK2 signaling pathway (Peavy et al., 2001). 
Being reactive astrogliosis one of the main features of MTLE-HS (Binder and 
Steinhäuser, 2006; Rassendren and Audinat, 2016; Wilcox et al., 2015), it is 
remarkable that following the first days after different focal brain injury models, EGFR 
has been reported to be increased in astroglia in both rats (Nieto-Sampedro et al., 
1988; Río et al., 1995) and humans (Ferrer et al., 1996). Also, receptor expression was 
shown in rats in reactive astrocytes and microglia within the first three days after 
ischemia (Planas et al., 1998), suggesting a role of the receptor in the glial reactive 
response. 
As previously mentioned, in a rodent MTLE model NSCs have also been shown 
to massively activate and contribute to the reactive astrogliosis, losing their neurogenic 
capabilities (Sierra et al., 2015). Interestingly, isolating EGFR-expressing cells was 
demonstrated that EGFR plays a fundamental role in the regulation of the adult SVZ 
neurogenic niche, where EGFR expression correlates with activated NSCs (Codega et 
al., 2014; Pastrana et al., 2009). During embryonic development, EGFR affects the 
migration capacity of cortical progenitors at embryonic stages (Burrows et al., 1997; 
Caric et al., 2001; Ciccolini et al., 2005) and modulates progenitor proliferation, 
maturation and cell fate, inducing them to differentiate towards astrocytic lineage at 
neuronal expense. However, this effect on glial cell fate is dependent on the presence 
of high extracellular ligand amount (Burrows et al., 1997; Viti et al., 2003). Supporting 
the role of EGFR on glial vs neuronal differentiation, it was reported that SVZ 
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progenitors divide asymmetrically in terms of EGFR expression during development. 
Thus, after mitosis, a cell containing high levels of EGFR would be fated towards 
astrocytic lineage while its low EGFR-expressing sister cell would not (Sun et al., 
2005). Moreover, another study demonstrated that overexpression of EGFR in the SVZ 
disrupts the neurogenic niche stability, expanding the neural precursor population but 
reducing the NSC number and therefore losing the long term neurogenic potential 
(Aguirre et al., 2010). Using a knock-out mouse model for EGFR, Maria Sibilia and 
colleagues found a reduced number of astrocytes in the developing cortex, with 
impaired proliferative capacity when cultured in vitro (Sibilia et al., 1998). Indeed, they 
demonstrated later that the increased apoptosis displayed by cortical astrocytes was 
due to a defective Akt signaling, which consequently affected also neuronal survival. 
Moreover, they found this effect to be restricted to cortical astrocytes, with midbrain 
astrocytes being unaffected (Wagner et al., 2006). Furthermore, these mice were found 
to be more susceptible to intraperitoneal KA-induced epileptic seizures (Robson et al., 
2018). 
EGFR has been reported to modulate progenitor migration and proliferation in 
the developing HPF (Carrillo-García et al., 2014; Sibilia et al., 1998). In the adult DG, 
EGFR expressing cells were shown to colocalize with the proliferating cells in the SGZ 
(Okano et al., 1996), and it was used to isolate active NSCs (Jhaveri et al., 2015; 
Walker et al., 2016), although it was claimed that in contrast to SVZ, in the DG EGFR 
can be expressed also by quiescent NSCs (Jhaveri et al., 2015). Regardless of the 
identity of NSC subpopulations expressing EGFR, the functionality of the receptor in 
the hippocampal neurogenic niche remains largely unknown, especially in MTLE-HS 
conditions. We suggest that activation of EGFR mediates in the pathological 
consequences of this disease. 
3.6.2.3. Zinc (Zn+2) as a mediator of EGFR activation after KA 
Among metal ions, Zn+2 is well-known to be critical for brain development during 
fetal and postnatal periods and also for the correct brain function in the adulthood, 
including modulation of the neurogenic process both at developmental and adult stages 
(Levenson and Morris, 2011; Sandstead, 2012; Sandstead et al., 2000). About the 80% 
of the total Zn+2 in the brain exists in metalloproteins such as metallothioneins (MTs) 
that act as storage units for Zn+2, while the 20% left exists in the presynaptic vesicles of 
a subclass of glutamatergic neurons to serve as a signal factor in the intracellular 
cytosolic compartment as well as in the extracellular compartment (Frederickson, 1989; 
Frederickson and Danscher, 1990; Kambe et al., 2015; Maret, 2017; Takeda and 
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Tamano, 2009) (Figure I23 A). This synaptic Zn+2 is histochemically reactive and it can 
be revealed by Danscher’s sulfide-silver staining method (Danscher, 1981).  
We know since the serendipitous discovery of Helmut Maske that Zn+2 presence 
in the HPF is one of the most intense in the brain (Maske, 1955). The majority of the 
Zn+2 in the HPF can be found widespread through the different areas, including 
subiculum and EC (Frederickson et al., 1983; Slomianka, 1992). Around 10% of the 
total hippocampal Zn+2 and the majority of synaptic Zn+2 can be found in the giant 
boutons of the MFs in the hilus, where it is contained in presynaptic vesicles 
(Frederickson et al., 1983; Sindreu et al., 2003). Also, around half of Schaffer 
collaterals was shown to contain Zn+2 in presynaptic vesicles (Sindreu et al., 2003) 
(Figure I23 B). 
 
Figure I23. A) Once Zn
+2
 gets released into the synaptic cleft, it can modulate the postsynaptic neuron 
either directly (1) or through receptor binding (2). It can be reuptaken by the presynaptic cell (3) or 
released into the extracellular space (4). B) Synaptic Zn
+2
 is mainly expressed in the HPF, especially in the 
MFs, and also in the amygdala (modified from Takeda et al, 2013 and Burdette et al., 2000). 
After an electrical impulse that triggered neuronal excitation in hippocampal 
slices, Zn+2 was demonstrated to be released into the extracellular space (Assaf and 
Chung, 1984), primarily from MFs (Aniksztejn et al., 1987). In fact, the released Zn+2 
was shown to be re-uptaken by MFs, suggesting a role of Zn+2 in neural signaling 
processes for the first time (Howell et al., 1984). Years later, using novel methods for 
Zn+2 staining and tracing, it was found that after electrical stimulation, the released Zn+2 
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crosses the synaptic cleft and enters postsynaptic neurons, potentially triggering 
intracellular responses (Li et al., 2001).  
Since all the Zn+2 containing neurons in the brain are glutamatergic, Zn+2 and 
glutamate are thought to be contained in the same vesicle and get released together 
(Paoletti et al., 2009; Qian and Noebels, 2005). Indeed, expression of vesicular 
glutamate transporter 1 (VGLUT-1) was reported in the synaptic vesicles containing 
Zn+2 (Sindreu et al., 2003). Thus, Zn+2 could act as a modulator in glutamatergic 
neurotransmission. Indeed, in a series of in vivo experiments, the released Zn+2 from 
Schaffer collaterals and MFs after neuronal stimulation was shown to negatively 
modulate calcium signaling at presynaptic level, acting as a negative feed-back factor, 
and also at postsynaptic level. Consequently, the blocking of calcium signaling leads to 
the suppression of glutamate release (Minami et al., 2006; Takeda et al., 2003, 2006). 
Supporting these results, chelation of Zn+2 using N,N,N′,N′-tetrakis (2-pyridylmethyl) 
ethylenediamine (TPEN), a membrane-permeable Zn+2 chelator, increased presynaptic 
calcium signaling (Quinta-Ferreira and Matias, 2004). Also, Zn+2 has been proposed to 
activate presynaptic ATP sensitive potassium channels, thereby protecting neurons 
from hyperactivation, excessive glutamate release and excitotoxicity (Bancila et al., 
2004). In addition to suppressing extracellular glutamate release, Zn+2 has the opposite 
effect upon GABA (Takeda et al., 2004), leading to the decrease of the general circuit 
activity, in which Zn+2 acts as a neuromodulator. 
In the context of epilepsy, after seizures induced by amygdalar and 
hippocampal kindling, the amount of Zn+2 was shown to increase in the hippocampal 
area within the first two weeks after seizure induction (Kasarskis et al., 1987; Mody and 
Miller, 1985). In mice, when KA was intraperitoneally injected, the increase of Zn+2 was 
also observed in the HPF within the first three days after injection. Also, MT1 and MT2, 
which recapture Zn+2 from both intracellular and extracellular spaces, were also highly 
increased (Carrasco et al., 2000). In fact, in a mouse model of congenital TLE, Zn+2 
levels were lowered in the DG (Fukahori et al., 1988). Altogether, these findings 
suggest that increased levels of Zn+2 may play a role during the onset of seizures, while 
it would disappear thereafter. Indeed, in the intrahippocampal KA administration model 
of MTLE, Zn+2 increased in the HPF during the first 2 weeks post-injection, followed by 
a progressive decline with a complete loss of staining at 56 days after KA 
administration (Mitsuya et al., 2009). 
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The exact role of Zn+2 in the seizure-induced hippocampal response remains 
controversial. Some studies from the 70s-80s indicated a pro-convulsive effect of Zn+2, 
basing on elevated Zn+2 levels in non-human primates moderately sensitive to 
photically induced seizures (Alley et al., 1981) or the generation of seizures after 
intraventricular Zn+2 injection in rats (Donaldson et al., 1971) and rabbits (Pei et al., 
1983). On the contrary, Zn+2-deficient diet contributes to increased seizures in a 
congenital TLE mouse model, while enriching the diet with Zn+2 has the opposite effect 
(Fukahori and Itoh, 1990). Likewise, subcutaneously-administered Zn+2 lowers the risk 
of noise-induced seizure incidence in rats, even though no effect was observed when 
seizures were induced by intraperitoneal KA administration (Morton et al., 1990). 
However, taking a different approach and instead of administering Zn+2, chelating it 
after subcutaneous KA administration or electrical stimulation of the PP, aggravated 
the seizures induced in both models (Mitchell and Barnes, 1993; Mitchell et al., 1990). 
Moreover, it has been reported that in knock-out mice for MT1 and MT2 or MT3, where 
the recapture of Zn+2 is impaired, the seizures after intraperitoneal KA injections were 
aggravated (Carrasco et al., 2000; Cole et al., 2000). The same effect was reported in 
knock-out mice for Zn+2 transporter 3 (ZNT3), in which Zn+2 is absent from the 
presynaptic vesicles (Cole et al., 2000). 
Remarkably, Zn+2 was demonstrated to activate EGFR signaling through 
different ways. In fibroblast cell lines as well as human skin A431 and bronchial 
epithelial cells, Zn+2 was shown to induce EGFR phosphorylation at tyrosines Y845, 
Y1068 and Y1173 through trans-activation in a c-src dependent manner (Samet et al., 
2003). Moreover, Zn+2 was reported to provoke the extracellular release of HB-EGF, 
indirectly triggering the EGFR activation (Wu et al., 2004). As previously mentioned, 
HB-EGF is a potent mitogen ligand of EGFR that is membrane-anchored under its 
precursor form and can be converted into a soluble and an active form  through 
metalloproteinase cleavage (Gschwind et al., 2002; Prenzel et al., 1999). Interestingly, 
HB-EGF is increased in the DG after intraperitoneal KA administration as soon as 
within the first 24 h, while it decreases thereafter (Opanashuk et al., 1999). This early 
increase of HB-EGF could be relevant, given that HB-EGF is known to affect 
proliferation, differentiation and morphology of cultured astrocytes (Jia et al., 2018; 
Kornblum et al., 1999; Puschmann et al., 2014), as well as to promote neurogenesis in 
the SGZ when it is intraventricularly administered (Jin et al., 2002). 
We herein propose that Zn+2 might play a role in the initial stage of MTLE-HS, 
either by direct activation of EGFR or by the extracellular releasing of HB-EGF. Aiming 
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to understand this process, the next step would be to block EGFR signalization in the 
context of seizures to investigate the specific role of the receptor activation. 
3.6.2.4. Blocking EGFR signaling 
Inhibition of EGFR has been demonstrated to be a useful approach to 
ameliorate the reactive gliosis in spinal cord injury models (Li et al., 2014; Qu et al., 
2012). Furthermore, being EGFR highly implicated in the evolution of different cancer 
diseases (Arteaga, 2011; Nicholson et al., 2001; Salomon et al., 1995; Sasaki et al., 
2009; Sharma et al., 2007b), different potential strategies aiming to target EGFR have 
been developed. Among these approaches, monoclonal antibodies and tyrosine kinase 
inhibitors (TKI) are the most advanced ones, both resulting in the effective blockade of 
the EGFR downstream signaling transduction. Between both strategies, the TKI have 
been more extensively studied (Chen, 2013). 
Gefitinib (ZD1839) was the first EGFR-targeted small-molecule TKI being 
approved with the aim to reduce tumor proliferation. It reversibly targets EGFR at the 
ATP binding site within the tyrosine kinase that acts as an activator of the signaling 
pathway. Its side effects use to range from mild to moderate, consisting of a dose-
dependent skin rash and diarrhea (Wakeling et al., 2002). Also, Afatinib, an irreversible 
EGFR inhibitor has been recently approved and clinically tried (Watanabe et al., 2018; 
Yang et al., 2015). Here, we suggest that the use of Gefitinib and Afatinib could 
potentially ameliorate the pathological consequences of MTLE-HS, especially the NSC 
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4. HYPOTHESES AND OBJECTIVES 
Hippocampal NSCs represent the first step of the adult neurogenic cascade, 
acting as a non-renewable source of new neurons during the lifespan of most 
mammals. Thus, the initial size of NSC population will determine the total potential 
neurogenic output throughout lifetime. Moreover, once the NSC population is 
generated, pathophysiological conditions such as epilepsy can alter their properties, 
strongly affecting neurogenesis. Based on these premises and our preliminary data we 
hypothesize that: 
1. Adult NSCs are generated de novo during the early postnatal stages 
of DG development.  
2. Adult NSCs are generated on-site in the early postnatal DG. 
3. Adult NSCs generation in the early postnatal DG requires the 
expression of cD2. 
4. The expression and activity of the FGFR1 and EGFR signaling 
pathways increase after seizures, playing a fundamental role in the 
massive activation and induction of React-NSCs. 
5. The efficient inhibition of EGFR by Gefitinib prevents the massive 
activation and induction of React-NSCs after seizures. 
6. The massive release of Zn+2 after seizures induces the EGFR-
mediated activation and induction of React-NSCs. 
7. The massive release of HB-EGF after seizures induces the EGFR-
mediated activation and induction of React-NSCs. 
 
General objective 1: To study the development and formation of 
adult NSCs in the mouse. 
Objective 1.1. To analyze the role of cD2 on the postnatal formation of the 
adult NSC population. For this purpose we will use a double transgenic mouse model 
that results from the crossing of cD2KO mouse and a Nestin-GFP mouse that 
expresses GFP under the regulatory element of Nestin, a NSC marker. We will analyze 
in a comparative manner (WT vs cD2KO) the development of NSCs (number and 
division dynamics) and cell death in the SGZ+GCL along different postnatal time points 
by means of confocal microscopy-based quantitative image analysis. 
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Objective 1.2. To study the contribution of early postnatal NSPCs from 
different spatial locations (DMS and DG) to the adult NSC population. For this 
purpose, we will develop and validate a method to perform cell labelling by region-
targeted retroviral infections in the DMS and the DG early after birth. We will analyze 
the identity of the labelled progeny at later time points by confocal microscopy-based 
quantitative image analysis. 
Objective 1.3. To characterize the expression of LPA1 in the dNSCs and 
adult NSCs in the DG. For this purpose we will use a transgenic mouse model in 
which EGFP is driven by the expression of LPA1. We will analyze the expression of 
LPA1-EGFP in the DG and specifically in the NSCs at different postnatal time points by 
means of confocal microscopy-based quantitative image analysis. 
 
General objective 2: To study the development of the hippocampal 
neurogenic niche in humans. 
Objective 2.1. Analyze different dNSC populations along the human HPF 
development. For this purpose, we will perform IHC in human embryonic and early 
postnatal hippocampal samples and explore the development of the different progenitor 
matrixes that will form the DG by means of confocal microscopy-based quantitative 
image analysis. 
 
General objective 3: To study mechanisms of induction of React-
NSCs in MTLE. 
Objective 3.1. To study the potential implication of FGFR1 in the 
hippocampal response early after the induction of MTLE. For this purpose, we will 
analyze through real time-quantitative polymerase chain reaction (RT-qPCR) and 
western blot (WB) the mRNA and protein levels of FGFR1 at different early time points 
after the intrahippocampal injection of KA as a model of MTLE.  
Objective 3.2. To study the potential implication of the EGFR signalling 
pathway in MTLE. For this purpose we will analyze through RT-qPCR and WB the 
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mRNA and protein levels of EGFR and its downstream signalling pathways Akt, 
ERK1/2 and STAT3 at different early time points after the induction of MTLE. We will 
also study EGFR expression in Nestin-GFP mice and Nestin-GFP-derived NSPCs by 
IHC and confocal microscopy-based quantitative image analysis. 
Objective 3.3. To test the efficacy of Gefitinib to block the EGFR signalling 
pathway in NSPCs in vitro. For this purpose we will culture NSPCs and assess the 
effect of the EGFR inhibitor Gefitinib over the proliferating capacity of Nestin-GFP-
derived NSPCs. Using WB and confocal microscopy-based quantitative image analysis 
we will determine the efficiency of Gefitinib in the EGFR signalling pathway blockage 
and its effect over NSPC proliferation capacity measured by BrdU incorporation. 
Objective 3.4. To analyze the effect of Gefitinib in vivo on NSCs and 
neurogenesis in MTLE. For this purpose, we will administrate Gefitinib to adult mice 
during the first three days after the induction of MTLE by intrahippocampal KA injection. 
After the treatment, we will evaluate the number, activation and morphological 
complexity of NSCs, as well as the presence of NBs in the SGZ+GCL by confocal 
microscopy-based quantitative image analysis.  
Objective 3.5. To evaluate the potential action of Zn+2 on NSCs in MTLE. 
For this purpose we will first evaluate the amount of Zn+2 and MTs, the metalloproteins 
in charge of Zn+2 storage, in the HPF by means of Danscher staining and RT-qPCR 
respectively early after the induction of MTLE. We will study the effect of Zn+2 
administration in vitro on NSPCs and in vivo in the NSCs of the DG by means of 
confocal microscopy-based quantitative image analysis.  
Objective 3.6. To determine the potential EGFR-mediated induction of 
React-NSCs by Zn+2. For this purpose, we will determine the phosphorylation of 
various EGFR tyrosine sites (Y845 and Y1068) by WB after Zn+2 administration to 
NSPCs in vitro. We will also evaluate by confocal microscopy-based quantitative image 
analysis in vivo the potential restoration by Gefitinib administration of the Zn+2-induced 
proliferation in the SGZ. 
Objective 3.7. To evaluate the effect of Zn+2 quelation on NSCs and 
neurogenesis in MTLE. For this purpose we will use the Zn+2 quelator TPEN, 
administrating it to adult mice during seven days after the induction of MTLE and 
evaluating the potential prevention of the GCD and cellular death by confocal 
microscopy-based quantitative image analysis in vivo. 
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Objective 3.8. To evaluate HB-EGF as a possible mechanism for EGFR 
activation in MTLE. For this purpose we will quantify using the enzyme-linked 
immunosorbent assay (ELISA) the amount of HB-EGF released in vivo within the first 
three days after the induction of MTLE and in vitro by NSPCs in proliferating conditions. 
We will also resort to IHC to check the distribution of HB-EGF inside the DG after KA 
intrahipocampal injection and to WB to measure the activation of the EGFR signalling 
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5. MATERIALS AND METHODS 
5.1. Animals 
All the animals used in the present study were maintained with ad libitum 
access to food and water in a colony room at a constant temperature (19–22°C) and 
humidity (40–50%) on a 12:12h light/dark cycle. All procedures were approved by the 
University of the Basque Country (UPV/EHU) Ethics Committee (Leioa, Spain) and the 
Diputación Foral de Bizkaia under protocol M20/2015/236 and followed the European 
directive 2010/63/UE and NIH guidelines. 
Nestin-GFP transgenic mice were generated in the laboratory of Grigori 
Enikolopov at Cold Spring Harbor Laboratory (Cold Spring Harbor, NY, USA), who 
kindly provided the strain, and have been thoroughly characterized before (Mignone et 
al., 2004)  
LPA1-EGFP transgenic mice, generated by the GENSAT project at Howard 
Hughes Medical Institute (The Rockefeller University, NY, USA) (Gong et al., 2003), 
were provided by Gerd Kempermann at the Center for Regenerative Therapies 
Dresden (Technische Universität Dresden, Dresden, Germany). The characterization of 
the expression of LPA1-GFP in adult NSCs has been characterized elsewhere 
(Valcárcel-Martín et al., 2020; Walker et al., 2016). 
Both animal strains were crossed with C57BL/6 mice for at least 10 generations 
in order to homogenize genetic variability. Nestin-GFP mice were used for the 
postnatal characterization of the DG neurogenic niche, spleen-focus forming virus 
gamma-retrovirus (SFFV-RV) injections and also for MTLE experiments whereas LPA1-
GFP mice were used only for the postnatal characterization of the DG neurogenic 
niche. 
In order to characterize the role of cD2 in the postnatal development of the DG, 
knock-out mice for the ccnd2  (Sicinski et al., 1996), referred to as cD2KO, were 
crossed with a different version of the Nestin-GFP mice (Yamaguchi et al., 2000) in the 
laboratory of Anja Urbach (Universitätsklinikum Jena, Jena, Germany). Heterozygous 
offspring of this breeding were mated with each other to obtain Nestin-GFP-positive 
mice homozygous for the cD2KO or wild type (WT) littermates. Their brains were fixed 
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at different time points during postnatal development (P0, P7, P14 and P28) and sent 
to us for the histological analysis. 
5.2. Human Samples 
Gestational (GW14 and GW30) and early postnatal (3 weeks) post-mortem 
control cases were collected by Mercedes Paredes after previous written consent of 
their progenitors and in strict observance of the legal and institutional ethical 
regulations of the University of California, San Francisco (UCSF) Committee on Human 
Research. Protocols were approved by the Human Gamete, Embryo and Stem Cell 
Research Committee (Institutional Review Board) at UCSF. As previously described 
(Sorrells et al., 2018), all samples from the temporal lobe were cut from the amygdaloid 
complex to the posterior end of the inferior horn of the LV into approximately 1.5-cm 
blocks, fixed in 4% paraformaldehyde (PFA)(Sigma-Aldrich, #441244) for an additional 
two days, cryoprotected in a 30% sucrose solution, and then frozen in embedding 
medium (OCT) for its histological analysis. 
5.3. Stereotaxic intrahippocampal injections 
5.3.1. Postnatal SFFV-RV infections 
We optimized a method to perform intrahippocampal injections in accordance to 
our requirements: 1) The need to inject independently in two different regions (DG and 
DMS) of the HPF, and 2) Its adaptation to the varying size of these regions during early 
postnatal development. To achieve that we tested different coordinates from a wide 
variety of published experimental approximations that have previously implemented 
stereotaxic intrahippocampal injections in neonatal mice (Jiang et al., 2017; Xu et al., 
2012). 
We traced the lineage of postnatal hippocampal progenitors with mCerulean- 
and mCherry-expressing SFFV-RVs, kindly given by Diego Gómez-Nicola (University 
of Southampton, UK) (Gomez-Nicola et al., 2014a; Weber et al., 2012). P2 and P5 old 
mice were anaesthetized by hypothermia by placing them in ice for 2 minutes and then 
secured to a platform placed in the stereotaxic apparatus. Aided by a fiber optic light, 
Lambda was localized by head transillumination and it was used as reference to inject, 
using a heat-pulled glass microcapillar at the following stereotaxic coordinates: for DG, 
-1 mm anteroposterior (AP), ±1.2 mm laterolateral (LL), -1.7 mm dorsoventral (DV); for 
the DMS -0.9 mm AP, ±1.4 mm LL, -1.7 mm DV. The microcapillar was introduced 
percutaneously to inject 0.3 µl of SFFV-RV in each hippocampal region at 0.3 µl/min 
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rate flow. After surgery, mice were quickly placed in a warm water bath first and later 
on a thermal blanket until their respiration, color of the skin and locomotor activity 
returned to normal. Finally, in order to facilitate re-acceptance of the mother, they were 
impregnated with a mixture of the mother´s own stool, bedding and water prior to 
returning them to the breeding cage. The whole procedure for each pup was carried 
out in less than 10 minutes to minimize as much as possible maternal stress. No pups 
were rejected or abused by the dam. However, and despite mortality was almost 
negligible, all the pups that did not recover from anesthesia corresponded to the P5 
age group, suggesting a major susceptibility to hypothermia at this age. 
The implemented method allows the delivery of viral particles in the targeted 
anatomical regions, yet the injection accuracy is not 100% due to the variability in each 
animal size and methodological limitations. Therefore, given the proximity of both 
injection sites and the small size of the pups at these postnatal stages, we employed 
also a posteriori criteria to assign correctly injected animals to each group; to classify 
an injection as “DG” we ensured that no cells were labeled by the SFFV-RV in the 
DMS. On the other hand, to classify injections to the “DMS” group, SFFV-RV-positive 
cells needed to be populating the entire stream above the fimbria from the injection site 
into the DG. Furthermore, the path of the microcapillar was observable in several 
cases, assuring the identification of the injection site. Injections that only reached the 
meninges were differentiated from DMS injections due to their location forming a 
stream under the ventral blade of the DG and the characteristic elongated morphology 
of the cells in this region. 
5.3.2. Adult stereotaxic intrahippocampal injections 
Intrahippocampal KA injections were performed as previously described (Sierra 
et al., 2015). Briefly, animals were anesthetized intraperitoneally with a mixture of 
Ketamine- (75 mg/kg; Ketamine, #581140) and Medetomidine- (1 mg/kg; Sedastart, 
Pfizer) induced anesthesia and received a single subcutaneous dose of analgesic 
Buprenorphine (1 mg/kg; Buprecare, Animalcare Lted., #582039). Mice were ensured 
to be in deep anesthesia by checking for regular, relaxed respiration and the lack of 
response to tail/toe pinch. Then, the hair over the scalp was shaved and after 
positioning the mice in the stereotaxic apparatus, povidone iodine was applied to clean 
and disinfect prior a surgical incision to separate the skin over the scalp. Stereotaxic 
coordinates were taken from the reference point Bregma. The hippocampal region was 
selected at the following coordinates: -1.8 mm AP, -1.6 mm LL and -1.9 mm DV. In 
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order to reach the desired position, the skull was perforated using a 0.6 mm 
micromotor high-speed drill. 
To induce SE 50 nl of a 20 mM solution of KA (Sigma-Aldrich, #K0250/K3375) 
were delivered using a nanoinjector (Nanoject II, Drummond Scientific, #3-000-205A) 
attached to a pooled glass microcapilar filled with mineral oil as previously described 
(Sierra et al., 2015). To assess the role of Zn+2 in the neurogenic niche, 5, 20 and 30 
nM were administered using a stainless steel cannula (outer diameter, 0.28 mm) 
connected to a Hamilton microsyringe (Hamilton, #84250). For EGFR inhibition Afatinib 
dimaleate (Selleck Chemicals, #S7810) was diluted with saline to a concentration of 70 
µM and injected intrahipocampally prior KA injection. In each case, a solution in 0.9% 
sterile NaCl was used for control animals. The cannula was left for 5 minutes to avoid 
the reflux along the cannula tract and then the skin over the mice skull was sutured and 
the animals were placed in a thermal blanket until they got recovered from anesthesia. 
5.4. Treatments 
5.4.1. Intranasal administration of the EGFR inhibitor Gefitinib 
10 mg/Kg of Gefitinib (Selleck Chemicals, #S1025) were diluted with 0.5% 
Methylcellulose and 0.2% Tween 80 following manufacturer instructions and 
intranasally administered starting immediately after stereotaxia and twice a day for the 
first three days, as previously described (Hanson et al., 2013; Pineda et al., 2013). 10 
µl of the solution were administered into the right nostril using a pipette tip and holding 
the mice as previously described (Hanson et al., 2013). To avoid that the mice snorted 
out solution drops, administration was performed in several series, waiting a few 
seconds between each administration while keeping the animal immobilized. Pipette 
tips were replaced for every animal in order to avoid dose excesses. 
5.4.2. Subcutaneous administration of the Zn+2 chelator TPEN 
To chelate extracellular Zn+2, TPEN solution was freshly prepared in 10% 
ethanol (10% ethyl alcohol in normal physiological saline, Merck, #616394) and 
injected subcutaneously under the nape skin of the animals twice a day at 5 mg/kg (9–
10 am and 17–18 pm) as previously described (Kim et al., 2012). Administration was 
done for one week after KA intrahippocampal injection. For control animals, an 
equivalent volume of 10% ethanol was administered each time. 
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5.4.3. BrdU administration 
BrdU (Sigma, #B5002-1G) was diluted in sterile saline and administered 
intraperitoneally at 150 mg/kg three consecutive times separated by 3 h intervals. For 
the analysis three days after KA or Zn+2 intrahippocampal injection and seven days 
after Zn+2 intrahippocampal injection, BrdU was given 24 h before sacrifice in order to 
label proliferating cells. For the experiments 14 days after KA or Zn+2 intrahippocampal 
injection, BrdU was administered right after the last Gefitinib administration (third day 
after KA/Zn+2) in order to see the fate of newly generated cells born after the end of 
treatments. In the in vitro experiments, a pulse of at 10 µM BrdU for 1 h was performed 
before cell fixation in order to label proliferating cells. 
5.5. Cell cultures 
NSPC cultures were obtained using an adaptation of the protocol previously 
described for HPF and SVZ (Jhaveri et al., 2015; Pineda et al., 2013) in which a mix of 
Papain and DNAse enzymatic solution (20.000 U; 195 U/µl) was preheated (37ºC and 
5% CO2) for extracellular matrix digestion and Ovomucoid was used to halt enzymatic 
activity avoiding serum, instead of DMEM/F-12 medium. Briefly, hippocampi were 
extracted from either C57BL/6 or Nestin-GFP mice, pooled and placed in ice-cooled 
phosphate buffered saline (PBS)-Glucose (50 µl glucose 30% into 50 ml PBS), cut into 
small pieces of approximately 2 mm. Next, the sample was placed into a 15 ml tube, 
washed to minimize risk of contamination and incubated with the previously-heated 
enzymatic digestion for 15 minutes at 37ºC. The sample was mechanically agitated 
every 5 min to avoid aggregation of the tissue.  
Afterwards, supernatant was discarded and the enzymatic reaction halted using 
950 µl of the Papain inhibitor Ovomucoid. Then, cells were disaggregated by pipette tip 
mechanical dissociation. The resultant cell suspension was filtered into a 15 ml tube 
and cells were centrifuged 10 min at 200G, the pellet was resuspended in 500 µl of 
Neurocult proliferation medium enriched with 10% proliferation supplement (Stem Cell 
Technologies, #05702), 2% B27, 0.24% Heparin (Stem Cell Technologies, #07980), 
0.8% EGF and 0.2% FGF (Peprotech, #P01132 and #P15655) of the total volume and 
placed in T25 flask with 5 ml of Neurocult enriched medium. Cells were maintained at 
standard conditions in a humidified 37ºC incubator containing 5% CO2. 
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NSPC cultures were then passaged every 7 days by enzymatic disaggregation 
with Accutase (Stem Cell Technologies, #7920) in presence of the antibiotics Penicillin 
100 U/ml and Streptomycin 150 µg/ml (Gibco, #15140 and #15122), as previously 
described (Pineda et al., 2013). NSPC cultures were maintained for a maximum of 4 
total passages in order to preserve heterogeneous population and avoid cell selection 
issues. For IHC assays, NSPCs were seeded into 12 mm coverslips coated with 
Laminin (Sigma, #L2020) as previously described (Silvestre et al., 2012). For the 
assessment of cell signalization by WB in control and KA conditions, 400,000 NSPCs 
per condition were used. For proliferation/inhibition assays, the number of NSPCs was 
reduced to 25,000 cells per well in order to reduce cell density and avoid inhibition of 
cell proliferation by cell-to-cell contact. In order to study the effects of Zn+2 over EGFR 
signaling pathway and its inhibition (using Gefitinib), cells were rinsed and cultured with 
starved media without growth factors during 2 h to downregulate EGFR downstream 
signaling. Then, cells were preincubated with 2 µM Gefitinib and/or stimulated either 
with 200 µM of Zn+2, 100 ng/ml of HB-EGF and 20 ng/ml of EGF for 2 h. 
5.6. RNA extraction RT-qPCR 
5.6.1. RNA extraction and reverse transcription 
Hippocampi dissected at different time points (0 h 1.5 h 12 h 24 h 72 h post KA 
injection) were immediately frozen with RLT buffer. Total RNA extraction and DNAse 
treatment to eliminate genomic DNA residues were carried out following manufacturer’s 
instructions (Qiagen). The quantity of RNA was measured using the Nanodrop 2000. 
Next, 1.5 µg of RNA were retrotranscribed using random hexamers and Superscript III 
Reverse Transcriptase kit (Invitrogen, #10432122), accordingly to manufacturer’s 
instructions using a Veriti Thermal Cycler (Applied Biosystems, #4375305). 
5.6.2. RT-qPCR 
RT-qPCR was performed on a BioRad CFX96 using Power SybrGreen 
(BioRad, #1708880) for complementary DNA amplification and the primers shown in 
Table 1. The protocol was 3 min at 95oC for denaturing, 45 cycles of 10 sec at 95oC for 
annealing and 30 sec at 60oC. Each sample was normalized to endogenous GAPDH 
and HPRT expression. Each reaction was performed at least twice in duplicate. 
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HPRT NM_013556.2 150 
Fwd:5’-GTTGGGCTTACCTCACTGCT-3’ 
Rev:5’-TCATCGCTAATCACGACGCT-3’ 
GAPDH NM_001289726.1 153 
Fwd:5’-CCAGTATGACTCCACTCACG-3’ 
Rev:5’-GACTCCACGACATACTCAGC-3’ 
EGFR NM_007912.4 165 
Fwd:5’-GCCAACTGTACCTATGGATGT-3’ 
Rev:5’-GGCCCAGAGGATTTGGAAGAA-3’ 
FGFR1 NM_001079908.2 88 
Fwd:5’-CCAAACCCTGTAGCTCCCTA-3’ 
Rev:5’-TGAACTTCACCGTCTTGGCA-3’ 
FGFR2 NM_010207.2 105 
Fwd:5’-CCGAATGAAGACCACGACCA-3’ 
Rev:5 -TCGGCCGAAACTGTTACCTG-3’ 
MTH1 NM_013602.3 86 
Fwd:5’-TCACCACGACTTCAACGTCC-3’ 
Rev:5’-CAGTTGGGGTCCATTCCGAG-3’ 








Table 1. List of primers used for RT-qPCR. 
5.7. IHC  
5.7.1. Rodent brain tissue 
IHC was performed as previously described using the methods optimized for 
the use in transgenic mice (Encinas and Enikolopov, 2008; Encinas et al., 2011a). In 
brief, animals were transcardially perfused with 30 ml of PBS 1X followed by 30 ml of 
4% PFA in PBS, pH 7.4. Next, the brains were removed and postfixed for 3 h at room 
temperature in the same fixative solution, transferred to PBS-0.2% sodium azide and 
kept at 4ºC. Serial 50 µm-thick sagittal sections were cut using a Leica VT 1200S 
vibrating blade microtome (Leica Microsystems GmbH). For postnatal SFFV-RV 
experiments, serial 70 µm-thick coronal sections were cut to properly visualize the 
extension of the SFFV-RV infection. For the IHC, sections were incubated with blocking 
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and permeabilization solution (PBS containing 0.25% Triton-X100 and 3% bovin serum 
albumin (BSA)) for 3 h at room temperature and then incubated overnight with the 
primary antibodies (diluted in the same solution) at 4ºC. After the incubation, the 
primary antibody was removed and the sections were washed with PBS three times for 
10 minutes. Next, the sections were incubated with fluorochrome-conjugated 
secondary antibodies diluted in the permeabilization and blocking solution for 3 h at 
room temperature. After washing with PBS, the sections were mounted on gelatin 
coated slides with Fluorescent Mounting Medium (DakoCytomation, #S302380). For 
the BrdU analysis and Nestin-including experiments, sections were treated with 2M 
chlorhydric acid (HCl) during 20 minutes at 37ºC and immediately incubated with 0.1M 
tetraborate for 10 minutes at room temperature before the staining. Aferwards, the 
sections were washed with PBS and the staining followed as describe above. GFP 
signal from Nestin-GFP and LPA1-EGFP transgenic mice, as well as the mCerulean 
signal from SFFV-RV, was detected with an antibody against GFP for enhancement 
and better visualization. Likewise, mCherry signal from SFFV-RV was detected with an 
antibody against DsRed for enhancement and visualization. The complete list of 
primary and secondary antibodies is indicated in Tables 2 and 3. 
5.7.2. Cell cultures 
After every treatment, cell cultures were fixed with PFA 4% dissolved in PBS-
4% sucrose. Next, the coverslips with cells attached were incubated with PBS-0.3% 
Triton-X100 1% BSA during 3 minutes at room temperature for permeabilization and 
incubated with the primary antibody diluted in 0.2% Triton-X100 and 3% BSA in PBS 
over night at 4ºC. After, they were washed with PBS three times and incubated with the 
secondary antibody containing DAPI in the same solution for 2 h at room temperature. 
Finally, the coverslips were mounted upside down on glass slides with Fluorescent 
Mounting Medium. For the BrdU experiments, cells were treated before the staining 
using 2M HCl during 5 minutes at 37ºC and immediately incubated with 0.1M 
tetraborate for 10 minutes at room temperature. Aferwards, sections were washed with 
PBS and the staining followed as describe above. The list of antibodies can be found in 
Tables 2 and 3. 
5.7.3. Human tissue 
Blocks of human brain tissue were cut into 30 μm-thick sections using a cryostat 
and then directly attached to pre-frozen (-20ºC) Superfrost glass slides (1 section per 
slide) and stored at -80ºC until use. For each case, a minimum of three sections were 
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colored with Cresyl Violet staining to confirm anatomical landmarks and orientation of 
the sample. IHC was conducted following the protocol previously described (Sorrells et 
al., 2018). 
Prior to IHC, frozen slides were allowed to equilibrate to room temperature for 3 
h and then baked at 65ºC for 30 min. After rehydrating the slides using 0.05% Triton-
X100 in PBS (TNT buffer), they were post-fixed with 4% PFA for 45 min. Slides were 
rinsed with TNT and distilled water and then the endogenous peroxidase was 
quenched using a solution of 1% H2O2 in PBS for 30 min. For the epitopes requiring 
antigen retrieval an additional incubation with 10 mM sodium citrate buffer, pH 6.0 at 
95ºC for 10 min, and then the slides were cooled down at room temperature. After that, 
slides were washed with TNT for 10 min three times and re-placed in 1% H2O2 in PBS 
for 1 h 30 min to ensure proper quenching of the endogenous peroxidase. Unspecific 
unions were blocked with 0.1 M Tris-HCl, pH 7.5, 0.15 M NaCl, 0.5% blocking reagent 
from PerkinElmer (TNB solution) for 1 h and then the slides were incubated with the 
primary antibodies diluted in TNB overnight at 4 °C (Table 4).  
Next day after the overnight incubation, slides were washed with TNT for 10 min 
three times and incubated with secondary antibodies in TNB. For the strongest signals 
directly coupled secondary antibodies were used. For the weakest signals, an 
amplification of staining intensity was performed using the Tyramide signal 
amplification kit (PerkinElmer). Briefly, biotinylated secondary antibodies (Jackson 
Immunoresearch Laboratories) were incubated for 2.5 h at room temperature. Then, 
the binding of streptavidin–horseradish peroxidase (diluted at 1:200 in TNB) was 
allowed for 30 min. Finally, tyramide-working solution with the conjugated fluorophores 
(FITC: 1:50; Cy3: 1:100; Cy5: 1:100) was incubated for 5 min and the reaction 
terminated with the Reaction Stop Reagent. 
The IHC protocol was performed sequentially for different antibodies, incubating 
the strongest primary antibody and its respective secondary antibody in the first place. 
Therefore, after the tyramide-working solution incubation, slides were re-fixed for 
another 30 minutes and incubated in 3% H2O2 H2O2 in PBS, re-initiating the protocol for 
the rest of primary antibodies. Finally, once all antibodies were incubated, sections 
were thoroughly washed with TNT, dehydrated, mounted and coverslipped. 
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PRIMARY ANTIBODIES FOR IHC 

























































Table 2. Primary antibodies used for mice tissue and cell cultures. 
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SECONDARY ANTIBODIES FOR IHC 
ANTIBODY COMPANY DILUTION 
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PRIMARY ANTIBODIES FOR IHC 





























Table 4. Primary antibodies used for human tissue. 
5.8. WB 
Depending on the experiment, hippocampal tissue or cultured NSPCs were 
collected at indicated time points in RIPA buffer mixed with protease inhibitor cocktail 
and phosphatase inhibitors. Each sample was conserved at -80ºC until its use. The day 
of the experiment, samples were homogenized and centrifuged at 14000 rpm for 10 
min. Supernatant protein (20 µg) was loaded in a 10% Tris-Glycine gels and 
transferred to a nitrocellulose membrane (Life technologies, #88018). Ponceau staining 
(Sigma-Aldrich, #P7170) was carried out in the membranes to check the correct protein 
and band migration. To stain our proteins of interest, membranes were blocked in 5% 
nonfat dry milk in TBS-T (150 mM NaCl, 20 mM Tris-HCl, pH 7.5, 0.05% Tween 20) for 
1 h and then incubated with the primary antibodies (Table 5) for 2 h. After three 
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washes in TBS-T, membranes were incubated with secondary antibodies (Table 6) for 
another hour and visualized by ECL SuperSignal (Thermo Fisher, #34095) Western 
blotting analysis system. 
PRIMARY ANTIBODIES FOR WB 





Mouse anti-EGFR Abcam 1:1000 













































Table 5. Primary antibodies used for WB. 
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SECONDARY ANTIBODIES FOR WB 











Table 6. Secondary antibodies used for WB.  
5.9. ELISA 
To measure HB-EGF levels in the NSPC cultures or in brain tissue exposed to 
KA at different time points, we used the R&D DuoSet Immunoassay as described 
previously (Luzuriaga et al., 2019). Either cellular pellet or brain tissue were lysed using 
a buffer containing Hepes 25 mM, 5 MgCl2 5 mM EGTA 1 mM, EDTA 1.3 mM, PMSF 1 
mM and a protease and phosphatase cocktail inhibitors (Thermo Fisher, #88665 and 
#78420).  
For cell cultures, 250,000 cells were seeded in a 96 well plate using 150 µl of 
culture media deprived of growth factors. The cell containing media was collected 72 h 
after plating. After centrifuging 10 min at 14,000 rpm at 4ºC, 100 µl of the lysed cell 
pellet and/or supernatant were diluted 1:1 in reagent diluent for the analysis. In parallel 
conditions, right after 72 h of culture, the number of cells was counted using a Bio-Rad 
TC20 automated cell counter, as well as trypan blue to mark and exclude death cells. 
We therefore determined the amount of HB-EGF per cell at the end of the experiment.  
For analysis of HB-EGF levels in brain tissue, mice were deeply anesthetized in 
a CO2 chamber at 0 h, 1.5 h, 12 h, 24 h and 72 h post-KA or saline administration (n=4 
per condition). Their hippocampus was extracted on ice and rapidly frozen using dry 
ice. Samples were homogenized in lysis buffer and immediately centrifuged (20 min at 
14,000 rpm at 4ºC). Supernatants were collected and the total protein content was 
analyzed using the BCA protein assay kit (Pierce, #23227). 100 µg of protein were 
loaded for each point diluted 1:1 in reagent diluent buffer. 
Both in vitro and in vivo quantifications were performed using the following four 
parameter logistic (4-PL) curve fit: 
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Where x and y were the independent and dependent variables respectively, a 
and d were the minimum and maximum values measured, c was the point of inflection 
halfway between a and d and b was the Hill’s slope of the curve (steepness of the 
curve at point c). 
For in vitro analyses the values were normalized and expressed as µg of HB-
EGF per ml and for in vivo analyses the values were calculated as µg of HB-EGF per 
µg of tissue protein. 
5.10. Danscher stainning 
For indirect autometallographic Danscher method, 20 mg/kg of sodium selenite 
was injected intraperitoneally 30 minutes before PFA 4%-Glutaraldehyde 0.5% 
perfusion and the tissue processed by serial cutting of 50 µm slices. The staining was 
developed as previously described (López-García et al., 2002). Granule size and 
quantification was carried out determining the ROI of the GFP cell region (15-20 cells 
per condition) and particle analyzer using ImageJ software. 
5.11. Image analysis 
Most of fluorescence immunostaining images were collected using the 40X oil-
immersion objective of a Leica SP8 laser scanning confocal microscope. For the 
quantification of total areas of the DG the 10X objective was used to completely 
visualize the DG in each section. For the pictures of developing mouse DG in which 
DMS is illustrated, and for all human pictures, the 3DHistech panoramic digital 
slidescanner was used. The signal from each fluorochrome was collected sequentially, 
and brightness, contrast, and background were adjusted equally for the entire image 
using the software of the confocal microscopy Leica LAS X Life Science.  
5.11.1. Quantitative analysis of cell populations  
Quantitative analysis of cell populations in vivo was performed by design-based 
(assumption free, unbiased) stereology using a modified optical fractionator sampling 
scheme as previously described (Encinas and Enikolopov, 2008; Encinas et al., 2006, 
2011a). 
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For cell densities, quantifications were done maintaining the same z-stack size 
between conditions. The values were normalized to the volume of the SGZ+GCL in the 
counted area. For total numbers, the whole area of the DG was determined for every 
slice of a single series and then multiplied by the thickness of the GCL, that was 
measured at least in three points in each slice. The obtained value was multiplied by 5 
to obtain the volume of the whole DG. 
For experiments during postnatal stages prior to P14, where NSCs are still not 
morphologically adult-like (Brunne et al., 2013; Nicola et al., 2015), cells were 
quantified as dNSCs when they had their soma located inside the GCL, and fulfilled the 
following criteria: Expression of the well-described NSC markers Nestin-GFP and 
GFAP (Encinas and Enikolopov, 2008; Kronenberg et al., 2003; Seri et al., 2001) and 
presence of a radial process extended towards the ML. From P14 on, NSCs were 
counted following previously described criteria for their identification (Encinas and 
Enikolopov, 2008; Kronenberg et al., 2003).To identify proliferating cells, it was used 
the marker Ki67. NSCs positive for the criteria described above and positive for this 
marker were counted as proliferating dNSCs/NSCs. 3-4 pictures of 1024x1024 frame 
size z-stacks were chosen randomly in the GCL of 3-5 medial DG slices (depending on 
the age of the animal). For adult tissue sections, 3-4 z-stacks located at random 
positions in the DG were collected per hippocampal section, and 4-6 sections per 
series were analyzed, depending on the experiment. For cultured NPSCs, 5 pictures of 
4 µm-thick random z-stacks of the coverslips were collected per sample and condition.  
For the experiments using SFFV-RV infections, we quantified all cells infected 
in the GCL for each condition. We also quantified the number of NSCs in the infected 
area (region with SFFV-RV-positive cells) to obtain the percentage of NSCs infected 
with the SFFV-RV per condition. 
To measure cell death, apoptotic cells were defined as cells with abnormal 
nuclear morphology (pyknotic/karryorhectic). In MTLE experiments, GCD was 
measured in DAPI- and NeuN-stained sections. 
For the anaysis of EGFR expression after KA administration, an open-source 
plug-in for ImageJ was used. In brief, the area was measured as the pixels occupied by 
EGFR. Using the same “noise-tolerance” for all conditions the area was quantified with 
“find maxima” option obtaining the total area occupied by EGFR.  
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The proliferation of cultured NSPCs was measured by the incorporation of 
BrdU. The relative proportions of BrdU-positive NSPCs were referred to the total 
number of cells (DAPI staining) quantified per coverslip and conditions. The 
proliferation in all the conditions was refered to the basal proliferation of the control 
condition. 
5.11.2. Morphological analysis of NSCs: SHOLL analysis 
3D confocal images were exported and cell morphology analyzed using 
NeuronStudio 0.9.92 software (Rodriguez et al., 2006). Results were exported into 
Excel to pool all the cells and GraphPad Prism v5 was used for graph representation 
and statistical analysis. 
5.12. Statistical analysis 
SigmaPlot was used for statistical analysis, except for the morphological 
analyses for which GraphPad Prism v5 was used. For analysis of pairs of groups the 
Student’s t test was performed, resorting to U-Mann Whitney test when data were non 
parametric. When more than two groups were present, one-way analysis of variance 
(ANOVA) test of all groups was performed to determine the overall effect of each 
factor, resorting to Kruskal-Wallis test when data were no parametric. Two-way ANOVA 
was performed to detect interaction between factors. In all cases, all pairwise multiple 
comparisons (Holm-Sidak, Dunn or Student-Newman-Keuls test) were used as a post 
hoc test to determine the significance between groups in each factor or comparisons 
versus control group (Holm-Sidak, Dunn, Dunnet or Tukey test) to determine the 
significance of each factor compared to the control group. A logarithmic transformation 
of the data was performed when required to comply with ANOVA assumptions 
(normality and homocedascity). p<0.05 was considered as statistically significant. 
Results were presented as mean ± standard error mean (SEM). The number of 


















6.1. cD2 is essential for the formation of the adult NSC population 
To investigate the role of postnatal cell proliferation on the formation of adult 
NSCs, we examined the development of the DG in the presence (WT) or absence of 
cD2 (cD2KO); a relevant factor involved in the transition from G1 to S phase during cell 
cycle (Matsushime et al., 1992; Meyerson and Harlow, 1994; Sherr, 1995). cD2KO 
mice have been shown before to have only residual AHN left (Ansorg et al., 2012), but 
it is unknown whether this is due to an impairment in the neurogenic capacity of adult 
NSCs or in contrast, to a failure in the formation of the NSC pool during development. 
Here, we visualized NSCs on the Nestin-GFP/cD2KO mutant mice and compared to 
the Nestin-GFP/WT at five different postnatal time points (P0, P7, P10, P14 and P28) 
(Figures R1-R3). We defined as NSCs those cells located inside the GCL, expressing 
both Nestin-GFP and GFAP markers and extending a radial process towards the ML. 
6.1.1. In the absence of cD2, adult NSC population failed to form 
The embryonic development, up to early postnatal stages, of the DG in cD2KO 
mice is similar to the WT (Kowalczyk et al., 2004), which makes this mouse a valuable 
tool to assess the relevance of postnatal proliferation in the formation of the 
hippocampal neurogenic niche. Indeed, the overall proliferation is decreased in the 
GCL of the cD2KO from P7 onwards and AHN is almost completely absent (Ansorg et 
al., 2012). Therefore, we wondered whether the absence of AHN was due to an 
impaired neurogenic capacity of the NSCs or to a failure in the formation/establishment 
of the NSC population during the postnatal period. We assessed the number and 
proliferation dynamics (by Ki67 expression) of the NSCs present in the GCL at different 
ages (P0, P7, P10, P14 and P28) (Figures R1-R3) in cD2KO and WT mice using 
stereology, strict marker expression and morphological criteria to define NSCs 
(expression of both Nestin and GFAP, soma inside the GCL, extended process 
towards the ML and broccoli-like crown). As well, we measured the volume of the GCL 
using DAPI. Since at least during the postnatal period the distinction between dNSCs 
and adult NSCs remains unclear (as we will further address later) and the precise 
moment of generation of adult NSCs is not known, we based on temporal criteria to 
differentiate them. The population of NSCs is considered adult at a population level at 
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P14 (Nicola et al., 2015) and therefore, before P14 we referred to the NSCs in the GCL 
as dNSCs, and as adult NSCs after P14. 
Our results showed that at P0 the morphology of dNSCs was similar between 
both conditions, as well as the number of dNSCs located in the GCL and the volume of 
the GCL (Figure R1 A-F). However, these similarities shifted at P7. In the absence of 
cD2, a smaller GCL was clearly observable, the dNSCs were significantly fewer than in 
the WT and they showed an abnormal morphology with a shorter process (Figure R1 I-
N). We also assessed whether cell division was specifically altered in dNSCs using the 
cell cycle marker Ki67 to quantify the proliferating dNSCs at each time point. The total 
number and proportion of dNSCs that remained cycling in cD2KO mice was not 
significantly different from the WT neither at P0 nor P7, although a trend towards a 
reduced total number of proliferating dNSCs was observable at P7 (Figure R1 G-H;O-
P).  
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Figure R1. In the cD2KO mice, dNSCs failed to properly expand during the first postnatal week. A-
D) Representative confocal images of the dNSCs (Nestin-GFP /GFAP) and proliferating cells (Ki67) in the 
DG of WT and cD2KO mice at P0. E) Quantification of the total number of dNSCs in the GCL of WT and 
cD2KO mice at P0. F) Quantification of the GCL volume of WT and cD2KO mice at P0. G) Quantification 
of the total number of cycling dNSCs in the GCL of WT and cD2KO mice at P0. H) Quantification of the 
percentage of cycling dNSCs in the GCL of WT and cD2KO mice at P0. I-L) Representative confocal 
images of the dNSCs (Nestin-GFP /GFAP) and proliferating cells (Ki67) in the DG of WT and cD2KO mice 
at P7. M) Quantification of the total number of dNSCs in the GCL of the DG of WT and cD2KO mice at P7. 
N) Quantification of the GCL volume of WT and cD2KO mice at P7. O) Quantification of the total number of 
cycling dNSCs in the GCL of WT and cD2KO mice at P7. P) Quantification of the percentage of cycling 
dNSCs in the GCL of WT and cD2KO mice at P7. GCL: Granule cell layer. SGZ: Subgranular zone. Scale 
bars are of 10 µm. *p<0.05 and ***p<0.001 Student ‘s t-test. Bars show mean ± SEM. Dots show individual 
data.  
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At P14, when the hippocampal neurogenic niche is already considered to be 
adult-like (Nicola et al., 2015), NSCs in the cD2KO were morphologically distinct 
(Figure R2 A-D) and the number was significantly lower compared to the WT (Figure 
R2 E). Likewise, the GCL volume was highly smaller in the absence of cD2 (Figure R2 
F) and the total number of proliferating NSCs was also significantly reduced (Figure R2 
G), although the percentage of proliferating NSCs among the total NSCs was unaltered 
(Figure R2 H). Moreover, the differences observed at P14 were aggravated later at 
P28 and the few remaining cells in the cD2KO were morphologically aberrant (Figure 
R2 I-L). At P28, the number of NSCs was more than 3-fold lower and the GCL volume 
was 50% smaller (Figure R2 M-N). Also, NSC proliferation was clearly impaired with a 
negligible number of proliferating NSCs and a reduced percentage of proliferating 
NSCs (Figure R2 O-P). 
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Figure R2. In the absence of cD2, the adult NSC population did not get fully generated, leading to 
its early depletion at P28. A-D) Representative confocal images of the NSCs (Nestin-GFP /GFAP) and 
proliferating cells (Ki67) in the DG of WT and cD2KO mice at P14. E) Quantification of the total number of 
NSCs in the GCL of the DG of WT and cD2KO mice at P14. F) Quantification of the GCL volume of WT 
and cD2KO mice at P14. G) Quantification of the total number of cycling NSCs in the GCL of WT and 
cD2KO mice at P14. H) Quantification of the percentage of cycling NSCs in the GCL of WT and cD2KO 
mice at P14. I-L) Representative confocal images of the NSCs (Nestin-GFP /GFAP) and proliferating cells 
(Ki67) in the DG of WT and cD2KO mice at P28. M) Quantification of the total number of NSCs in the GCL 
of the DG of WT and cD2KO mice at P28. N) Quantification of the GCL volume of WT and cD2KO mice at 
P28. O) Quantification of the total number of cycling NSCs in the GCL of WT and cD2KO mice at P28. P) 
Quantification of the percentage of cycling NSCs in the GCL of WT and cD2KO mice at P28. GCL: 
Granule cell layer. SGZ: Subgranular zone. Scale bars are of 10 µm. *p<0.05, **p<0.005 and ***p<0.001 
Student’s t-test. Bars show mean ± SEM. Dots show individual data.  
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In summary, in the absence of cD2 the DG was not correctly formed and 
dNSCs failed to expand between P0-P14 (Figure R3 A-F; I-J). Therefore, the cD2KO 
DG hosted substantially fewer NSCs from P14 onwards, resulting in the almost 
depletion of the NSC population at P28 that explains the absent AHN in these mice 
(Figure R3 G-I). In addition, a trend towards fewer NSCs entering cell cycle was 
observed in the cD2KO from P7 on, being statistically significant from P14 on (Figure 
R3 K). However, the percentage of dividing NSCs was unaltered until P28, when a 
trend towards lower dividing NSCs was observed in the cD2KO (Figure R3 L). Hence, 
we hypothesized that the observed diminished size of the adult NSC pool in the cD2KO 
could be due to a reduced expansion of the dNSCs, or on the contrary due to aberrant 
dNSC dynamics at early postnatal stages (related to cell survival and apoptosis) that 
would impede its correct formation. 
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Figure R3. Mice lacking cD2 failed to generate the adult NSC population during the first two 
postnatal weeks. A-H) Representative confocal images of the DG and the neurogenic niche of WT and 
cD2KO mice from P0 to P28. I) Quantification of the total number of NSCs in the GCL of the DG of WT and 
cD2KO mice from P0 to P28 J) Quantification of the GCL volume of WT and cD2KO mice from P0 to P28. 
K) Quantification of the total number of cycling NSCs in the GCL of the DG of WT and cD2KO mice from 
P0 to P28. L) Quantification of the percentage of cycling NSCs in the GCL of WT and cD2KO mice from 
P0 to P28. GCL: Granule cell layer. ML: Molecular layer. Scale bars are of 100 µm. *p<0.05, **p<0.01 and 
***p<0.001. Two-way ANOVA followed by all pairwise comparisons by Holm-Sidak post hoc test. Dots 
show mean ± SEM. To comply with homoscedasticity all data were Log10 transformed. 
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6.1.2. Cell death is not increased in the absence of cD2 
We next moved to investigate whether the abnormally reduced postnatal 
expansion of the NSC population in cD2KO mice could be accounted by possible 
increased cell death of dNSCs. To evaluate cell death, we quantified the density of 
pyknotic nuclei in the GCL at each time point (P0, P7, P14, P28) (Figure R4 E-F), as 
pyknosis involves the irreversible condensation of chromatin in cells undergoing 
necrosis or apoptosis (Burgoyne, 1999). The results showed no alterations in the 
density of pyknotic cells neither at P0 nor at P7 (Figure R4 F). However, after P14 
there were less pyknotic nuclei in the cD2KO (Figure R4 A-D; F), which could be 
attributable to the fact that there were fewer NSCs and lower neurogenesis. Therefore, 
in the absence of cD2 dNSCs developed following the same apoptotic dynamics than 
in the WT, whereas after P14 cell death is reduced in the cD2KO consistent with a 






















Figure R4. The absence of 
cD2 did not affect the cellular 
apoptotic dynamics until the 
complete formation of the 
neurogenic niche. A-D) 
Representative confocal images 
of the GCL of WT and cD2KO 
mice at P14. Arrows point to 
apoptotic cells in the WT mice. 
E) Representative confocal 
image of an apoptotic cell. F) 
Quantification of the cell death 
density at different time points 
during the DG postnatal 
formation (P0, P7, P14, P28). 
GCL: Granule cell layer. Scale 
bars are of 10 µm in A-D and 5 
µm in E. **p<0.01 and 
***p<0.001. Two-way ANOVA 
followed by all pairwise 
comparisons by Holm-Sidak 
post hoc test. Dots show mean 
± SEM. To comply with 






6.2. Postnatal on-site generation of the adult DG NSC population 
Our previous results indicated that early postnatal proliferation, in a cD2-
dependent manner, was essential for the adult NSC pool formation. Nonetheless, 
during the formation of the DG, including the postnatal period, several transitory 
neurogenic/gliogenic niches get generated in different regions of the HPF (Hodge et al., 
2013; Li et al., 2013). One of these transient neurogenic/gliogenic niches is the DMS, a 
migratory stream formed during the early embryonic period by dNSCs and progenitors 
that migrate from the DNe into the DG. Importantly, the DMS remains active during the 
early postnatal period (Hodge et al., 2013; Li et al., 2013; Nakahira and Yuasa, 2005; 
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Sugiyama et al., 2013). Therefore, the adult NSC precursors could be proliferating in 
the DMS or be already inside the DG early after birth. Taking this into account, we next 
moved to evaluate the contribution of the precursors located in these two regions of the 
HPF to the formation of the DG and especially to the adult neurogenic niche, i.e. 
progenitors located inside the DG and the ones coming from the DMS during the 
postnatal development (Altman and Bayer, 1990a; Berg et al., 2019; Hodge et al., 
2013; Sugiyama et al., 2013).  
6.2.1. SFFV-RV infections to identify the spatial origin of adult NSCs 
Aiming to differentially label dividing dNSCs located inside the DG or the DMS, 
we resorted to the intrahippocampal administration of SFFV-RVs, which are exclusively 
incorporated by cells undergoing mitotic phase (Weber et al., 2012). To test the 
accuracy of the injections and the efficiency and diffusion of the SFFV-RV, we infected 
mice in vivo by intrahippocampal injections of a SFFV-RV-mCherry vector at P2 and P5 
and studied the location of SFFV-RV-infected cells shortly after (two days post-
infection) (Figure R5 A).  
We set up two different injection paradigms. First, we injected inside the DG to 
stain dividing cells exclusively in the hilus and GCL. This led to infections in which 
labeled cells were completely excluded from the DMS (Figure R5 B-C). In the second 
paradigm we injected outside the DG, in the DMS. These injections labeled dividing 
cells settled in the DMS without infecting any cell inside the DG (Figure R5 D-E). Thus, 
these two injection paradigms were probed to be effective to reveal independently the 
differential lineage of the dNSCs located in the two hippocampal regions. 
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 Previous page. Figure R5. Postnatal SFFV-RV infections as a tool to spatially label different HPF 
dNSC populations. A) Schematics of the experimental paradigm. B-E) Fluorescence slide scanner 
images showing different spatial stereotaxic SFFV-RV-infections. Pups were injected at P2 either inside 
the DG (A) or in the DMS (B) and the injection site was evaluated at P4. C-D) Fluorescence slide scanner 
images showing different spatial stereotaxic SFFV-RV-infections. Pups were injected at P5 either inside 
the DG (C) or in the DMS (D) and the injection site was evaluated at P7. The square delimitates the DMS 
and the arrow the injection path. At both ages, infected cells were never observed in both DG and DMS, 
indicating that the injections were exclusive from each other. CA: Cornu ammonis. DG: Dentate gyrus. 
DMS: Dentate migratory stream fi: fimbria. GCL: Granule cell layer. LV: Lateral ventricle. Scale bars are of 
10 µm. 
To further demonstrate the lineage-tracing independency of these two 
paradigms, we performed both injection types in the same HPF at P2 and distinguished 
each injection paradigm by different fluorescent reporter genes-encoding SFFV-RVs. 
We injected a SFFV-RV-mCherry vector in the DMS and a SFFV-RV-mCerulean vector 
in the DG, thus enabling the visual distinction of the cell lineages derived from each 
region (Figure R6 A). We evaluated the lineage of the infected cells at P14, a period in 
which the population of NSCs is already established in the SGZ (Nicola et al., 2015). 
The different localization of the injections (DG vs DMS) led to independently labeled 
cell populations that did not show any overlapping, even though the lineage of both 
populations ended up located in the GCL. Indeed, the cells infected by injections in the 
DG were more restricted to the medial portions of the rostrocaudal axis, whereas the 
cells infected in the DMS injection model were observable from rostral to caudal 
regions of the DG (Figure R6 B-E), suggesting again that the different injections led to 
different cell populations, even if all were located in the DG at P14. 
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 Previous page. Figure R6. Postnatal SFFV-RV infections exclusively labeled cells in the injected 
region. A) Schematics of the experimental paradigm B-E) Fluorescence slide-scanner images showing 
different spatial stereotaxic SFFV-RV-infections in the same animal. Images are shown in the rostrocaudal 
axis in a representative way of the extension of the infection. Pups were injected at P2 either inside the DG 
(green) or in the DMS (red) and the location of the infected cells was evaluated at P14. The square 
delimitates the DMS and the arrows show the injection path. Infected cells coming from independent 
regions never overlapped, although the final destination of most cells was the GCL in both injection 
models. This indicated that the injections were exclusive from each other. CA: Cornu ammonis. DG: 
Dentate gyrus. DMS: Dentate migratory stream. fi: fimbria. GCL: Granule cell layer. LV: Lateral ventricle. 
Scale bars are of 10 µm.  
6.2.2. Only DG-located precursors contributed to generate adult NSCs 
Once the method was set up and in order to identify the spatial origin of the 
adult NSC population, we studied the full postnatal lineage of the infected hippocampal 
cells that were dividing in the DMS or in the DG at P2 and P5. For that purpose, the 
SFFV-RV-mCherry vector was used and the fate of the infected cells was evaluated at 
P14. In both time points, after DG injections the DG appeared full of SFFV-RV-infected 
cells at the medial and medial-caudal levels, near the site where the injection was 
performed. As expected, there was not a single infected cell within the DMS (Figure 
R7 A). At the same time, we could also identify many of them as neurons by 
morphology and absence of expression of NSC/astrocytic markers and we observed 
the axons of these infected GCs reaching the rostral DG in the hilar region (Figure R7 
A). On the other hand, after DMS injections the labeled lineage appeared fully 
populating the GCL, with neuron-like properties, at the medial and caudal portions of 
the DG, and the axons of the GCs reaching the rostral part. In contrast to what was 
observed in the DG injection model, the DMS was full of SFFV-RV-mCherry-expressing 
cells from rostral to caudal levels, presumably due to glial differentiation of the 
postnatally mitotic dNSCs (Figure R7 B). 
Despite both injection models resulted in infected cells populating the GCL at 
P14, some differences were observable. After DG injections at P2, cells were 
distributed all over the GCL including the SGZ, while DMS-injected cells were restricted 
to the upper part of the GCL, leaving the SGZ completely empty. Moreover, the SFFV-
RV-mCherry-labeled cells had different cellular fates in each injection model. In DG 
infections, the majority of infected cells were neurons (neuronal morphology with 
dendrites and axons and absence of expression of either Nestin-GFP or GFAP). 
However, the 4-5% of the SFFV-RV-mCherry-positive cells among both the total SFFV-
RV-mCherry-positive cells and the total NSCs were adult NSCs, identified by their 
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positive labeling for Nestin-GFP and GFAP, radial morphology and their soma located 
in the SGZ. On the contrary, we saw a negligible number of NSCs infected by the 
SFFV-RV in DMS infections (Figure R7 C-F; Figure R9). 
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 Previous page. Figure R7. The vast majority of adult NSC precursors were located inside the DG 
at early postnatal stages. A-B) Fluorescence slide-scanner images showing the spatial destination of 
SFFV-RV-infected cells in the DG (A) or in the DMS (B) from rostral to caudal. Pups were injected at P2 
and the spatial destination of the infected cells was assessed at P14. The arrow marks the injection path. 
C-D) Confocal images showing the morphology and NSC marker expression (Nestin-GFP and GFAP) of 
the SFFV-RV-infected cells located in the GCL. Arrows point to a SFFV-RV-infected NSC. E) 
Quantification of the percentage of SFFV-RV-positive NSCs among the total SFFV-RV-positive cells. F) 
Quantification of the percentage of SFFV-RV-positive NSCs among the total NSCs. CA: Cornu ammonis. 
DG: Dentate gyrus. DMS: Dentate migratory stream fi: fimbria. GCL: Granule cell layer. LV: Lateral 
ventricle. SGZ: Subgranular zone Scale bars are 200 µm in A-B and 10 µm in C-D. ***p<0.001. Student’s 
t-test. Bars show mean ± SEM. Dots show individual data.  
The observed region-dependent differences were maintained at P5. When 
precursors were infected inside the DG at this age, the SFFV-RV-mCherry-positive 
cells were found more restricted to the lower part of the GCL and along the SGZ at P14 
(Figure R8 A-D). As before, most of them were identified as neurons. Importantly, 3-
4% of the SFFV-RV-mCherry-positive cells were NSCs (Figure R8 E; Figure R9), 
corresponding in turn to the 2% of the total adult NSC population (Figure R8 F; Figure 
R9). On the other hand, following the same pattern than at P2, when precursors were 
infected in the DMS, the vast majority of the SFFV-RV-mCherry-positive cells located in 
the GCL at P14 were neurons with identifiable dendrites and axons that lacked Nestin-
GFP and GFAP labeling (Figure R8 C-F). This set of in vivo fate-mapping studies 
strongly suggested that the adult NSC population was directly generated from dNSCs 
located exclusively inside the DG early after birth, even though there were progenitors 
coming from the DMS that contributed to the neuronal formation of the DG. In 
combination with the cD2 data we postulated that a population of dNSCs located in the 
DG generated the adult NSC population directly and on-site through cD2-dependent 
mitosis during the early postnatal period. Therefore, we concluded that adult NSCs are 
a different population from dNSCs that gets independently generated after birth and 
AHN is not a mere remnant of developmental neurogenesis but a distinct phenomenon. 
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 Previous page. Figure R8. All adult NSC precursors were located inside the DG before the end of 
the first postnatal week. A-B) Fluorescence slide scanner images showing the spatial destination of 
SFFV-RV-infected cells in the DG (A) or in the DMS (B) from rostral to caudal. Pups were injected at P5 
and the spatial destination of the infected cells was assessed at P14. The arrow marks the injection path. 
C-D) Confocal images showing the morphology and NSC marker expression (Nestin-GFP and GFAP) of 
the SFFV-RV-infected cells located in the GCL. Arrows point to a SFFV-RV-infected NSC. E) 
Quantification of the percentage of SFFV-RV-positive NSCs among the total SFFV-RV-positive cells. F) 
Quantification of the percentage of SFFV-RV-positive NSCs among the total NSCs. CA: Cornu ammonis. 
DG: Dentate gyrus. DMS: Dentate migratory stream fi: fimbria. GCL: Granule cell layer. LV: Lateral 
ventricle. SGZ: Subgranular zone. Scale bars are 200 µm in A-B and 10 µm in C-D. Student’s t-test. Bars 








 Previous page. Figure R9. The SFFV-RV infections effectively labeled NSCs when injecting 
inside DG. A-B) Confocal images showing SFFV-RV-infected NSCs in the GCL. Injecting the SFFV-RV at 
P2 and P5 inside the DG, several Nestin-GFP and GFAP-expressing cells were labeled. The soma in the 
SGZ, the process towards the ML and the broccoli-like crown arborizing in the ML were perfectly 
identifiable. GCL: Granule cell layer. ML: Molecular layer. SGZ: Subgranular zone. Scale bars 10 µm.  
6.2.3. Divergent spatial contribution to the DG from DMS progenitors 
Our previous results indicated that the precursors that will give rise to adult 
NSCs are already located inside the DG at early postnatal stages. However, the DMS 
remained active during these postnatal stages, so we next moved to further explore the 
extent of the DMS precursor contribution to the GCL. After SFFV-RV-mCherry 
infections in the DMS at P2 and P5, we assessed the differential spatial fate preference 
of the divided cells at P14. 
At both ages, neuron-like cells were more densely packed in the ventral arm of 
the DG than in the dorsal arm. SFFV-RV-infected cells were mainly grouped near the 
edge of the ventral arm, while scattered cells could be observed throughout the rest of 
the GCL (Figure R10 A-B). Moreover, ventral and dorsal SFFV-RV-mCherry-
expressing cells diverge in their morphology. The ventral ones were settled down at 
different positions between the SGZ and ML and the majority of them had a short 
apical process from dendrites rapidly spread into the ML. On the contrary, the dorsal 
ones were commonly positioned in the lower half of the GCL and had longer processes 
from which dendrites spread into the ML (Figure R10 A-B). 
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Figure R10. Divergent spatial contribution to the DG from DMS progenitors. A-B) Representative 
fluorescent slide-scanner images showing at P14 the spatial distribution of the progeny from P2 and P5 
SFFV-RV-labeled DMS precursors. Neurons were observable widespread throughout the whole GCL. 
However, while in the dorsal arm individual, well-separated cells populated the GCL (A’, B’), the ventral 
arm of the DG appeared full of packed cell clusters (A’’, B’’). CA: Cornu ammonis. DG: Dentate gyrus. 
DMS: Dentate migratory stream. GCL: Granule cell layer. LV: Lateral ventricle. SGZ: Subgranular zone. 
Scale bars 10 µm. 
6.3. LPA1 as a differential marker of adult NSCs 
We had previously established that during early postnatal stages dNSCs 
proliferate inside the DG in a cD2-dependent manner. Taking that into account we next 
hypothesized that adult NSCs comprise a new independent population in the DG, 
rather than being a remnant from developmental dNSCs. However, one of the main 
issues when assessing the developmental dynamics of NSCs is the lack of markers for 
the differential identification of dNSCs and adult NSCs. Recently, LPA1 has been 
reported to selectively label adult hippocampal NSCs (Walker et al., 2016). Since LPA1 
acts as a modulator of AHN (Matas-Rico et al., 2008) and also cortical development 
(Estivill-Torrús et al., 2008), we aimed to assess its expression during the postnatal 
development of the DG using the LPA1-EGFP mouse model (Gong et al., 2003). 
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6.3.1. NSCs acquired LPA1 expression during the postnatal period 
We analyzed the DG and the neurogenic niche at five different postnatal time 
points (P4, P7, P10, P14 and P21). LPA1-EGFP expression was widespread 
throughout the hilus at P4, while it was almost negligible in the GCL. Later at P7, the 
expression of LPA1-EGFP started to switch from the hilar region to the GCL. By P14, 
the switch was completely evident and LPA1-EGFP expression was restricted to the 
SGZ (Figure R11 A). Interestingly, as there was no LPA1-EGFP expression in the GCL 
at P4, none of the Nestin-expressing and radially oriented dNSCs that were located 
there were LPA1-EGFP-positive. However, after P7 onwards, some dNSCs started to 
acquire LPA1-EGFP expression. Remarkably, at P14, when the NSC population 
becomes adult (Nicola et al., 2015), almost all NSCs expressed LPA1-EGFP (Figure 
R11 B). These results suggested that LPA1 could be a potential marker to distinguish 
the transition of NSCs from developmental to adult. 
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Figure R11. LPA1-EGFP expression differentially labeled adult NSCs from dNSCs. A-B) 
Representative confocal images of the LPA1-EGFP expression in the whole DG (A) and  specifically in the 
GCL (B) at P4, P7 and P14. The majority of dNSCs were negative for LPA1-EGFP, whereas almost the 
entire population of NSCs expressed it at P14. C) Quantification of the percentage of dNSCs/NSCs 
(defined as Nestin-positive, radially oriented cells) expressing LPA1-EGFP at P4, P7, P14 and P21. There 
was a significant increase in the percentage of LPA1-EGFP-expressing NSCs from developmental stages 
(P4 and P7) to P14. GCL: Granule cell layer. SGZ: Subgranular zone. ML: Molecular layer. Scale bars are 
of 10 µm. **p<0.01, ***p<0.001. One-way ANOVA followed by all pairwise comparisons by Holm-Sidak 








6.3.2. The cellular specificity of LPA1-EGFP expression switched from 
postnatal to adult stages 
We next evaluated the nature of the hilar LPA1-EGFP-expressing cells, 
hypothesizing that they could correspond to neuronal populations because of their 
morphology. Indeed, the results showed that there was a switch in the cell-specific 
expression of LPA1-EGFP. At P4-P7, the majority of LPA1-EGFP cells in the hilus were 
positive for the mature neuronal marker NeuN (Figure R12 A-B), while thereafter, 
coinciding with the period in which NSCs started to express LPA1-EGFP, only a few 
LPA1-EGFP-expressing cells were also positive for NeuN (Figure R12 C-D). 
Altogether, these results showed a spatial and cellular switch in the expression 
of LPA1-EGFP from the early postnatal period (P4-P7) to the end of the neurogenic 
niche formation (P14). The expression was mainly neuronal during early postnatal 
development, whereas it got restricted to the NSCs from P14 on. Thus, we suggest 
LPA1 as a valuable tool for the differentiation of dNSCs and adult NSCs, potentially 
playing a role in the transition of NSCs from developmental to adult. These results also 
support the notion of adult NSCs being altogether a distinct population from dNSCs. 
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 Previous page. Figure R12. LPA1-EGFP expression in the DG switched at early postnatal stages. 
A-D) Representative confocal images of the NeuN- and LPA1-EGFP- expressing cells in the hilar region at 
different postnatal time points. While several big cells appeared expressing both LPA1-EGFP and NeuN in 
the hilus at early postnatal stages, they gradually lost LPA1-EGFP expression with time. The dashed line 
delimitates the SGZ. Arrows point at those cells co-expressing both NeuN and LPA1-EGFP. Scale bars are 
of 10 µm. 
6.4. Human DG development is almost ended by mid-gestation 
Our previous results pointed towards the generation in the early postnatal DG of 
an independent neurogenic NSC population that will remain in the SGZ during the 
whole life of the mouse, being different from the dNSCs that form the DG and other 
regions from the HPF during the embryonic and early postnatal development 
development. Our next step was to investigate whether these results could be 
translated to humans. In a context in which the existence of AHN in humans remains 
controversial (Moreno-Jiménez et al., 2019; Sorrells et al., 2018), shedding light upon 
the formation patterns of the DG and its neurogenic niche would help us to explore the 
extent of the AHN in humans. 
6.4.1. The DMS was present in the early human development (GW14) 
In collaboration to Mercedes Paredes from the UCSF, who kindly let us access 
to human samples, we proceeded to histologically characterize the development of the 
human DG and more specifically the potential presence of different dNSC populations. 
Previous works have already shown proliferating progenitors and neurogenic RGCs 
forming the DMS at GW14 (Cipriani et al., 2017, 2018; Sorrells et al., 2018). 
Furthermore, this is the embryonic time period when hippocampal neurogenesis 
reaches its peak (Yang et al., 2014). Here, we further characterized the HPF at this 
age, using RGC and progenitor cell markers. Although at this age both dHPF and 
vHPF are observable, the ventral region is the one that more prominently evolves and 
thereby the one in which we focused our analysis (Figure R13 A).  
We observed that overlapping Nestin- and GFAP-positive fibers extended from 
the DNe to the DG, forming a RGC scaffold along the DMS. Nestin-expressing cells 
were also located inside the prospective DG, mainly in the outer limb and populating 
the ML close to the HF (Figure R13 B). Moreover, the GFAP-expressing fibers showed 
also HOPX expression, which labeling reached the DG through the FDJ, even though 
the GCL was free of HOPX staining (Figure R13 C). HOPX has been suggested to be 
a specific marker for GC precursors in mice from embryonic stages to adulthood (Berg 
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et al., 2019) and these results opened the possibility of a similar HOPX-positive 
progenitor population in humans. 
S100ß labels mature astrocytes in the adult mouse brain, although it has also 
been proposed as a neuronal precursor marker during postnatal DG development in 
mice (Namba et al., 2005). Here, we observed that S100ß-expressing cells were 
located along the DMS close to Tbr2-positive intermediate progenitors (Figure R13 D). 
Regarding proliferating cells, using the mitotic marker Ki67, they appeared distributed 
throughout the whole HPF, although a strong presence of Ki67-positive cell clusters 
was observable surrounding the FDJ towards the hilus (Figure R13 E).  
 
Figure R13. RGC and progenitors formed the DMS during the early development of the human HPF. 
A) Fluorescent slide-scanner image showing a hemisphere of a GW14 brain. The vHPF is marked by the 
dashed square. B) Nestin (green)- and GFAP (red)-expressing cells in the HPF at GW14. GFAP-
expressing fibers were present along the DMS, while Nestin-expressing fibers can be also observed in the 
prospective ML of the DG. C) Likewise, HOPX-expressing cells were also populating the DMS, largely 
colocalizing with GFAP-expressing fibers and D) S100β-expressing cells and Tbr2-expressing progenitors 
were also distributed along this region. E) Ki67-expressing cells (proliferating cells) were distributed from 
the DNe to the DG. CA: Cornu ammonis. Cx: Cortex. D: Dorsal. DG: Dentate gyrus. dHPF: Dorsal 
hippocampal formation. DMS: Dentate migratory stream. DNe: Dentate neuroepithelium. EC: Entorhinal 
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cortex fi: fimbria. GCL: Granule cell layer. HNe: Hippocampal neuroepithelium. L: Lateral. M: Medial. SUB: 
Subiculum. V: Ventral. vHPF: Ventral hippocampal formation. Scale bars are 500 µm for A and 100 µm for 
B-E. 
6.4.2. Differential spatial patterns during DG development 
We next moved to describe the distribution of the progenitor cell and 
proliferation markers along the anteroposterior axis of the HPF. Remarkably, in the 
anterior HPF the majority of Ki67- expressing cells can be found attached to the DNe 
and the HNe (also known as the ammonic neuroepithelium), while sparse nuclei 
populated the DMS and DG (Figure R14 A). However, at more medial positions Ki67-
expressing nuclei were more concentrated in the DMS and the hilus, even though there 
were proliferating cells still remaining in the DNe (Figure R14 B). This trend became 
more evident at posterior regions where the majority of the Ki67-expressing cells were 
restricted to the DG, especially at the edge of the inner limb where the DMS connects 
to the DG, but distributed also along the GCL and reaching the outer limb (Figure R14 
C). The different pattern of cellular expression between anterior and posterior regions 
of the HPF was not restricted to proliferating cells, being the HOPX-positive cells 
distributed in a similar manner. While in anterior regions they were attached to the DNe 
extending their processes along the DMS above the fimbria (Figure R14 D), in 
posterior regions they can be observed inside the DG almost entirely restricted to the 
hilar region (Figure R14 E). On the contrary, GFAP-expressing cells remained 
restricted to the DMS at the different anteroposterior levels (Figure R14 D-E). 
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Figure R14. Differential expression patterns along the anteroposterior axis of the HPF during early 
development. A-C) Fluorescent slide-scanner image showing the expression of proliferating (Ki67) cells at 
different levels along the anteroposterior axis (from left to right, anterior to posterior). In the anterior part, 
Ki67-expressig cells were mainly located in the DNe and HNe, while they switched to the DMS and DG at 
posterior slices. D-E) HOPX-expressing cells followed the same pattern. They were restricted to the DNe 
and DMS in the anterior HPF but they got into the DG in the posterior part. On the contrary, GFAP 
expression conserved the same pattern along the whole axis, being restricted to the DMS. CA: Cornu 
ammonis. D: Dorsal. DG: Dentate gyrus. DMS: Dentate migratory stream. DNe: Dentate neuroepithelium. 
fi: fimbria. GCL: Granule cell layer. HNe: Hippocampal neuroepithelium L: Lateral. M: Medial. V: Ventral. 
Scale bars are 100 µm.  
Altogether, the cellular expression patterns in GW14 embryos suggested a 
similar distribution of progenitors than in mice at embryonic and early postnatal stages, 
forming the DMS from the DNe to the DG. However, heterogeneous cell populations 
can be observed attending to their spatial location (inside or outside the DG) and 
marker expression. Likewise, the development of the DG followed different temporal 
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patterns along the anteroposterior axis. Next, we wanted to observe how these 
progenitor populations develop at later stages, after mid-gestation. 
6.4.3. DG formation is restricted to the GCL by GW30 
Aiming to explore the development of the progenitors during DG formation at 
mid-late embryonic stages, we moved to analyze the HPF of a GW30 embryo. At this 
age, the dHPF is still observable, although smaller than the vHPF that folds following 
the previously described patterns (Humphrey, 1967) (Figure R15 A). In contrast to the 
observations at GW14, at this age Nestin-expressing cells appeared completely 
populating the hilus, fanning out extending their fibers towards the GCL and ML. 
Remarkably, remaining Nestin-positive fibers were observable horizontally oriented 
along the DNe and through the DMS above the fimbria (Figure R15 B). Else, HOPX 
staining covered the entire HPF, suggesting a wide and non-specific cellular 
expression of the marker at this age compared to GW14. In the DG, HOPX-expressing 
cells appeared located in the hilus, extending processes towards the ML in a similar 
way than Nestin-expressing cells. Curiously, the inner limb of the DG lacked HOPX-
expressing cells, while they entirely covered the outer limb. On the other hand, strong 
expression of GFAP can be observed along the remaining DMS (Figure R15 C). 
Likewise, strong expression of S100 was present in the inner limb of the DG where 
the DMS ended (Figure R15 D), following a similar pattern than HOPX expression 
(Figure R15 C). The expression of S100 showed a differential pattern along the GCL, 
with cells located in the outer limb rather than in the inner limb (Figure R15 D). 
Importantly, Tbr2-expressing progenitors and Ki67-positive proliferating cells were 
restricted to the hilar region, surrounding the GCL and forming a layer below (Figure 
R15 D-E), which indicates that at GW30 the formation of the DG is mostly completed, 
resembling the late postnatal stages (P7-P14) of the mouse DG development. 
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Figure R15. RGCs and progenitors were restricted to the hilus at GW30. A) Fluorescent slide-scanner 
image showing one hemisphere of a GW30 brain. The vHPF was marked by the dashed square. B) 
Nestin-expressing cells appeared fanning out inside the DG at GW30. They formed a scaffold that crossed 
the hilus and GCL towards the ML. C) GFAP-expressing fibers were present along the DMS, while HOPX 
expressing cells were observable throughout the whole HPF, including DG forming RGC scaffold similar to 
the Nestin one. D) S100-positive cells were widespread throughout the GCL and ML, although the 
expression was much stronger in the outer limb of the DG than in the inner one. In contrast, cells positive 
for the intermediate progenitor marker Tbr2 formed a wide layer beneath the GCL. E) Likewise, 
proliferating cells were now restricted to the hilus, forming a wide layer beneath the GCL. CA: Cornu 
ammonis. Cx: Cortex. D: Dorsal. DG: Dentate gyrus. dHPF: Dorsal hippocampal formation. DMS: Dentate 
migratory stream. EC: Entorrhinal cortex. fi: fimbria. GCL: Granule cell layer. L: Lateral. M: Medial. SUB: 
Subiculum. V: Ventral. vHPF: Ventral hippocampal formation. Scale bars are 500 µm for A and 100 µm for 
B-E.  
6.4.4. A RGC scaffold was still present in the DG early after birth 
Despite the HPF gets already formed for the most part before birth, resembling 
the adult structure already at the neonatal period (Figure R16 A), the last waves of 
migratory NBs reach the GCL and establish their synapses during the first years after 
birth, forming the hippocampal circuitry (Cipriani et al., 2018; Seress et al., 2001; 
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Sorrells et al., 2018). One month after birth, RGCs populated the hilus beneath the 
GCL, with their processes crossing the GCL towards the ML. Interestingly, while 
Vimentin staining can be observed distributed along the entire GCL, Nestin expression 
was restricted to the inner limb of the DG, suggesting potential heterogeneity among 
the remaining RGC populations (Figure R16 B-C). Also, Ki67-positive proliferating 
cells were distributed throughout the hilus, although we did not observe any discernible 
SGZ as the one present in the adult mouse (Figure R16 D), supporting the previous 
results of Arturo Alvarez-Buylla and colleagues (Sorrells et al., 2018). Altogether, the 
results indicated that there might be heterogeneous RGC populations in the human DG 
after birth, although proliferation took place mainly in the hilus suggesting that those 
populations would be mainly quiescent. 
 
Figure R16. Early after birth, there were RGCs and proliferating cells in the DG. A) Fluorescent slide 
scanner image showing the HPF of a 1 month old brain. B-C) Vimentin- and Nestin-expressing cells in the 
DG 1 month after birth. There were fibers expressing both RGC markers crossing the GCL from the hilus 
to the ML. D) Regarding proliferation, we observed Ki67-expressing cells inside the DG at this age, 
although they populated the hilus rather than the GCL. D: Dorsal. DG: Dentate gyrus. EC: Entorhinal 
cortex. GCL: Granule cell layer. L: Lateral. M: Medial. ML: Molecular layer. SUB: Subiculum. V: Ventral. 
vHPF Ventral hippocampal formation. Scale bars are 500 µm for A and 50 µm for B-D.  
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The results obtained in the first part of this thesis indicated that in mouse, adult 
hippocampal NSCs comprise a differentiated cell population from the dNSCs that 
participate in the formation of the DG during the developmental period. Moreover, the 
formation of adult NSCs takes place precisely inside the DG early after birth. Else, in 
humans, hippocampal proliferation is already restricted to the DG before birth, 
suggesting that the potential formation of a neurogenic niche in the GCL would be 
already completed. Despite the recent controversy regarding the existence of NSCs 
and neurogenesis in adult humans (Moreno-Jiménez et al., 2019; Sorrells et al., 2018), 
the existence of RGCs expressing NSC markers during the first years after birth is not 
under debate (Figure R16; Blümcke et al., 2001; Cipriani et al., 2018; Sorrells et al., 
2018). Indeed, Nestin-expressing cells have been reported to increase in the DG after 
infantile seizures, suggesting a possible role of these cells in response to pathological 
insults.  
Thus, we moved back to explore in mice the role that a possible population of 
NSCs could have in the DG in response to pathological stimuli such as seizures. In 
mouse, adult hippocampal NSCs get massively activated and become reactive after 
seizures (Muro-García et al., 2019; Sierra et al., 2015), although the mechanism 
leading to this outcome remains unknown. Here, using an MTLE mouse model in which 
seizures are induced by KA intrahippocampal injection (Bouilleret et al., 1999; Sierra et 
al., 2015), we explored two possible receptors (FGFR1 and EGFR) that might be acting 
on the early response of NSCs. 
6.5. FGFR1 was not involved in the early response of the neurogenic 
niche after MTLE induction 
The FGFR1 signaling pathway, especially in response to its high-affinity ligand 
FGF2, has been demonstrated to be a modulator of the mitotic activity of cultured 
NSPCs and astrocytes (Reynolds and Weiss, 1992; Tropepe et al., 1999). In fact, the 
increase of both FGF2 and FGFR1 were observed after intraperitoneal KA injections, 
especially in reactive glial cells (Van Der Wal et al., 1994; Gómez-Pinilla et al., 1995). 
Thus, we consider that FGFR1 could be playing an important role on the activation and 
induction of React-NSCs that takes place as an early response in mouse models of 
MTLE (Muro-García et al., 2019; Sierra et al., 2015). 
Here, we aimed to evaluate the expression of FGFR1 in a well-characterized 
model of MTLE (Bouilleret et al., 1999; Sierra et al., 2015). For that, we administered 1 
nM of either KA (MTLE group) or saline (as control group) intrahippocampally to adult 
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mice and collected their hippocampi at different time points after the injection (Figure 
R17 A). In contrast to what we expected, FGFR1 was not altered at either the mRNA or 
protein levels within the first 72 h after the KA injection, as measured by RT-qPCR and 
WB respectively (Figure R17 B-C). In addition, we also checked the FGFR2 mRNA 
levels, as it also has high affinity to FGF2 (Dionne et al., 1990; Johnson et al., 1990) 
and thereby a possible activation route for the FGFR signaling pathway, but we 
observed no differences within the first 72 h after KA administration (Figure R17 C). 
Wondering about the possibility that the analysis of the whole HPF might be masking or 
diluting a possible alteration of FGFR1 specifically in the DG, we moved to assess the 
FGFR1 expression in tissue by IHC at 24 h post-KA injection. We considered 24 h to 
be the best time point to observe FGFR1 alterations in the neurogenic niche, given that 
after KA administration proliferation in the neurogenic niche starts to be increased at 24 
h and reaches its peak at 72 h (Sierra et al., 2015). Therefore, we considered that in 
order to trigger the response FGFR1 should be increased at 24 h. However, we 
detected no differences between the control animals and the ones injected with KA 
(Figure R17 D), indicating that FGFR1 was not involved in the early response after the 
induction of MTLE.  
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Figure R17. FGFR1 levels were not altered after KA administration. A) Schematic of the time course 
followed for hippocampi collection after KA injection. B) WB analysis showed that FGFR1 protein levels 
were not altered within the first 72 h after KA injection. C) RT-qPCR analysis showed no changes in 
FGFR1 mRNA expression during the first 72 h after KA injection. In addition, the mRNA levels of FGFR2 
were also unaltered. D) Representative confocal pictures showing the GCL and Nestin-GFP-expressing 
cells after saline (control) or KA administration. There were no changes in the FGFR1 expression 24 h 
after KA injection. CTRL: Control. GCL: Granule cell layer. KA: Kainic acid. Scale bars are of 20 µm. There 
were no statistical differences in (C) as indicated by one-way ANOVA followed by Holm-Sidak post hoc 
test versus control group. Bars show mean ± SEM. Dots show individual data. 
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6.6. EGFR was involved in the early response of the neurogenic 
niche after MTLE induction 
Thus, in light of the previous results discarding FGFR1 as a candidate to 
regulate the response of the neurogenic niche and NSCs after seizures, we moved to 
evaluate our next candidate, the EGFR signaling pathway, which is also involved in 
cultured NSPC proliferation (Reynolds and Weiss, 1992; Tropepe et al., 1999), being 
its nuclear expression strongly correlated with highly proliferating cells (Lin et al., 
2001). EGFR has been demonstrated to be highly mitogenic for astrocytes (Simpson et 
al., 1982) and it is highly involved in the development of glioblastoma (Lee et al., 2006; 
Libermann et al., 1985; Vivanco et al., 2012). Moreover, EGFR increases in astroglia 
after different focal injury models both in rats and humans (Ferrer et al., 1996; Nieto-
Sampedro et al., 1988; Río et al., 1995) and importantly, the expression of ErbB family 
(to which EGFR belongs) increases in the HPF after KA (Sierra et al., 2015). However, 
the precise implication of EGFR in the hippocampal response after seizures is not 
known and thus, we proceeded to evaluate possible alterations in the EGFR signaling 
pathway in a MTLE mouse model. 
6.6.1. Increased expression and activation of the EGFR signaling pathway 
were early events after the induction of MTLE 
We sought to evaluate EGFR expression following the same experimental 
paradigm than before; we administered either KA or saline (control group) 
intrahippocampally and collected the hippocampi thereafter following a temporal time-
course (1.5 h, 12 h, 24 h, 72 h) (Figure R18 A). We assessed the mRNA levels of 
EGFR through RT-qPCR analysis, observing a 2-3-fold increase at 1.5 h, 24 h and 72 
h post-KA administration (Figure R18 B). Next, since the levels of EGFR were 
increased after KA we proceeded to measure the activation of the EGFR pathway by 
WB. We evaluated the amount of EGFR phosphorylation (activation) on its Y845 
residue, highly involved in EGFR-mediated mitogenesis (Biscardi et al., 1999; Sato et 
al., 1995; Tice et al., 1999), and the results revealed a progressive increase of the 
proportion of phosphorylated EGFR Y845 among the total EGFR, becoming significant 
from 24 h onwards (Figure R18 C-D). 
EGFR Y845 phosphorylation modulates the activation of several downstream 
signaling pathways, including STAT3, Akt and ERK1/2, involved in glial reactivity 
responses, cell survival and apoptosis or cellular proliferation (Goffin and Zbuk, 2013; 
Lill and Sever, 2012; Meloche and Pouysségur, 2007; Priego et al., 2018). Our WB 
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analyzes demonstrated a significant increase of the phosphorylated levels of STAT3 
respect to the total amount of STAT3 12 h post-KA administration, decreasing 
thereafter (Figure R18 C-E). Regarding the Akt signaling pathway, the ratio of 
phosphorylated Akt respect to the total Akt was significantly increased from 24 h after 
KA onwards (Figure R18 C-F). Similarly, phosphorylated ERK1/2 increased at the 1.5 
h timepoint after KA administration and kept increasing until the last time point checked 
(72 h after KA). Importantly, these changes were subdued to the total amount of protein 
(as we measured the ratio of phosphorylation among the total amount), which might be 
altered in different manners. Indeed, whereas the WB showed a tendency to increase 
in the total amount of EGFR and STAT3, Akt and ERK1/2 tended to decrease (Figure 
R18 C). In any case, we could conclude that the expression of EGFR not only 
increased in the HPF early after inducing MTLE, but it also got highly phosphorylated at 
least in its Y845 site. Moreover, several downstream signaling pathways of EGFR 
(STAT3, Akt and ERK1/2) got also phosphorylated early after KA, suggesting a 
possible important role of the signaling pathway in the hippocampal response after 
seizures. 
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Figure R18. The increased expression and activation of the EGFR signaling pathway were early 
events of MTLE. A) Schematic illustrating the time course for the hippocampi collection after KA injection. 
B) RT-qPCR showed the increase of mRNA levels of EGFR at different time points after KA administration. 
C) WB showed changes in the total and phosphorylated amount of protein for EGFR (and its tyrosine site 
EGFR Y845), STAT3, Akt and ERK1/2 at different time points after KA. D-G) Quantifications of the 
proportion of phosphorylated isoforms compared to the total amount of protein for EGFR (and its tyrosine 
site EGFR Y845) and its downstream signaling pathways STAT3, Akt and ERK1/2. The data in each graph 
was normalized taking the mean of the control group as 1 ± SEM. *p<0.05, **p<0.01 and ***p<0.001. One-
way ANOVA followed by multiple comparisons versus control group by Holm-Sidak post hoc test in (A), (D) 
and (G). Kruskal-Wallis followed by multiple comparisons versus control group by Dunnet post hoc test in 
(E) and (F). Bars show mean ± SEM. Dots show individual data. 
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Once confirmed that the expression of EGFR was increased and that several of 
its downstream signaling pathways (STAT3, Akt, ERK1/2) were activated in the HPF 
early after the KA-induced MTLE, our next hypothesis was that EGFR expression 
would be increased specifically in the NSCs, playing a role in their massive activation 
and reactive transformation. To check this, we performed intrahippocampal injections 
of either KA or saline (control group) in Nestin-GFP transgenic mice and analyzed the 
EGFR expression in the neurogenic niche 24 h later. For that, we combined IHC and 
confocal microscopy, measuring the colocalization of EGFR-positive pixels with the 
area covered by Nestin-GFP-expressing cells that corresponded to the RGC-like adult 
NSCs and ANPs.  
In control conditions, EGFR expression was tightly restricted to a limited 
number of Nestin-GFP-expressing cells. In sharp contrast, 24 h after KA EGFR 
expression increased noticeably in the neurogenic niche and especially in the Nestin-
GFP-expressing NSCs and ANPs (Figure R19 A). Indeed, after KA the quantification 
of the number of EGFR-positive pixels showed a tendency to increase in the whole 
GCL, not only in the Nestin-GFP-expressing cells, (Figure R19 B) and also a 
significant increase in the hilus (Figure R19 C). More importantly, the colocalization of 
EGFR with Nestin-GFP-expressing NSCs, identified by morphological criteria (Mignone 
et al., 2004), was increased by 450% after KA (Figure R19 D), strongly suggesting a 
role of the receptor in the response of NSCs after seizures.  
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Figure R19. EGFR increased in NSCs after KA administration. A) Representative confocal images 24 h 
after saline (CTRL) or KA injections. B-D) Quantifications of EGFR expression (in pixels) in different 
regions of the DG (GCL and hilus) and the colocalization with NSCs. The data in each graph was 
normalized taking the mean of the control group as 100 ± SEM. GCL: Granule cell layer. KA: Kainic acid. 
SAL: Saline. Scale bars 20 µm. *p<0.05 and ***p<0.001. Mann Whitney test in (B) and Student’s t test in 
(C) and (D). Bars show mean ± SEM. Dots show individual data. 
6.6.2. EGFR participated in the proliferating activity of cultured NSPCs 
The obtained results suggested a potential action of EGFR on NSCs after 
seizures, due to its increase in the neurogenic niche and particularly in NSCs after KA 
administration. Thus, seeking to unravel the role of the receptor we moved to isolate 
and enrich hippocampal NSPCs in vitro adapting previously optimized methods 
(Pineda et al., 2013). This approach allowed us to check the presence of EGFR and 
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directly modulate its signaling without the interference of external niche signals (ions, 
molecules or circuital electrical activity).  
As expected, we isolated NSPCs from 2-month-old Nestin-GFP mice and 
confirmed that after being cultured for one week EGFR was present in all cells (Figure 
R20 A). Therefore, once demonstrated the presence of EGFR in NSPCs artificially 
induced to proliferate, we sought to assess the effect of EGFR inhibition in their 
proliferating capacity. Having the NSPCs in continuous proliferating conditions and with 
the EGFR signaling activated upon EGF and FGF stimulation, we checked the effect of 
the pharmacological inhibition of EGFR signaling using the reversible inhibitor Gefitinib, 
that efficiently blocks phosphorylation of all the tyrosine sites of EGFR (Pedersen et al., 
2005). In this case, trying to get a more global sense of the effect of Gefitinib upon 
EGFR inhibition, we checked not only the Y845 phosphorylation site, as we did before, 
but also the autophosphorylation site Y1068, which is well-known to regulate the 
EGFR-mediated cell proliferation (Downward et al., 1984). Furthermore, we tested 
ERK1/2 phosphorylation as well, since it is the downstream signaling pathway of EGFR 
that is more directly related with cell proliferation (Meloche and Pouysségur, 2007). The 
results showed by WB analysis that the addition of 2 µM Gefitinib for 1 h into cultured 
NSPCs efficiently reduced EGFR phosphorylation at both residues Y845 and Y1068, 
as well as ERK1/2 phosphorylation (Figure R20 B-E). Thus, the effect of Gefitinib upon 
NSCs was revealed, as well as its potential therapeutic effect as a candidate to reverse 
the massive activation and React-NSC induction after seizures.  
RESULTS 





Figure R20. Gefitinib efficiently shut off EGFR signaling in cultured NSPCs. A) Representative 
confocal images showing EGFR expression in cultured Nestin-GFP-expressing NSPCs. B) Representative 
WB images of EGFR and ERK1/2 and their activation in NSPCs stimulated with EGF and FGF and in 
presence of the EGFR inhibitor Gefitinib. C-E) Quantification of the phosphorylated isoforms compared to 
the total amount of protein levels for EGFR (Y845 and Y1068) and its downstream signaling pathway 
ERK1/2. The data in each graph was normalized taking the mean of the control group as 100 ± SEM. 
Scale bar 20 µm. *p<0.05. Mann Whitney test in (C). Student’s t test in (D) and (E). Bars show mean ± 
SEM. Dots show individual data. 
Our results indicated so far that EGFR was present in cultured hippocampal 
NSPCs and that Gefitinib can efficiently block its signalization activity. Next, we aimed 
to shed light into the potential role of EGFR on the proliferating activity of the NSPCs. 
EGFR has been shown to be present in activated NSCs of the SVZ (Codega et al., 
2014; Pastrana et al., 2009), but its role on the hippocampal NSCs remains unknown. 
Thus, following with our in vitro experimental paradigm, we measured first the intensity 
of EGFR expression in both mitotic and non-mitotic NSPCs, and then evaluated the 
RESULTS 




functional effect of Gefitinib on them using BrdU to assess the proportion of 
proliferating NSPCs. According to the results, EGFR expression increased in cultured 
NSPCs undergoing mitosis compared to those in interphase, identified by the 
chromosomal disposition by DAPI staining (Figure R21 A-C). Moreover, the NSPCs 
that incorporated BrdU 1 h before fixation were reduced in a 37% in presence of 2 µM 
Gefitinib compared to those in presence of vehicle (dimethyl sulfoxide; DMSO) (Figure 
R21 D-E), confirming the essential relevance of EGFR for NSPC proliferation and its 
effective blockage by Gefitinib. 
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Figure R21. The EGFR-mediated proliferation activity of NSPCs was reduced in the presence of 
Gefitinib. A) Confocal representative images of mitotic and non-mitotic NSPCs (identified by chromosome 
disposition using DAPI) showing higher intensity of EGFR in mitotic NSPCs. Arrows point location of the 
cells (C). B-C) Quantifications of the EGFR intensity in the area of the cell (B) and the total cellular area in 
mitotic and non-mitotic NSPCs. D) Representative confocal images showing the decrease in the number of 
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proliferating cells (as shown by BrdU incorporation) in Gefitinib-treated NSPCs respect to control NSPCs 
treated with DMSO. E) Quantification showing the decrease of BrdU- positive NSPCs in the presence of 
Gefitinib respect to the control group (DMSO-treated NSPCs). The data in each graph was normalized 
taking the mean of the control group as 100 ± SEM. Scale bar 20 µm. ***p<0.001. Mann Whitney in (B) 
and (E). Student’s t test in (C). Bars show mean ± SEM. Dots show individual data.  
Given that Gefitinib, a reversible inhibitor of EGFR, was effectively able to 
reduce proliferation in NSPCs, we sought to explore whether Afatinib, an irreversible 
inhibitor of EGFR, would have a stronger effect. Afatinib potently suppresses the 
kinase activity of EGFR and it was designed to overcome the resistance that tumor 
patients developed to the reversible inhibitors like Gefitinib, due to mutations in the 
kinase domain (Li et al., 2008). In sharp contrast with the results obtained using 
Gefitinib, 2µM of Afatinib inhibitor induced massive cell death of the NSPCs at 48 h, 
indicated by the almost complete loss of NSPCs, as well as the rounded morphology, 
small size and nuclear DNA condensation of the few remaining ones (Figure R22 A). 
Interestingly, the quantification showed a reduction in the percentage of BrdU-positive 
cells in the presence of Afatinib, although conclusions on the effectiveness of Afatinib 
on mitosis cannot be drawn due to the high cellular loss provoked by its administration 
(Figure R22 B). 
 
Figure R22. Irreversible blockage of EGFR by Afatinib led to cell death in NSPCs. A) Representative 
confocal images showing the normal growth and incorporation of BrdU of NSPCs in control conditions and 
the devastating effects produced by Afatinib, provoking massive cell loss. B) Quantification showing the 
reduction of BrdU-positive cells in the condition treated with Afatinib respect to the control condition. The 
data in each graph was normalized taking the mean of the control group as 100 ± SEM. Scale bar 20 µm. 
***p<0.001. Mann Whitney. Bars show mean ± SEM. Dots show individual data.  
Therefore, based on the results we concluded that Gefitinib was the appropriate 
candidate to inhibit EGFR in experimental MTLE in vivo and evaluate the effect of its 
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blockage over the neurogenic niche. The adverse effect of Afatinib in vitro dissuaded 
us to try it as a potential therapeutic strategy. 
6.6.3. Pharmacological blockage of EGFR ameliorated the pathological 
response of NSCs after MTLE 
Given the massive cell death provoked by Afatinib we chose to continue with 
Gefitinib to evaluate the effect of EGFR inhibition over the neurogenic niche and NSCs 
after intrahippocampal KA administration. In order to reduce the risk of lesion by direct 
injection (as a higher volume than for KA would be required), seeking to facilitate the 
potential applicability in humans and because Gefitinib does not cross the blood brain 
barrier (BBB) we resorted to intranasal administration (Chen, 2013; McKillop et al., 
2004). This direct route to brain has been previously used for other anti-epileptic drug 
treatments validating its effectiveness (Barakat et al., 2006).  
Previous studies have reported that proliferation increases early on (24 h) and 
reaches the peak at 72 h after the intrahippocampal injection of KA (Sierra et al., 2015). 
Although it was reported that a single dose of Gefitinib can reduce cell proliferation for 
72 h (Pedersen et al., 2005), we administered it every 12 h starting right after the 
induction of MTLE in order to maximize its presence in the tissue when the peak of 
proliferation is observed (Sierra et al., 2015) (Figure R23 A). As expected, the results 
showed that 72 h after KA proliferation was highly reduced in the DG (hilus and 
GCL+SGZ) when Gefitinib was administered compared to control animals treated just 
with the intranasal vehicle DMSO (Figure R23 B). Further, the specific analysis of the 
neurogenic niche showed that the density of Ki67-expressing cells located in the SGZ 
and the percentage of NSCs expressing Ki67 were also significantly reduced in mice 
treated with Gefitinib right after KA administration (Figure R23 C and R23 D). These 
results indicated that EGFR mediates the massive activation of NSCs and general 
proliferative activity that takes place in the neurogenic niche after seizures and 
furthermore, its blockage by the use of Gefitinib might be a potential candidate to 
preserve the NSC population and neurogenesis at mid and long-term. 
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Figure R23. Administration of Gefitinib reduced the proliferation triggered in the neurogenic niche 
and NSCs after KA administration. A) Schematic of the experimental paradigm. After intrahippocampal 
administration of KA Gefitinib or DMSO (CTRL) were administered every 12 h until the moment of sacrifice 
72 h post-KA. B) Representative confocal images showing the DG after KA administration in animals 
treated with either CTRL or Gefitinib. C-D) Quantifications of the density of Ki67-expressing cells in the 
SGZ (C) and the percentage of NSCs expressing Ki67 (D) both in KA+CTRL and KA+Gefitinib groups. The 
data in each graph was normalized taking the mean of the KA+CTRL group as 100 ± SEM. CTRL: Control. 
GCL: Granule cell layer. GEFI: Gefitinib. KA: Kainic acid. SGZ: Subgranular zone. Scale bar 20 µm. 
**p>0.01, ***p<0.001. Student’s t test. Bars show mean ± SEM. Dots show individual data. 
Given that the general proliferation in the SGZ and the early activation of NSCs 
was prevented when Gefitinib was administered right after inducing MTLE, we 
wondered whether the treatment with Gefitinib would be able to protect NSCs at mid-
term, avoiding the characteristic React-NSC induction that leads to the exhaustion of 
the neurogenic capacity of the niche (Muro-García et al., 2019; Sierra et al., 2015; 
Valcárcel-Martín et al., 2020). Thus, we recapitulated the treatment with either DMSO 
or Gefitinib during the first 72 h after KA or saline (control group) administration, but 
this time the Nestin-GFP mice were sacrificed at 14 d after KA administration (Figure 
R24 A).  
At mid-term two of the main consequences in the MTLE model are the GCD 
and the lack of production of newly generated DCX-positive immature neurons (Muro-
García et al., 2019; Sierra et al., 2015). Here, we show that the total number of DCX-
expressing cells was reduced by 4-fold in the KA-injected animals treated with DMSO 
(KA+CTRL) in comparison to the saline-injected animals treated with DMSO 
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(CTRL+CTRL). Interestingly, in the KA-injected animals that were treated with Gefitinib 
(KA+GEFI) the total number of DCX-expressing cells was recovered up to control 
levels, strongly suggesting that Gefitinib-induced EGFR inhibition can conserve the 
neurogenic capacity of the hippocampal niche at mid-term after seizures. As a control 
measure for the effect of Gefitinib on the neurogenic niche in control conditions, we 
administered it after injecting the animals with saline (CTRL+GEFI). In this case, the 
total number of DCX-expressing cells was no different than in the saline-injected 
animals treated with DMSO (CTRL+CTRL), suggesting that the inhibition of EGFR by 
Gefitinib in control conditions does not affect neurogenesis (Figure R24 B-C). We also 
analyzed the GCD (measured by DAPI staining as the thickness of the GCL from the 
hilus to the ML) in saline- and KA-injected animals after the treatment with either 
DMSO or Gefitinib. The results showed GCD when animals were injected with KA 
(KA+CTRL) respect to the control animals injected with saline (CTRL+CTRL). 
Following the same trend as observed before in the DCX-expressing cell numbers, 
when KA-injected animals were treated with Gefitinib (KA+GEFI) the observed GCD 
returned to control levels (Figure R24 B-D). As expected, the GCD was similar in the 
saline-injected animals treated with DMSO (CTRL+CTRL) or Gefitinib (CTRL+GEFI). 
We concluded that the Gefitinib-induced inhibition of EGFR after KA administration is 
able to protect the neurogenic niche, at least in terms of DCX-expressing cell numbers 
and GCD. Furthermore, the induction of React-NSCs seemed to be reduced in KA-
injected animals treated with Gefitinib in comparison to the ones treated with DMSO 
(Figure R24 B), leading us to wonder whether EGFR could play a role in the React-
NSC induction after KA, and whether the inhibition of the receptor using Gefinitib could 
protect them at mid-term. 
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 Previous page. Figure R24. The intranasal treatment with Gefitinib protected the neurogenic 
niche 14 d after KA administration. A) Schematic of the experimental paradigm. After the 
intrahippocampal administration of either saline (control) or KA, Gefitinib or its vehicle (DMSO) were 
administered every 12 h during 72 h and the animals were sacrificed 14 d post-injection, forming four 
different experimental groups (CTRL+CTRL; CTRL+GEFI; KA+CTRL; KA+GEFI). B) Representative 
confocal images showing the DG after DMSO or Gefitinib administration in animals injected with either 
saline or KA. C-D) Quantifications of the total number of DCX-expressing cells in the GCL of each group 
(C) and the GCD (measured by DAPI) in each group (D). CTRL: Control. GCL: Granule cell layer. GEFI: 
Gefitinib. KA: Kainic acid. ML: Molecular layer. SGZ: Subgranular zone. Scale bar 20 µm. *p<0.05, 
***p<0.001. One-way ANOVA followed by multiple comparisons versus control group by Holm-Sidak post 
hoc test in (C) and Kruskal-Wallis followed by all pairwise comparisons by Student-Newman-Keuls post 
hoc test in (D). Bars show mean ± SEM. Dots show individual data. 
Thus, we next focused on the React-NSC induction after KA administration, 
evaluating the potential effect of Gefitinib treatment to revert it. We followed the same 
paradigm than before, injecting intrahippocampally saline or KA and intranasally 
treating the animals with either DMSO or Gefitinib within the first days after the 
injections, forming a total of four different groups (CTRL+CTRL; CTRL+GEFI; 
KA+CTRL; KA+GEFI). To evaluate the NSCs and their potential conversion into React-
NSCs at mid-term we sacrificed the animals 14 days after the intrahippocampal 
injection (Figure R25 A). One of the hallmarks of reactive astrocytes is the 
hypertrophied morphology with enlarged soma and thickened processes (Sofroniew, 
2009) and NSCs were described to undergo similar changes after seizures, being a 
characteristic of the React-NSCs (Muro-García et al., 2019; Sierra et al., 2015). 
Therefore, to assess these morphological changes in our model we resorted to 3D 
Sholl analysis (Rodriguez et al., 2006), measuring the length, branching points and the 
process volume of the NSCs in Nestin-GFP mice. 
The intrahippocampal administration of KA followed by intranasal administration 
of the Gefitinib vehicle DMSO as a control (KA+CTRL) provoked an increase in the 
process length, volume and number of branching points of NSCs compared to the 
control group (CTRL+CTRL), which translates in observably thicker and more 
arborized cells after KA, a characteristic morphology of a reactive phenotype in general 
and React-NSCs in particular (Figure R25 B-E). Importantly, as we observed before in 
a general assessment of the neurogenic niche (GCD and DCX-expressing cell 
number), the reactive morphology induced by KA administration on the Nestin-GFP-
expressing NSCs is reverted by Gefitinib administration (KA+GEFI). Noteworthy, even 
though NSCs in the KA+GEFI group did not show differences compared to the 
CTRL+CTRL and CTRL+GEFI group for the selected morphological criteria, it can be 
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appreciated that they lost their broccoli-like crown, another hallmark of React-NSCs. 
Nonetheless, we can conclude that EGFR was involved in the induction of React-NSCs 
and its inhibition via intranasal Gefitinib administration was able preserve the normal 
morphology of the NSCs at mid-term (14 d), although losing their characteristic 
broccoli-like crown (Figure R25 B-E). On the other hand, Gefitinib administration in 
saline-injected animals (CTRL+GEFI) provoked changes in the NSCs too, decreasing 
their volume and the number of branching points in comparison to the control group 
(CTRL+CTRL) (Figure R25 D-E). 
 
Figure R25. Gefitinib administration reduced the KA-induced React-NSC transformation at mid-
term. A) Schematic of the experimental paradigm. After intrahippocampal administration of either saline 
(control animals) or KA, Gefitinib or its vehicle (DMSO) were administered every 12 h during 72 h and the 
animals were sacrificed 14 d post-injection, forming four different experimental groups (CTRL+CTRL; 
CTRL+GEFI; KA+CTRL; KA+GEFI). B) Representative confocal images showing the morphology of 
Nestin-GFP-expressing cells of each experimental group. C-E) Quantifications through 3D Sholl analysis 
of the length of the Nestin-GFP-expressing NSCs (C), the volume of the Nestin-GFP-expressing NSCs (D) 
and the number of branching points of the process of Nestin-GFP-expressing NSCs (E) in each 
experimental group. The data in each graph was normalized taking the mean of the CTRL+CTRL group as 
100 ± SEM. CTRL: Control. GCL: Granule cell layer. GEFI: Gefitinib. KA: Kainic acid. SGZ: Subgranular 
zone. Scale bar 20 µm. ***p<0.001. One-way ANOVA followed by multiple comparisons versus control 
group by Holm-Sidak post hoc test. Bars show mean ± SEM. Dots show individual data. 
RESULTS 




6.7. The role of Zn+2 on the NSC activation and React-NSC induction 
after MTLE 
Once demonstrated the participation of EGFR signaling pathway in the early 
response that takes place in the neurogenic niche and NSCs in the mouse model of 
MTLE, we moved on to look for possible mechanisms that could lead to its activation. 
In this line, we drew our focus towards Zn+2, which has been reported to trigger EGFR 
signaling directly and also indirectly by promoting HB-EGF release (Samet et al., 2003; 
Wu et al., 2004). Moreover, Zn+2 has been reported to act as neuroprotector, preventing 
hyperactivation of the general neuronal circuit (Bancila et al., 2004; Takeda et al., 
2003). Indeed, after seizures, when neuronal activity is exacerbated, Zn+2 has been 
shown to be increased in the HPF (Carrasco et al., 2000; Kasarskis et al., 1987; Mody 
and Miller, 1985). Nonetheless, its effect upon glial cells is unknown. We wondered 
about a possible role of Zn+2 over neurons to modulate the hyperactivation induced 
after seizures and we proposed it as an alternative mechanism that regardless of its 
role in neurons, might be triggering the EGFR-mediated massive activation and React-
NSC induction after seizures. 
6.7.1. The levels of Zn+2 increased in the neurogenic niche in MTLE  
First, seeking to evaluate whether the described release of Zn+2 in the HPF after 
seizures (Carrasco et al., 2000; Kasarskis et al., 1987; Mody and Miller, 1985) 
specifically affected the neurogenic niche, we resorted to the Danscher staining to 
measure levels of histochemically reactive (free) Zn+2. The Danscher staining requires 
an injection of sodium selenite at a very controlled time (30 minutes prior to the 
sacrifice) in all conditions in order to precipitate free Zn+2 without varying the size of 
Zn+2 granules (Danscher, 1981). Thus, we measured the amount of Zn+2 colocalizing 
with Nestin-GFP-expressing cells in the GCL+SGZ 72 h after either saline or KA 
intrahippocampal administration, when the peak of cell proliferation after KA 
administration has been reported to occur (Sierra et al., 2015). The results showed that 
Zn+2 was almost absent in the GCL+SGZ in control animals injected with saline, being 
restricted to the hilus where MFs contain synaptic vesicles with Zn+2 (Frederickson et 
al., 1983; Sindreu et al., 2003) and therefore with very little colocalization with Nestin-
GFP-expressing cells. In contrast, after KA administration Zn+2 granules were spread 
throughout the GCL+SGZ, partially colocalizing with Nestin-GFP-expressing NSCs 
(Figure R26 A). Indeed, the quantification of Zn+2 granules, measured in pixels, 
confirmed these observations. We first checked the size of Zn+2 granules as a control 
for the quality of the Danscher staining technique, observing no statistically significant 
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differences between saline and KA injections and thus discarding possible differences 
due to variability in the technique (Figure R26 B). On the other hand, the number of 
Zn+2 granules colocalizing with Nestin-GFP-expressing cells in the GCL showed an 
almost 2-fold increase after KA administration compared to the control condition 
(Figure R26 C). Therefore, we concluded that after KA Zn+2 was released and 
accumulated in the neurogenic niche close to or in the NSCs, which opened the 
possibility for a possible interaction between them.  
Furthermore, given that the amount of Zn+2 increased in the HPF and 
specifically in the neurogenic niche after KA, we hypothesized that the expression of 
MTs would also be increased in these conditions. MTs are metalloproteins in charge of 
decreasing the intracellular labile Zn+2 levels, controlling Zn+2 homeostasis in the 
central nervous system (CNS) (Kägi and Schäffer, 1988; Vašák and Hasler, 2000). To 
test our hypothesis, we followed the same experimental timeline than in the previous 
experiments, sacrificing the animals at different time points after KA administration (1,5 
h, 12 h, 24 h, 72 h) (Figure R26 D). We determined the protein levels of MT1 and MT2 
through WB and the results showed that the expression of both MT1 and MT2 begun to 
increase 12 h after KA in comparison to control levels (Figure R26 E). Likewise, we 
determined mRNA levels of MT1, MT2 and also MT3 through RT-qPCR. In this case, 
the mRNA levels of MT1 increased after KA becoming significant from 24 h onwards. In 
addition, although not statistically significant, the same tendency can be observed for 
MT2. In contrast, the mRNA levels of MT3 were not altered at any of the time points 
after KA administration (Figure R26 E-F). Altogether, the results suggested a massive 
release of Zn+2 in the HPF after KA that the system tried to contain through the 
increase of MT levels. Nonetheless, regarding its accumulation in the GCL, Zn+2 might 











 accumulated in the neurogenic niche after KA administration. A) Representative 
fluorescent microscope images showing the increase of Zn
+2
 in the neurogenic niche and its overlapping 
with NSCs 72 h after KA administration. Images were pseudo-colored (Zn
+2 
in red) for visualization 
purposes. B) Quantification of the size of Zn
+2
 granules as a control measure of the quality of the 
Danscher technique. The lack of significant differences between the control and KA group indicated an 
efficient application of the technique. C) Quantification of the number of Zn
+2
 granules colocalizing with 
Nestin-GFP-expressing cells, showing a significant increase after KA. D) Schematic of the experimental 
timeline. Hippocampi were collected at different time points after intrahippocampal KA administration E) 
WB of the hippocampi collected at different time points after KA administration showed increase in MT1 
and MT2 expression from 12 h after KA onwards. F) RT-qPCR of the hippocampi collected at different time 
points after KA administration showing a tendency of MT1 and MT2 levels, but not MT3, to increase after 
12 h. The data in each graph was normalized taking the mean of the control group as 1 ± SEM. SAL: 
Saline. KA: Kainic acid. Scale bar 20 µm. *p<0.05, ***p<0.001. Student’s t test in (B-C). Kruskal-Wallis 
followed by multiple comparisons versus control by Dunnet post hoc test for MT1 and MT3 and One way 
ANOVA followed by multiple comparisons versus control by Dunnet post hoc test for MT2 in (F). Bars 
show mean ± SEM. Dots show individual data.  
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6.7.2. Zn+2 promoted proliferation in NSPCs in a dose-dependent manner 
Next, we moved to evaluate the possible effect of Zn+2 over NSCs. For that, we 
resorted to cultured NSPCs to manipulate them in proliferating conditions and evaluate 
the effect exerted by the addition of different doses of Zn+2 (5, 10 and 400 µM). We 
cultured 25,000 NSPCs into laminin-coated coverslips, treated them with the 
correspondent dose of Zn+2 and gave them a BrdU pulse 1 h before fixation in order to 
determine cell proliferation. The results showed that after treating NSPCs with 5 M 
Zn+2 there was an almost 3-fold increase in the number of cells that incorporated BrdU 
(Figure R27 A-B). However, subsequent increase in the Zn+2 doses (10 M and 400 
M) provoked a deleterious effect upon the NSPCs leading to a clear loss of 
cytoplasmic Nestin-GFP and the presence of bright and small pycnotic nuclei that 
suggested cell death (Figure R27 A-B). These results indicated that Zn+2 induced 
proliferation in NSPCs at low doses but caused cell death at higher doses. In light of 
the obtained results, we wondered about the possible role of Zn+2 over NSCs in MTLE 




 affected NSPCs in a dose-dependent manner. A) Representative confocal images 
showing proliferating NSPCs. Images illustrate a higher number of NSPCs that incorporated BrdU after a 
treatment with 5 µM of Zn
+2
, while the number decreased with higher doses. Likewise, the small and 
rounded nuclei observed when NSPCs were treated with 10 µM or 400 µM indicated that these doses of 
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 caused cellular death. B) Quantification of the total number of NSPCs that incorporated BrdU in each 
experimental condition. There was a significant increase when cells were treated with 5 µM of Zn
+2
, while 
the number decreased with higher doses. CTRL: Control. Zn
+2
: Zinc. Scale bar 20 µm. *p<0.05. Kruskal-
Wallis followed by multiple comparisons versus control by Dunn post hoc test. Bars show mean ± SEM. 
Dots show individual data. 
6.7.3. The intrahippocampal administration of Zn+2 mimicked the 
alterations produced in the neurogenic niche in MTLE 
Taking into account that after KA administration Zn+2 spread in the GCL, 
colocalizing with Nestin-GFP-expressing cells, and that in vitro it can affect cultured 
NSPCs promoting their proliferation, we next moved to evaluate the effects of Zn+2 
administration in vivo on the neurogenic niche, hypothesizing that it may be playing an 
important role on the massive activation and React-NSC induction that is observed 
after seizures. To test this, we injected intrahippocampally saline (control group) or 
different doses of Zn+2 (5, 20 or 30 nM) and we checked the effects over the 
neurogenic niche and NSCs 7 days later. 24 h before sacrificing the animals we 
injected BrdU intraperitoneally to identify proliferating cells (Figure R28 A). The results 
showed no observable effect of Zn+2 over the neurogenic niche at 5 nM (data not 
shown) but in contrast, a strong dose-dependent effect causing the alteration of the 
neurogenic niche could be observed with higher doses. With the doses of 20 nM and 
30 nM GCD, increase of BrdU-positive cells and the reactive-like morphology and 
displacement of the NSCs were observable (Figure R28 B-D), replicating some of the 
main effects that define the KA-induced response in the neurogenic niche. 
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Figure R28. Intrahippocampal Zn
+2
 disrupted the neurogenic niche in a dose-dependent manner. A) 
Schematic of the experimental timeline. Nestin-GFP mice were sacrificed 7 d after intrahippocampal Zn
+2
 
administration. 24 h before the sacrifice 3 BrdU intraperitoneal injections were administered, separated by 
3 h intervals in order to mark the proliferating cells. B-D) Representative confocal images showing the 
effect of intrahippocampal saline (CTRL) (B), 20 nM of Zn
+2
 (C) or 30 nM of Zn
+2
 (D) administration. It can 
be observed that Zn
+2
 affected the neurogenic niche provoking GCD, increase of BrdU-positive cells and 
morphological and spatial alterations in the NSCs, becoming reactive-like and abandoning the SGZ 




. Scale bar 20 µm.  
To further characterize the effects produced by Zn+2, we decided to follow this 
study using the minimal amount (20 nM) that produced alterations in the neurogenic 
niche. We followed the previous experimental timeline, sacrificing mice 7 d after Zn+2 
intrahippocampal administration and injecting BrdU intraperitoneally 24 h prior to the 
sacrifice (Figure R29 A-B) and we assessed the replication of some of the main 
characteristics that define the neurogenic niche disruption after seizures. We first 
evaluated the GCD (Houser, 1990) basing on DAPI staining and measuring the 
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thickness of the GCL and then we evaluated the number of cells that incorporated 
BrdU in the neurogenic niche. The results showed significant nuclei dispersion in the 
GCL of the Zn+2-injected animals compared to saline-injected control animals (Figure 
R29 D). Moreover, there was an almost 4-fold increase in the density of cells that 
incorporated BrdU in the neurogenic niche after Zn+2 administration (Figure R29 E). 
These results further proved that Zn+2 administration provoked changes in the 
neurogenic niche that shared similitude with the effects observed after KA 
administration.  
We next moved to assess the effect of Zn+2 administration specifically upon 
NSCs. We quantified the density of NSCs in the GCL in both experimental groups and 
also the proportion of NSCs that incorporated BrdU. Interestingly, the density of NSCs 
7 days post-Zn+2 infusion showed a tendency to reduce (Figure R29 F), but the 
proportion of BrdU-positive NSCs respect to the total number of NSCs did not show 
significant differences (Figure R29 G). This suggested an effect of Zn+2 over the 
neurogenic niche without affecting NSC activation, which would be differentially 
regulated. Yet, we cannot exclude a transitory activation of the NSCs early after Zn+2 
administration that will shut off earlier than 7 d post-injection, a time-point when NSCs 
would acquire control activation levels again. 
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Figure R29. The intrahippocampal administration of Zn
+2
 recapitulated some of the KA-induced 
effects in the neurogenic niche. A) Schematic of the experimental timeline. Nestin-GFP mice were 
sacrificed 7 d after intrahippocampal Zn
+2
 administration. 24 h before the sacrifice 3 BrdU intraperitoneal 
injections were administered, separated by 3 h intervals in order to mark the proliferating cells. B-C) 
Representative confocal images of the neurogenic niche after saline (CTRL) (B) or 20 nM Zn
+2
 (C) 
intrahippocampal administration. D) Quantification of the GCD based on DAPI staining. The results 
showed a significant increase in the GCL thickness after intrahippocampal Zn
+2
 administration. E) The 
quantification of the density of BrdU-positive cells showed a significant increase in the neurogenic niche 
after Zn
+2
 administration. F) Quantification of the density of NSCs. The results showed a trend to decrease 
in the density of NSCs after Zn
+2
, although it was not significant. G) Quantification of the percentage of 
activated NSCs over the total NSC number. The results showed no statistical differences. GCL: Granule 
cell layer. ML: Molecular layer. Zn
+2
: Zinc. Scale bar 20 µm. ***p<0.001. Student’s t test. Bars show mean 
± SEM. Dots show individual data. 
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6.7.4. The effect of Zn+2 on the neurogenic niche was EGFR-mediated 
Our previous results showed that Zn+2 was massively released after KA, getting 
accumulated into the neurogenic niche and being able to provoke its disruption in a 
similar manner to what occurs in the experimental MTLE model. Moreover, other 
studies indicate that Zn+2 can stimulate the EGFR signaling pathway (Samet et al., 
2003; Wu et al., 2004), meaning that their interplay could be driving or contributing to 
the response observed in the neurogenic niche and NSCs after seizures. To test 
whether the presence of Zn+2 could modulate NSCs in an EGFR-mediated way, we 
resorted again to cultured NSPCs. In order to observe a potential effect of Zn+2 over 
EGFR, we first needed to shut down the growth factor signaling that is normally active 
in cultured NSPCs to maintain them in proliferating conditions, due to the application of 
EGF and FGF in the medium. For this purpose, we incubated the NSPCs with growth 
factor-starved media and our preliminary data showed a remarkable loss of 
phosphorylated ERK1/2 at 2 h (data not shown). Thus, NSPCs were dissociated and 
incubated in growth factor-starved media for 2 h in order to silence the growth factor-
induced EGFR activation and properly test the potential activation of the receptor by 
Zn+2 administration.  
We evaluated the capacity of Zn+2 to activate EGFR on NSPCs by following an 
adaptation of the protocol previously described (Wu et al., 2004). In addition to the 
starved group (Stvd), we administered either 100 ng/ml EGF as a control of the EGFR 
activation (EGF) or 200 M Zn+2 (Stvd+ Zn+2) creating two additional groups. 
Furthermore, we added another group in which NSPCs were pretreated with 2 M 
Gefitinib for 60 min prior to the 200 M Zn+2 administration (Stvd+ Zn+2+Gef). Protein 
extracts were blotted sequentially against EGFR Y845 and Y1068 and also against the 
total EGFR in order to perform the ratio of receptor phosphorylation (Figure R30 A). 
Interestingly, Zn+2-administrated NSPCs showed a mild phosphorylation of the residue 
Y845 in comparison to the starved NSPCs, being fully blocked in presence of Gefitinib 
(Figure R30 C). However, Y1068 phosphorylation was triggered in the presence of 
EGF, but not in the presence of Zn+2 (Figure R30 D).  
Furthermore, we analyzed the downstream signaling pathway of EGFR ERK1/2, 
highly related with cell proliferation (Downward et al., 1984). The results showed that 
Zn+2 exposure in starved conditions was able to increase the phosphorylated ERK1/2 
signaling and importantly, the inhibition of EGFR reduced its phosphorylation to basal 
levels (Figure R30 B; E). These results suggested that on NSPCs Zn+2 was able to 
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directly activate EGFR on its Y845 phosphorylation site and it can also activate its 
downstream signaling pathway ERK1/2, while inhibiting EGFR was sufficient to 




 triggered the activation of EGFR signaling pathway on NSPCs. A) WB for Y845-










-stimulated after Gefitinib treatment conditions. C) Quantification of the WB 
showing a 10-fold decrease in the ratio of Y845-EGFR respect to the total EGFR in NSPCs treated with 
EGF compared to starved cells. Likewise, Zn
+2
 increased the Y845 phosphorylation significantly, although 
this activation was blocked by Gefitinib pre-treatment. D) Quantification of the WB showing a 6-fold 
increase in the ratio of Y1068-EGFR respect to the total EGFR in NSPCs treated with EGF compared to 
starved cells. In this case, Zn
+2
 was not able to trigger Y1068-EGFR activation, and the previous treatment 
with Gefitinib did not cause any alteration neither. E) Quantification of the WB showing stimulation of P-
ERK1/2 ratio respect to the total ERK1/2 in presence of Zn
+2
, and its consequent inhibition after Gefitinib 
pre-treatment.*p<0.05 and ***p<0.001. Kruskal-Wallis followed by all pairwise comparisons by Student-
Newman-Keuls post hoc test in (C-D).One-way ANOVA followed by all pairwise comparisons by Holm-
Sidak post hoc test in (E). Bars show mean ± SEM. Dots show individual data. 
Observing that Zn+2 was capable of stimulating EGFR on NSPCs, at least in the 
Y845 phosphorylation site, we next moved to assess whether the neurogenic niche 
disruption that we observed after Zn+2 administration in vivo could be driven by EGFR 
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activation. For this purpose, we tested the effect of EGFR inhibition in Nestin-GFP mice 
that received a single dose of Zn+2 20 nM intrahippocampally administering Gefitinib 
intranasally during the first 72 h post-injection following the same paradigm used for 
KA-administration experiments (Figure R23-R25). 24 h before sacrifice the animals 
received three doses of intraperitoneal BrdU in order to track dividing cells (Figure R31 
A). As expected, the results showed that the intrahippocampal Zn+2 administration 
significantly increased the density of cells that incorporated BrdU in the neurogenic 
niche. Importantly, EGFR inhibition via Gefitinib administration reduced this Zn+2-
induced increase of BrdU-positive cells, while Gefitinib administration to saline-injected 
mice did not cause any alteration (Figure R31 B-C). These results demonstrated the 
involvement of EGFR in the Zn+2-induced response of the neurogenic niche, 
suggesting the possible interplay between both factors in MTLE conditions. 
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 Previous page. Figure R31. Zn
+2
 promoted proliferation in the neurogenic niche of the DG in an 
EGFR-mediated manner. A) Schematic of the experimental timeline. Nestin-GFP mice were sacrificed 72 
h after intrahippocampal saline (CTRL) or Zn
+2
 administration after receiving 6 intranasal treatments with 
DMSO (CTRL) or Gefitinib in 12 h intervals. 24 h before the sacrifice 3 BrdU intraperitoneal injections were 
administered, separated by 3 h intervals in order to mark the proliferating cells. B) Representative confocal 
pictures of the DG of mice intrahippocampally injected with saline (CTRL) or Zn
+2
 and intranasally treated 
with DMSO (CTRL) or Gefitinib. C) Quantification of the density of BrdU-positive cells in the GCL showing 
an increase after intrahippocampal Zn
+2
 administration compared to control animals injected with saline. 
The increase in the density of BrdU-positive cells was reduced with Gefitinib treatment after Zn
+2 




. Scale bar 20 µm. **p<0.01. ***p<0.001. One-way 
ANOVA followed by all pairwise comparisons by Holm-Sidak post hoc test. Bars show mean ± SEM. Dots 
show individual data. 
6.7.5. Zn+2 chelation in MTLE increased cell death in the GCL 
Considering the high presence of Zn+2 in the GCL at 72 h post KA and its 
effects over the neurogenic niche, mediated by the EGFR signaling pathway, we 
speculated that Zn+2 chelation could be a valid strategy to minimize the alterations 
observed in the neurogenic niche after KA administration. To test this hypothesis, we 
performed intrahippocampal injections of either saline (CTRL) or KA and administered 
subcutaneously 5 mg/kg of the Zn+2 chelating agent TPEN or its vehicle saline (CTRL) 
as previously described (Kim et al., 2012) twice a day during 7 consecutive days, 
sacrificing the animals right after the treatment. We evaluated the density of pyknotic 
cells in the GCL as a measure of the efficiency of TPEN. The results showed that the 
number of dying cells identified by condensed DAPI staining tended to increase after 
KA (KA+CTRL) compared to saline–injected mice (CTRL+CTRL). On the other hand, 
the TPEN administration after an intrahippocampal injection of saline (CTRL+TPEN) 
did not provoke any alteration in the GCL. Unexpectedly, dead cells in the GCL 
increased in the animals injected with KA and treated thereafter with TPEN (KA+TPEN) 
compared to the control groups (CTRL+CTRL; CTRL+TPEN) and showed a tendency 
to increase compared to the KA-injected animals treated with vehicle (KA+CTRL) 
(Figure R32 A-B). Therefore, these results revealed that chelation of Zn+2 further 
increased cell death, discarding this strategy as a potential therapeutic approach in 
MTLE. 
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Figure R32. Chelation of Zn
+2
 in MTLE further increased cell death in the GCL. A) Representative 
confocal pictures of the GCL after intrahippocampal saline (CTRL) or KA injections and vehicle or TPEN 
subcutaneous treatments (CTRL or TPEN). B) Quantification of the density of pyknotic cells in the GCL. 
There was a significant increase of pyknotic cells after KA that TPEN treatment further increased. CTRL: 
Control. KA: Kainic acid. SAL: Saline. Scale bar 20 µm. *p<0.05. Kruskal-Wallis followed by all pairwise 
comparisons by Dunn post hoc test. Bars show mean ± SEM. Dots show individual data. 
The obtained results suggested that EGFR and Zn+2 played an important role in 
the response of the neurogenic niche after seizures. Indeed, Zn+2 was able to stimulate 
the phosphorylation of EGFR on its Y845 tyrosine site, suggesting it as a possible 
mechanism that contributes to the activation of EGFR after seizures. Interestingly, 
cellular internalization of Zn+2  has been reported to trigger the release of HB-EGF from 
the cell membrane, which is a potent ligand for EGFR (Samet et al., 2003; Wu et al., 
2004). Thus, we proceeded to evaluate whether HB-EGF could be mediating the 
activation of EGFR after KA administration. 
6.8. HB-EGF was massively released in the DG after KA  
The previous results pointed towards an integrated role of Zn+2 and EGFR in the 
response after KA. Given that cellular reuptake of Zn+2 can trigger the release of HB-
EGF from the cell membrane (Samet et al., 2003; Wu et al., 2004), and Zn+2 was 
massively released in the GCL after seizures, we decided to explore whether HB-EGF 
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could be triggering the EGFR-mediated effect in MTLE. HB-EGF is able to affect 
proliferation, differentiation and morphology of cultured astroglia (Jia et al., 2018; 
Kornblum et al., 1999; Puschmann et al., 2014) and it has been reported to be 
upregulated after intraperitoneal KA administration (Opanashuk et al., 1999). Moreover, 
HB-EGF intensely stimulates astroglial migration (Faber-Elman et al., 1996). Therefore, 
given that after KA we already found that NSCs increased the EGFR expression and 
were later mislocalized and disorganized, we sought to characterize HB-EGF changes 
in the DG in our intrahippocampal KA administration model. 
Following the same experimental timeline than before, we administered KA 
intrahippocampally to 2-month old Nestin-GFP mice and collected the injected 
hippocampi at different times after KA (1.5 h, 12 h, 24 h, 72 h) (Figure R33 A). To 
evaluate the amount of released HB-EGF in the HPF we measured the HB-EGF in 
tissue at each time point after KA through ELISA and compared the results to the 
amount of HB-EGF in saline-injected (CTRL) animals. The results showed a 
statistically significant increase of around 25% at 12 h after KA compared to the control 
condition in which mice were injected with saline. However, this increase reached its 
peak at 24 h and rapidly decreased thereafter (Figure R33 B). Since the ELISA 
approach gave us information about the overall HB-EGF levels in the whole HPF rather 
than in the neurogenic niche, we resorted to IHC in order to evaluate the presence of 
the ligand specifically in the DG 72 h after saline or KA injection. The results showed 
that HB-EGF staining was enriched in the immediate upper ML and the hilar region, 
although the GCL did not show observable differences compared to control (Figure 
R33 C). However, we cannot exclude the occurrence of a transitory increase of HB-
EGF in the GCL prior to 72 h after KA administration. Therefore, HB-EGF could be 
playing a role specifically in the DG. Given the high expression observed in the ML and 
its reported role as chemoattractant (Faber-Elman et al., 1996), we speculated of a 
possible role of HB-EGF in the migration of NSCs towards the ML after seizures. 
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Figure R33. HB-EGF increased in the DG early after KA administration. A) Schematic of the 
experimental timeline. Hippocampi were collected at different time points after intrahippocampal KA 
administration. B) Measurement of the amount of HB-EGF in tissue through ELISA at different time points 
after KA administration. There was a significant increase at 12 h and 24 h after KA in the number of pg/µg 
of HB-EGF, decreasing thereafter. C) Representative confocal pictures of HB-EGF expression in the DG. 
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The staining showed that while HB-EGF increased in the ML and hilus after KA administration, the GCL 
remained unaltered compared to control animals injected with saline. GCL: Granule cell layer. KA: Kainic 
acid. ML: Molecular layer. SAL: Saline. Scale bar 20 µm. ***p<0.001. One-way ANOVA followed by 
multiple comparisons versus control group by Holm-Sidak post hoc test. Bars show mean ± SEM. Dots 
show individual data. 
Given that HB-EGF was released in the DG after KA administration, we next 
moved to assess the potential contribution of NSCs in the release of HB-EGF after KA 
and the capacity of HB-EGF to activate EGFR and its downstream signaling pathway 
ERK1/2 in cultured hippocampal NSPCs. We maintained cultured NSPCs in 
proliferating conditions and analyzed through IHC the presence of HB-EGF in the 
NSPCs. The results showed that even though HB-EGF expression was present in 
some cultured NSPCs in comparison to the control condition without primary HB-EGF 
antibody, the majority of NSPCs did not show any HB-EGF labeling (Figure R34 A). 
However, given that NSPCs were constantly maintained in proliferating conditions, we 
wondered about the possibility of HB-EGF being constantly released from the cell 
membrane and acting as a ligand for EGFR. Thus, we evaluated the HB-EGF amount 
by ELISA separately in NSPCs (Pellet), their culture media (Supernatant) and 
compared the results to a culture media without NSPCs as a control group (Media). 
The results showed a significant increase of around 200% in the amount of HB-EGF in 
the cultured media containing NSPCs (Supernatant) compared to the control media 
(Media) and cellular pellet (Pellet), demonstrating that NSPCs were able to release HB-
EGF to the extracellular media in proliferating conditions (Figure R34 B). 
Next, to test whether HB-EGF was able to trigger the activation of EGFR 
signaling pathway, we first starved NSPCs from EGF and FGF to shut off the EGFR 
signaling pathway. Then, we stimulated the starved NSPCs with HB-EGF and also with 
HB-EGF and Zn+2 together, aiming to get the most similar condition to in vivo and test 
the capacity of HB-EGF to activate EGFR in NSPCs. Furthermore, we added another 
experimental group pre-treating the NSPCs with Gefitinib and then exposing them to 
HB-EGF and Zn+2. We measured the activation of EGFR on its phosphorylation sites 
Y845 and Y1068 and also the phosphorylation of the EGFR downstream signaling 
pathway ERK1/2. The results showed that HB-EGF was able to strongly phosphorylate 
EGFR at both Y845 and Y1068 residues, as well as ERK1/2. Remarkably, Zn+2 
stimulation did not produce any significant additive effect, probably prevailed by the 
excess of HB-EGF. Finally, the pre-treatment with Gefitinib was able to block 
phosphorylation on Y845 and Y1068 even in the concomitant presence of both Zn+2 
and HB-EGF, as well as to reduce the phosphorylation of ERK1/2 (Figure R34 C-D). 
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These results pointed towards the possible interaction of HB-EGF and EGFR to trigger 
the effects observed in the neurogenic niche after KA administration, perhaps regulated 
by Zn+2-induced release of HB-EGF. 
 
Figure R34. HB-EGF triggered the activation of the EGFR signaling pathway in cultured NSPCs. A) 
Representative confocal pictures of the HB-EGF expression on cultured NSPCs after IHC both with 
primary HB-EGF antibody and without the primary antibody. B) Quantification by ELISA of the amount of 
HB-EGF in culture media without NSPCs (media), media from cultured NSPCs (supernatant) and the pellet 
of cultured NSPCs (pellet). The results showed a significant increase in the amount of HB-EGF in the 
media from cultured NSPCs, showing that NSPCs released the ligand in proliferative conditions. C-D) WB 
showing increasing levels of phosphorylated EGFR Y845, EGFR Y1068 and the downstream signaling 
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pathway ERK1/2 in the conditions treated with HB-EGF. E-G) Quantifications of phosphorylation levels 
compared to the total amount of protein levels for EGFR (Y845 and Y1068) and the downstream signaling 
pathways ERK1/2. The control group was normalized to 100% ± SEM. Scale bar 20 µm. *p<0.05 and 
**p<0.01. Kruskal-Wallis followed by multiple comparisons versus control group by Tukey post hoc test in 
(B). One-way ANOVA followed by multiple comparisons versus control group by Holm-Sidak post hoc test 
in (E), (F) and (G). Bars show mean ± SEM. Dots show individual data. 
The results obtained in the second part of this thesis pointed to EGFR as one of 
the relevant mediators in the seizure-induced React-NSC transformation taking place in 
the DG that leads to the total loss of the neurogenic capacity. Our work opened an 
avenue towards EGFR activation as an alternative mechanism for the hippocampal 
response to MTLE. Indeed, we found the intranasal administration of Gefitinib to be a 
valid method to inhibit EGFR, overcoming the BBB and ameliorating the dramatic 
effects of seizures over the hippocampal neurogenic niche (Loss of DCX, GCD and 
React-NSC induction). Further, we proposed Zn+2 and HB-EGF, and the interaction 
between them, to play a role in the induction of EGFR activation, as they were found to 
be massively released into the extracellular media after seizures. Keeping in mind that 
the triggering of the hippocampal response after seizures will involve more than a 
single actor, our results shed light into one of the governing mechanisms of the React-
NSC induction and loss of neurogenesis. These findings pave the way for further 
research focused on other pathways, including other ErbB receptors, that could be 




























































7.1. Adult NSCs are genereated on-site in the DG after birth 
In the rodent DG, adult NSCs give rise to new neurons postnatally and during 
the whole life of the organism (Altman and Das, 1965; Kempermann et al., 2015). 
However, after getting activated adult NSCs lose their neurogenic capacity by 
differentiating into astrocytes or directly into neurons (Encinas et al., 2011a; Pilz et al., 
2018) and despite their presumed capacity to self-replicate (Bonaguidi et al., 2011), 
they undergo gradual exhaustion over time until they get depleted at a population level 
(Encinas and Sierra, 2012). Thus, the formation and establishment of the adult 
hippocampal NSC population during the developmental period will determine the adult 
neurogenic potential of an individual. The general believe in the field is that AHN is a 
remnant process from the embryonic development, yet the specific spatial origin of 
adult NSCs remains unknown and somehow controversial (Berg et al., 2019; 
Gonçalves et al., 2016; Hodge et al., 2013; Li et al., 2013; Matsue et al., 2018). 
Furthermore, the DG is one of the brain regions that get mainly formed postnatally. The 
majority of neurons reach the GCL at early postnatal stages (Bayer, 1980) and the 
blockage of the proliferation of postnatal progenitors impedes the formation of the adult 
NSC population, therefore abolishing AHN (Youssef et al., 2019). Interestingly, mice 
lacking cD2, a relevant factor for cell cycle, show lack of AHN in the DG (Ansorg et al., 
2012). Thus, we hypothesized that adult NSCs are not a remnant from the embryonic 
development but a whole new population generated through cD2-dependent 
proliferation at early postnatal stages. We found our hypothesis to be true by analyzing 
the postnatal development of the neurogenic niche in the absence of cD2.  
7.1.1. Cyclin D2 is fundamental for the postnatal generation of adult NSCs 
To assess the relevance of cD2 in the formation of adult NSC population we 
analyzed the postnatal DG at different time points (P0, P7, P14, P28) in a Nestin-GFP 
mouse model lacking cD2 (cD2KO) using tissue kindly sent by Anja Urbach, in whose 
laboratory both transgenic lines were crossed. In the cD2KO mice, the embryonic 
development of the DG is close to normal, getting formed as in the WT (Kowalczyk et 
al., 2004). In fact, we did not find any difference neither in the dNSC number nor in the 
proliferating dynamics within the GCL of the cD2KO mouse at P0. This might be due to 
a compensatory action exerted by the other D-type cyclins (Ciemerych et al., 2002), as 
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the three D-type cyclins are expressed in cultured NSPCs derived from P5 hippocampi, 
while in NSPCs derived from adult hippocampi the whole system relies on the cD2 
(Kowalczyk et al., 2004). However, in B-lymphocytes only cD3 (and not cD1) 
compensates for the loss of cD2 and induces proliferation with a slower cell cycle (Lam 
et al., 2000), opening the possibility for a non-essential role of cD2 during the 
embryonic development of the DG, potentially explaining the lack of effect in its 
absence, rather than compensation from the other D-type cyclins.  
After birth, in normal conditions dNSCs proliferate and expand themselves until 
P14, when the NSC population becomes “adult” (Nicola et al., 2015). Our results 
indicate that in normal conditions the number of NSCs progressively increases during 
the first postnatal weeks, confirming previous data that reported an outgrowth in the 
total number of NSCs from P7 to P28 (Gilley et al., 2011). In the absence of cD2, this 
expansion fails to happen, leading to an almost entirely depleted population of adult 
NSCs. Moreover, the remaining ones divide at lower proportion than in the WT. This 
could be due to a premature senescence of the neurogenic niche, at least in terms of 
the NSC number and their activation rate. Indeed, the remaining adult NSCs are 
morphologically different and resemble the senescent-like and aged-associated 
phenotype of the omega NSCs (Martín-Suárez et al., 2019). Our results are in 
agreement with a previous model that ablated dividing GFAP-positive cells during the 
first postnatal week, provoking the absence of NSCs in the adult DG (Youssef et al., 
2019). Thus, we suggest that dNSCs divide and generate de novo adult NSCs in the 
postnatal DG (P0-P14), in a process dependent of cD2, and hypothesize that any insult 
affecting dNSC proliferation during this period will affect the neurogenic niche in a long-
lasting fashion (Figure D1). 
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Figure D1. cD2-mediated proliferation is essential for the generation of adult NSCs. A) After birth 
and during the first 14 postnatal days, dNSCs proliferate and give rise to adult NSCs that locate in the 
SGZ, giving birth to newborn neurons during the whole lifetime. B) In the absence of cD2, proliferation is 
impaired during the early postnatal period, affecting to the generation of adult NSCs that translates in a 
diminished initial pool size that will affect the neurogenic capacity during the whole lifetime. 
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We next wondered whether the loss of adult NSCs could be due to increase cell 
death rather than to impaired cell proliferation. In the cerebellum, GCs and stellate 
interneurons are reduced in cD2KO mice, due to both reduction in primary 
neurogenesis and increase in apoptosis (Huard et al., 1999). However, cD2KO mice do 
not show increased cell death in the GCL at early postnatal stages. On the contrary, 
cell death tends to decrease suggesting that the failure in the generation of adult NSCs 
is due to a lack of expansion of dNSCs rather than cell death. We interpret the 
decreased cell death as a reflection of a reduced number of NSCs being generated, as 
apoptosis is high in this cell type and correlates with both their number and their 
proliferation (Sierra et al., 2010).  
D-type cyclins constitute a molecular bridge between extracellular mitogenic 
signaling and the activity of cell cycle machinery (Matsushime et al., 1994; Tanguay 
and Chiles, 1996) and their loss forces the cell into a quiescent state (Andreu et al., 
2015; Kippin et al., 2005). Furthermore, studies of different brain regions have shown 
association of cD2 with the maintenance of the undifferentiated state of NSCs and their 
expansion at the expense of their neuronal differentiation, being the latter more related 
to cD1 (Glickstein et al., 2007b, 2009; Lukaszewicza and Anderson, 2011; Ross et al., 
1996; Tsunekawa et al., 2012). We propose that in the absence of cD2 dNSCs are not 
capable to proliferate during the early postnatal period, entering quiescence without 
expanding and failing to generate adult NSC population. Nevertheless, the generation 
of adult NSCs is not completely abolished and a limited pool gets formed in the cD2KO 
mice and therefore we cannot exclude a potential role of other mechanisms, including 
the other D-type cyclins. 
7.1.2. dNSCs divide on-site in the DG to generate adult NSCs 
Having established that dNSCs need to proliferate during the early postnatal 
period to generate adult NSCs, we next wondered about the specific location where 
this proliferative stage takes place. One of the hallmarks of the DG development is the 
formation of the DMS by dNSCs and progenitors that get detached from the DNe 
during the embryonic development. Although dNSCs enter the DG already at 
embryonic stages, forming a new progenitor matrix inside the DG, the DMS is still 
active during the early postnatal period (Altman and Bayer, 1990a; Berg et al., 2019; 
Hodge et al., 2013; Li et al., 2009; Sugiyama et al., 2013). Thus, we aimed to assess 
the migration and division dynamics, as well as the contribution of the postnatal dNSCs 
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from the DMS compared to the ones that have already reached the DG during the 
postnatal formation of the DG. 
In order to trace the lineage of dNSCs from both HPF regions, we resorted to 
SFFV-RVs, a well-known tool to birth-date newborn cells. SFFV-RVs only infect mitotic 
cells and the limited diffusion of the virus particles allows the regional infection of 
dNSCs and progenitors (Gomez-Nicola et al., 2014b; Weber et al., 2012). We injected 
postnatal mice at P2 and P5 either inside the DG or in the DMS aiming to assess 
possible fate differences related to the spatial location of dNSCs. In both injection 
models (DMS and DG), SFFV-RV-infected cells were restricted to the targeted area 
inside the HPF, demonstrating the usefulness of the technique. In some animals, the 
VZ got infected due to the flowing back when removing the capillary after the injection. 
However, the infected area outside the HPF is not a source of DG progenitors and 
thereby we considered it not to be affecting the experimental purposes. Furthermore, 
we used two different SFFV-RVs expressing different fluorescent markers (SFFV-RV-
mCherry and SFFV-RV-mCerulean) to test the capacity of the model to independently 
label dNSCs from each region. This dual injection model has been previously used to 
label progenitors to study the neuronal formation of the DG, although performing each 
injection separately at different ages (Mathews et al., 2010). We implemented it to 
spatially differentiate dNSCs during a single experimental procedure. Indeed, the 
progeny of the dNSCs from the different regions showed no overlapping at P14, 
demonstrating the independent and restricted efficacy of the infections. When 
infections were done in the DMS, the viral particles showed high diffusion covering the 
DMS from septal to temporal regions, while inside the DG the diffusion was highly 
restricted to the injection site. In both models, axons from labeled GCs were visible 
even in adjacent slices where GC somas were not present. 
Next, to better assess the cellular identity of the SFFV-RV-labeled progeny we 
performed the same experiments in Nestin-GFP mice. Previous studies, through the 
use of SFFV-RV infections too, have proposed that at P5 proliferative GFAP-positive 
astrocytes from the DG give rise mostly to granule neurons and stellate astrocytes, but 
also to adult NSCs (Namba et al., 2005). Likewise, DG progenitors from P7 organotypic 
slices give rise to neurons, astrocytes and radial GFAP-positive cells (Yokose et al., 
2011). Our results confirmed previous discoveries, additionally reporting that while 
precursors of neuronal and astroglial populations are both in the DMS and DG, adult 
NSC precursors are confined to the DG by birth. In contrast, injecting an EGFP-
expressing retrovirus in the hippocampal VZ of P5 mice, neuronal and astroglial 
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lineage were reported in the DG at P10 and P45, as well as the presence of EGFP-
positive cells located in the SGZ with radial morphology and Nestin expression on at 
least one of them (Navarro-Quiroga et al., 2006). However, we believe that since 
neurons born at P5 locate in the inner part of the GCL and extend their axons towards 
the ML, the identification of adult NSCs by a radial process extending towards the ML 
and a soma located in the SGZ can be confusing. Moreover, the authors showed one 
single Nestin-positive cell with radial orientation that lacked the broccoli-like crown. We 
consider that adult NSC markers are shared by other cell populations, as pericytes or 
astrocytes in the case of Nestin (Clarke and Van Der Kooy, 2011; Encinas et al., 
2011a; Komitova and Eriksson, 2004; Petrik and Encinas, 2019), being therefore 
necessary the use of more than one marker and strict morphological criteria to identify 
adult NSCs as such. Although we do not completely rule out the possibility that some 
isolated adult NSC precursors might come from the DNe/DMS at postnatal stages, as 
we observed when injecting the SFFV-RV in the DMS at P2, we consider the sole 
presence of isolated adult NSC-like cells insufficient to make claims at a population 
level. Moreover, other studies that electroporated the DNe of neonatal (Ito et al., 2014) 
and E16.5 (Sugiyama et al., 2013) mice did not find any other cell type in the GCL but 
neurons. We propose that at E16 all the adult NSC precursors are already detached 
from the DNe, on the DMS or already in the DG, involved in a migratory process that 
gets completed at P2 or before. 
When we discuss about the developmental origin of the adult NSCs, the DMS is 
not the only pathway from which they have been reported to migrate into the DG. An 
alternative route following the SPZ has been described by some authors, with 
progenitors forming the so-called “transient subpial neurogenic niche” along the HF, 
prior to migrating downwards into the DG (Hodge et al., 2013; Li et al., 2009). In a 
groundbreaking work, Samuel Pleasure and coworkers described another migratory 
stream coming from the vHPF at embryonic stages. They claimed that progenitors 
coming from the DNe contribute to the formation of the outer shell of the 
suprapyramidal blade of the DG, while the temporoseptal pathway contributes to the 
inner shell of the GCL and SGZ, including adult NSCs. Cell migration from outside the 
HPF into the DG has also been described. During development, the caudal ganglionic 
eminence is source of hilar interneurons and neurons of the GCL that reach the DG 
postnatally attracted by FGF signalization (Aguirre et al., 2004; Cuccioli et al., 2015; 
Pleasure et al., 2000b). Given the neuronal contribution of the ganglionic eminence, it 
seems logic to think that progenitors could also be migrating into the DG to contribute 
DISCUSSION 




to the adult NSC population. In our injection models, we found that adult NSC 
precursors proliferate inside the DG at P2-P5, and not in the DMS. Moreover, as our 
method does not provide 100% accuracy regarding the site of injection and variability 
ensued, it led to several off-target injections that gave us valuable information. When 
the injection site was the transient subpial neurogenic zone, we observed later few 
neurons in the GCL but never adult NSCs, and we did not observe any cell migration to 
the dorsal DG when progenitors were labeled in the ventral DG (data not shown). 
However, the possibility of a heterogeneous adult NSC population with different spatial 
origins during embryonic gestation is a possibility that calls for further exploration 
(Figure D2). 
One could also argue that with SFFV-RV injections we are missing quiescent 
dNSCs that could be migrating towards the DG from outside. We think that given the 
importance of proliferation for the adult NSC pool generation after birth (Ortega-
Martínez and Trejo, 2015; Youssef et al., 2019), and the role of cD2 previously 
discussed, dNSC migration without proliferation during this period seems improbable. 
Our studies show that regardless of where they initially come from, there is a 
population of dNSCs that enter mitosis inside the DG to give rise to adult NSCs early 
after birth, while the dNSCs coming from the DNe at this period are only neurogenic. In 
summary, we think that adult NSCs are generated as a whole new population in a 
differentiated process that takes place postnatally inside the DG, meaning that adult 
NSCs are not a mere continuation of the embryonic development. 
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Figure D2. Heterogeneous origin of adult NSCs. A) During the embryonic period, various sources have 
been described as the origin of NSCs. On the one hand, the more classic view indicating the DNe as the 
source from where progenitors (in green) migrate into the DG until they locate in the SGZ (Altman and 
Bayer, 1990a; Berg et al., 2019; Hodge et al., 2013; Li et al., 2009; Sugiyama et al., 2013). On the other 
hand, adult NSCs have been described to migrate from ventricular area of the vHPF in a shh-responsive 
manner (in blue) (Li et al., 2013). The pictures represent the HPF from medial to lateral in a coronal view, 
from left to right. B) This would mean that heterogeneous populations of progenitors (Shh-responsive and 
non-responsive) migrate following different dynamics during the embryonic period and get into the DG. 
Regardless of their different precedence, the adult NSC precursors gather inside the DG after birth, 
proliferating there, on-site, to give rise to the adult NSC pool. C) The different origin might involve 
heterogeneous populations of adult NSCs sharing their location in the SGZ and responding differently to 
external or internal stimulus. 
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Despite our main focus in this study was to determine the spatial developmental 
origin of adult NSCs, the majority of the cells generated from the infected dNSCs in 
both DMS and DG were neurons, leading to observations into the neuronal formation of 
the GCL. The GCL is well-known to form following an outside-in pattern, where the 
outer layer is the one formed by the earliest born GCs (Angevine, 1965; Schlessinger 
et al., 1975). In addition, this formation gets completed following a supra-to-
infrapyramidal layer pattern. Around P0, NBs migrate to the marginal zone of the 
suprapyramidal blade of the DG and later complete the GCL formation migrating 
towards the infrapyramidal blade, that gets formed during the early postnatal period 
(Bayer, 1980; Schlessinger et al., 1975). In our injection models we found that dNSCs 
coming from the DMS give rise to neurons that populate both the ventral and dorsal 
blade of the DG. However, the organizational pattern is quite different in each place. 
While in the dorsal blade neurons locate in the inner part of the GCL forming an easily 
observable layer, they gather up in the ventral blade forming packed cell clusters that 
extend from the hilus to the ML. This supports the dorsal-to-ventral organizational 
dynamic previously described and suggests that postnatal neurogenesis is determinant 
for the formation of the ventral GCL and therefore key for the region-related functions 
during the adulthood. 
7.1.3. LPA1 differentiates adult NSCs from dNSCs 
During the last years, the developmental origin of adult NSCs has been studied 
assuming that adult neurogenesis is a mere continuation from the developmental 
neurogenesis (Berg et al., 2019; Hochgerner et al., 2018; Nicola et al., 2015; Seki et 
al., 2014). Progenitors forming the DG during development have been reported to 
share molecular features with adult NSCs (Pleasure et al., 2000a). Notch1 and Notch2 
have been suggested to be involved in maintaining the proliferative and 
undifferentiated stage of dNSCs during development until they become adult (Breunig 
et al., 2007a; Nelson et al., 2020) and protein expression markers such as GFAP (Seki 
et al., 2014) or Hopx (Berg et al., 2019) have been claimed as common markers for 
dNSCs and adult NSCs under the idea of a single population of NSCs giving birth to 
GCs during the whole life. In contrast, although defending adult neurogenesis as a 
developmental continuum, some authors have outlined the postnatal apparition of a 
“new structure” which corresponds to different functionality in the SGZ (Nicola et al., 
2015). In this line, there are cell autonomous differences, as well as different 
transcriptional profiles and cell properties between P7 and P28 Nestin-GFP-expressing 
NSCs (Gilley et al., 2011) and some dNSCs undergo protein expression changes from 
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the embryonic to postnatal development, such as expression of BLBP (Matsue et al., 
2018). However, the lack of specific markers for NSCs leads to possible biases in the 
result interpretation, so the specific identification and lineage tracing of the dNSCs that 
will give rise to adult NSCs remain a challenge in the field. 
Using the LPA1-EGFP transgenic mouse, LPA1 has been proposed to 
specifically label adult NSCs in the DG (Walker et al., 2016). We have recently 
validated the expression of LPA1-EGFP as a true reflection of LPA1 expression and its 
validity as a specific marker of NSCs (Valcárcel-Martín et al., 2020). Thus, we 
postulated LPA1 as a possible candidate to specifically distinguish adult NSC 
precursors during development and a potential option to track them down. Surprisingly, 
we found that LPA1-EGFP expression is spread all over the hilus during the early 
postnatal development and later switches to the SGZ and specifically to adult NSCs 
between P10 and P14. During the early postnatal period LPA1-EGFP labels NeuN-
positive neurons in the hilus, while dNSCs in the GCL express Nestin but not LPA1-
EGFP. By P14, LPA1-EGFP expression is almost absent from the hilus, while almost all 
of adult NSCs express it. Therefore, even though LPA1 is not useful to trace adult NSC 
precursors from development stages, it reveals as a valuable tool to specifically 
distinguish between dNSCs and adult NSCs and further supports the notion of adult 
NSCs and adult neurogenesis being qualitatively different from dNSCs and 
developmental neurogenesis. Indeed, Sten Linnarson and coworkers showed using 
scRNA-seq that RGCs (NSCs) undergo a clear shift in the molecular expression from 
the second postnatal week on, when they become closer to astrocytes. Importantly, 
this shift is defined also by LPA1 expression (Hochgerner et al., 2018), as we observe 
through IHC. Although the role of LPA1 in progenitors modulating proliferation and adult 
neurogenesis has been outlined (Estivill-Torrús et al., 2008; Matas-Rico et al., 2008) 
and our recent data show that the seizure-induce massive activation of NSCs is 
reduced in mice lacking expression of LPA1 (Valcárcel-Martín et al., 2020), its role 
during development is unclear. Regardless, we propose that dNSCs enter mitosis 
during the first postnatal week inside the DG and modulated by cD2 give rise to a 
brand new population of cells, known as adult NSCs, that start to express LPA1 (Figure 
D3). 
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Figure D3. LPA1 specifically differentiates adult NSCs from dNSCs. Early after birth, dNSCs divide to 
generate adult NSCs. During this process dNSCs do not express LPA1, whereas they acquire its 
expression when they become adult-like around the second postnatal week. 
We thus consider that adult NSCs comprise a differentiated SC type with 
specific functions different from the dNSCs, and this should be taken into account when 
studying them. The identity and actual SC nature of adult NSCs has been debated 
before, stating that rather than considering them as undifferentiated cells, it may be 
more productive to think of them as appropriately differentiated for their specific tissue 
niches (Clarke and Van Der Kooy, 2011; Seaberg and Van Der Kooy, 2003; Weiss et 
al., 1996). Defining the origin and identity of adult NSCs influences the way we study 
them in rodents, and the way we extrapolate this knowledge into humans. Therefore, 
this represents a more serious question than simple semantics. Regarding the recent 
controversy on the absence of adult neurogenesis in the human brain, we should 
consider the existence of adult NSCs in terms of the generation of a specific cell type 
with specific functions during development, rather than SC endurance over lifetime. 
7.2. Human and mouse DG share similitude in their formation 
The existence of newborn neuron generation in the human adult DG has 
recently come to a new historical hotspotand the community has been shaken mainly 
due to two studies claiming opposite results, i.e. presence and absence of DCX-
positive NBs in the adult GCL (Moreno-Jiménez et al., 2019; Sorrells et al., 2018). We 
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understand the NSC pool formation as the foundation of lifelong neurogenesis and as 
such, we consider the study of this process as key to assess the extension and 
relevance of the postnatal neurogenic niche and neurogenesis. We think that by 
applying our knowledge from mouse to human we could determine how, if so, dNSCs 
give rise to a new population of adult neurogenic cells. One of the unique 
characteristics of human (and primate) DG formation is the generation of the dentate 
plate during the early embryonic development (Abraham et al., 2004; Cipriani et al., 
2017). However, probably the most important difference between rodents and human 
HPF lies on the spatial location. During the early gestational period the human HPF 
extends both at dorsal and ventral level. However, before mid-gestation the dorsal part 
of the HPF gets constraint due to the growth of the corpus callosum. Thus, the HPF 
ends up placed at a ventromedial level, with a prominent anterior part and a narrow 
posterior part known as the induseum griseum or the hippocampal tail (Meyer et al., 
2019; Rakic and Yakovlev, 1968). These differences could lead us to think of a 
completely different developmental process in both species. Yet, the human HPF 
shows similar migratory dynamics than mice, with RGCs and progenitors moving from 
the DNe into the DG, forming the DMS (Sorrells et al., 2018). We hypothesized that 
despite possible differences between mouse and human HPFs, both are developed 
following similar patterns, and therefore adult NSCs would be generated in a similar 
fashion. 
7.2.1. The DG formation is almost completed between GW14-GW30 
The study of human tissue poses obvious hurdles for the identification and 
tracking of dNSCs. We first proceeded to study potential dNSC and progenitor 
populations in humans through IHC. To better characterize the DG formation and 
identify the potential formation of a population similar to mouse adult NSCs, we 
analyzed the cellular expression of dNSC, intermediate progenitor and proliferating cell 
markers across the human embryonic and early postnatal development. At GW14, the 
cellular distribution in the HPF resembles the mouse late embryonic/early postnatal 
development. Hopx-, GFAP-, S100ß- and Nestin-expressing fibers are clearly 
positioned above the fimbria and SPZ, forming a RGC scaffold that extends along the 
DMS, surrounded by progenitors and proliferating cells. Remarkably, while GFAP, 
S100ß and Hopx expression terminates when the fibers contact the medial blade of the 
DG, the presence of Nestin-positive fibers covers also the hilus and part of the lateral 
blade of the GCL, suggesting the presence of an independent dNSC population that 
invades the DG earlier than the rest. Interestingly, at GW30 intermediate progenitors 
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and proliferating cells appear restricted to the DG forming a layer below the GCL, as it 
happens during the late postnatal development (P10-P14) in mouse. In contrast, the 
DMS is almost devoid of proliferating cells, although remaining Nestin-expressing fibers 
can be observed all the way above the fimbria without any observable attachment to 
the DNe, fanning out into the ML once they reach the hilus. On the other hand, the 
expression of Hopx and S100ß, markers of adult NSC precursors in mouse (Berg et al., 
2019; Namba et al., 2005), changes and gets spread out all over the HPF, suggesting 
their lack of specificity as dNSC markers at mid-gestation. Curiously, we observed lack 
of both Hopx and S100ß in the medial blade of the DG, precisely where DCX-positive 
immature neurons concentrate at that age (Sorrells et al., 2018). Previous studies have 
reported that the DG gets completely formed before mid-gestation (GW30-32), with a 
peak of proliferation at GW14 that goes decreasing thereafter, and is almost absent by 
term (Arnold and Trojanowski, 1996; Yang et al., 2014). Our observations support the 
idea that the human DG gets formed sharing certain similitude with mouse during the 
early-mid gestation (GW14-GW30), with dNSCs and progenitors detaching from the 
DNe and forming different matrixes (DNe, DMS, FDJ, DG) until they get restricted into 
the hilus, close to the GCL. 
7.2.2. The human DG develops differently along the longitudinal axis 
The spatial location is one of the most striking differences comparing mouse 
and human HPF. The anterior-posterior axis in humans is homologous to the ventral-
dorsal axis in the mouse, where the dorsal part is well-developed and more prominent 
than the ventral, while in humans it is the opposite (Fanselow and Dong, 2010; 
Poppenk et al., 2013; Strange et al., 2014). In mice, cognitive functional differences 
have been well described comparing the involvement of the vHPF and dHPF 
(Bannerman et al., 2002; Strange et al., 2014). Likewise, the response to pathological 
insults, such as SE, varies depending on the position in the longitudinal axis (Häussler 
et al., 2012) and the maturation of the adult newborn neurons, as well as perinatal 
interneurons, is also different. This heterogeneity has also been reported in humans, 
presenting genetic, functional and connectivity differences between the anterior and 
posterior HPF (Fanselow and Dong, 2010; Strange and Dolan, 1999; Vogel et al., 
2020). Interestingly, we found that at GW14 the anterior part of the ventral DG appears 
to develop slower than its more posterior counterpart. In the anterior DG, the 
expression of Ki67 is observable mostly in the DNe, with some cells in the DMS but 
none inside the prospective DG. This pattern changes when looking at more posterior 
positions, where Ki67 cells disappear from the DNe to spread all over the DMS and 
DISCUSSION 




have already entered the DG. This pattern is also observable with Hopx-positive cells 
located gradually closer to the DG in an anterior to posterior trend. Moreover, these 
differences are inconspicuous at GW30, arguing in favor of an already close to an end 
developmental formation of the DG in both the anterior and posterior poles. Therefore, 
the window between GW14-GW30 would be essential in the formation of the DG, with 
temporal differences along the longitudinal axis that may imply further functional 
distinctions. We wonder whether these differences might also affect in the potential 
generation of a NSC niche in the GCL. 
7.2.3. RGCs remain in the DG early after birth: Potential role as NSCs? 
After birth, the presence of NSCs in the human DG, and their actual neurogenic 
capacity is under debate. Although some authors have reported a lack of Nestin-
expressing cells at term (Arnold and Trojanowski, 1996; Yang et al., 2014), the majority 
of the literature reports that RGCs are still present in the DG during the first years after 
birth. Proliferating BLBP- and Nestin-expressing cells have been reported in the hilus 
and other regions of the HPF (Blümcke et al., 2001; Cipriani et al., 2018; Sorrells et al., 
2018). Our results support previous findings of a potential NSC population with 
Vimentin- and Nestin-positive cells populating the DG 3 weeks after birth. In contrast to 
what we observe in the mouse SGZ, these cells have their nuclei located in the hilus 
and extend their fibers towards the ML, crossing the GCL. In addition, the few Ki67-
positive cells that are observable inside the DG at this age are spread throughout the 
hilus, meaning that the Nestin- and Vimentin- expressing RGCs would be mainly 
quiescent. We speculate that they form the ultimate RGC scaffold, comparable to the 
secondary RGC scaffold in mouse, helping the last waves of immature neurons to 
migrate from the hilus into the GCL (Seress et al., 2001). However, their neurogenic 
capacity remains under debate, and their endurance during adulthood is currently a hot 
topic. Arturo Alvarez-Buylla and colleagues defend that NSCs are absent in the GCL in 
cases older than 7 years. They reported that although BLBP- and Vimentin-expressing 
cells are present in the ML (but not in the GCL), they do not proliferate (Sorrells et al., 
2018). Opposite to this view, other authors reported presence of Nestin-expressing 
cells inside and outside the DG during adulthood. However, while some defended their 
NSC nature and ability to proliferate (Boldrini et al., 2018; Tobin et al., 2019) others 
claimed that they lack neurogenic capacity (Cipriani et al., 2018). Given that the 
formation of the GCL seems to be finished by GW30, we wonder whether the postnatal 
RGCs that we observe could represent a population equivalent to adult NSCs in 
mouse, following similar activation/depletion dynamics that drive the niche to a 
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deforestation during the first years of childhood (Encinas and Sierra, 2012; Encinas et 
al., 2011a), leaving an almost barren neurogenic niche comparable to the aged SGZ in 
mouse. 
Regardless of their presence during adulthood, the early postnatal NSCs might 
play an important role in the hippocampal response in normal and also pathological 
conditions, such as epilepsy. Indeed, the developing human brain has a predominance 
of excitation over inhibition and is therefore at higher risk of developing seizures, 
particularly during the first month of life (Holmes, 2009; Rakhade and Jensen, 2009). 
Seizure occurrence during neonatal age appear to play a significant role in later 
developing epilepsy, intellectual disability and headache (Oh et al., 2019). Interestingly, 
Nestin expression strikingly increases in the hilus and GCL of TLE patients younger 
than 2 year old compared to adult and control cases, suggesting a significant role of 
this population in the pathological response provoked by epilepsy (Blümcke et al., 
2001), although this overexpression of Nestin could be attributed to the generation of 
reactive astrocytes. Thus, we next moved to study the NSCs in normal and pathologic 
conditions. We explored possible mechanisms involved in the massive activation and 
induction of React-NSCs in a mouse model of MTLE. 
7.3. EGFR is involved in the early response of NSCs in MTLE 
We have used in the laboratory a context of pathophysiological relevance, 
epilepsy (MTLE specifically), to study novel properties of NSCs and we have started to 
unveil the mechanisms driving the response of adult NSCs and their neurogenic niche 
in this pathological context. Seizures induce NSCs to drastically change their 
morphology and to become functionally proinflammatory (Martín-Suárez et al., in 
preparation); to get massively activated; to switch to a symmetric mode of cell division 
and to ultimately differentiate into reactive astrocytes abandoning their neurogenic 
program (Muro-García et al., 2019; Sierra et al., 2015; Valcárcel-Martín et al., 2020). 
MTLE is one of the most common epilepsies (Falconer et al., 1964; Savage, 2014; 
Wiebe, 2000) and it is resistant to drug treatment in high proportion of cases (35%), 
having one of the worse prognosis (Wieser, 2004). Thus, our study might be useful not 
only to answer fundamental questions about the role of NSCs in pathological 
conditions, but also to shed light about MTLE and potential strategies to prevent its 
negative effects over the HPF. 
In the mouse model of MTLE induced by intrahippocampal or intra-amygdalar 
injection of KA, neuronal hyperexcitation induces NSCs to develop a hypertrophic 
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cytoplasm and a multibranched phenotype with overexpression of Nestin, GFAP and 
LPA1 (Muro-García et al., 2019; Sierra et al., 2015; Valcárcel-Martín et al., 2020). At the 
same time, they get activated in much higher proportion than in normal conditions. 
Thus, NSCs transform into React-NSCs which end up differentiating into reactive 
astrocytes. Strikingly, in MTLE React-NSCs change their mode of division from the 
typical asymmetric manner of normal NSCs that is ANP-generating and neurogenic to 
a symmetric mode that generates more React-NSCs (Sierra et al., 2015). It is 
remarkable that just the initial episode of seizures triggers the induction of React-NSCs 
and their massive activation. Furthermore, the conversion of NSCs into React-NSCs 
and their posterior differentiation into reactive astrocytes contribute to the development 
of HS in the DG, a hallmark of MTLE that correlates with bad prognosis and resistance 
to antiepileptic drugs (Quirico-Santos et al., 2013; Sierra et al., 2015; Thom, 2014). 
Previous research of the lab on mouse and human MTLE show a very similar reactive 
transformation in both species, although we cannot make any claim about the possible 
transformation of NSCs into React-NSCs in epilepsy patients (Muro-García et al., 
2019). The induction of React-NSCs after seizures does not only contribute to the HS, 
but also leads to the complete loss of neurogenic capacity in the SGZ. In fact, the few 
neurons that are newly born get aberrantly located outside the GCL (Overstreet-
Wadiche et al., 2006; Parent et al., 2006). Despite all this, the mechanisms by which 
NSCs transform into React-NSCs are still unknown. We have described before that 
lack of LPA1 reduces the massive activation of NSCs by seizures (Valcárcel-Martín et 
al., 2020) and other research lines of the laboratory are now exploring ATP through 
purinergic 2X receptors (ATP-P2XR pathway) as a key mechanism for the induction of 
React-NSCs (Martín-Suárez et al., in preparation 2020). Nonetheless, an additional 
molecular signaling in which we have more insight gained is that of the EGFR. Here, 
we have explored the possibility of FGFR1 and EGFR as important players in the 
neurogenic niche and NSC response in MTLE. Both have been reported as potent 
mitogenic factors for hippocampal NSCs and astroglia (Reynolds and Weiss, 1992; 
Tropepe et al., 1999). Moreover, ErbB family, to which EGFR belongs, has been 
reported to increase within the first three days after an intrahippocampal injection of KA 
(Sierra et al., 2015). We hypothesized that both FGFR and EGFR would play a role in 
the massive activation and reactive transformation of NSCs in MTLE. 
7.3.1. EGFR, but not FGFR, overexpression is an early event after KA 
To induce seizures adult mice were injected with KA, provoking as soon as 30 
minutes convulsive seizures (SE) that keep repeating up to 6 h after the injection. In 
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addition, mice develop unprovoked spontaneous chronic seizures after a few days, 
becoming epileptic (Bouilleret et al., 1999; Sierra et al., 2015). Following focal seizures, 
KA induces cell death, inflammation and GCD, all hallmarks of HS (Abiega et al., 2016; 
Bouilleret et al., 1999; Sierra et al., 2015). Although there are other widely used models 
of epilepsy such as pilocarpine we discarded this option due to their high mortality rate 
and the difficulty to replicate it due to the high variability (Curia et al., 2008; Lévesque 
et al., 2016). Pilocarpine is a systemic injection with a high spectrum of action being 
uncontrollable in terms of the region of the brain which is going to be affected. In 
contrast, the intrahippocampal injection of KA is directly delivered in the ML in a very 
small volume, restricting the area of action and without systemic alterations as those 
induced by the intraperitoneal alternative. Indeed, the intraperitoneal injection of KA in 
mice, although more consistent in rats, induces high mortality and too wide variability in 
mice. Previous research of the laboratory using both the intrahippocampal (Sierra et 
al., 2015) and intra-amygdalar (Muro-García et al., 2019) single injection of KA show 
that the dramatic effect on (ipsi and contralateral) hippocampal NSCs and the 
neurogenic niche is driven by neuronal hyperexcitation and not because of the injection 
of KA itself. Further, working with a model of generalized epilepsy (Dravet syndrome, a 
rare but devastating infant epilepsy), React-NSCs and aberrant neurogenesis are also 
induced (Martín-Suárez et al., 2020). 
We measured the protein and mRNA levels of two different isoforms of our first 
candidate FGFR (FGFR1 and FGFR2), within the first three days after KA 
administration. Both FGFR1 and FGFR2 have high affinity for the FGF2 ligand and 
their interaction promotes astroglial inflammation and glutamate release (Gómez-Pinilla 
et al., 1995a; Tao et al., 1996), both hallmarks of MTLE (Eid et al., 2019; Meldrum et 
al., 1999). Also, FGF2 is well-known to induce proliferation of hippocampal NSPCs in 
vitro (Kalluri et al., 2005; Reynolds and Weiss, 1992; Tropepe et al., 1999). 
Unexpectedly, we did not find any alteration either in the mRNA or protein levels of 
FGFR1 or FGFR2 in the HPF after KA. Furthermore, looking for possible particular 
alterations in the DG that the analysis of the whole HPF could be masking, we 
analyzed FGFR1 levels in the neurogenic niche 24 h after KA, with no observable 
differences in the FGFR1 expression in the GCL and in Nestin-GFP cells. Thus, we 
discarded FGFR as a mediator of the early neurogenic niche response in MTLE. 
Although we cannot rule out the possibility of FGFR1 activation without needing to 
increase its expression, we moved on to the study of EGFR and its downstream 
signaling pathway.  
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EGFR is highly involved in cell proliferation, playing a key role in the growth of 
several tumors types (Arteaga, 2011; Nicholson et al., 2001; Salomon et al., 1995; 
Sasaki et al., 2009; Sharma et al., 2007b). Moreover, it promotes proliferation of NSCs 
from both the SVZ and DG (Reynolds et al., 1992; Tropepe et al., 1999) and can 
induce astroglial differentiation (Sun et al., 2005). Importantly, the expression of ErbB 
family, from which EGFR is part, increases within the first three days after a KA 
intrahippocampal injection (Sierra et al., 2015). Here, following the same experimental 
timeline as before, we show that mRNA and protein expression levels of the receptor 
increase within the first three days after KA in the whole HPF, suggesting a role of 
EGFR in MTLE. In normal conditions, EGFR is expressed in neuronal populations of 
the HPF, with higher intensity in the neurons of CA2 (Tucker et al., 1993), making us 
wonder whether the increase of EGFR in MTLE can affect specifically to the 
neurogenic niche and NSCs. Interestingly, the expression of EGFR also increases in 
the GCL after KA, with EGFR observable in the nuclei and processes of the Nestin-
GFP-expressing NSCs. In fact, EGFR interaction with any of its ligands induces the 
internalization and trafficking of the receptor to early endosomes, mitochondria or 
nucleus where it can act as transcriptional regulator, tyrosine kinase and mediator of 
other physiological processes (Gazzeri, 2018; Roepstorff et al., 2009), suggesting that 
the nuclear location of EGFR in NSCs might be due to its prior activation. Moreover, we 
show that not only the total amount of EGFR is increased after KA, but there is also 
higher phosphorylation of the tyrosine site Y845, which has been reported to control 
cell cycle and promote activation, especially via MAPK and Akt. Indeed, the EGFR 
downstream signaling pathways Akt, ERK1/2 and STAT3 were also activated, which 
are implicated in cell proliferation, survival and astroglial reactivity (Deschênes-Simard 
et al., 2014; Dibble and Cantley, 2015; De La Iglesia et al., 2008; Lewis et al., 1998; 
Morgensztern and McLeod, 2005; Morrison, 2012; Priego et al., 2018). We conclude 
that the increase of EGFR levels together with an increased activation of the receptor 
and its downstream signaling pathways play an important role in the early response 
that takes place in the HPF and specifically in the neurogenic niche of the DG of mice 
subjected to MTLE. 
7.3.2. EGFR mediates the massive activation and induction of React-NSCs 
In light of the high upregulation and activation of the EGFR signaling pathway in 
MTLE, we next sought to manipulate it in NSPCs resorting to cultures. We extracted 
the HPF from adult mice and grew neurospheres in proliferating conditions as 
previously described (Jhaveri et al., 2015; Pineda et al., 2013). Although the presence 
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of EGFR in NSPCs from both SVZ and DG has been long known (Reynolds et al., 
1992; Tropepe et al., 1999), opposite results with NSPCs not being responsive to EGF 
due to a lack of EGFR have been also described (Kalluri et al., 2005), suggesting a 
possible differential action of the receptor depending on the cell line. Therefore, we first 
confirmed the clear expression of EGFR in our model of NSPCs directly derived from 
the mouse DG. Furthermore, the labeling was more intense in cells undergoing mitosis, 
arguing in favor of the role of EGFR in cell division.  
Next, we used the reversible inhibitor Gefitinib, widely used to revert tumor 
proliferation (Chen, 2013; Singh et al., 2016), to modulate the EGFR signaling 
pathway. We found that Gefitinib is able to turn off the Y845 phoshorylation site of 
EGFR and also the phosphorylation of ERK1/2, the downstream signaling pathway 
more closely related to cellular proliferation (Deschênes-Simard et al., 2014; Lewis et 
al., 1998; Morrison, 2012). Moreover, the addition of Gefitinib in the culture media 
drastically reduces the proliferation of NSPCs in terms of BrdU integration into the 
DNA. Thus, observing the efficiency of Gefitinib to block EGFR, we decided to try an 
irreversible inhibitor, Afatinib, also used to stop tumor proliferation in cancer (Watanabe 
et al., 2018; Yang et al., 2015). However, even though Afatinib apparently reduces the 
proliferating capacity of NSPCs it can be due to its dramatic effect on cell viability. 
Therefore, we conclude that because the irreversible blockage of EGFR leads to NSPC 
death, its reversible blockage through the use of Gefitinib poses an interesting 
alternative in order to manipulate the proliferation and the induction of React-NSCs. 
The massive activation and proliferation of the NSCs has been reported to 
reach its peak three days after the KA administration, when React-NSCs have been 
induced, accompanying the total disruption of the neurogenic niche and leading to very 
reduced and aberrant neurogenesis remaining (Sierra et al., 2015). Taking this into 
account, we administered Gefitinib during the first three days after KA starting from the 
moment right after the injection. As we expected, mice treated with Gefitinib showed 
decreased cellular proliferation (including NSCs) in the SGZ three days after KA. Then, 
we wondered whether the neurogenic capacity would be preserved at mid-term after 
KA (14 d). Interestingly, mice treated with Gefitinib preserved the population of DCX 
cells in the GCL and SGZ, otherwise greatly reduced in the MTLE mice treated with 
vehicle. Indeed, the increased morphological complexity characteristic of React-NSCs 
was also diminished. Moreover, GCD was prevented. The mechanism underlying GCD 
is still unknown but our data suggest that EGFR is also involved in this process directly 
or indirectly. In favor of a direct implication, both EGFR signaling and its natural ligand 
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HB-EGF have been previously shown to regulate developmental migratory processes 
in the cortex and in the HPF (Aguirre et al., 2004; Caric et al., 2001; Fox and Kornblum, 
2005; Kornblum et al., 1999), as well as to confer migratory properties to non-migratory 
neural progenitors during the postnatal period (Aguirre et al., 2005). Also, EGFR is 
implicated in migratory functions during the adulthood in regions such as the RMS or 
the white matter of the hippocampus (Craig et al., 1996; Sibilia et al., 1998) and HB-
EGF has been demonstrated to induce migration of immature neurons upon receptor 
binding (Sugiura et al., 2005; Zhou et al., 2012). Our results show that during the first 
events after intrahippocampal KA delivery there is an increase of both EGFR and HB-
EGF ligand and progressive neuronal and neurogenic niche dispersion. Niche 
disorganization produces aberrant ectopic circuitry leading to strong consequences. 
Indeed, neuronal circuits generated after aberrant neurogenesis has been related to 
play a role in the susceptibility and recurrence of seizures (Jessberger and Parent, 
2015), although it has been also suggested that aberrant neurogenesis is not causative 
of GCD (Fahrner et al., 2007). The mechanisms responsible for neurogenic niche 
alteration include the migratory properties of NSCs, the mislocalization of the newly 
generated neurons and the altered pattern of vasculogenesis, which are all key aspects 
to support neural activity. Their fine characterization is of utmost importance to 
understand how these alterations can affect normal neuronal circuitry. We hypothesize 
that reactive gliosis, in turn controlled by EGFR, is driven by GCD and therefore results 
reduced by Gefitinib. 
Some studies have pointed that the absence of EGFR provokes hypersensitivity 
to epileptic seizures (Robson et al., 2018) and that although NSPCs present their 
proliferative capacity impaired, they are more prone to differentiate into astrocytes 
(Robson et al., 2018; Sibilia et al., 1998). Nonetheless, these results were reported 
using the intraperitoneal model of KA, in which the location of seizures can be more 
widespread than in MTLE, and a knock-out mouse model for EGFR (Robson et al., 
2018). Thus, we postulate that the absence/blockage of EGFR could have different 
effects in different brain areas and that while a reversible inhibition of EGFR might be 
beneficial in MTLE, the whole absence of the receptor might lead a completely different 
and adverse scenario, as the one we observe with the use of Afatinib. In addition, due 
to recurrent seizures taking place over time in MTLE (Sierra et al., 2015), we cannot 
exclude the possibility that the neurogenic niche gets disrupted in the long-term even 
with the initial blocking of EGFR. Although in turn a longer administration of Gefitinib 
could be proposed. Indeed, given that seizures trigger a plethora of responses within 
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the HPF, and regarding that blocking of EGFR causes a partial reduction of the effect 
on the neurogenic niche, we do not consider EGFR to be a unique or the main 
protagonist governing the induction of React-NSCs, but a part of a more complicated 
network in which other factors, including other ErbB receptors, ATP and LPA1 can be 
playing important roles. However, we do demonstrate the participation of the EGFR 
signaling pathway in the initiation of the process and the capacity to restrain the 
adverse effects caused in the neurogenic niche at short-mid-term by blocking it (Figure 
D4). 
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Figure D4. Gefitinib ameliorates the adverse effects provoked by KA in the neurogenic niche and 
NSCs. A) When KA is intrahippocampally administered the neurogenic niche gets altered. While in normal 
conditions 2-4% of NSCs get activated (Encinas et al., 2011a), this percentage increases short after KA. 
This massive activation is preceded by an increase of EGFR expression in NSCs. EGFR, usually present 
in activated NSCs and ANPs (Jhaveri et al., 2015; Pastrana et al., 2009) switches its expression and it is 
observable in many NSCs after KA. These early events provoke GCD, induction of React-NSCs and 
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reactive astrocytes and the complete loss of neurogenic capacity of the niche at mid-term. B) The 
administration of Gefitinib during the first days after KA leads to the reversible blocking of EGFR signaling 
(illustrated as the absence of the receptor for visualization purposes), thus ameliorating the GCD provoked 
by KA at mid-term and the induction of React-NSCs. Likewise, the neurogenic capacity of the niche is 
preserved. Nonetheless, even though the NSCs are not converted into React-NSCs, they lose their 
characteristic broccoli-like crown, indicating that the effect of KA is not completely reverted. 
7.4. Zn+2 as a mechanism in the early response of the neurogenic 
niche and the NSCs in MTLE 
Exploring further potential mechanisms that could elicit the response over the 
NSCs and neurogenic niche after seizures, we drew our attention towards trace metals. 
Their involvement in convulsive disorders has been previously studied, with iron being 
the first one reported to induce epileptiform activity and recurrent seizures in different 
mammalian species (Lange et al., 1980; Willmore et al., 2020). Here we focus on Zn+2, 
which has been described to be released in the HPF after seizures (Kasarskis et al., 
1987; Mody and Miller, 1985) and can also potentially act as modulator of neuronal 
activity (Bancila et al., 2004; Takeda et al., 2004), also being able to induce cell death 
(Koh et al., 1996; Lee et al., 2000b). Finally, Zn+2 has been shown to interact with the 
EGFR pathway, activating the receptor both directly and indirectly through the release 
of HB-EGF (Samet et al., 2003; Wu et al., 2004). We used the Danscher staining 
method to analyze the amount of Zn+2 accumulated in the GCL and in the NSCs after 
KA. The increase in the granules of Zn+2 in the GCL and their colocalization with 
Nestin-GFP suggest for the first time a possible role of the released Zn+2 over the 
neurogenic niche and NSCs. We also observed the increase of MT1 and MT2 in the 
HPF, both in charge of encapsulating Zn+2. In contrast, we did not observe any 
alteration on the levels of MT3, which could be due to differences in the location and 
regulation respect to MT1 and MT2 (Aschner et al., 1997; Hidalgo et al., 1997). 
Supporting our results, MT1 and MT2 have been previously reported to increase in the 
HPF after intraperitoneal KA (Carrasco et al., 2000). Indeed, their absence provokes 
aggravation of seizures (Carrasco et al., 2000; Cole et al., 2000). Altogether, our 
results suggest a possible role of Zn+2 in the neurogenic niche and on NSCs after 
seizures. Nonetheless, the system tries to tightly regulate this response, in sight of the 
increased levels of MT1 and MT2 expression, probably because even though Zn+2 
could be beneficial in epilepsy by reducing glutamatergic synaptic activation (Bancila et 
al., 2004; Minami et al., 2006; Takeda et al., 2003), it can also exert neurotoxic effects 
(Bitanihirwe and Cunningham, 2009; Konoha et al., 2006; Mizuno and Kawahara, 
2013). 
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 We assessed the specific effect of Zn+2 over the NSCs. For that, we cultured 
NSPCs in vitro and applied Zn+2 at different concentrations. We found that low Zn+2 
concentrations (5 µM) promotes proliferation of NSPCs but these effect switches in a 
dose-dependent manner, with concentrations higher than 10 µM leading to massive 
cell death in the cultures. The obtained results agree with previous findings in which 
cell death was observed in response to Zn+2  (Koh et al., 1996; Lee et al., 2000b) and 
suggests a detrimental effect of Zn+2 that is massively released in MTLE. To check the 
effect on NSCs in vivo and given the dose-dependent opposite effect observed in vitro, 
we injected different concentrations of Zn+2 intrahippocampally in the DG and analyzed 
the neurogenic niche 7 d after the injection. Given that the peak of proliferation after KA 
takes place 3 d after the injection (Sierra et al., 2015), we selected this time point to 
ensure the correct visualization and assessment of the potential effect of Zn+2 upon the 
niche. We found that Zn+2 administration triggers an increase of dividing cells in the 
SGZ, as well as the morphological induction of React-NSCs and GCD in a dose-
dependent manner, thus mimicking the effect of the injection of KA. Therefore, to 
continue our experiments we picked the lowest dose (20 mM) with which we observed 
the mentioned effects. Even though Zn+2 mediates the morphological transformation of 
NSCs into React-NSCs, the massive activation or entrance of NSCs into cell cycle is 
not recapitulated by Zn+2 injection. Nonetheless, we could not exclude the option of an 
early direct effect on NSCs in which they get activated, returning to normal levels 
thereafter in the absence of further stimuli. In contrast to the KA model, animals do not 
manifest seizures after Zn+2 administration which would explain an early and transitory 
activation of NSCs that we would be missing analyzing the tissue 7 d after the injection, 
since we administer BrdU 24 h before sacrifice. Instead, we would be observing the 
ANP proliferation after the first burst of NSC activation, that in the absence of recurrent 
seizures do not get massively activated anymore. 
7.4.1. Zn+2 effect can be driven by EGFR activation 
 We have described the implication of EGFR and Zn+2 in the early events that 
occur in the hippocampal neurogenic niche after seizures. Interestingly, as indicated 
before, Zn+2 can promote the activation of EGFR either directly and also indirectly by 
provoking the release of the EGFR natural ligand, HB-EGF, from the cell membrane 
(Samet et al., 2003; Wu et al., 2004). We hypothesized that the response of the 
neurogenic niche and especially NSCs could be driven by the interplay of both factors. 
Resorting to in vitro NSPCs, we discovered that Zn+2 directly phosphorylates EGFR on 
the Y845 phosphorylation site, but not on Y1068. Importantly, Zn+2 is also able to 
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strongly provoke the phosphorylation of the ERK1/2, highly related with cellular 
proliferation (Deschênes-Simard et al., 2014; Lewis et al., 1998; Morrison, 2012). 
Nevertheless, even though ERK1/2 is one of the downstream signaling pathways of 
EGFR, Zn+2 can also affect this pathway directly through intracellular action (Park and 
Jae-Young, 1999; Tice et al., 1999). Furthermore, we tested the capacity of Gefitinib to 
ameliorate the effects that Zn+2 provoke on the neurogenic niche. We followed the 
paradigm previously used for the Gefitinib administration, within the first 3 d post-
injection. Our results showed that the Zn+2-induced increase in cell proliferation was 
reduced in the SGZ by administration of Gefitinib. Moreover, the induction of React- 
NSCs seemed to be ameliorated. We propose that when Zn+2 is injected 
intrahippocampally, in a model that does not cause recurrent seizures, its EGFR-
mediated effect is exerted upon the cells that express EGFR in normal conditions, i.e. 
ANPs and the few already active NSCs (Jhaveri et al., 2015; Walker et al., 2016). In 
contrast, KA-induced seizures provoke the increase of EGFR in NSCs, opening the 
way for extracellular Zn+2 to massively activate them. Moreover, since the 
administration of Zn+2  alone let the majority of NSCs untouched and does not cause 
seizures, we speculate that its effect will be transitory, provoking a boost of 
neurogenesis that will return to basal levels with time, as it occurs in other models 
where ANPs, but not NSCs, are induced to activation (Deisseroth et al., 2004; Gould et 
al., 1999a; Lee et al., 2000a; Lemaire et al., 2000; Nilsson et al., 1999; Van Praag et 
al., 1999) (Figure D5). Regardless, our results indicate that the effect of Zn+2 over the 
neurogenic niche, at least proliferation, is mediated by the activation of EGFR signaling 
pathway, shedding light upon a new mechanism and its therapeutic modulation. 
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Figure D5. Zinc alone does not provoke the long-term depletion of the neurogenic capacity. A) The 
intrahippocampal administration of KA provokes the increase of EGFR in NSCs and the massive liberation 
of Zn
+2
 into the GCL. Consequently, Zn
+2
 binds to NSCs inducing React-NSC transformation and 
proliferation via EGFR. Thus, React-NSCs symmetrically divide, losing their neurogenic capacity. B) In the 
absence of KA, EGFR expression is restricted to the activated NSCs and ANPs. Moreover, the 
proliferation induced by intrahippocampal administration of Zn
+2
 is limited to the cells expressing EGFR, 
provoking the massive division of ANPs. However, Zn
+2
 induces the transformation of NSCs into React-
NSCs even in the absence of EGFR, suggesting the implication of other mechanisms or the direct effect of 
Zn
+2
 upon NSCs. Nevertheless, since the intrahippocampal administration of Zn
+2
 does not provoke 
seizures, it represents a single insult and its effects will be diluted with time, potentially leading to the 
recovery of the neurogenic capacity. 
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7.4.2. Zn+2  chelation as a therapeutic approach in MTLE 
 We next wondered about the possibility of Zn+2 being key protagonist in the 
response of the neurogenic niche after seizures and about the potential beneficial 
action of its chelation. Therefore, administrated TPEN, a membrane permeable Zn+2 
chelator (Kim et al., 2012), in our model of MTLE. We tested in vitro the possibility of 
trying Clioquinol, another Zn+2 chelator (Bareggi and Cornelli, 2012), but we were 
inclined to the use of TPEN due to the high level of cell death induced by Clioquinol 
(data not shown). Thus, we administered TPEN subcutaneously during 7 d after 
intrahippocampal KA administration, but instead of the expected improvement, we 
observed a devastating effect in the GCL. In the animals treated with TPEN, not only 
the GCD is not reduced but the cell death tends to increase. Moreover, the reactivity of 
the niche, including React-NSCs, was not ameliorated, possibly affected by the huge 
amount of cellular death undergoing in the GCL. These results are probably due to the 
neuroprotective effect that Zn+2 exerts in a context of neuronal hyperactivation as 
MTLE, and support the studies observing an increase of the apoptotic cells and 
worsening of seizures in mice lacking Zn+2 (Carrasco et al., 2000; Minami et al., 2006; 
Takeda et al., 2003). The obtained results indicate that while Zn+2 can be one of the 
mechanisms contributing to the induction of React-NSCs, GCD and hyperproliferation 
in the SGZ, its quelation is not an effective therapeutic approach in MTLE, as it might 
counteract the neuroprotective role of Zn+2 in the GCL.  
7.5. Massively released HB-EGF can activate EGFR in NSPCs in 
MTLE 
 So far, we had explored two mechanisms regulating the response of the 
neurogenic niche and NSCs after seizures: EGFR and its signaling pathway and Zn+2. 
Interestingly, one of the ways for the possible interplay between both mechanisms 
involves HB-EGF (Samet et al., 2003; Wu et al., 2004), one of the natural ligands of 
EGFR (Jones et al., 1999). Therefore, we decided to assess the levels of HB-EGF 
release in our MTLE model. In normal conditions, HB-EGF expression is present in all 
the principle layers of the DG from birth to P7, whereas from P14 on it is mainly 
concentrated in the GCL. Moreover, after seizures induced by intraperitoneal KA, the 
expression increases during the first 24 h post-injection in the GCL, the ML and also 
CA1 and CA3. The expression decreases thereafter, yet it remains elevated in 
vulnerable regions of the HPF and the amygdaloid complex (Opanashuk et al., 1999). 
Supporting these observations, we observed in our MTLE model an increase of HB-
EGF in the HPF within the first 24 h post-KA followed by a return to control levels at 72 
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h. Nonetheless, the increased HB-EGF levels were maintained in the ML and the hilus 
at 72 h post-injection, suggesting a possible sustained effect of the ligand in these 
regions. We propose a model in which after seizures, EGFR is upregulated in NSCs 
and further activated by the massively released Zn+2, either by direct action or indirect 




 activates EGFR through different manners. A) After seizures, massively released Zn
+2
 
activates EGFR, which expression is increased in NSCs. B) Zn
+2
 can directly activate EGFR, 
phosphorylating the receptor on its tyrosine kinase Y845 (Samet et al., 2003; Wu et al., 2002). C) Zn
+2
 also 
provokes the release of HB-EGF from its cell-membrane anchored form, probably through matrix 
metalloproteinase (MMP) shedding (Sanderson et al., 2006; Wu et al., 2004). Indeed, HB-EGF is a potent 
neuroprotective EGFR ligand that is massively released in the DG after seizures. 
We next sought to evaluate the effect of HB-EGF on NSCs resorting to cultured 
NSPCs. First, we observed that cultured NSPCs release HB-EGF to the media in 
proliferating conditions. The levels of HB-EGF were highly increased in the media 
compared to the cellular pellet, suggesting a constant release of HB-EGF from the cell 
membrane in proliferating conditions. Moreover, after NSPCs are starved from growth 
factors and EGFR and ERK signaling have been shut off, HB-EGF is capable of 
stimulating the EGFR signaling pathway again by increasing phosphorylation in both 
Y845 and Y1068 sites. In contrast, the additional administration of Zn+2 does not 
increase the effect probably due to the prevailing excessive effect of HB-EGF. 
Nonetheless, although HB-EGF is mainly related to proliferation and migratory 
processes, ErbB ligands may have different signal transduction cascades depending 
on the ErbB family receptor they activate/stimulate (Kochupurakkal et al., 2005; 
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Willmarth and Ethier, 2006; Wilson et al., 2012) and thereby further research would be 
necessary to properly assess the respond of hippocampal NSCs to HB-EGF. On top of 
that, we consider worth bearing in mind the possible action of HB-EGF on ErbB4, 
another receptor of the EGFR family to which HB-EGF can bind. Although the effect on 
cellular proliferation is not induced by the binding to ErbB4, cellular chemotaxis is, 
therefore potentially affecting the GCD and React-NSC migration towards the ML 
(Elenius et al., 1997). 
We postulate that HB-EGF might play an important role in the GCD and NSC 
activation that occur after seizures. The massive liberation of this ligand can provoke 
an increased activation of the EGFR signaling pathway, triggering the consequent 
cellular responses (proliferation, reactivation, migration). We do not postulate this as 
being the only mechanism taking place in MTLE, as we understand that such a 
complex response has to be driven by a plethora of different mechanims. Indeed, 
several potential mechanisms could be playing a role through EGFR. LPA1, a selective 
marker of adult DG NSCs (Walker et al., 2016) that plays a role in the activation of 
seizure-induced React-NSCs (Valcárcel-Martín et al., 2020), and its activation by LPA 
could play a role by EGFR transactivation (Cunnick et al., 1998; Daub, 1997; Daub et 
al., 1996) in the Y845 phosphorylation site (Gotoh et al., 1992; Tice et al., 1999) in a 
similar manner than we observe with Zn+2. Additionally, there are diverse ligands 
capable of producing distinct cellular EGFR-mediated responses (Wilson et al., 2009); 
Neuregulin-1, another natural ligand of EGFR, selectively increases proliferation and 
overall neurogenesis in the mouse DG, yet its effects are restricted to the ventral part 
(Mahar et al., 2016). TGF-α, also a natural ligand of EGFR that is synthesized in the 
developing and mature brain (Brown et al., 1990) mimics the effects of EGF on NSPCs 
in vitro (Reynolds and Weiss, 1992). Although we did not explore these mechanisms 
herein, we cannot leave out the possibility of them playing a role in MTLE. We consider 
that our results open interesting avenues for the study of potential therapies that will 
preserve the neurogenic niche and neurogenesis, which is our ultimate goal, with 
special focus in the EGFR signaling pathway. We believe that future alternatives 
should aim to target more than a unique pathway to avoid compensatory mechanisms, 
yet studies like ours contribute to the knowledge and help to establish a first stone to 





















































 1. Adult NSCs are generated postnatally as a new population 
independent from dNSCs rather than remaining as a mere residue 
from the DG development. 
  - Adult NSCs are generated during the early postnatal period in a cD2 
dependent manner. 
  - Progenitors located inside the DG early after birth contribute to the 
generation of the adult NSC pool, while progenitors coming from the DMS are strictly 
neurogenic. 
  - The postnatal onset of LPA1 expression in the SGZ distinguishes adult 
NSCs from dNSCs. 
 
2. The formation of sequential progenitor matrixes (DNe, DMS, 
DG) share similar features during the development of human and 
mouse DG. 
  - During the human early embryonic development (GW14) 
heterogeneous populations of dNSCs populate different regions of the HPF (DNe, 
DMS, DG). 
  - In humans, Tbr2-expressing progenitors and Ki67-expressing 
proliferating cells are restricted to the hilus (close to the GCL) before birth. 
  - Nestin-expressing RGCs remain in the human DG early after birth, 
although with residual proliferating capacity. 
 
 3. The massive activation and induction of React-NSCs in 
MTLE is regulated by Zn+2- and HB-EGF-induced activation of EGFR. 
  - EGFR, but not FGFR, is involved in the early response of the HPF after 
KA administration. 
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  - The increase in the expression and the activation of EGFR and its 
downstream signaling pathway (STAT3, Akt, ERK1/2) is a key event within the first 
three days after KA administration. 
  - Gefitinib is able to inhibit EGFR and its downstream signaling pathway 
ERK1/2 in NSPCs in vitro, effectively blocking their proliferation. 
  - The intranasal administration of Gefitinib after KA reduces the 
proliferation in the neurogenic niche and GCD, as well as the activation and reactive 
transformation of NSCs. 
  - Zn+2 is massively released in the DG after KA administration, 
accumulating in the GCL close to NSCs. 
  - Zn+2 stimulates proliferation of NSPCs in vitro in a dose-dependent 
manner, causing cell death in high doses. 
  - Intrahippocampal injection of Zn+2 induces proliferation in the SGZ, 
GCD and reactive transformation of NSCs. 
  - Zn+2 administration into cultured NSPCs induces direct phosphorylation 
of EGFR in its tyrosine site Y845, but not Y1068. 
  - The intranasal administration of Gefitinib reverts the massive 
proliferation in the SGZ provoked by intrahippocampal Zn+2 administration. 
  - Quelation of Zn+2 by repeated subcutaneous injections of TPEN after 
KA administration induces additional cell death, invalidating it as a potential therapy for 
MTLE. 
  - HB-EGF is massively released in the DG after KA administration, 
accumulating in the ML and hilus. 
  - HB-EGF administration into cultured NSPCs induces strong activation 
of both EGFR tyrosine sites Y845 and Y1068, as well as its downstream signaling 
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1. LABURDUREN LISTA 
AHN Hipokanpoko neurogenesi heldua 
ANOVA Bariantza analisia 
ANP Neurona sortzaile anplifikadoreak 
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BrdU 5-bromo-2'-deoxiuridina 
BSA Behi serum albumina 
CA Cornu ammonis 
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CNS Nerbio-sistema zentrala 





DG Hortzdun zirkunboluzioa 
dHPF Bizkarraldeko hipokanpoko formazioa 
DMS Horzdun migrazio-korrontea 
DNA Azido desoxirribonukleikoa 
DNe Horzdun neuroepitelioa 
dNSC Garapen zelula ama neurala 
DV Bizkarraldetik sabelaldera 
EC Kortex entorrinala 
EGF Hazkuntza faktore epidermala 
EGFP Proteina fluoreszente berde aberastua 
EGFR Hazkuntza faktore epidermal hartzailea 
EM Mikroskopia elektronikoa 
FDJ Fimbrio-hortzdun lotunea 
FGF Hazkuntza faktore fibroblastikoa 
FGFR Hazkuntza faktore fibroblastiko hartzailea 
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GC Zelula granular 
GCD Zelula granular dispertsioa 
GCL Zelula granular geruza 
GFP Proteina fluoreszente berdea 
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LV Bentrikulu laterala 
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MF Goroldio zuntza 
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NSC Zelula ama neurala 
NSPC Zelula ama neural eta sortzaileak 
Px Jaio ondorengo eguna  
PBS Fosfato tanpoi soluzio isotonikoa 
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ROI Interes gunea 
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Ugaztun gehienen burmuina neurona berriak sortzeko gai da bizitza osoan 
zehar, jaio ondorengo aroa eta helduaroa barne, neurogenesi heldua bezala ezagutzen 
den prozesu baten bitartez. Gaur egun ongi jakina da prozesu neurogeniko heldu osoa 
zelula ama neural (ingelesetik neural stem cell; NSC) helduetan oinarritzen dela. Zelula 
hauetatik jaiotzen dira aurretiaz ezarritako zirkuituetan integratuko diren neurona 
berriak, behintzat burmuinaren bi zonaldetan; bentrikulu lateraletan aurkitzen den gune 
azpibentrikularrean (ingelesetik subventricular zone; SVZ) eta hipokanpoko formazioko 
(ingelesetik hippocampal formation; HPF) horzdun zirkunboluzioan (ingelesetik dentate 
gyrus; DG) aurkitzen den gune azpigranularrean (ingelesetik subgranular zone, SGZ). 
Azken honetan jazotzen dena hipokanpoko neurogenesi heldu (ingelesetik adult 
hippocampal neurogenesis, AHN) bezala ezagutzen da, tesi honetan jorratuko duguna.  
Saguetan, SGZko ahalmen neurogenikoa denborarekin murriztu egiten dela 
deskribatu da. Adinarekin erlazionaturik dagoen AHNaren murrizketa hau NSCen 
agortzeagatik jazotzen dela proposatu da, neurona aurrekariak sortzeko ziklo 
zelularrean barneratzen diren (bestela esanda, aktibatuak izaten diren) NSCek 
prozesuaren ostean pairatzen duten diferentziazio astrozitiko edo neuronalaren 
ondorioz. Gainera, nahiz eta SGZ helduan NSCen auto-errepikapena posiblea dela 
deskribatu den ez da NSC populazioaren agorpen progresiboari aurre egiteko gai. 
Honela, norbanakoaren ahalmen neurogenikoa hasierako NSC kopuruak baldintzatzen 
du. Honen harira, NSCen jatorria ondo ezagutzen ez den arren, hauek zein AHNa jaio 
aurreko hipokanpoaren garapeneko hondakin bat direla da zabalduen dagoen 
ikuspegia.  
Gizakietan, AHNaren benetako jazoera eta hedadura historikoki debate beroak 
sorrarazi dituen gaia izan da. Duela gutxi, debatea berpiztua izan zen umezarotik 
aurrera AHNaren gabezia argitaratu zuen ikerlan baten ondorioz. Hala ere, beste 
autore batzuek doblekortina (ingelesetik doublecortin, DCX) espresatzen duten zelulen 
presentzia adierazi izan dute DG helduko SGZan, AHNaren izatea ondorioztatuz. 
Gaurdaino, bi ikuspegi kontrajarriek eztabaidapean diraute. 
Tesi honen lehengo zatian, NSC helduen garapeneko jatorriari helduko diogu. 
Honetarako, DGaren jaio ondorengo garapena ziklina D2rik (ingelesetik cyclin D2, cD2) 
gabeko sagu transgeniko lerro batean ikertu genuen, zeina NSCak behar bezala 
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ikusaraztea ahalbidetzen duen Nestin-proteina fluoreszente berde (ingelesetik green 
fluorescente protein, GFP) sagu transgeniko batekin gurutzatua izan zen. Jaio 
ondorengo burmuineko eremu ezberdinetan ugaritzen zeuden zelulak markatu eta 
haien leinuaren jarraipena egiteko, eremu espezifikoetara zuzenduriko infekzio 
retrobiralak erabili genituen. Emaitzek adierazten dutenez, NSC helduen populazioa 
tokian sortzen da DGan jaio ondorengo lehen 2-7 egunen artean eta cD2ren menpeko 
prozesu baten bitartez. Aurkikuntza honek NSC helduek garapeneko sortzaileengandik 
ezberdina den populazio bat osatzen dutela iradokitzen du, jaio ondoren sortuak 
izanda era independente batean. Hala, jaio ondorengo eta helduaroan zehar ematen 
den AHNa ez da jaio aurreko garapenaren hondakin soil bat. Emaitza hauek babestuz, 
garapeneko NSCek aurkezten ez duten biomarkatzaile baten espresio diferentziala 
aurkitu genuen. Azido lisofosfatidiko 1 hartzailea (ingelesetik lysophosphatidic acid 
receptor 1, LPA1)-areagoturiko proteina fluoreszente berdea (ingelesetik enhanced 
green fluorescent protein, EGFP) sagu transgenikoa erabiliz, LPA1 NSCetan jaio 
ondorengo 10-14 egunetatik (ingelesetik postnatal, P10-P14) aurrera espresatua izaten 
hasten dela ikusi genuen, hortik aurrera bere espresioak hipokanpoko NSCetan 
dirauelarik. 
Esan bezala, AHNaren existentzia gizakietan azkenaldian eztabaida beroa 
sortu duen gaia izan da guztiz kontrajarriak diren emaitzak argitaratu direlarik. Arazoari 
garapen ikuspegi batetik helduz, giza eta sagu garapen prozesuek dinamika tenporal 
ezberdinak jarraitu litzaketela deskribatu genuen, nahiz eta formazio patroi antzekoak 
konpartitu. Nagusiki, jaio ondorengoa den sagu DGaren garapenaren aurrean, 
gizakietan prozesu hau ia guztiz amaiturik dago haurdunaldi erdirako. Nolanahi ere, 
zelula glial erradial (ingelesetik erradial glial cell, RGC) populazioak oraindik presente 
daude jaio eta gutxira. Hala, giza DGan jaio ondorengo garai goiztiarrean NSC 
populazio baten existentzia (duen hedadura tenporala kontuan hartu barik) garrantzia 
handikoa izan litzake patologia egoeretan.  
Hipokanpoko gune neurogenikoaren galerak, eteteak edo alterazioak zonalde 
honekin erlazionaturiko ariketa kognitibo guztien gaitza dakar, hala nola ikaskuntza, 
memoria, patroi separazioa, antsietatea, etab. Izan ere, AHNaren alterazio patologikoa 
erlazionatua izan da gaitz neurodegeneratibo ezberdinekin, adibidez epilepsia, 
Parkinson, Alzheimer eta Huntington gaixotasunak eta dementzia, patologia guzti 
hauetan gutxienez sintomen parte bat potentzialki eraginda edo bultzatuak izan 
litezkeelarik AHN alteratu edo murriztu batengatik. Izan ere, nire laborategi hartzaileak 
duela gutxi erakutsi du konbultsioek sustaturiko hiperaktibitate neuronalak NSCak NSC 
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erreaktibo (ingelesetik reactive NSC, React-NSC) bihurtzera bultzatzen dituela, euren 
propietate morfologiko eta mitotikoak errotik aldatuz eta azkenera astrozito 
erreaktiboak sortuz, neurogenesiaren kaltean.  
Tesiaren bigarren partean, lobulu tenporal medialaren epilepsia (ingelesetik 
mesial temporal lobe epilepsy, MTLE) aztertu genuen azido kainiko (ingelesetik kainic 
acid, KA) injekzio bakarra HPFan gauzatuz. Ondoren, hazkuntza faktore epidermal 
hartzailearen (ingelesetik epidermal growth factor receptor, EGFR) seinalizazio 
ibilbideak konbultsio ostean gune neurogenikoan duen erantzun patologikoaren 
hasieran duen rola aztertu genuen. Konbultsioak jazo eta gutxira, EGFR NSCetan 
areagotu egiten dela eta EGFRren inhibitzaile itzulgarria den Gefitinib (gliomaren 
tratamendurako erabiltzen dena) MTLE indukzioaren ondoren erabiliz, ugaritze 
jarduera masiboa eta React-NSC indukzioa murrizturik zeudela erakutsi genuen, 
prozesu honetan EGFR ibilbideak rol nagusi bat jokatzen duela iradokiz. Gainera, 
garrantzitsua da neurogenesia, DCX espresatzen zuten neurona heldugabeen 
presentzia bezala ulertuz, babestu egiten zela Gefitinib jaso zuten MTLE saguetan. Are 
gehiago, konbultsio ostean gertatzen den zink (Zn+2) askapenaren areagotzeak React-
NSC indukzioan parte hartzen duela ere demostratu dugu, bai EGFRren estimulazio 
zuzenaren bitartez zein zelula mintzera loturik dagoen heparinari loturiko-hazkuntza 
faktore epidermalaren (ingelesetik heparin binding-epidermal growth factor, HB-EGF) 
mozketa bultzatuz, azken hau EGFRren estekatzaile natural bat izanik, KA 





























































3.1. Hipokanpoko formazioa (Ingelesetik hippocampal formation, 
HPF): Burmuineko itsas zaldia 
1587a zen Giulio Cesare Arantius anatomistak itsas zaldiaren antza handia 
hartzen zuen estruktura bat aurkitu zuenean giza burmuinaren lobulu tenporal 
medialaren barnealde sakonean. Antzekotasuna onartuz, itsas izaki honen greziar 
hitza hartu zuen estruktura izendatzeko: “Hippocampus” (HP) (Arantius, 1587). Ordutik, 
estruktura arkikortikal honek hainbat ikertzaileren interesa piztu du, zeinek bere 
ezaugarri morfologiko eta funtzionalak argitzeko lan egin duten. Gaur egun, HP 
terminoak “cornu ammonis” (CA) edo “ammon’s horn” izenak ere hartu izan dituen 
estruktura bat adierazten du. Izen hauek estrukturak ahari adar batekiko duen antzaren 
eraginez eman zitzaizkion eta baita Amun Knepth jainkosaren ondotik, honen sinboloa 
ahari bat izanik (de Garengeot, 1742). Era xelebrean, CA izendapena mantendu egin 
zen harrezkero HParen azpieremuak definitzeko (CA1, CA2, CA3 and CA4) (S1 A 
Figura). 
HPa burmuineko beste eremu batzuekin konektaturik dago, guztiek batera 
HPFa osatzen dutelarik, Golgik lehenbizikoz errepresentatu (Golgi, 1886) eta Santiago 
Ramón y Cajalek eta bere ikasle Raphael Lorente de Nók osotasunean deskribatu 
zutena (Lorente de Nó, 1934; Ramón y Cajal, 1893, 1911). Haien ikerlanetan 
oinarriturik, egun badakigu HPFa HPak baino estruktura gehiagok osatzen dutela, hala 
nola subikuluma, presubikuluma, parasubikuluma, kortex entorrinala (ingelesetik 
entorhinal cortex, EC), albeoloa, hipokanpoko arrakala (ingelesetik hippocampal 
fissure, HF), buztan hipokanpala, HP-amigdala trantsizio eremua (ingelesetik HP-
amygdala transition area, HATA) eta baita ere horzdun zirkunboluzioa (ingelesetik 
dentate gyrus, DG) (Iglesias et al., 2015) (S1 A Figure). Estruktura hauek, nahiz eta 
tamainan ezberdinak, ugaztun guztietan daude presente sagutik gizakira (S1 B 
Figura). 
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S1 Figura. A) HPFko azpieremu ezberdinak. B) Arratoiaren, tximinoaren eta gizakiaren HPFa (Iglesias et 
al., 2015 eta Savage et al., 2013 artikuluetatik eraldatua). 
3.2. Neurona sorrera burmuin helduan 
90. hamarkadan, 5-bromo-2'-deoxiuridina (BrdU) arrakasta osoz erabili zen 
saguetan neurogenesi helduaren existentzia demostratzeko bai bentrikulu lateralaren 
(ingelesetik lateral ventricle, LV) gune azpibentrikularrean (ingelesetik subventricular 
zone, SVZ) zein DGko gune azpigranularrean (ingelesetik subgranular zone, SGZ) 
(Cameron et al., 1993; Kuhn et al., 1996; Seki and Arai, 1993) (S2 Figura). Are 
garrantzitsuago, hamarkadaren amaiera aldera Elizabeth Gould eta bere kideek 
hainbat ikerlan argitaratu zituzten BrdU erabiliz eta neurogenesi hipokanpal helduaren 
(ingelesetik adult hippocampal neurogenesis, AHN) existentzia erakutsiz zuhaitz 
basakuetan, mundu zaharreko tximinoetan (Gould et al., 1997, 1999a, 1999b) eta 
makakoen SVZan (Gould et al., 1999c). Aurkikuntza hauek beste autore batzuek 
babestu zituzten hurrengo urteetan zehar (Kornack and Rakic, 1999, 2001; Pencea et 
al., 2001), mundu zaharreko tximinoetan AHNa saguetan baino hamar aldiz baxuagoa 
zela adierazi zuten arren (Kornack and Rakic, 1999). Hala, hurrengo urteetan 
BrdUaren erabilera eta interpretazio egokiak sorrarazitako iritzia ezegonkorra 
izanagatik (Nowakowski, 2000), Joseph Altmanen lehenengo aurkikuntzetatik 50 urtera 
(Altman and Das, 1965) neurogenesi helduaren kontzeptua guztiz onartua eta biziki 
ikertua izan zen.  
SARRERA 





S2 Figura. Gune neurogeniko helduak LVko SVZan eta hipokanpoko DGko SGZan. 
3.3. Urjauzi neurogeniko hipokanpala 
DG helduan, proteina azidiko fibratzaile gliala (ingelesetik glial fibrillary acid 
protein, GFAP) espresatzen zuten zelula glial erradialak (ingelesetik erradial glial cells, 
RGCs) zatitzeko kapazak zirela aurkitu zen (Kosaka and Hama, 1986; Rickmann et al., 
1987), nahiz eta ugaritze aktibitate hau gliogenesiarekin erlazionatu zen hasiera 
batean (Cameron et al., 1993; Kaplan and Bell, 1984). Nolanahi ere, handik urte 
batzuetara Arturo Álvarez-Buylla eta bere kideek lehenengoz deskribatu zuten, 
BrdUaren erabileraren bitartez zelula mitotikoen jarraipena eginez, GFAP positiboak 
ziren astrozito erradialak zelula ama (ingelesetik stem cell, SC) bezala aritzen zirela 
eta neurona jaioberriak ematen zituztela DG helduko SGZan (Seri et al., 2001). 
Gutxira, bitarteko zelula ama neuroektodermalen markatzaile (ingelesetik 
neuroectodermal stem cell intermediate marker, Nestin) SC neuroepitelialen 
markatzailearen espresioan oinarriturik zelula ama neuralak (ingelesetik neural stem 
cells, NSCs) ikusaraztea ahalbidetzen zuten sagu transgeniko anduiak garatu ziren 
(Lendahl et al., 1990). Sagu transgeniko berri hauen bitartez SGZko astrozito erradial 
haiek hobeto karakterizatu ahal izan ziren. Honela, urjauzi neurogeniko helduaren 
lehenengo urratsa diren astrozito erradialak mota-1 zelulak deitarazi ziren (Filippov et 
al., 2003; Kronenberg et al., 2003). Morfologia karakteristiko bat adierazten zuten 
zelula bezala identifikatuak izan ziren, soma SGZan kokaturik eta prozesu bat geruza 
molekularrerantza (ingelesetik molecular layer, ML) luzaturik zituztelarik, azken hau 
zelula granular geruzaren (ingelesetik granule cell layer, GCL) kanpoaldera iritsi bezain 
pronto arbolaztatzen zelarik, brokoliaren itxurako koro bat osatuz (Filippov et al., 2003; 
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Mignone et al., 2004) (S3 A Figura). GFAPaz eta Nestinaz gain, beste markatzaile 
batzuen espresioa erakusten dutela deskribatu da, hala nola Vimentin, garun lipido 
atxikitzaile proteina (ingelesetik brain lipid-binding protein, BLBP) eta Y kutxa 2 sexu 
determinatzaile eremua (ingelesetik sex determining region Y box 2, Sox2), astrozito 
helduen markatzaile den S100-ren gabezia bezala (Encinas and Enikolopov, 2008; 
Filippov et al., 2003; Gould et al., 1992; Yamaguchi et al., 2000). Zelula hauek sortzaile 
neural iraunkor bezala deskribatu izan dira baita ere, populazio mailan orokorrean 
iraunkorrak direnetik, %2-5a bakarrik sartuta mitosian edozein une aleatoriotan 
(Encinas et al., 2011). Sortzaile terminoa nahiago izan zen baita momentu hartan 
neuronak bakarrik ematen zituztela uste zelako eta ez beste edozein zelula mota, 
beraz SC definizioarekin bat etorri ezinik. Gaur egun, era orokorrean onartuak daude 
bona fide NSC bezala (eta hala izendatuko ditugu hemendik aurrera) multipotentzialak 
direnetik, bere burua berritzeko gai izanda baita ere. 
Zientzia komunitateak duela askotik heldu dio NSCek zatitzeko erabiltzen 
dituzten mekanismo eta dinamikak ikertzeari, SGZan jazotzen diren zelula zatiketa 
patroiak argitzeko asmoz. Leinuaren jarraipen induziblea BrdU markapenarekin 
konbinatuz eta beranduago in vivo bi-fotoi irudikapenarekin, erreportatu da behin 
aktibatuta NSCak batez-beste hiru aldiz ugaritzen direla (gehienetan era asimetrikoan) 
(Encinas et al., 2011; Pilz et al., 2018), beren buruaren kopia bat eta zelula alaba 
borobildu bat sortuz, azken honek GFAP eta Vimentin espresiorik ez dutelarik (Encinas 
et al., 2006; Kempermann et al., 2004; Kronenberg et al., 2003; Seki et al., 2007). 
Sortzaile hauen patua neurogenikoa den bitartean, aktibaturiko NSCak astrozitoetan 
diferentziatzen amaitzen dute, horrela euren kapazitate neurogenikoa galduz (Encinas 
et al., 2011) (S3 B Figura). 
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 Aurreko orrialdean. S3 Figura. A) Nestin (berdez) eta GFAP (gorriz) espresatzen duen NSC bat, 
soma SGZan kokaturik eta prozesua MLrantza luzaturik duelarik, bertan brokoli antzeko koro bat osatuz. 
B) Urjauzi neurogeniko hipokanpala. NSCek, morfologia erradialarekin, gehienbat iraunkorrak dira, baina 
behin aktibatzen direlarik hainbat aldiz ugaritzen dira, era asimetrikoan beren buruaren kopia bat eta 
neurona sortzaile anplifikadore (ingelesetik amplifying neural progenitor, ANP) bat sortuz, zeina apoptosi 
prozesu baten bitartez hil edo neurona granular heldu batean diferentziatzen den (Encinas et al., 2011 eta 
Encinas and Sierra 2012 artikuluetatik eraldatua). 
Kontuan harturik NSC aktiboen proportzioa aldakaitz mantentzen dela 
denboran zehar, NSCen agorpen jarraitu eta esponentziala da adinarekin datorren 
AHNaren murriztea eragiten duen faktore printzipala (Encinas and Sierra, 2012; 
Encinas et al., 2011) (S4 Figura). Nahiz eta NSCak potentzialki gai diren beren 
buruaren kopiak emateko, ahalmen hau ez da nahikoa adinarekin gertatzen den 
NSCen galera ekiditeko populazio mailan (Bonaguidi et al., 2011; Encinas et al., 2011; 
Pilz et al., 2018). Denak batera, dinamika hauek NSCen hasierako kopuruaren 
garrantzia iradokitzen dute, honek norbanako batek bizitza osoa zehar izango duen 
kapazitate neurogenikoa determinatzen duenetik. Honela, berebizikoa da zelai honetan 
azken hamarkadetan egon den galdera baten gainean argia igortzea. Noiz eta nola 
sortzen dira hipokanpoko NSC helduak?  
 
S4 Figura. NSC populazioaren agorpena adinarekin. A) DG gazte bat NSCz beterik SGZ osoan zehar. B) 
DG edadetu bat non bakarrik NSC bakan batzuk geratzen diren. C-D) Sagu gazteen (C) eta edadetuen 
(D) GCLaren hurbileko konfokal irudiak (Encinas et al., 2011 artikulutik hartua). 
3.4. NSC helduen jatorria 
3.4.1. NSC helduen jatorria jaio aurretik 
DGak SVZarenekotik ezberdintasun azpimarragarriak dituen gune neurogeniko 
bat du. Hala, bentrikulutik urrun aurkitzen da. Izan ere, DGko SGZa bere jaio aurretiko 
hozi-gunetik guztiz banandua mantentzen da (Altman and Bayer, 1990). DGaren 
garapena deskribatua izaten hasi zenean, argitaratua izan zen hipokanpoko NSC 
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helduak garapenean zehar horzdun neuroepitelioan (ingelesetik dentate 
neuroepithelium, DNe) kokatuak zeuden aurrekariengandik sortuak zirela, bai 
translokazio zuzenaren bitartez (Eckenhoff and Rakic, 1984) edo DGa osatzeko 
sortzen diren migrazio prozesu ezberdinen bitartez, hala nola horzdun migrazio 
korrontea (ingelesetik dentate migrazio stream, DMS)(Altman and Bayer, 1990), jaio 
ondoren DGko SGZan kokaturik amaitzen duten arte (Nicola et al., 2015; Sugiyama et 
al., 2013). Hala, NSC helduak eta AHNa jaio aurretiko HPFaren garapenaren hondakin 
bat direla orokorki onartu den ikuspegia izan da, Gage eta kolaboratzaileek adierazi 
bezala (Gonçalves et al., 2016). 
Ikuspegi hau babestuz, markatzaile ezberdinak eta sagu transgenikoak erabiliz 
hainbat ikerlanek ustezko garapeneko NSCak (ingelesetik developmental NSCs, 
dNSCs) DNetik SGZra migratzen identifikatu dituzte: Nestin, eomesodermin bitarteko 
aurrekarien markatzaileak, T-kutxa garun protein 2 bezala ezagutua (ingelesetik T-box 
brain protein 2, Tbr2) (Hodge et al., 2008, 2012) eta neurogenina-2 (ingelesetik 
neurogenin-2, Ngn2) DG-aren jaio aurretiko garapenean sortzen diren hozi-matrizeetan 
aurrekari neuronalak markatzen dituztela deskribatu izan da (Galichet et al., 2008; 
Hodge et al., 2013; Li et al., 2009). Ildo honetatik, Samuel Pleasure eta kideek iradoki 
egin zuten sortzaile hauetako batzuk DNetik migratzen dutela, euren diferentziatu 
gabeko egoera mantenduz seinale neurogenikoen inhibizioari esker, SGZra jaio 
ondorengo aroan iristen diren arte, bertan mantenduz helduaroan zehar (Pleasure et 
al., 2000). Are gehiago, deskribatu egin zuten dNSCek HFaren eta fimbrio-horzdun 
lotunearen (ingelesetik fimbrio-dentate junction, FDJ) arteko gune neurogeniko 
iragankor batean egoten direla, gune azpipialean (ingelesetik subpial zone, SPZ), 
gutxienez aste batez SGZan ezarri baino lehen (Li et al., 2009) (Figure S5). 
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S5 Figura. A-C) HFean zehar SPZan kokaturiko Cajal-Retzius (CR) zelulek gidaturik, NSC helduen 
aurrekariek DNetik DGra migratzen dute SGZan zehar kokatu egiten diren arte, NSC helduen populazioa 
eratuz (Hodge et al., 2013 artikulutik eraldatua). 
Homeodomeinu protein kutxa (ingelesetik homeodomain protein box, Hopx) 
DGko NSC helduetan espresatua da eta SVZko NSCetatik desberdintzen ditu (Shin et 
al., 2015). Baita, Hopx-ek AHNaren gainean rol bat jokatzen duela iradoki egin da 
Notch seinalizazioarekin jazotzen den interakzioaren bitartez (Li et al., 2015). Duela 
gutxi, Daniel Berg eta kolaboratzaileek Hopx positiboak diren dNSCek DNetik SGZra 
migratzen dutela deskribatu dute, DGaren formazioari ekarpena eginez jaio aurretiko 
eta jaio ondorengo etapetan zehar, gerora iraunkor bihurtu eta NSC helduen 
populazioa eratzeko. Are gehiago, aldarrikatzen dute Hopx positibo diren sortzaileek 
zelula granularrak (ingelesetik granule cell, GC) bakarrik sortzen dituztela, leinu 
neuronal honenganako duten joera espezifikoa azpimarratuz. Emaitza hauetan 
oinarrituz, AHNa jaio aurretiko eta ondorengo garapenaren bizitza osoko hedapena 
besterik ez dela babesten dute, “jarraipen” modelo bat defendatuz non Hopx positibo 
diren sortzaileek GCak sortzen dituzten bizitza osoan zehar, garapenetik helduarora 
(Berg et al., 2019). 
NSC helduen jatorri espazialari erreparatuz, sortzaileen korronte migratzaile 
tenporal-septal berri bat adierazi zuen Samuel Pleasure eta kideen lana erronka bezala 
iritsi zen ikerkuntza zelaira. Autore hauen arabera NSC helduen aurrekariek 
sabelaldeko DGtik hurbil dagoen gune bentrikularretik (ingelesetik ventricular zone, VZ) 
bizkarraldeko DGra bidean migratzen dute jaio aurretiko eta jaio ondoko etapan, 
SGZan ezartzen direlarik jaio ondorengo lehen asteetan. Sonic kirikiñoaren (ingelesetik 
sonic hedgehog, Shh) gabeziak edo bere erregulatzaileetan okerren presentziak 
ekartzen duen NSC helduen populazioaren formazio okerrak adierazten duen bezala, 
aurrekariek seinalizazio ibilbide honen menpeko eran migratzen dute (Li et al., 2013). 
Shh seinalizazio ibilbidea kirikiño (ingelesetik hedgehog, Hh) familiako kide ezagun bat 
da eta neokortexaren hazkuntzan zein garapenean RGC eta sortzaileen hedapenean 
inplikatua dagoela demostratu izan da. Edonola ere, Samuel Pleasure eta bere kideen 
lanak seinalizazio ibilbide hau hipokanpoaren bazterrera ekarri zuen. Izan ere, 
ikerkuntza zelaian zegoen ikuspegi orokorra kontrajarri zuten DNeak GCLaren 
kanpoko geruzari, lehenbizi sortzen denari,  bakarrik egiten diola ekarpena iradokiz. 
Ostera,  barnealdeko GCLa eta NSC helduen populazioa sabelaldeko DGtik migratzen 
duten dNSCek sortuko lukete, Shh-ren menpeko era batean. Hala, deskribaturiko bi 
migrazio korronteak jaio ondoan FDJan konektatzen direla azaltzen duen modelo bat 
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proposatu zuten, NSC helduen jatorri espazial bat baino gehiagoren aukerari atea 
zabalduz (Li et al., 2013). 
3.4.2. dNSC vs NSC helduak 
DG helduko NSCen jatorriaren inguruan argia igortzeak ikerkuntza zelaian 
gertatzen den galdera nagusietako bati erantzuna ematera hurbiltzea ahalbidetuko du: 
AHNa DGaren sorrera dakarren garapeneko neurogenesiaren hondakin bat da edo 
ostera aparteko fenomeno biologiko bezala eraikia den prozesu independente bat da? 
Galdera honi heltzea AHNaren funtzioak ulertzeko nahitaezkoa izan daiteke, hala nola 
bere rola hainbat egoera normal zein patologikotan zein den argitzeko.  
Bizitza osoan zehar bentrikulutik kanpo neurona berriak emateko kapaza den 
estruktura berri baten jaio ondorengo agerpenak autore batzuk garapeneko 
neurogenesiaren eta neurogenesi helduaren arteko ezberdintasunak azpimarratzera 
eraman ditu (Nicola et al., 2015). Nolanahi ere, SGZa DGa osatzeko prozesuan 
jazotzen diren prozesu eta estruktura iragankor desberdinen helmuga izanik, gaur 
egungo ikuspegi orokorra AHNa DGaren formazioan ematen den azken urratsaren 
hedapena dela da. Beste hitz batzuetan esanda, garapeneko neurogenesiaren 
programaren jarraipen bat (Berg et al., 2019; Matsue et al., 2018; Nicola et al., 2015; 
Seki et al., 2014). 
Duela gutxi argitaraturiko lan batek, zelula bakarreko azido ribonukleiko-
sekuentziazio (ingelesetik single cell RNA-sequencing, scRNA-seq) teknologia erabiliz, 
prozesu neurogenikoak bai garapenean zein helduaroan ibilbide molekular antzekoak 
jarraitzen dituela deskribatu zuen. Hala, ANPak, neuroblastoak (ingelesetik neuroblast, 
NB) eta neurona heldugabeak molekularki oso antzekoak dira jaio aurretik, jaio ondoan 
eta helduaroan (Hochgerner et al., 2018). Emaitza hauek AHNa garapeneko hondakin 
bat dela defendatzeko erabiliak izan dira (Berg et al., 2019). Hala ere, Sten Linnarson 
eta kideek jaio aurreko etapetatik jaio ondorengo/helduaro adinera bitartean NSCek 
pairatzen dituzten propietate molekularren aldaketak identifikatu zituzten baita ere. 
Autoreen arabera, dNSCek aldaketa molekularrak jasaten dituzte (iraunkortasun 
handiagoa eta markatzaile espresioan aldaketak) SGZan kokatzen diren momentuan, 
aurreko dNSCengandik argi eta garbi desberdintzen den zelula populazio bat osatuz 
(Hochgerner et al., 2018). Ildo honetan, Jennifer Gilley eta bere taldeak jaio ondorengo 
aro goiztiarretik helduarora bitartean aldaketa zelular autonomoak bistaratu zituen 
saguetan, bi adinetan transkripzio perfil ezberdinak antzemanez (Gilley et al., 2011). 
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Dena batera hartuta, emaitza hauek garapeneko neurogenesia eta neurogenesi heldua 
prozesu ezberdinak direla pentsatzera eraman gintuen, behintzat NSCeei dagokienez.    
3.5. Giza neurogenesi heldua: Izan ala ez izan 
Saguetan bezala, giza DGa hipokanpoan osatzen den azken estruktura da eta 
GCak GCLera gehituak izaten dira 30. haurdunaldi astetik (ingelesetik gestational 
week, GW30) aurrera eta gutxienez jaio ondorengo aro goiztiarrera bitartean (Arnold 
and Trojanowski, 1996; Humphrey, 1967; Seress et al., 2001), garai honetan Nestin 
espresatzen duten zelulek hilusa eta GCLa populatzen dutelarik oraindik ere (Cipriani 
et al., 2018; Sorrells et al., 2018). Hala, NB migrazioaren azken olatuak GCL bidean 
jaio ondorengo lehenengo zortzi hilabeteetan gertatzen dira (Seress, 1988; Seress et 
al., 1992). Nolanahi ere, GCL haurdunaldi erdirako ia guztiz osatua geratzen dela 
kontsideratzen da, ugaritzea haurdunaldiaren bigarren erdian eta jaio ondoren oso 
murriztua agertzen delarik (Arnold and Trojanowski, 1996; Humphrey, 1967; Seress et 
al., 2001; Sorrells et al., 2018). Jaio ondorengoko gune neurogeniko baten existentziak 
zientzialarien kuriositatea piztu izan du beti eta autore asko saiatu dira jaio ondorengo 
giza AHNaren (ingelesetik human AHN, hAHN) hedapena argitzen, bere potentzial 
terapeutikoaren inplikazioak erakarrita. 
Duela gutxi, hAHNa itxuraz errotuta eta ia zalantza guztietatik at zirudienean, 
duela gutxi argitaraturiko ikerlan berriek halako prozesu baten gabezia aldarrikatu dute, 
komunitate zientifikoa nahasiz eta galdera berriak plazaratuz. Hauetatik lehenengoa 
inmunohistokimika (ingelesetik immunohistochemistry, IHC) emaitzetan oinarriturik 
etorri zen, 3 urtetatik aurrera giza DGan ugaritzen den zelula mota bakarra mikroglia 
dela adieraziz (Dennis et al., 2017). Emaitza hauekin eztabaida eta sinesgaiztasuna 
sortu zen neurogenesi helduaren plazan (Dennis et al., 2017; Marucci, 2017), nahiz eta 
komunitatea ez zen benetan aztoratu Arturo Álvarez-Buylla eta bere kideen lana agertu 
zen arte. Autore hauek jaio aurreko, jaio ondoko eta helduaroko laginetan argi eta 
mikroskopia elektroniko (ingelesetik electron microscopy, EM) irudiak aztertuz, DCX 
zelula positiboetan murrizte bortitza deskribatu zuten jaio aurretiko arotik jaio osteko 
lehenengo urteetara, DCX zelula positiboen kopuru arbuiagarriak aurkituz zazpi eta 13 
urteetako laginetan (Sorrells et al., 2018) (S6 A Figura). Halaber, Sorrells eta bere 
taldeak bizitzaren bederatzigarren hamarkadaz geroztik hAHNaren gabezia aldarrikatu 
ondoren eta gutxira, artikulu berri batek bereganatu zuen komunitatearen aditasuna. 
Euren lana DCX eta kalretinina (neurona heldugabeen beste markatzaile bat) 
espresioan oinarritu zuten eta neurona jaioberrien presentzia aldarrikatu zuten 
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metodologikoki oso zaindua zen lan batekin, zeinetan finkapen protokoloak oso 
zorrozki kontrolatuak izan ziren (Moreno-Jiménez et al., 2019) (S6 B Figura). 
 
S6 Figura. A) Ugaritze fasean aurkitzen diren zelulen eta neurona heldugabeen murriztea haurtzarotik 
helduarora bitartean, gizakietan neurogenesi helduaren gabezia iradokiz, Sorrells et al.-ek (2018) adierazi 
bezala. B) DCX espresatzen duten zelulen presentzia (gorriz) gizaki helduen GCLean (47-83 urte), DAPI 
(urdinez) eta NeuN (berdez) tindaketekin gainjarriz. Emaitza hauek GCLean neurona heldugabeen 
presentzia iradokitzen dute, Moreno-Jiménez et al-ek (2019) adierazi bezala (Sorrells et al., 2018 eta 
Moreno-Jiménez et al., 2019 artikuluetatik eraldatua). GCL: Zelula granular geruza. ML: Geruza 
molekularra. 
Eztabaida guzti honen arren, jaio ondorengo etapa goiztiarrean neurogenesia 
giza DGan oraindik jazotzen denaren gainean adostasuna dago komunitatean (Cipriani 
et al., 2018; Knoth et al., 2010; Sorrells et al., 2018). Gainera, helduaroan ez bezala, 
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bizitzaren lehenengo urteetan jasandako estres sozialak edo kimikoak garunaren 
funtzioan efektu iraunkorrak sorrarazten dituztela erakutsi da, potentzialki hipokanpoko 
disfuntzioa ere barne (Cooper et al., 2015; Dorn et al., 2014; Rees and Inder, 2005). 
Honek jaioberri etapan leiho iragankor baten existentzia iradokitzen du zeinetan 
edozein eragin patologikok efektu itzulezinak sortu litzakeen oraindik osatu barik 
dagoen HPF batean. Izan ere, helduaroko egoera epileptikoetan ikusiriko emaitzak 
kontrajarriz (Fahrner et al., 2007; Seki et al., 2019), hasiera goiztiarreko lobulu 
tenporaleko epilepsia (ingelesetik temporal lobe epilepsy, TLE) zuten paziente 
pediatrikoetan areagotutako neurogenesia adierazten zuten frogak aurkeztu ziren 
(Blümcke et al., 2001), ziurrenik jaio aurreko garapen fetaletik geratzen diren Nestin 
espresatzen duten zelula astroglialetatik eratorria (Cipriani et al., 2018; Kruglyakova et 
al., 2005; Sorrells et al., 2018). 
TLEn, hAHNaren areagotze eza demostratu den arren (Fahrner et al., 2007; 
Seki et al., 2019), neuronen eta astroglia populazioen erreorganizazioa erakutsi da 
(Crespel et al., 2005; Liu et al., 2018; Verwer et al., 2015). Izan ere, sagu modeloetan 
adierazi egin da NSCek era aktiboan ekarpena egiten diotela konbultsio osteko gliosiari 
(Muro-García et al., 2019; Sierra et al., 2015). Guzti honek giza DGaren formazioaren 
gainean argia igortzeak duen garrantzia adierazten du, neurona eta glia populazio 
ezberdinak hasieratik zelan antolatzen diren osoki ezagutuz, gune neurogeniko 
helduak duen ahalmen neurogenikoaz aparte. Era berean, hipokanpoaren 
funtzionalitatearekin estu loturik dauden mekanismo patologikoak ulertzeak, hala nola 
TLEa, eta DGko zelula populazio ezberdinetan eragiten duten efektua ikertzeak 
estruktura honi lotutako ezaugarriak deskubritzen lagunduko du. 
3.6. Lobulu tenporal medialeko epilepsia (ingelesetik medial 
temporal lobe epilepsy, MTLE) eta NSCak 
Konbultsioak probokatu eta jarduera neuronala areagotu egin den sagu 
modeloetan hipokanpoko NSC helduak aktibatuak izaten direla erakutsi egin da (Gray 
and Sundstrom, 1998; Hüttmann et al., 2003; Lugert et al., 2010; Segi-Nishida et al., 
2008; Sierra et al., 2015). Izan ere, proposatua izan da jarduera neuronala eta NSCen 
aktibazioa erlazionaturik daudela, lehenak bigarrena eragiten duelarik (Deisseroth et 
al., 2004). Hala ere, argitaratua izan da konbultsio epileptiko kronikoek AHNa 
gaitzesten dutela estimulatu beharrean (Hattiangady et al., 2004; Heinrich et al., 2006; 
Kralic et al., 2005; Sierra et al., 2015). Arratoietan bai azido kainiko (ingelesetik kainic 
acid, KA) injekzio intrahipokanpalak zein intraperitonealak, sortzaileen ugaritzean 
hasierako areagotze baten ostean, neurogenesiaren desagerpena probokatzen dute 
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epe luzera (Hattiangady et al., 2004). Horrez gain, animali epileptiko kronikoetan Sox2 
edo Vimentin positiboak diren NSCak geratzen ez direnez, ahalmen neurogenikoaren 
murriztea gune neurogenikoaren aldaketagatik azaldua izan da, zeina NSCenganako 
aurkako ingurugiroa bilakatzen den (Kuruba and Shetty, 2007). 
KA intrahipokanpalki injektatua izaten den sagu modeloetan MTLE eta 
hipokanpoko esklerosiaren (ingelesetik hippocampal sclerosis, HS) ezaugarriak 
errepikatuak izaten dira: 1) Lesioaren osteko jarduera mitotikoa ez da neurogenikoa, 
aurretik aurkeztutako mikrogliosiari eta astrogliosiari ekarpena eginez (Heinrich et al., 
2006; Kralic et al., 2005; Lee et al., 2003). 2) Etendako gune neurogeniko batean 
neurona jaioberrien produkzioa nabarmen murriztu egiten da, orduan “NSCen 
iraunkortasunaren indukzioa” bezala azaldu zena (Kralic et al., 2005). 3) Gure 
laborategiaren aurretiazko ikerlanetan, Juan Manuel Encinas eta kideek modelo 
intrahipokanpala aplikatu zuten Nestin-GFP sagu transgeniko konstitutibo eta 
induzibleak erabiliz, NSCen aktibazio masiboa eta euren programa neurogenikoaren 
aldaketa bortitza berretsiz. HPFa eta ondoko eremuei eragiten dien konbultsioen 
ostean, NSCek aldaketa dramatikoa pairatzen dute euren morfologian, fenotipo 
erreaktiboa bereganatuz (hipertrofikoa eta poliadartua) eta egoera neurogeniko batetik 
gliogeniko batera aldatuz. Hala, zelula ama neural erreaktiboek (ingelesetik reactive 
neural stem cell, React-NSC) simetrikoki zatitzeko joera aurkezten dute, bere buruaren 
kopia gehiago sortuz, zeinak azkenean astrozito erreaktiboetan diferentziatzen diren 
zatiketa edo transformazio zuzenaren bitartez. Honela, NSCen transformazioak React-
NSCetan hipokanpoko gliosi erreaktiboari ekarpena egiten dio eta neurogenesia 
gaitzesten du epe luzera (Muro-García et al., 2019; Sierra et al., 2015; Valcárcel-Martín 
et al., 2020) (S7 Figura). 
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S7 Figura. KA injekzioak eragindako MTLEtik 150 egunera, gune neurogeniko hipokanpala guztiz etenda 
suertatzen da. NSCak masiboki aktibatuak dira, React-NSCak sortuz eta gliosi erreaktiboari ekarpena 
eginez (Sierra et al., 2015 artikulutik eraldatua). 
NSC erreserbaren eteteak epilepsia kronikoaren ondorio patologikoei dakarkien 
ekarpen potentzialaren arren, alterazio hauek eragiten dituen mekanismoak ezezagun 
dirau. Hazkuntza faktoreak luzaroan ezagunak izan dira neurona jaioberrien formazioa 
erregulatzeko daukaten kapazitatearengatik, SC eta sortzaile ugaritzea, diferentziazioa 
eta biziraupena modulatuz (Calof, 1995). Are gehiago, konbultsioek eragindako faktore 
trofikoen espresioak, hala nola garunetik eratorritako faktore neurotrofikoa (ingelesetik 
brain-derived neurotrophic factor (BDNF), hazkuntza faktore endothelial baskularra 
(ingelesetik vascular endothelial growth factor, VEGF) eta beste batzuek zeharka 
NSCen ugaritzea eragin lezakete (Gall, 1993; Gall et al., 1991). 
3.6.1. MTLE-HSan mekanismo posibleak 
Aspaldian erakutsi zen hazkuntza faktore epidermala (ingelesetik epidermal 
growth factor, EGF) hazitako astrozitoetan mitogenikoa dena (Simpson et al., 1982). 
Geroago, biak EGF eta hazkuntza faktore fibroblastikoa 2 (ingelesetik fibroblast growth 
factor 2, FGF2) hazitako SC eta sortzaileetan ugaritzea estimulatzen zutela erakutsi 
zen (Reynolds et al., 1992; Tropepe et al., 1999) eta zenbait ikerlanek bi faktoreen 
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efektu mitogenikoa seinalatu zuten sagu garun heldutik eratorritako NSCak erabiliz 
(Kuhn et al., 1997; Palmer et al., 1995). Garrantzitsua da baita ere nola EGFk NSCen 
hedapena eragiten duen SVZan in vivo injektatua izan eta gero (Craig et al., 1996). 
Denak batera harturik, emaitza hauek faktore hauen eta euren seinalizazio ibilbidearen 
rol posible bat iradokitzen dute NSCen eta astrozitoen aktibazioan, beraz epilepsiaren 
testuinguruan kontuan hartzeko zerbait izanik.  
3.6.2. Hazkuntza faktore epidermal hartzailea (ingelesetik epidermal 
growth factor receptor, EGFR) 
EGFR (HER edo ErbB1 bezala ezagutua baita) ErbB familiako lehen hartzailea 
da, zeina EGFRrekin erlazionaturik dauden hiru mintz-bitarteko hartzaile gehiagoz 
osatua dagoen: ErbB2 (Semba et al., 1985), ErbB3 (Kraus et al., 1989; Plowman et al., 
1990) eta ErbB4 (Plowman 1993). EGFR 1978an deskubritua izan zen Graham 
Carpenter eta bere taldearengatik. Zelularik gabeko mintz prestakuntza bat erabilita, 
lehen aldiz erakutsi zuten tirosina kinasa hartzaile bat, zeinari EGF batzen zitzaion 
barneko eta kanpoko proteinen fosforilazioa eraginez (Carpenter et al., 1978). 
Beranduago, hartzailearen amino azido sekuentzia osoa aurkeztu zen, bere rol zelular 
zein seinalizazio ibilbidean sakontzeko bidea irekiz (Ullrich et al., 1984). 
ErbB hartzaile kinasa bakoitza kate bakarreko mintz-bitarteko polipeptido 
proteinak dira, hiru domeinu ezberdin dituztenak: 1) zisteina-aberatsa den zelulaz 
kanpoko domeinu bat, hartzailearen aktibazioa eragingo duten estekatzaileentzako 
lotura leku bezala jarduten duena, 2) mintz-bitarteko domeinu bat estekatzailearen 
estimulazioaren ondoren hartzaileen arteko dimerizazioan parte hartzen duena eta 3) 
tirosina kinasa zitoplasmatiko domeinu handi bat tirosina hondakinak proteina 
sustratoetan fosforilatzen dituena, dagokion seinalizazio ibilbidea piztuz, emaitza 
zelular konkretu bat eragiten amaituko duena  (Bessman et al., 2014; Herbst, 2004; 
Riese and Stern, 1998; Yarden and Sliwkowski, 2001) (S8 Figura). 
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S8 Figura. EGFRren estruktura estekatzaile batekiko loturaren aurretik eta ondoren. zelulaz kanpoko 
modulua osatzen duten lau domeinu ezberdinek dimero bat osatzen dute estekatzaileari lotu eta mintz-
bitarteko domeinuaren eta juxtamintz domeinuaren bitartez tirosina kinasa domeinuaren aktibazioa 
eragiteko (zelulaz barneko domeinua) ur-beherako seinalizazio ibilbide ezberdinak aktibatuz (Kovacs et 
al., 2015 artikulutik eraldatua). 
3.6.3. Zink (Zn+2) parte hartzaile bezala KAren osteko EGFRren aktibazioan 
Ioi metalen artean, Zn+2 aski ezaguna da jaiotzaren aurretiko eta ondorengo 
garaietan garunaren garapenean eta garun helduaren funtzionamendu aproposean 
kritikoa izateagatik, prozesu neurogenikoaren modulazioa barne (Levenson and Morris, 
2011; Sandstead, 2012; Sandstead et al., 2000). Gutxi gora behera garunean dagoen 
Zn+2aren %80a bere biltegiratze lanetan aritzen diren metalotioneinak (ingelesetik 
metallothionein, MT) bezalako metaloproteinetan existitzen da, beste %20a neurona 
glutamatergiko azpiklase baten besikula aurresinaptikoetan dagoelarik. Azken honek  
seinalizazio faktore lanak egiten ditu zelulaz barneko konpartimentu zitosolikoetan zein 
zelulaz kanpoko konpartimentuetan (Frederickson, 1989; Frederickson and Danscher, 
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1990; Kambe et al., 2015; Maret, 2017; Takeda and Tamano, 2009) (S9 A Figura). 
Zn+2 sinaptiko hau histokimikoki erreaktiboa da eta Danscherren zilar-sulfido tindaketa 
metodoaren bitartez azaleratu daiteke (Danscher, 1981). 
Helmut Maskek ausaz eginiko aurkikuntzaz geroztik jakin izan dugu HPFan 
dagoen Zn+2 presentzia garuneko handienetakoa dena (Maske, 1955). Zn+2 gehiena 
HPFaren eremu ezberdinetan sakabanaturik aurkitu daiteke, subikuluma eta ECa 
barne (Frederickson et al., 1983; Slomianka, 1992). Zn+2 hipokanpalaren %10 inguru 
eta Zn+2 sinaptikoaren gehiengoa hiluseko goroldio zuntzen (ingelesetik mossy fiber, 
MF) botoi erraldoietan aurki daiteke, besikula aurresinaptikoetan (Frederickson et al., 
1983; Sindreu et al., 2003). Baita, Schaffer kolateralen erdiek besikula 
aurresinaptikoetan Zn+2a dutela erakutsi da (Sindreu et al., 2003) (S9 B Figura).  
 
S9 Figura. A) Behin Zn
+2
 arraila sinaptikoan askatua denean, neurona postsinaptikoa modulatu dezake 
bai zuzenean (1) edo hartzaile bati lotzearen bitartez (2). Hala nola, zelula aurresinaptikoak berreskuratu 
lezake (3) edo zelulaz kanpoko espazioan askatua izan (4). B) Zn
+2
 sinaptikoa batez ere HPFan askatua 
izaten da, bereziki MFtan, eta baita amigdalan (Takeda et al, 2013 eta Burdette et al., 2000 artikuluetatik 
eraldatua). 
3.6.4 EGFR seinalizazioa blokeatuz 
EGFRaren inhibizioa orno-muinaren gliosi erreaktiboa murrizteko estrategia 
egokia dela erakutsi da (Li et al., 2014; Qu et al., 2012). Are gehiago, EGFR oso 
inplikatua izanik kantzer gaixotasun ezberdinen eboluzioan (Arteaga, 2011; Nicholson 
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et al., 2001; Salomon et al., 1995; Sasaki et al., 2009; Sharma et al., 2007), EGFR 
jomuga duten estrategia ezberdinak garatu dira. Estrategia hauetatik, antigorputz 
monoklonalak eta tirosina kinasa inhibitzaileak (ingelesetik tyrosine kinase inhibitors, 
TKI) aurreratuen daudenak dira, biak EGFRren ur-beherako seinalizazio 
transdukzioaren blokeo efektiboa eragiten dutenak. Estrategia bien artean, TKIak izan 
dira ikertuenak (Chen, 2013). 
Gefitinib (ZD1839) tumoreen ugaritzea murrizteko helburuarekin onarturiko 
EGFR jomuga zuen molekula txikiko lehen TKIa izan zen. EGFRri lotzen zaio era 
itzulgarrian adenosina trifosfato (ingelesetik adenosine triphosphate, ATP) lotura 
lekuan seinalizazio ibilbidearen aktibatzaile bezala jarduten duen tirosina kinasaren 
barruan. Albo-efektuak leunetik moderatura doaz, dosiaren menpekoak diren azal 
narritadura eta diarrea barne (Wakeling et al., 2002). Aldi berean, Afatinib, EGFRren 
inhibitzaile itzulezin bat duela gutxi onartua eta klinikoki saiatua izan da (Watanabe et 
al., 2018; Yang et al., 2015). Hemen, Gefitiniben eta Afatiniben erabilerak MTLE-
HSaren ondorio patologikoak murriztu litzakeela iradokitzen dugu, bereziki NSCen 
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4. HIPOTESIAK ETA HELBURUAK 
NSC hipokanpalak urjauzi neurogeniko helduaren lehenengo urratsa dira, 
neurona berrien iturri ez berriztagarria izanda ugaztun gehienen bizitza osoan zehar. 
Honela, NSC populazioaren hasierako tamainak norbanakoak bere bizitza guztian 
izango duen ahalmen neurogenikoa mugatzen du. Are gehiago, behin NSC populazioa 
sortzen denean, epilepsia bezalako egoera patofisiologikoek NSCen propietateak 
eraldatu ditzakete, neurogenesia biziki eraginez. Premisa hauetan eta gure atariko 
emaitzetan oinarrituz hurrengo hipotesiak azaleratzen ditugu:  
1. NSC helduak de novo sortuak izaten dira DGaren garapenaren jaio 
ondorengo etapa goiztiarrean  
2. NSC helduak tokian sortuak izaten dira jaio ondorengo DGan 
3. NSC helduen sorrerak jaio ondorengo DGan cD2ren espresioa 
eskatzen du. 
4. Hazkuntza faktore fibroblastiko hartzailea (ingelesetik fibroblast 
growth factor receptor, FGFR) eta EGFR seinalizazio bideen 
espresio eta jarduera igo egiten da konbultsio ostean, rol 
garrantzitsua jokatuz aktibazio masiboan eta React-NSC indukzioan. 
5. Gefitiniben bidezko EGFRren inhibizio eraginkorrak konbultsio 
osteko aktibazio masiboa eta React-NSC indukzioa ekiditen ditu. 
6. Konbultsio osteko Zn+2 askapen masiboak EGFRren bitartezko 
aktibazioa eta React-NSC indukzioa sustatzen ditu.  
7. Konbultsio osteko HB-EGF askapen masiboak EGFRren bitartezko 
aktibazioa eta React-NSC indukzioa sustatzen ditu. 
8.  
1. Helburu orokorra: Saguetan ikertu NSC helduen garapena eta 
formazioa. 
1.1. Helburua. Aztertu cD2ren rola NSC helduen populazioaren jaio 
ondorengo formazioan. Helburu honetarako sagu transgeniko bikoitz bat erabiliko 
dugu, cD2rik gabeko sagu baten (cD2KO) eta Nestin-GFP sagu baten gurutzaketatik 
ateratzen dena. Era konparatibo batean aztertuko ditugu (WT vs. cD2KO) NSCen 
garapena (kopurua eta dibisio dinamikak) eta heriotza zelularra GCL+SGZ zonaldean 
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jaio ondorengo denbora-puntu ezberdinetan zehar mikroskopia konfokalean 
oinarrituriko irudi analisi kuantitatiboaren bitartez. 
1.2. Helburua. Aztertu eremu ezberdinetako (DMS eta DG) jaio ondorengo 
zelula ama neural eta sortzaile (ingelesetik neural stem and progenitor cells, 
NSPC) goiztiarrek NSC helduen populazioari egiten dioten kontribuzioa. Helburu 
honetarako, eremu espezifikoetan (DMS eta DG) jaio ondorengo etapa goiztiarrean 
infekzio erretrobiralen bidezko zelula markaketa egiteko metodo bat garatu eta 
balioztatuko dugu. Markaturiko zelulen leinuaren identitatea aztertuko dugu 
mikroskopia konfokalean oinarrituriko irudi analisi kuantitatiboaren bitartez. 
1.3. Helburua. Karakterizatu LPA1en espresioa dNSC zein NSC helduetan 
DGan. Helburu honetarako sagu modelo transgeniko bat erabiliko dugu zeinetan 
areagoturiko proteina fluoreszente berdea (ingelesetik enhanced green fluorescent 
protein, EGFP) espresioa LPA1 espresioak gidatzen duen. LPA1-EGFPren espresioa 
aztertuko dugu DGan eta espezifikoki NSCetan jaio ondorengo denbora-puntu 
ezberdinetan mikroskopia konfokalean oinarrituriko irudi analisi kuantitatiboaren 
bitartez. 
 
2. Helburu orokorra: Ikertu gune neurogeniko hipokanpalaren 
garapena gizakietan. 
2.1. Helburua. Aztertu dNSC populazio ezberdinak giza HPFaren 
garapenean zehar eta sagu datuekin konparatu. Helburu honetarako, IHCa 
gauzatuko dugu haurdunaldiko eta jaio ondorengo etapa goiztiarreko giza laginetan eta 
DGa sortuko duten sortzaile matrize ezberdinak ikertuko ditugu mikroskopia 
konfokalean oinarrituriko irudi analisi kuantitatiboaren bitartez.  
 
3. Helburu orokorra: Ikertu React-NSC indukzio mekanismoak 
MTLEn. 
3.1. Helburua. Ikertu MTLEren indukzioa eta berehala ematen den 
hipokanpoaren erantzunean FGFRk duen inplikazio potentziala. Helburu 
honetarako, uneko polimerasa kate erreakzio kuantitatiboa (ingelesetik real time-
quantitative polymerase chain reaction, RT-qPCR) eta western blot (WB) bitartez 
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FGFR azido ribonukleiko mezularia (ingelesetik messenger ribonucleic acid, mRNA) 
eta proteina nibelak neurtuko ditugu MTLE modelo bezala KA injekzio intrahipokanpala 
gauzatu eta denbora-tarte ezberdinetara.  
3.2. Helburua. Ikertu EGFR seinalizazio ibilbideak MTLEn duen inplikazio 
potentziala. Helburu honetarako RT-qPCR eta WB bitartez EGFR eta bere ur 
beherako seinalizazio ibilbide diren Akt, ERK1/2 eta STAT3 mRNA eta proteina nibelak 
neurtuko ditugu MTLEren indukzioa eta denbora-tarte ezberdinetara. EGFRren 
espresioa aztertuko dugu baita Nestin-GFP saguetan eta Nestin-GFP saguetatik 
eratorritako neuroesferetan, IHC eta  mikroskopia konfokalean oinarrituriko irudi analisi 
kuantitatiboaren bitartez. 
3.3. Helburua. Ebaluatu Gefitiniben eraginkortasuna EGFRren seinalizazio 
ibilbidea blokeatzeko in vitro NSPCtan. Helburu honetarako NSPCak hazi eta 
EGFRren inhibitzaile Gefitinibek euren ugaritze kapazitatean duen eragina ebaluatuko 
dugu. WB eta mikroskopia konfokalean oinarrituriko irudi analisi kuantitatiboaren 
bitartez Gefitinibek EGFR seinalizazio ibilbidean duen eraginkortasuna determinatuko 
dugu eta NSPCen ugaritze kapazitatean duen efektua BrdU bereganatzearen bidez 
neurtuko dugu. 
3.4. Helburua. Aztertu Gefitiniben efektua in vivo NSC eta 
neurogenesiaren gainean MTLEn. Helburu honetarako, Gefitinib administratuko 
diegu sagu helduei KA injekzio intrahipokanpalaren bitartez MTLEa induzitu eta 
lehenengo hiru egunetan zehar. Tratamenduaren ostean, NSCen kopuru, aktibazio eta 
konplexutasun morfologikoa ebaluatuko ditugu. Gainera, NBen presentzia SGZ+GCL 
zonaldean mikroskopia konfokalean oinarrituriko irudi analisi kuantitatiboaren bitartez.  
3.5. Helburua. Ebaluatu Zn+2ak MTLE egoeran duen akzio potentziala 
NSCengan. Helburu honetarako lehenik Zn+2 eta MT kopurua ebaluatuko ditugu 
HPFan Danscher tindaketa eta RT-qPCR tekniken bitartez MTLEa induzitu eta gutxira. 
Zn+2 administrazioaren efektua ikertuko dugu in vitro NSPCetan eta in vivo DGko 
NSCetan mikroskopia konfokalean oinarrituriko irudi analisi kuantitatiboaren bitartez.  
3.6. Helburua. Determinatu Zn+2aren efektu potentziala EGFRren bidezko 
React-NSC indukzioa sustatzeko. Helburu honetarako, pare bat EGFR tirosina 
lekuren fosforilazioa determinatuko dugu (Y845 eta Y1068) WB bidez in vitro  hazitako 
NSPCei egindako Zn+2 administrazioaren ondoren. Baita ere, in vivo ebaluatuko dugu 
mikroskopia konfokalean oinarrituriko irudi analisi kuantitatiboaren bitartez Zn+2 bidezko 
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SGZan potentzialki sorturiko ugaritzea Gefitinib administrazioak murrizteko duen 
ahalmena. 
3.7. Helburua. Ebaluatu Zn+2 kelazioaren efektua NSC eta neurogenesian 
MTLEn. Helburu honetarako Zn+2 kelatzailea den TPEN erabiliko dugu, sagu helduetan 
MTLEa induzitu eta lehenengo zazpi egunetan zehar administratuz eta zelula granular 
dispertsioa (ingelesetik granule cell dispersion, GCD) eta heriotza zelularraren babes 
potentziala ebaluatuko ditugu mikroskopia konfokalean oinarrituriko irudi analisi 
kuantitatiboaren bitartez.  
3.8. Helburua. Ebaluatu HB-EGF EGFRren aktibazioa sustatzen duen 
mekanismo posible bezala MTLEn. Helburu honetarako Entzimari loturiko saiakera 
inmunosorbentea (ingelesetik Enzyme-linked immunosorbent assay (ELISA)) 
erabiliz kuantifikatu dugu in vivo MTLE indukzioaren osteko lehenengo hiru egunetan 
eta in vitro ugaritze kondizioetan mantendutako NSPCetan askaturiko HB-EGF 
kopurua. IHCra ere joko dugu KA injekzio intrahipokanpalaren ostean DGaren barruan 
HB-EGF distribuzioa ebaluatzeko eta WBra EGFR seinalizazio ibilbidearen aktibazioa 
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5. MATERIALAK ETA METODOAK 
5.1. Animaliak 
Ikerlan honetan erabilitako animalia guztiek janaria eta ura ad libitum izan dute 
eskuragarri, tenperatura (19-22°C) eta hezetasun (%40-50) konstantea zuen gela 
batean mantendu direlarik, 12:12 orduko argi/iluntasun zikloetan. Prozedura guztiak 
Euskal Herriko Unibertsitateko (UPV/EHU) Komite Etikoarengandik eta Bizkaiko Foru 
Aldundiarengandik onartuak izan dira M20/2015/236 protokolopean, 2010/63/UE 
direktiba europearra eta NIH jarraibideak segituz. 
Nestin-GFP sagu transgenikoak Grigori Enikolopoven  laborategian sortuak 
izan dira (Cold Spring Harbor, NY, USA), honek adeitasun osoz anduia gure 
laborategiari eman ziolarik. Nestin-GFP saguak aldez aurretik erabat karakterizatuak 
izan dira (Mignone et al., 2004). 
LPA1-EGFP sagu transgenikoak Howard Hughes Institutu Medikoko (The 
Rockefeller University, NY, USA) GENSAT proiektuan sortuak izan dira, gure 
laborategira Dresden Terapia Erregeneratzaileentzako Zentruko (Technische 
Universität Dresden, Dresden, Germany) Gerd Kempermannek adeitasun osoz 
helarazita. LPA1-EGFPren espresioaren karakterizazioa NSC helduetan beste ikerlan 
batzuetan egina izan da (Valcárcel-Martín et al., 2020; Walker et al., 2016). 
Bi sagu anduiak C57BL/6 saguekin gurutzatuak izan ziren gutxienez 10 
belaunaldiz, aldagarritasun genetikoa homogeneizatzeko xedez. Nestin-GFP saguak 
DGko gune neurogenikoaren jaio ondorengo karakterizazioa, bare gunean eraturiko 
virus gamma-erretrobirus (ingelesetik spleen-focus forming virus gamma-retrovirus, 
SFFV-RV) injekzioak eta MTLEko esperimentuak egiteko erabili ziren. LPA1-EGFP 
saguak garapen ikerlanetan erabiliak izan ziren. 
cD2k jaio ondorengo DGaren garapenean duen rola karakterizatzea helburu, 
ccnd2 gabeko saguak, cD2KO izendatuak, Nestin-GFP sagu mota ezberdin batekin 
(Yamaguchi et al., 2000) gurutzatuak izan ziren Anja Urbachen laborategian 
(Universitätsklinikum Jena, Jena, Germany). Lehenengo hazkuntzaren ondorengoak 
euren artean gurutzatuak izan ziren cD2KO edo WT homozigoto eta Nestin-GFP 
saguak lortzeko. Azken hauen burmuinak jaio ondorengoko garapenaren adin 
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ezberdinetan (P0, P7, P14 and P28) finkatuak izan ziren, ostean gure laborategira 
bidaliak izateko guk analisi histologikoa egin genezan.  
5.2. Giza Laginak 
Haurdunaldiko eta jaio ondorengo post-mortem kontrol laginak Mercedes 
Paredesen eskutik batuak izan ziren gurasoen baimen idatzia jaso ostean eta 
University of California, San Franciscoko (UCSF) erregulazio etiko legal eta 
instituzionalen behaketa zorrotzean. Protokoloak Human Gamete, Embryo eta Stem 
Cell Research Comittearengandik onartuak izan ziren, UCSFen. Aurretik deskribatu 
bezala (Sorrells et al., 2018), lobulu tenporaleko lagin guztiak konplexu amigdaloidetik 
LVaren azpiko adarraren atzeko amaierararte moztuak izan ziren gutxi gora behera 1.5 
zm-ko blokeetan, %4 paraformaldehidoan (ingelesetik paraformaldehyde, PFA)(Sigma-
Aldrich, #441244) finkatuak beste bi egunez, kriobabestuak %30ko sukrosa soluzioan 
eta azkenik murgiltze medioan (OCT) izoztuak, analisi histologikoak aurrera eraman 
arte. 
5.3. Injekzio intrahipokanpal estereotaxikoak 
5.3.1. Jaio ondorengo SFFV-RV infekzioak 
Injekzio intrahipokanpalak burutzeko metodo bat optimizatu genuen gure 
baldintzei egokituz: 1) HPFaren bi zonalde ezberdinetan injektatzeko beharra (DG eta 
DMS) eta 2) zonalde hauek jaio ondorengo garapenean zehar jasotzen duten tamaina 
aldaketarekiko adaptazioa. Hau lortzeko aurretiaz publikaturiko sagu jaioberrietan 
eginiko injekzio intrahipokanpalen saiakeretan erabilitako koordenada ezberdinak 
frogatu genituen  (Jiang et al., 2017; Xu et al., 2012). 
Jaio ondorengo sortzaileen leinua denboran zehar jarraitzeko mCerulean eta 
mCherry espresioa zuten SFFV-RVak erabili genituen, zeinak adeitasun osoz Diego 
Gómez-Nicolak (University of Southampton, UK) helarazi zizkigun (Gomez-Nicola et 
al., 2014; Weber et al., 2012). P2 eta P5 adineko saguak hipotermia bidez 
anestesiatuak izan ziren, animaliak bi minutuz izotz kubo batean jarriz, segituan 
aparatu estereotaxikoan jarritako plataforma batean kokatuak zirela. Zuntzezko argi 
optiko baten laguntzaz, Lambda lokalizatua izan zen saguaren burua transiluminatuz, 
ondoren injektatzeko erreferentzia gisa erabiliz. Injekzioa burutzeko beirazko 
mikrokapilare bat erabili zen, hurrengo koordenatuetan: DGrako, -1 mm aurretik atzera 
(ingelesetik anteroposterior, AP), ± 1.2 mm albotik albora (ingelesetik laterolateral, LL), 
-1.7 mm bizkarraldetik sabelaldera (ingelesetik dorsoventral, DV); DMSrako, -0.9 mm
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AP, ±1.4 mm LL, -1.7 mm DV. Mikrokapilarea azala zeharkatuz izan zen barneratua 
zegokion injekzio tokian, SFFV-RVaren 0.3 µl injektatuz 0.3 µl/min-ko jario ratioan. 
Ebakuntza amaitu eta berehala saguak ur berozko bainu batean jarriak izan ziren 
lehenbizi eta manta termiko batean ondoren, arnasketa, azalaren kolorea eta aktibitate 
lokomotorea normalera itzuli arte. Azkenik, amaren berronarpena ahalbidetzeko xedez, 
amaren beraren gorotz, azpi eta urez osaturiko nahaste batekin blaituak ziren 
hazkuntza kaiolara itzuli baino lehen. Amaren estresa ahal bezain beste gutxiesteko, 
prozedura osoa kume bakoitzeko 10 minutu baino gutxiagoan burutzen zen. Kume bat 
ere ez zen amarengandik ukatua edo kaltetua izan. Aldiz, nahiz eta heriotza tasa oso 
txikia izan, anestesiatik errekuperatzea lortu ez zuten kume guztiak P5 adin taldekoak 
izan ziren, adin honetan hipotermiarekiko minberatasun handiagoa iradokiz. 
Inplementaturiko metodoak birus partikulak proposatutako gune anatomikoetan 
zabaltzea ahalbidetzen du, injekzioaren prezisioa %100 ez bada ere, erabilitako 
adinetan suertatzen diren animalien arteko tamaina diferentzien eta muga 
metodologikoen poderioz. Hala, kontuan harturik helburu bezala hartutako bi guneen 
tamaina txikia eta elkarren arteko gertutasuna, a posteriori irizpideak erabili genituen 
injektaturiko animaliak talde zuzenean egokitzeko; injekzio bat “DG” taldean 
sailkatzeko, DMSan SFFV-RVak markatutako zelula bakar bat ere ez egotea ziurtatu 
genuen. Gainera, mikrokapilarearen ibilbidea ikusi zitekeen kasu askotan, injekzio 
motaren identifikazioa erraztuz. Bestalde, injekzioak “DMS” taldean sailkatzeko, SFFV-
RV zelula positiboen presentzia finbriaren gainaldetik korronte osoan zehar, injekzio 
lekutik DGerantz, beharrezkoa zen. Soilik meningeetara iritsitako injekzio motak “DMS” 
injekzio motengandik ezberdindu genituen euren kokapena, DGaren azpiko adarraren 
azpialdetik korronte bat osatuz, eta SFFV-RV-positibo ziren zelulen morfologia luzea 
kontuan hartuz. 
5.3.2. Injekzio intrahipokanpal estereotaxikoak helduetan 
KA injekzio intrahipokanpalak aurretiaz deskribatu bezala burutu ziren  (Sierra 
et al., 2015). Laburbilduz, animaliak intraperitonealki lokartuak izan ziren ketamina (75 
mg/kg; Ketamine, #581140) eta medetomidina (1 mg/kg; Sedastart, Pfizer) nahasten 
zituen anestesiarekin eta buprenorfina (1 mg/kg; Buprecare, Animalcare Lted., 
#582039) analgesikoaren azal-azpiko injekzio bakarra jaso zuten. Saguak anestesia 
sakonean murgilduak zeudena ziurtatu genuen arnasketa erlaxatu eta erregularraren 
presentzia kontrolatuz eta buztan/hatzaparrean atximurka egin ondoko erantzun eza 
egiaztatuz. Ondoren, buru gaineko ilea moztu eta sagua aparatu estereotaxikoan ipini 
eta gero ur oxigenatua aplikatzen zitzaion garezurretik banantzeko mozketa 
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kirurgikoaren aurretik azala garbitu eta desinfektatzeko. Koordenada estereotaxikoak 
Bregma erreferentzia puntutik hartuak izan ziren. Hipokanpoa aurkitzen den zonaldean 
injektatzeko hurrengo koordenadak jarraitu ziren: -1.8 mm AP, -1.6 mm LL eta -1.9 mm 
DV. Finkaturiko posiziora heltzea helburu, garezurra zulatua izan zen 0.6 mm-ko
abiadura handiko zulagailu mikromotore bat erabiliz. 
Status epilepticusa sorrarazteko 20 mM-ko KA (Sigma-Aldrich, #K0250/K3375) 
soluzio bateko 50 nl administratu ziren olio mineralez beteriko beirazko mikrokapilare 
bati loturiko nanoinjektore (Nanoject II, Drummond Scientific, #3-000-205A) bat erabiliz, 
aurretiaz deskribatu bezala (Sierra et al., 2015). Zn+2aren rola gune neurogenikoan 
zein den ebaluatzeko, 5, 20 eta 30 nM administratu genituen Hamilton mikroxiringa 
(Hamilton, #84250) bati konektatutako altzairu herdoilgaitzez eginiko kanula bat erabiliz 
(kanpoko diametroa, 0.28 mm). EGFRaren inhibitzaile Afatinib bimaleatua (Selleck 
Chemicals, #S7810) 70 µM-ko kontzentraziora diluitua izan zen disoluzio isotonikoan 
eta intrahipokanpalki injektatu zen KA injekzioaren aurretik. Kasu bakoitzean, %0.9ko 
NaCl esterilezko soluzioa erabili zen kontrol animalia taldea osatzeko. Kanula 5 
minutuz injekzio puntuan geldirik mantendu zen kanularen ibilbidean errefluxurik gera 
ez zedin eta ondoren saguaren garezurraren gainaldeko azala josia izan zen, azkenik 
animaliak manta termiko batean lagaz anestesiaren efektuak igaro arte. 
5.4. Tratamenduak 
5.4.1. EGFRaren inhibitzaile Gefitinibaren sudurretiko administrazioa 
10 mg/Kg Gefitinib (Selleck Chemicals, #S1025) %0.5 metilzelulosarekin eta 
%0.2 Tween 80rekin diluituak izan ziren ekoizlearen argibideei jarraituz eta sudurretik 
administratu estereotaxia amaitu eta berehala hasita, egunean birritan lehenengo hiru 
egunetan zehar, aurretiaz deskribatu den bezala (Hanson et al., 2013; Pineda et al., 
2013). Soluzioaren 10 µl eskumako sudurzuloan administratu ziren pipeta punta bat 
erabiliz eta sagua aurretiaz deskribatu den bezala helduz (Hanson et al., 2013). 
Saguak soluzio tantarik arnasaldi batez kanporatu ez zezan, administrazioa hainbat 
serietan egin zen, administrazio bakoitzeko segundo gutxi batzuk itxaronez animalia 
immobilizaturik mantentzen zelarik. Pipeta punta berriak erabili ziren animalia 
bakoitzeko, gehiegizko dosiak ekiditea helburu.  
5.4.2. TPEN  Zn+2 isolatzailearen azal-azpiko administrazioa 
Zelulaz kanpoko Zn+2a isolatzeko, TPEN  soluzioa fresko prestatu zen %10 
etanolean  (10% etil alkola disoluzio isotoniko fisiologiko normalean, Merck, #616394) 
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eta azal-azpitik injektatu zen animalien lepondoan egunean birritan, 5 mg/kg-ko 
kontzentrazioan, aurretiaz deskribatu bezala (Kim et al., 2012). Administrazioa aste 
oso batez burutu zen KAaren injekzio intrahipokanpalaren ostean. Kontrol animaliek 
%10 etanoleko bolumen baliokide bat jaso zuten administrazio bakoitzeko. 
5.4.3. BrdU administrazioa 
BrdUa (Sigma, #B5002-1G) disoluzio isotonikoan disolbatua eta 
intraperitonealki administratua izan zen 150 mg/kg-tan, hiru aldiz, hiru orduko tarteak 
utziz. KA edo Zn+2 injekzioaren ostean hiru egunetara eta Zn+2 injekzioaren ostean 
zazpi egunetara egindako analisietan, BrdUa animaliak sakrifikatu baino 24 ordu 
aurretik eman zen momentu horretan ugaritzen ari ziren zelulak markatzeko asmoz. KA 
edo Zn+2 injekzioaren ostean 14 egunera eginiko analisietan, BrdUa Gefitinib 
tratamendua amaitu eta berehala eman zen (KA/Zn+2 osteko hirugarren eguna), 
tratamendua amaitu bezain laster zatitzen ari ziren zelulen patua aztertzeko asmoz. In 
vitro esperimentuetan, 10 µM-ko BrdU pultsu bat gauzatu zen ordu batez, zelulak 
finkatu baino lehen, ugaritzen ari ziren zelulak markatzeko asmoz. 
5.5. Hazkuntza zelularrak 
NSPCen hazkutzak HPFarentzako eta SVZarentzako aurretiaz deskribaturiko 
protokolo bat egokituz lortu ziren (Jhaveri et al., 2015; Pineda et al., 2013) non papaina 
eta azido desoxirribonukleikoasa (ingelesetik desoxyribonucleic acid, DNA) nahasten 
dituen soluzio entzimatiko bat (20.000 U; 195 U/µl) aurretiaz berotu eta ondoren (37ºC 
and 5% CO2) Ovomucoid erabiliz DMEM/F-12 medioaren ordez jarduera entzimatikoa 
oztopatzeko. Laburki, hipokanpoak bai C57BL/6 edo Nestin-GFP saguetatik erauziak 
izan ziren, elkartu eta izotzean hoztutako fosfato tanpoi soluzio isotoniko (Ingelesetik 
phosphate buffered saline, PBS) -Glukosa %30n ipiniak izan ziren, ondoren gutxi gora 
behera 2 mm-ko zati txikietan moztuak izateko. Ostean, lagina 15 ml-ko hodian jarri, 
kontaminazio arriskua murrizteko garbitu eta aurretiaz beroturiko soluzio 
entzimatikoarekin inkubatua izan zen, 37ºCtan 15 minutuz. Lagina bost minuturo 
mekanikoki agitatua izan zen ehunaren metaketa ekiditeko asmoz. 
Gero, gainjalkina alde batera utzi eta erreakzio entzimatikoa oztopatua izan zen 
papainaren inhibitzaile den 950 µl Ovomucoid erabiliz. Horrenbestez, zelulak pipeta 
punta batekin disoziazio mekanikoaren bitartez disgregatuak izan ziren. Ondorioz, 
geraturiko zelula suspentsioa 15 ml-ko hodietan filtratua izan zen, segidan zelulak 10 
minutuz 200 Gtan zentrifugatu. Zelula alea berriro nahasia izan zen bolumen totalaren 
%10 ugaritze osagarriarekin (Stem Cell Technologies, #05702), %2 B27rekin, %0.24 
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Heparinarekin (Stem Cell Technologies, #07980), %0.8 EGFrekin eta %0.2 FGFrekin 
(Peprotech, #P01132 eta #P15655) aberasturiko 500 µl Neurocult ugaritze medioan 
eta Neurocult medio aberastuko 5 ml-rekin beteriko T25ko flaskoetan kokatua izan zen. 
Zelulak kondizio estandarretan mantenduak izan ziren %5 CO2  duen 37 ºCko 
inkubagailu heze batean. 
NSPC hazkuntzak 7 egunetik behin pasatuak izan ziren disgregazio 
entzimatikoaren bitartez, Akutasa (Stem Cell Technologies, #7920) erabiliz aurretiaz 
deskribatu bezala (Pineda et al., 2013), 100 U/ml penizilinaren eta 150 µg/ml 
streptomizinaren (Gibco, #15140 eta #15122) presentzian. Populazioaren 
heterogeneitiatea kontserbatu eta zelula hautaketa arazoak ekiditeko NSPC 
hazkuntzak gehienez 4 aldiz pasatu ziren. IHC saiakeretan NSPCak lamininarekin 
gainjantzitako 12 mm-ko estalkietan (Sigma, #L2020) ereinak izan ziren, aurretiaz 
deskribatu bezala (Silvestre et al., 2012). Kontrol eta KA egoeretan WB bidezko 
seinalizazio zelularraren ebaluaketa egiteko, kondizioko 400.000 NSPC erabili ziren. 
Ugaritze/inhibitze saiakeretan, NSPC kopurua putzuko 25.000 zelulara murriztua izan 
zen dentsitate zelularra gutxitu eta zelulen arteko kontaktuaren ondorioz suertaturiko 
ugaritzearen inhibizioa murrizteko asmoz. Zn+2ak eta honen inhibizioak (Gefitiniba 
erabiliz) EGFR seinalizazio bidearengan duen efektua neurtzeko asmoz, zelulak 
garbituak eta bi orduz hazkunde faktorerik gabeko  hazkuntza medioan inkubatuak izan 
ziren EGFR seinalizazio bidea itzaltzea xede. Ondoren, zelulei 2 µM Gefitinibekin 
aurreinkubatuak izan ziren eta/edo bi orduz estimulatuak bai 200 µM Zn+2kin, bai 100 
ng/ml edo 20 ng/ml EGFrekin 
5.6. RNA erauzketa eta uneko polimerasa kate erreakzio 
kuantitatiboa (Ingelesetik real time- quantitative polymerase chain 
reaction, RT-qPCR) 
5.6.1 RNA erauzketa eta alderantzizko transkripzioa 
Denbora-puntu ezberdinetan eratorritako hipokanpoak (0, 1.5, 12, 24 eta 72 
ordu KA injekzioaren ostean) berehala izoztuak izan ziren RLT tanpoiarekin. RNA 
totalaren erauzketa eta DNA soberakinak eliminatzeko DNAsa tratamenduak 
ekoizlearen irizpideak jarraituta burutu ziren (Qiagen). RNA kantitatea Nanodrop 2000 
erabiliz neurtu zen. Ondoren, ausazko hexameroak eta Superscript III alderantzizko 
transkriptasa kita (Invitrogen, #10432122) erabiliz 1,5 µg RNA erretrotranskribatuak 
izan ziren, ekoizlearen irizpideen arabera Veriti ziklatzaile termikoa erabiliz (Applied 
Biosystems, #4375305). 
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RT-qPCRa BioRad CFX96 baten gauzatu zen (California, USA) eta 
osagarriaren anplifikaziorako Power SybrGreen (BioRad, #1708880) eta 1. Taulan 
erakutsitako primerrak erabiliz. Protokoloa hurrengoa izan zen: 3 min 95ºC-tan 
desnaturalizaziorako, 10 segundoko 45 ziklo 95ºCtan sendotzeko eta 30 segundo 
60ºCtan. Lagin bakoitza GAPDHen eta HPRTen barne espresioa kontuan hartuz 



















MATERIALAK ETA METODOAK 
Hipokanpoko NSCak: Garapenetik Patologiara 
48 




HPRT NM_013556.2 150 
Fwd:5’-GTTGGGCTTACCTCACTGCT-3’ 
Rev:5’-TCATCGCTAATCACGACGCT-3’ 
GAPDH NM_001289726.1 153 
Fwd:5’-CCAGTATGACTCCACTCACG-3’ 
Rev:5’-GACTCCACGACATACTCAGC-3’ 
EGFR NM_007912.4 165 
Fwd:5’-GCCAACTGTACCTATGGATGT-3’ 
Rev:5’-GGCCCAGAGGATTTGGAAGAA-3’ 
FGFR1 NM_001079908.2 88 
Fwd:5’-CCAAACCCTGTAGCTCCCTA-3’ 
Rev:5’-TGAACTTCACCGTCTTGGCA-3’ 
FGFR2 NM_010207.2 105 
Fwd:5’-CCGAATGAAGACCACGACCA-3’ 
Rev:5 -TCGGCCGAAACTGTTACCTG-3’ 
MTH1 NM_013602.3 86 
Fwd:5’-TCACCACGACTTCAACGTCC-3’ 
Rev:5’-CAGTTGGGGTCCATTCCGAG-3’ 






1. Taula. RT-qPCRean erabilitako primer lista.
5.7. IHC 
5.7.1. Sagu burmuin ehuna 
IHCa aurretiaz deskribatu den bezala burutu zen sagu transgenikoentzako 
optimizaturiko metodoak erabiliz (Encinas and Enikolopov, 2008; Encinas et al., 2011). 
Labur, animaliak bihotzetik perfusatuak izan ziren lehenik 30 ml PBS 1X eta ondoren 
%4 PFA PBSn (Ph 7.4) erabiliz. Gero, burmuinak atera eta hiru orduz gehiago 
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finkatzen uzten ziren, PFA soluzio berean eta giro tenperaturan, PBS- %0.2 sodio 
azide soluzio batera aldatuak izan baino lehen, non 4 ºCtan gordeak izaten ziren. 50 
µm lodi ziren sekzio sagitalak moztuak izan ziren era serialean Leica VT 1200S 
bibrazio xafla mikrotomo (Leica Microsystems GmbH, Wetzlar, Germany) bat erabiliz. 
Jaio ondorengo SFFV-RV esperimentuetan, 70 µm lodi ziren sekzio koronalak moztu 
ziren era serialean, SFFV-RV infekzioen hedadura zuzen eta egoki ikustea 
ahalbidetzeko. IHC esperimentuetan, sekzioak blokeo eta permeabilizazio soluzioetan 
inkubatuak izaten ziren (PBSa %0.25 Triton-X100-arekin eta %3 behi serum albumina 
(Ingelesetik bovin serum albumin, BSA)) hiru orduz giro tenperaturan, ondoren gau 
osoan zehar antigorputz primarioarekin inkubatuak izateko (soluzio berean diluituak) 
4ºCtan. Inkubazioaren ostean, antigorputz primarioa kendu eta sekzioak PBSa erabiliz 
garbitzen ziren hiru aldiz 10 minutuz. Ostean, sekzioak blokeo eta permeabilizazio 
soluzioan diluituriko fluorokromo bati itsatsitako antigorputz sekundarioekin inkubatzen 
ziren 3 orduz giro tenperaturan. Azkenik, PBS erabiliz garbitu eta sekzioak gelatinaz 
gainjantzitako laminatan kokatuak ziren DakoCytomation kokatze medio fluoreszentea 
erabiliz (DakoCytomation, #S302380). BrdU eta Nestin erabilpena eskatzen zuten 
esperimentuetan, sekzioak 2M azido klorihidrikoarekin (Ingelesetik chlrohydric acid, 
HCL) tratatuak izan ziren 37ºC-tan 20 minutuz eta segituan 0.1M tetraboratoarekin 
inkubatu giro tenperaturan 10 minutuz tindaketa hasi baino lehen. Ondoren, sekzioak 
PBS erabiliz garbitu eta tindaketak lehenago deskribatu bezala jarraitu zen. Nestin-
GFP eta LPA1- EGFP animalia transgenikoen GFP seinalea, SFFV-RVen mCerulean 
seinalea bezalaxe, GFParen kontrako antigorputz bat erabiliz detektatu zen 
seinalearen areagotze eta irudikapen hobea lortzeko. Era berean, SFFV-RVen 
mCherry seinalea DsRedaren kontrako antigorputz batekin detektatu zen seinalearen 
areagotze eta irudikapen hobea lortzeko. Antigorputz primario eta sekundarioen lista 
osoa 2. eta 3. Tauletan aurki daiteke.  
 5.7.2. Hazkuntza zelularrak 
Tratamendu bakoitzaren ondoren, hazkuntza zelularrak finkatuak izan ziren 
PBS-%4 sukrosan disolbaturiko %4 PFA erabiliz. Gero, permeabilizatu zitezen, 
zeluladun estalkiak PBS-%0.3 Triton-X100 eta %1 BSArekin inkubatuak izan ziren hiru 
minutuz giro tenperaturan eta %0.2 Triton-X100 eta %3 BSA PBSan diluituriko 
antigorputz primarioekin inkubatuak gau osoan zehar 4ºCtan. Ostean, PBS erabiliz 
garbituak izan ziren hiru aldiz eta antigorputz sekundarioekin inkubatuak bi orduz giro 
tenperaturan, DAPI ere bazuen soluzioan. Azkenik, estalkiak beirazko laminetan buruz 
behera kokatuak izan ziren DakoCytomation kokatze medio fluoreszentea erabiliz. 
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BrdU esperimentuentzako, tindaketa baino lehenago zelulak 2M HCl erabiliz bost 
minutuz 37ºCtan tratatuak eta segituan 10 minutuz inkubatuak izan ziren giro 
tenperaturan 0.1M tetraboratoa erabiliz. Ondoren, sekzioak PBS bidez garbitu eta 
tindaketak lehenago deskribatu bezala jarraitu zuen. Antigorputzen lista osoa 2. eta 3. 
Tauletan aurki daiteke. 
5.7.3. Giza ehuna 
Giza garuneko ehun blokeak 30 μm-ko lodierarekin moztuak izan ziren kriostato 
bat erabiliz, ondoren zuzenean aurreizoztutako (-20ºC) Superfrost beirazko laminetan 
(sekzio bat lamina bakoitzeko) atxiki eta erabili arte -80ºCtan gordez. Kasu bakoitzean, 
gutxienez hiru sekzio kresil bioleta tindaketaren bitartez koloreztatuak izan ziren 
laginaren orientazioa eta mugarri anatomikoak konfirmatzeko. IHCa aurretiaz 
deskribatuko protokoloa jarraituz burutu zen (Sorrells et al., 2018). 
IHCa baino lehen, izoztutako laminak giro tenperaturan orekatzen ziren hiru 
orduz, 65ºCtan 30 minutuz labean sartu baino lehen. %0.05 Triton-X100 PBSa (TNT 
tanpoia) erabiliz laminak berriro hidratatu eta gero, %4 PFA erabiliz finkatuak izan ziren 
45 minutuz. Laminak TNTa eta ur destilatua erabiliz garbituak izan ziren eta ondoren 
barruko peroxidasa seinalea itzalia izan zen PBS-%1 H2O2ko soluzioa erabiliz 30 
minutuz. Antigenoaren berreskurapena behar zuten epitopoen kasuan (4. Taula), 
10mM sodio zitrato tanpoi batekin inkubazio gehigarri bat egin zen, pH 6.0 95ºCtan 10 
minutuz, eta gero laminak giro tenperaturan hozten utzi ziren. Horren ostean, laminak 
TNTarekin garbituak izan ziren 10 minutuz hiru aldiz eta berriro PBS-%1 H2O2an jarriak 
ordubete eta 30 minutuz barne peroxidasa seinalearen itzaltzea ziurtatzeko asmoz. 
Lotura ez zehatzak 0.1 M Tris-HCl, pH 7.5, 0.15 M NaCl, %0.5 PerkinElmereko blokeo 
erreaktiboarekin blokeatuak izan ziren (TNB soluzioa) ordubetez eta laminak TNBn 
diluituriko antigorputz primarioekin inkubatuak izan ziren (4. Taula). 
Gau osoko inkubazioaren ondoren, laminak TNT erabiliz 10 minutuz hiru aldiz 
garbituak eta TNBn diluituriko antigorputz sekundarioekin inkubatuak izan ziren. Alexa 
seinale indartsuenentzako zuzenean akoplaturiko antigorputz sekundarioak erabili 
ziren. Seinalerik ahulenentzako, Tiramida seinale anplifikazio kitarekin (PerkinElmer) 
tindaketa intentsitatearen handitze bat gauzatu zen. Labur, biotindaturiko antigorputz 
sekundarioak (Jackson Immunoresearch Laboratories) 2.5 orduz inkubatuak izan ziren 
giro tenperaturan. Ondoren, streptabidina peroxidasarekiko (TNB-n 1:200ean diluiturik) 
lotura 30 minutuz ahalbidetua izan zen. Azkenik, tiramida soluzio bat fluoroforo 
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konjugatuekin 5 minutuz inkubatua izan zen, azkenik erreakzioa bukatutzat emateko 
“Reaction Stop Reagent” erabiliz. 
IHC protokoloa antigorputz ezberdinentzako sekuentziak jarraituz gauzatu zen, 
antigorputz primarioetatik indartsuena eta zegokion antigorputz sekundarioa lehenbizi 
inkubatuz. Honela, tiramida soluzioaren inkubazioaren ostean, laminak beste 30 
minutuz finkatuak eta %3 H2O2 PBSn inkubatuak izan ziren, protokoloa berriz ere 
hasteko gainontzeko antigorputz primarioentzako. Azkenik, behin antigorputz guztiak 
inkubaturik, sekzioak TNTn zeharo garbituak, deshidratatuak, laminetan kokatuak eta 
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IHC-RAKO ANTIGORPUTZ PRIMARIOAK 





















Goat anti- DCX 



































2. Taula. Sagu ehunean eta hazkuntza zelularretan erabilitako antigorputz primarioak. 
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IHC-RAKO ANTIGORPUTZ SEKUNDARIOAK 
ANTIGORPUTZA KONPAINIA DILUZIOA 




































3. Taula. Sagu ehunean eta hazkuntza zelularretan erabilitako antigorputz sekundarioak.
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IHC-RAKO ANTIGORPUTZ PRIMARIOAK 





























4. Taula. Giza ehunean erabilitako antigorputz primarioak. 
5.8. WB 
Esperimentuaren arabera, hipokanpo ehuna edo hazitako NSPCak adierazitako 
denboretan bilduak izan ziren RIPA tanpoia proteasa inhibitzaile koktelarekin eta 
fosfatasa inhibitzaileekin nahasturik erabiliz. Lagin bakoitza -80ºCtan gordea izan zen 
erabili arte. Esperimentu egunean, laginak homogeneizatuak eta 10 minutuz 14000 
rpm-tan zentrifugatuak izan ziren. Proteina gainjalkina (20 µg) %10 Tris-Glizina geletan 
kargatua eta nitrozelulosa mintz batera (Life technologies, #88018) transferitua izan 
zen. Ponceau tindaketa (Sigma-Aldrich, #P7170) mintzetan gauzatu zen proteinaren 
eta bandaren migrazio zuzena egiaztatzeko asmoz. Gure intereseko proteinak 
tindatzeko, mintzak %5 gantzik gabeko lehorturiko esnea TBS-Tn (150mM NaCl, 20 
mM Tris-HCl, pH 7.5, %0.05 Tween 20) blokeatuak izan ziren ordubetez, ondoren 
antigorputz primarioekin (5. Taula) bi orduz inkubatuak izateko. TBS-Tn hiru garbiketa 
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egin ostean, mintzak antigorputz sekundarioekin (6. Taula)  inkubatuak izan ziren 
beste ordubetez eta ECL Supersignal (Thermo Fisher, #34095) WB analisi sistemaren 
bitartez irudikatuak. 
WB-ERAKO ANTIGORPUTZ PRIMARIOAK 
ANTIGORPUTZA KONPAINIA DILUZIOA 

















































5. Taula. WBerako erabilitako antigorputz primarioak.
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WB-ERAKO ANTIGORPUTZ SEKUNDARIOAK 











6. Taula. WBerako erabilitako antigorputz sekundarioak. 
5.9. ELISA 
NSPCtan edo KAra esposaturiko garun ehunean HB-EGF maila neurtzeko 
xedez, “R&D DuoSet Immunoassay” erabili genuen, aurretiaz deskribaturik bezala 
(Luzuriaga et al., 2019). Bai zelula alea zein garun ehuna Hepes 25 mM, 5 MgCl2 5 
mM EGTA 1 mM, EDTA 1.3 mM, PMSF 1 mM eta proteasa eta fosfatasa koktel 
inhibitzaileak zituen tanpoia erabiliz lisatuak izan ziren (Thermo Fisher, #88665 eta 
#78420). 
Hazkuntza zelularren kasuan, 96 putzuko plaka batean hazkuntza faktorerik 
gabeko150 µl kultibo medio erabiliz 250.000 zelula hazi ziren. Medioa, zelulak barne, 
plakan jarri eta 72 ordura bildua izan zen. 4ºCtan, 14.000 rpm-tan 10 minutuz 
zentrifugatu ostean, ondorengo analisiak egiteko lisaturiko zelula alearen eta/edo 
gainjalkinaren 100 µl erreaktibo diluentean 1:1 diluituak izan ziren. Baldintza 
paralelotan, 72 orduko kultiboaren segidan, zelula kopurua Bio-Rad TC20 zelula 
kontatzaile automatizatua erabiliz zenbatua izan zen, era berean zelula hilak markatu 
eta baztertzeko asmoz trypan urdina erabiliz. Hala, esperimentu amaieran zelula 
bakoitzeko HB-EGF kopurua kalkulatu genuen. 
Garun ehunean zegoen HB-EGF kopuruaren analisirako, saguak CO2 kamera 
baten 0, 1.5, 12, 24 eta 72 ordu KA edo disoluzio isotoniko administrazioa eta gero 
(n=4 kondizioko) sakon anestesiatuak izan ziren. Euren hipokanpoak izotzean erauziak 
eta laster izotz lehorraren bitartez izoztuak izan ziren. Laginak lisis tanpoian 
homogenizatuak eta segituan zentrifugatuak izan ziren (20 minutu 14000 rpm-tan 
4ºCtan). Gainjalkinak bildu eta proteina kopuru totala BCA proteina saiakera kita 
(Pierce, #23227) erabiliz neurtua izan zen. 1:1 erlazioan disolbaturik erreaktibo diluente 
tanpoiean 100 µg proteina kargatu ziren puntu bakoitzerako. 
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Biak in vitro eta in vivo kuantifikazioak hurrengo lau parametro logistikoak 
erabiliz burutuak izan ziren: 
    
   





Non x eta y aldagai aske eta mendekoak ziren, a eta d neurturiko balio minimo 
eta maximoak ziren, c inflexio puntua zen, a eta d erdibidea eta b kurban Hillen aldapa 
zen (Kurbaren malda c puntuan). 
In vitro analisietan balioak normalizatuak eta HB-EGF pg/ml bezala aurkeztuak 
izan ziren eta in vivo analisietan balioak HB-EGF pg ehun proteina µg-ko bezala 
kalkulatuak izan ziren. 
5.10. Danscher tindaketa 
Danscher metodo autometalografiko ez zuzena egiteko, 20 mg/Kg sodio 
selenito %4 PFA- %0.5 Glutaraldehido perfusioa baino 30 minutu lehenago 
intraperitonealki injektatuak izan ziren eta ehuna 50 µm-ko sekzio serialetan 
prozesatua izan zen. Tindaketa aurretiaz deskribatu izan den bezala burutua izan zen 
(López-García et al., 2002). Granuloen tamaina eta kuantifikazioa GFP zelula 
eremuaren interes gunea (ingelesetik region of interest, ROI) determinatuz eta ImageJ 
softwarea erabiliz eraman zen aurrera (15-20 zelula kondizioko). 
5.11. Irudien analisia 
Fluoreszentzia IHC irudien gehiengoa Leica SP8 laser eskaner mikroskopio 
konfokal baten 40X olio-murgilketa objektiboa erabiliz bilduak izan ziren. DGaren area 
totalen kuantifikaziorako 10X objektiboa erabili zen sekzio bakoitzean DGa guztiz 
irudikatzeko asmotan. Garapeneko DGaren irudiak hartzeko, non DMS irudikaturik 
agertzen den, eta baita giza ehunean eginiko irudi guztientzako ere, “3DHistech 
panoramic digital slidescanner” izenekoa erabili zen. Fluorokromo bakoitzaren seinalea 
sekuentzietan bildua izan zen eta argitasuna, kontrastea eta atzealdea irudi osoan 
berdin orekatuak izan ziren Leica LAS X Life Science mikroskopio konfokalaren 
softwarea erabiliz. 
5.11.1. Zelula populazioen analisi kuantitatiboa  
Zelula populazioen analisi kuantitatiboa moldaturiko zatitzaile optiko sekzio 
eskema bat erabiliz in vivo diseinuan oinarritutako estereologia erabiliz gauzatu zen, 
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aurretiaz deskribaturiko eran (Encinas and Enikolopov, 2008; Encinas et al., 2006, 
2011). 
Zelula dentsitateentzako, kuantifikazioak kondizioen artean z-pilaketa tamaina 
berdinak mantenduz gauzatu zen. Kuantifikaturiko arean balioak SGZ+GCL 
bolumenera normalizatuak izan ziren. Zenbaketa totalentzako, DGaren area guztia 
serie bakoitzeko sekzio guztietan zehaztua izan zen, lortutako balioa ondoren GCLaren 
zabalerarengandik biderkatua izateko, zeina gutxienez sekzio bakoitzaren hiru puntu 
ezberdinetan kalkulatua izan zen. DG osoaren bolumena lortzeko lortutako balioa bost 
aldiz biderkatua izan zen. 
P14 baino lehenagoko jaio ondorengo esperimentuetan, non NSCak ez diren 
oraindik helduak (Brunne et al., 2013; Nicola et al., 2015), zelulak dNSC bezala 
kuantifikatuak izan ziren euren soma GCL barruan zutenean, hala nola hurrengo 
irizpideak betetzen zituztenean: Ondo deskribaturiko NSC markatzaile Nestin-GFPren 
eta GFAPren espresioa (Encinas and Enikolopov, 2008; Kronenberg et al., 2003; Seri 
et al., 2001) eta MLarengana luzaturiko prozesu ererradialaren presentzia. P14 
geroztik, NSCak aurretiaz deskribaturiko irizpideak jarraituz zenbatu ziren (Encinas and 
Enikolopov, 2008; Kronenberg et al., 2003). Ugaritze fasean aurkitzen ziren zelulak 
identifikatzeko, Ki67 ziklo zelular markatzailea erabili zen. Markatzaile honentzat 
positiboak ziren eta lehenago deskribaturiko irizpideak betetzen zituzten NSCak 
ugaritze fasean sarturiko dNSC/NSC bezala zenbatu ziren. DG sekzioren 
GCLean1024x1024 marko tamainazko 3-4 z-pilaketa ausaz aukeratu ziren 3-5 
(animaliaren adinaren arabera). Ehun helduko sekzioetan, hipokanpo sekzio 
bakoitzeko 3-4 z-pilaketa DGan ausaz kokaturiko eremuetan batu ziren eta serie 
bakoitzeko 4-6 sekzio analizatu ziren, esperimentuaren arabera. Hazkuntza 
zelularretan, lagin eta kondizio bakoitzeko estalkiaren ausazko eremuetan 4 µm-lodiko 
5 z-pilaketa bildu ziren. 
SFFV-RV infekzioak erabili ziren esperimentuetan, kondizio bakoitzeko GCLean 
infektaturiko zelula guztiak kuantifikatu genituen. Halaber, infektaturiko eremuan 
zeuden NSC zenbakia kuantifikatu genuen (zelula SFFV-RV-positiboak zituen 
eremua), kondizio bakoitzean SFFV-RVarekin infektaturiko NSC portzentajea lortzeko 
asmoz. 
Zelula heriotza neurtzeko, zelula apoptotikoak morfologia nuklear anormala 
zuten zelula bezala definituak izan ziren (piknotikoak/karriorektikoak). MTLE 
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esperimentuetan, GCDa DAPIrekin eta NeuNrekin tindatutako sekzioetan neurtua izan 
zen. 
KA administrazio osteko EGFR espresioaren analisietan, ImageJrentzako kode 
irekiko plugin bat erabili zen. Labur, EGFRk okupaturiko pixelen area neurtua izan zen. 
Kondizio guztientzako zarata-tolerantzia berbera erabiliz area “find-maxima” 
aukerarekin kuantifikatu zen, EGFRk okupaturiko area totala lortuz. 
NSPCen ugaritzea BrdU barneraketa kontutan hartuz neurtu zen. BrdU-
positiboak ziren NSPCen proportzio erlatiboak kondizio eta estalki bakoitzeko zelula 
kopuru totalarekin (DAPI tindaketa) konparatu zen. Kondizio guztietako ugaritze 
kopurua kontrol kondizioko ugaritze kopuru basalarekin konparatua izan zen. 
5.11.2. NSCen analisi morfologikoa: SHOLL analisia 
3D konfokal argazkiak esportatuak izan ziren eta zelula morfologia 
NeuronStudio 0.9.92 softwarea erabiliz analizatua izan zen (Computational 
Neurobiology and Imaging Center Mount Sinai School of Medicine, New York, 
NY)(Rodriguez et al., 2006). Zelula guztiak batzeko asmoz emaitzak Excelera 
esportatuak izan ziren eta analisi estatistiko eta errepresentazio grafikoak egiteko 
GraphPad Prism v5 erabili zen. 
5.12. Analisi estatistikoa 
Analisi estatistikoak egiteko SigmaPlot (San Jose, CA, USA) erabili zen, analisi 
morfologikoen kasuan salbu, zeinetan GraphPad Prism v5 erabili zen. Talde biren 
arteko analisiak egiteko Studenten t testa erabili zen, datuak parametrikoak ez ziren 
kasuetan U-Mann Whitneyra joz. Bi talde baino gehiagoren presentzian, faktore 
bakoitzaren efektu jenerala ikusarazteko asmoz talde guztien bide bakarreko bariantza 
analisia (ingelesetik analysis of variance, ANOVA) testa erabili zen. Era berean, datuak 
parametrikoak suertatu ez ziren kasuetan Kruskal-Wallis testa erabili zen. Faktoreen 
arteko interakzioa detektatzeko, bide bikoitzeko ANOVA erabili zen. Kasu guztietan, 
post-hoc test bezala faktore bakoitzeko taldeen arteko esangura determinatzeko 
binakako konparazio anizkoitzak (Holm-Sidak, Dunn or Student-Newman-Keuls test) 
erabili ziren eta kontrol taldearekin alderatuz faktore bakoitzaren esangura 
determinatzeko kontrol taldearekiko konparaketak (Holm-Sidak, Dunn, Dunnet or 
Tukey test). ANOVA baldintzekin (normaltasun eta homozedastizitatea) betetzeko 
behar zuten kasuetan datuen transformazio logaritmikoa gauzatu zen. p<0.05 
estatistikoki esanguratsu bezala ulertu zen. Emaitzak batez besteko ± errore 
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estandarraren batez bestekoa (ingelesetik standard error mean, SEM) bezala 













6.1. cD2 ezinbestekoa da NSC helduen populazioa sortu dadin 
Jaio ondorengo ugaritzeak NSC helduen sorkuntzan duen papera ikertzeko 
xedez, DGaren garapena cD2ren presentzian (WT) zein absentzian (cD2KO) aztertu 
genuen; ziklo zelularrean G1 fasetik S fasera bideko trantsizioan parte hartzen duen 
faktore garrantzitsu bat (Matsushime et al., 1992; Meyerson and Harlow, 1994; Sherr, 
1995). cD2KO saguek AHN maila arbuiagarria aurkezten dutela deskribatu izan da 
(Ansorg et al., 2012), nahiz eta oraindik hau NSC helduen kapazitate neurogenikoaren 
gaitz baten poderioz den edo ostera, NSC populazioaren formakuntzan jaio ondoren 
suertaturiko akats baten poderioz ezezaguna den. Hemen, Nestin-GFP/cD2KO eta 
Nestin-GFP/WT sagu mutanteetan jaio ondorengo bost denbora puntu ezberdinetan 
(P0, P7, P10, P14 and P28) NSCak irudikatu genituen (R1-R3 Figurak), NSC bezala 
definituz GCLean kokaturiko, Nestin-GFP eta GFAP espresatzen zuten eta MLrantza 
prozesu erradial bat luzatzen zuten zelula haiek. 
6.1.1. cD2ren absentzian, NSC helduen populazioa ez da sortzen 
DGaren enbrioi aroko garapena, jaio ondorengo aro goiztiarra iristen den arte, 
antzekoa da WT eta cD2KO saguetan (Kowalczyk et al., 2004). Halere, azken hauetan 
ugaritze orokorra GCLean P7tik aurrera gutxitu egiten da eta AHNa oso urria da 
(Ansorg et al., 2012). Honela, geure buruari galdetu genion AHNren absentzia NSCen 
ahalmen neurogenikoaren gaitzaren ondorioa edo euren formazioan/establezimenduan 
gertaturiko akatsen baten efektua ote zen. Hemen, cD2KO eta WT saguetan 
estereologia, espresio markatzaile zorrotzak eta NSCak definitzeko irizpide 
morfologikoak (Nestin eta GFAP espresioa, GCLean kokaturiko soma, MLrentzat 
luzaturiko prozesua eta brokoli formako koroa) erabiliz, GCLean presente zeuden 
NSCen zenbaki eta ugaritze dinamikak (Ki67 espresioa baliatuz) aztertu genituen jaio 
ondorengo adin ezberdinetan (P0, P7, P10, P14 and P28) (R1-R3 Figurak). Era 
berean, DAPI erabiliz GCLaren bolumena neurtu genuen. Gutxienez jaio ondorengo 
etapak iraun bitartean dNSC eta NSC helduen arteko bereizketa argi ez dagoenez 
(beranduago helduko diogun gaia izanik) eta NSC helduen populazioaren sorkuntza 
momentu zehatzak ezezagun darraionez, bi NSC moten arteko bereizketa egiteko 
irizpide tenporalak erabili genituen. Populazio mailan, NSCak heldu bezala onartzen 
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dira P14tik aurrera (Nicola et al., 2015) eta honegatik, GCLeko NSCak dNSC bezala 
identifikatu genituen P14ren aurretik eta NSC heldu bezala ondoren. 
Gure emaitzek adierazi zutenez, bi kondizioak konparatuta P0n dNSCen 
morfologia antzekoa zen, GCLean kokaturiko dNSC zenbakia eta GCL bolumena 
bezalaxe (R1 A-F Figurak). Hala ere, antzekotasun hauek P7ra iritsitakoan aldatu egin 
ziren. cD2 gabe, GCL txikiago bat argi ikus zitekeen, dNSCak era esanguratsuan 
gutxituak zeuden WT saguekin alderatuz eta morfologia arraroa erakusten zuten, 
prozesu laburragoarekin (R1 I-N Figurak). Ziklo zelularraren markatzailea den Ki67 
erabiliz, dNSCtan zelula dibisioa gaitzesturik ba ote zegoen ere ebaluatu genuen, adin-
puntu bakoitzean ugaritzen zebiltzan zelulak kuantifikatuz. cD2KO saguetan ugaritze 
prozesuan mantentzen zen zelulen kopuru totala eta proportzioa ez zen diferentea ez 
P0n ezta P7n ere ez, nahiz eta P7n ugaritze prozesuan zeuden dNSCen gutxitze bat 
















R1 Figura. cD2KO saguetan, jaio ondorengo lehenengo asteetan dNSCak ez ziren era egokian 
areagotzen. A-D) dNSCen eta ugaritze prozesuan zeuden zelulen (Ki67) (Nestin-GFP /GFAP) konfokal 
irudi errepresentatiboak WT eta cD2KO saguen DGan P0n. E) WT eta cD2KO saguen GCLean P0n 
eginiko dNSC kopuru totalaren kuantifikazioa. F) WT eta cD2KO saguetan P0n eginiko GCL bolumenaren 
kuantifikazioa.  G) WT eta cD2KO saguen GCLean P0n eginiko ugaritze prozesuan zeuden dNSC kopuru 
totalaren kuantifikazioa. H) WT eta cD2KO saguen GCLean P0n eginiko ugaritze prozesuan zeuden dNSC 
portzentaiaren kuantifikazioa. I-L) dNSCen (Nestin-GFP /GFAP) eta ugaritze prozesuan zeuden zelulen 
(Ki67) konfokal irudi errepresentatiboak WT eta cD2KO saguen DGan P7n. M) WT eta cD2KO saguen 
GCLean P7n eginiko dNSC kopuru totalaren kuantifikazioa. N) WT eta cD2KO saguetan P7n eginiko GCL 
bolumenaren kuantifikazioa. O) WT eta cD2KO saguen GCLean P7n eginiko ugaritze prozesuan zeuden 
dNSC kopuru totalaren kuantifikazioa. P) WT eta cD2KO saguen GCLean P7n eginiko ugaritze prozesuan 
zeuden dNSC portzentajearen kuantifikazioa. GCL: Zelula granular geruza. SGZ: Gune azpigranularra. 
Eskala barrak 10 µm-koak dira. *p<0.05 eta ***p<0.001 Student ‘s t-test. Barrek batez bestekoa ± errore 
estandarra erakusten dute. Puntuek datu indibidualak erakusten dituzte.  
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P14n, hipokanpoko gune neurogenikoa jada heldu kontsideratzen denean 
(Nicola et al., 2015), cD2KO saguetan NSCak morfolokoki ezberdinak ziren (R2 A-D 
Figura) eta WT saguekin alderatuta kopurua era esanguratsuan gutxitua zegoen (R2 E 
Figura). Era berean, cD2ren faltan GCL bolumena askoz ere txikiagoa zen (R2 F 
Figura) eta ugaritze fasean zeuden NSCen zenbakia ere era esanguratsuan murriztua 
zegoen (R2 G Figura), nahiz eta NSC guztien artean ugaritze prozesuan zeuden 
NSCen portzentaia aldakaitz aurkezten zen (R2 H Figura). Are gehiago, P14n ikusiriko 
diferentziak P28n areagotu egin ziren; cD2KO saguetan geratzen ziren NSC bakanak 
morfologikoki aberranteak ziren (R2 I-L Figura), NSC kopurua 3 aldiz baino gehiago 
murrizturik zegoen eta GCL bolumena %50 txikiagoa zen (R2 M-N Figura). Baita, 
P28n NSC ugaritzea nabari gaitzetsia zegoen, ugaritze prozesuan zeuden NSC kopuru 
eta portzentaje arbuiagarriarekin (R2 O-P Figura). 
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R2 Figura. cD2ren gabezian, NSC helduen populazioa ez da guztiz sortzen, P28 bezain goiz 
agortzen delarik. A-D) NSCen (Nestin-GFP /GFAP) eta ugaritze prozesuan zeuden zelulen (Ki67) 
konfokal irudi errepresentatiboak WT eta cD2KO saguen DGan P14n. E) WT eta cD2KO saguen GCLean 
P14n eginiko NSC kopuru totalaren kuantifikazioa. F) WT eta cD2KO saguetan P14n eginiko GCL 
bolumenaren kuantifikazioa.  G) WT eta cD2KO saguen GCLean P14n eginiko ugaritze prozesuan zeuden 
NSC kopuru totalaren kuantifikazioa. H) WT eta cD2KO saguen GCLean P14n eginiko ugaritze prozesuan 
zeuden NSC portzentajearen kuantifikazioa. I-L) NSCen (Nestin-GFP /GFAP) eta ugaritze prozesuan 
zeuden zelulen (Ki67) konfokal irudi errepresentatiboak WT eta cD2KO saguen DGan P28n. M) WT eta 
cD2KO saguen GCLean P28n eginiko NSC kopuru totalaren kuantifikazioa. N) WT eta cD2KO saguetan 
P28n eginiko GCL bolumenaren kuantifikazioa. O) WT eta cD2KO saguen GCLean P28n eginiko ugaritze 
prozesuan zeuden NSC kopuru totalaren kuantifikazioa. P) WT eta cD2KO saguen GCLean P28n eginiko 
ugaritze prozesuan zeuden NSC portzentajearen kuantifikazioa. GCL: Zelula granular geruza. SGZ: Gune 
azpigranularra. Eskala barrak 10 µm-koak dira.*p<0.05, **p<0.001 eta ***p<0.001 Student’s t-test. Barrek 
batez bestekoa ± errore estandarra erakusten dute. Puntuek datu indibidualak erakusten dituzte. 
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Laburbilduz, cD2ren gabezian DGa ez zen era egokian sortu eta dNSCak ez 
ziren P0-P14 artean zegokien bezala hedatu (R3 A-F; I-J Figura). Horrenbestez, P14 
geroztik cD2KO saguen DGak franko NSC gutxiago biltzen zituen, populazioaren ia 
agorpen osoa ekarriz P28 bezain pronto  (R3 G-I Figura). Gainera, cD2KO animalietan 
P7tik aurrera NSCen ugaritze fasean gutxiago sartzeko tendentzia ikusi zen, P28n 
estatistikoki esanguratsua izanik (R3 K Figura). Halere, dibisioan zeuden NSCen 
portzentajea P28 arte aldatu barik mantendu zen, nahiz eta adin honetan cD2KO 
saguetan dibisioan zeuden NSC gutxiago egoteko tendentzia ikusi zen (R3 L Figura). 
Hala, cD2KO saguetan ikusitako NSC populazioaren murriztea dNSCek jaio 
ondorengo etapan dituzten dinamika aberranteen ondorio bat izan litzake (zelula 
biziraupen eta apoptosiarekin erlazionatuak), zeinek NSCen sorkuntza egokia ekidingo 
luketen. 
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R3 Figura. cD2 gabeko saguetan NSC populazioa ez da guztiz sortzen jaio ondorengo lehen bi 
asteetan zehar. A-D) NSCen (Nestin-GFP /GFAP) eta ugaritze prozesuan zeuden zelulen (Ki67) konfokal 
irudi errepresentatiboak WT eta cD2KO saguen DGan P0tik P28ra. E) WT eta cD2KO saguen GCLean 
eginiko NSC kopuru totalaren kuantifikazioa P0tik P28ra. F) WT eta cD2KO saguetan eginiko GCL 
bolumenaren kuantifikazioa P0tik P28ra. G) WT eta cD2KO saguen GCLean eginiko ugaritze prozesuan 
zeuden NSC kopuru totalaren kuantifikazioa P0tik P28ra. H) WT eta cD2KO saguen GCLean eginiko 
ugaritze prozesuan zeuden NSC portzentajearen kuantifikazioa P0tik P28ra. GCL: Zelula granular geruza. 
SGZ: Gune azpigranularra. Eskala barrak 10 µm-koak dira. *p<0.05, **p<0.01 eta ***p<0.001. Bide 
bikoitzeko ANOVA Holm-Sidak post-hoc testaren bidezko binakako konparazio anizkoitzez jarraitua. 
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Puntuek batez bestekoa ± errore estandarra erakusten dute. Normaltasun eta homozedastizitatearekin 
betetzeko datu guztiak Log10era transformatuak izan ziren.  
6.1.2. cD2ren gabezian heriotza zelularra ez zen areagotu 
Ondoren cD2KO saguetan jaio ondoren ematen den NSC populazioaren 
sorkuntza murriztua dNSCetan emandako heriotza zelularraren areagotze baten 
ondorioz gerta ote zitekeen ikertu genuen. Heriotza zelularra ebaluatzeko, GCLean 
adin-puntu bakoitzean (P0, P7, P14, P28) nukleo piknotikoen dentsitatea kuantifikatu 
genuen (R4 E-F Figura), piknosiak nekrosia edo apoptosia pairatzen ari diren 
kromatinaren kondentsazio itzulezina adierazten duelarik (Burgoyne, 1999). Emaitzek 
nukleo piknotikoen alteraziorik eza erakutsi zuten P0 eta P7 adin-puntuetan (R4 F 
Figura). Halere, P14 geroztik cD2KO saguetan nukleo piknotiko gutxiago ageri ziren 
(R4 A-D; F Figura), NSC eta neurogenesi gutxiago egoteak azaldu lezakeena. 
Horrela, cD2ren gabezian dNSCek WTean ematen diren dinamika apoptotiko berak 
jarraituz burutu zuten euren garapena, P14 eta gero heroitza zelularra gutxitzen den 



















R4 Figura. Gune neurogenikoaren 
formazioa osatu artean cD2ren 
gabeziak ez ditu dinamika 
apoptotikoak alteratzen. A-D) Irudi 
konfokal errepresentatiboak WT eta 
cD2KO saguen GCLa erakutsiz P14n. 
Geziek zelula apoptotikoak adierazten 
dituzte WT sagu batean. E) Zelula 
apoptotiko baten konfokal irudi 
errepresentatiboa. F) Jaio ondorengo 
DGaren formazioan zehar adin 
desberdinetan (P0, P7, P14, P28)  
eginiko heriotza zelular dentsitatearen 
kuantifikazioa. GCL: Zelula granular 
geruza. Eskala barrak 10 µm-koak dira 
A-Dn eta 5 µm-koak E-n. **p<0.01 eta 
***p<0.001. Bide bikoitzeko ANOVA 
Holm-Sidak post-hoc testaren bidezko 
binakako konparazio anizkoitzez 
jarraitua. Puntuek batez bestekoa ± 
errore estandarra erakusten dute. 
Ikusarazte eta estatistika errazteko, 
datu guztiak log10 eskala batean 
irudikatuak agertzen dira. Normaltasun 
eta homozedastizitatearekin betetzeko 
datu guztiak Log10era transformatuak 
izan ziren. 
6.2. NSC helduen populazioaren jaio ondorengo sorkuntza 
Gure aurreko emaitzek NSC helduen erreserba sor zedin jaio ondorengo 
ugaritzea ezinbestekoa zela erakutsi zuten, cD2ren menpekoa zen prozesu batean. 
Hori bakarrik ez eta DGaren formazio etapan, jaio ondorengo periodoa barne, HPFko 
hainbat eremutan aldi baterako gune neurogeniko/gliogeniko anitz sortu egiten dira 
(Hodge et al., 2013; Li et al., 2013). Aldi baterako gune neurogeniko/gliogenikoetako 
bat DMSa da, enbrioi garapen goiztiarrean sortzen den korronte migratzaile bat, DNetik 
DGra doazen dNSCez eta sortzailez osatua. Nabarmen, jaio ondorengo etapa 
goiztiarrean zehar DMSa aktibo mantentzen da (Hodge et al., 2013; Li et al., 2013; 
Nakahira and Yuasa, 2005; Sugiyama et al., 2013). Hau kontuan harturik, HPFko bi 
leku desberdin hauetan kokaturiko aitzindariek, hau da DG barrualdean kokatuta 
daundenek eta DMStik datozenek (Altman and Bayer, 1990; Berg et al., 2019; Hodge 
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et al., 2013; Sugiyama et al., 2013), DGaren formazioari egiten dioten ekarpena ikertu 
genuen, jaio ondorengo etapan kontzentratuz. 
6.2.1. In vivo infekzio erretrobiralak NSC helduen jatorri espaziala 
identifikatzeko 
DGaren barruan edo DMSean kokaturiko sortzaileak era diferentzialean 
markatzeko asmoz, injekzio erretrobiralak erabili genituen, mitosi fasean dauden 
zelulek soilik barneratzen dituztenak (Weber et al., 2012). SFFV-RVen difusio eta 
efizientzia eta gure injekzioen zehaztasuna frogatzeko asmoz, P2 eta P5 adinetan 
SFFV-RVmCherry bektore baten injekzio intrahipokanpalaren bitartez in vivo infektatu 
genituen saguak eta SFFV-RVarekin infektaturiko zelulen kokapena aztertu hortik 
gutxira (2 egun injekzioaren ondoren) (R5 A Figura). 
Bi injekzio paradigma ezberdin antolatu genituen. Lehenik, DGaren 
barnealdean injektatu genuen soilik hilus eta GCLean zeuden sortzaileak tindatzea 
bilatuz. Honek tindaketa DMStik baztertua zeuden injekzioak suertatu zituen (R5 B-C 
Figura). Bigarren paradigman DGaren kanpoaldean injektatu genuen, DMSan zehazki. 
Injekzio mota hauekin DMSan ezarrita zeuden sortzaileak tindatu genituen DGaren 
barnealdeko sortzaile bakar bat ere ez infektatu barik (Figure R5 D-E). Honela, bi 
injekzio paradigma hauek HPFko bi eremu desberdinetan kokaturiko sortzaileen leinua 
era independentean jarraitzeko eraginkorrak zirela frogatu genuen. 
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 Aurreko orrialdean. R5 Figura. Jaio ondorengo SFFV-RV infekzioak HPFko populazio ezberdinak 
espazialki markatzeko erreminta gisa. A) Paradigma esperimentalaren eskema. B-E) Lamina-eskaner 
fluoreszente irudiak SFFV-RV infekzio espazial desberdinak erakutsiz. Kumeak P2 adinean injektatuak 
izan ziren bai DG barruan (A) zein DMSan (B) eta inkezioaren lekua P4n ebaluatua izan zen. C-D) 
Lamina-eskaner fluoreszente irudiak SFFV-RV infekzio espazial desberdinak erakutsiz. Kumeak P5 
adinean injektatuak izan ziren bai DG barruan (A) zein DMSan (B) eta inkezioaren lekua P7n ebaluatua 
izan zen. Karratuak DMSa zehazten du eta geziak injekzio bidea. Bi adinetan, infektaturiko zelulak ez 
ziren inoiz aldi berean eremu bietan (DG eta DMSa) ikusi, injekzioak bata bestearen esklusiboak zirela 
adieraziz. CA: Cornu ammonis. DG: Hortzdun zirkunboluzioa. DMS: Hortzdun migrazio korrontea. fi: 
fimbria. GCL: Zelula granular geruza. LV: Bentrikulu laterala. Eskala barrak 10 µm-koak dira.  
Bi paradigma hauen zelularen leinuaren jarraipen ahalmena haratago 
demostratzeko xedez, P2 adinean aldi berean bi injekzioak gauzatzea eta injekzio 
bakoitza gene erreportari fluoreszenteek kodetutako SFFV-RV ezberdinekin 
desberdintzea erabaki genuen. SFFV-RV-mCherry bektore bat DMSean eta SFFV-RV-
mCerulean bektore bat DGan injektatu genituen, honela eremu bakoitzetik eratorritako 
leinuaren ezberdintzea ahalbidetuz (R6 A Figura). P14an ebaluatu genuen 
infektaturiko sortzaileen leinua, garai hau izanik NSC helduak SGZan ezartzen diren 
garaia (Nicola et al., 2015), bi injekzioak diferente eta independenteak zirela ikusaraziz. 
Injekzioen kokapen ezberdinak (DGa eta DMSa) independenteki tindaturiko zelula 
populazioak ikusaraztea ekarri zuen, nahiz eta bi populazioek GCLean ezarririk amaitu. 
Are gehiago, DG injekzioetatik eratorriko zelulak ardatz rostrokaudalera mugatuago 
agertzen ziren bitartean, DMS injekzio modeloan infektaturiko zelulak HPFaren eremu 
dorsaletatik kaudaletara ikus zitezkeen (R6 B-E Figura). 
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 Aurreko orrialdean. R6 Figura. Jaio ondorengo SFFV-RV infekzioek selektiboki tindatu zituzten 
injekzio tokiko sortzaileak, beste eremuarekin gainjarri barik. A) Paradigma esperimentalaren 
eskema. B-E) Lamina-eskaner fluoreszente irudiak SFFV-RV animali berean eginiko infekzio espazial 
desberdinak erakutsiz. Irudiak ardatz rostro-kaudalean zehar erakusten dira infekzioaren extensioaren era 
adierazgarri batean. Kumeak P2n injektatuak izan ziren DGaren barnealdean (berdez) edo DMSan (gorriz) 
eta injekzio lekua P14n ebaluatua izan zen. Karratuak DMSa zehazten du eta geziak injekzio bidea. 
Eremu ezberdinetatik eratorritako zelulak ez ziren inoiz gainjarririk agertu, nahiz eta zelula gehiengoaren 
helmuga GCLa zen bi injekzio mota kasuetan. Honek injekzioak elkarren artean esklusiboak zirela adierazi 
zuen. CA: Cornu ammonis. DG: Hortzdun zirkunboluzioa. DMS: Hortzdun migrazio korrontea. fi: fimbria. 
GCL: Zelula granular geruza. LV: Bentrikulu laterala. Eskala barrak 10 µm-koak dira.  
6.2.2. NSC helduen populazioaren sorkuntzan soilik DG barruko 
aitzindariek egiten zuten ekarpena  
Behin metodoa antolaturik, NSC helduen populazioaren jatorri espaziala 
identifikatzeko asmoz P2 eta P5 adinetan sortzaile hipokanpalen leinu osoa ikertu 
genuen. Horretarako, SFFV-RV-mCherry bektorea erabili genuen. Bi adinetan, DG 
injekzioean ostean DGa bera SFFV-RVarekin infektaturiko zelulez betea agertu zen 
maila medial eta medial-kaudaletan, zeinetan injekzioa gauzatua izan zen. Itxaron 
bezala, DMSan ez zen infektaturiko zelularik aurkitu (R7 A Figura). Era berean, 
infektaturiko zelulen artean, gehienak neurona bezala identifikatu genituen, haien 
morfologia eta NSC/astrozito markatzaileen gabezia kontuan hartuz. GC hauen axoiak 
ikusi genituen DG rostralera iritsiz eremu hilarrean zehar (R7 A Figura). Bestalde, 
DMS injekzioen ostean tindaturiko leinua DGaren eremu medial eta kaudaletan GCL 
osoan zehar ikusi zitekeen, neurona propietateak agertuz, euren axoiek DGaren parte 
rostralera iristen zirelarik. Horrez gain, injekzio mota hauetan DMSa maila rostraletik 
kaudalera SFFV-RV-mCherryarekin infektaturiko zelulaz betea agertu zen, beharbada 
jaio ondoren dibiditutako dNSCen diferentziazio glialaren ondorioz (R7 B Figura). 
P2n egindako DG injekzioen ostean, zelulak GCL osoan zehar banatuak 
zeuden, SGZa barne, DMSan injektaturiko zelulak GCLaren goialdera mugatuak 
zeudelarik, SGZa guztiz libre utzirik. Are gehiago, SFFV-RV-mCherry tindaturiko 
sortzaileek patu ezberdinak zituzten injekzio modeloaren arabera. DG infekzioetan, 
infektaturiko zelulen gehiengoa neuronak ziren (neurona morfologia dendrita eta 
axoiekin eta Nestin-GFP eta GFAP markatzaileen gabezia), baina bai SFFV-RV-
mCherry zelula positibo guztien artean bai NSC guztien artean kuantifikatuta, SFFV-
RV-mCherry zelula positiboen %4-5a NSC helduak suertatu ziren, euren Nestin-GFP 
eta GFAP espresioarengatik, morfologia erradialarengatik eta SGZan kokaturiko 
somarengatik identifikatuak. Kontrara, SFFV-RV-mCherryak infektaturiko NSC 
zenbakia arbuiagarria izan zen DMSan (R7 C-F Figura; R9 Figura). 
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 Aurreko orrialdean. R7 Figura. Jaio ondorengo etapa goiztiarrean NSC helduen aitzindarien 
gehiengo haundia DGaren barruan kokatua zegoen. A-B) Lamina-eskaner fluoreszente irudiak SFFV-
RV infekzio espazial desberdinak erakutsiz. Kumeak P2 adinean injektatuak izan ziren bai DG barruan (A) 
zein DMSan (B) eta injekzioaren lekua P14n ebaluatua izan zen. Geziak injekzio bidea adierazten du. C-
D) Irudi konfokalak GCLean kokaturiko SFFV-RVaz infektaturiko zelulen morfologia eta markatzaile 
espresioa (Nestin-GFP eta GFAP) adieraziz. Geziek SFFV-RVak infektaturiko NSC bat adierazten dute. E) 
SFFV-RV NSC positiboen portzentajearen kuantifikazioa SFFV-RV zelula guztien artean. F) SFFV-RV 
NSC positiboen portzentajearen kuantifikazioa NSC guztien artean. CA: Cornu ammonis. DG: Hortzdun 
zirkunboluzioa. DMS: Hortzdun migrazio korrontea. fi: fimbria. GCL: Zelula granular geruza. LV: Bentrikulu 
laterala. Eskala barrak 200 µm-koak dira A-Bn eta 10 µm-koak C-Dn. Scale bars are 200 µm in A-B and 
10 µm in C-D. ***p<0.005. Student’s t-test. Barrek batez-bestekoa ± errore estandarra erakusten dute. 
Puntuek datu indibidualak erakusten dituzte. 
Ikusitako eremuaren menpeko diferentziak mantenduak izan ziren P5n. Adin 
honetan sortzaileak DGaren barnealdean infektatuak izan zirenean, SFFV-RV-mCherry 
zelula positiboak GCLaren behealdera mugatuak eta SGZan zehar kokatuak aurkitu 
ziren (R8 A-D Figura). Lehenago bezala, zelula gehienak neurona bezala 
identifikatuak izan ziren. Garrantzia handiz, SFFV-RV-mCherry zelula positiboen %3-
4a NSCak ziren (R8 E Figura; R9 Figura), NSC populazioaren %2a izanik (R8 F 
Figura; R9 Figura). Beste alde batetik, P2an ikusitako patroi berbera erakutsiz, 
aitzindariak P14n DMSan markatuak zirenean GCLean kokaturiko SFFV-RV-mCherry 
zelula positiboen gehiengo handia neuronak ziren, euren dendrita, axoi eta Nestin-GFP 
eta GFAP markatzaileen gabezia kontuan hartuta (R8 C-F Figura). In vivo patuaren 
jarraipen ikerketa hauek NSC populazio heldua jaio ondorengo aro goiztiarrean 
zuzenean sortua izan zela irmo iradoki zuten, esklusiboki DG barruan kokaturiko 
dNSC/sortzaile zelulengandik, nahiz eta DGaren formazio neuronalera ekarpena egiten 
zuten DMStik zetozen sortzaileak bazeuden baita. cD2 datuekin batera postulatu 
genezakeen DGan kokaturiko dNSC/sortzaile zelula populazio batek NSC populazio 
heldua zuzenean DGan bertan cD2-ren menpeko mitosiaren bitartez sortu zuela. Hala, 
gure konklusioa izan zen NSC helduek dNSCengandik desberdintzen den populazioa 
osatzen dutela eta beraz, AHNa ez dela garapenean zehar ematen den 
neurogenesiaren hondakin bat baizik eta fenomeno berri eta ezberdin bat. 
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 Aurreko orrialdean. R8 Figura. Jaio ondorengo lehen astearen amaiera aldera NSC helduen 
aitzindari guztiak DG barruan kokaturik zeuden. A-B) Lamina-eskaner fluoreszente irudiak SFFV-RV 
infekzio espazial desberdinak erakutsiz. Kumeak P5 adinean injektatuak izan ziren bai DG barruan (A) 
zein DMSan (B) eta inkezioaren lekua P14n ebaluatua izan zen. Geziak injekzio bidea adierazten du. C-D) 
Irudi konfokalak GCLean kokaturiko SFFV-RVaz infektaturiko zelulen morfologia eta markatzaile espresioa 
(Nestin-GFP eta GFAP) adieraziz. Geziek SFFV-RVak infektaturiko NSC bat adierazten dute. E) SFFV-RV 
NSC positiboen portzentajearen kuantifikazioa SFFV-RV zelula guztien artean. F) SFFV-RV NSC 
positiboen portzentajearen kuantifikazioa NSC guztien artean. CA: Cornu ammonis. DG: Hortzdun 
zirkunboluzioa. DMS: Hortzdun migrazio korrontea. fi: fimbria. GCL: Zelula granular geruza. LV: Bentrikulu 
laterala. Eskala barrak 200 µm-koak dira A-Bn eta 10 µm-koak C-Dn. Scale bars are 200 µm in A-B and 
10 µm in C-D. Barrek batez bestekoa ± errore estandarra erakusten dute. Puntuek datu indibidualak 
erakusten dituzte. 
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R9 Figura. SFFV-RVak eraginkortasunez markatu zituen NSCak DGaren barnean injektatzerakoan. 
A-B) Irudi konfokalak SFFV-RVarekin markaturiko NSCak erakutsiz GCLan. SFFV-RVa P2 edo P5 
adinetan injektatuz, Nestin-GFP eta GFAP espresioa erakutsi zuten hainbat zelula ikusarazi ziren. SGZan 
kokaturiko soma, MLrenganako prozesu luzatua eta MLean zabaltzen zen brokoli formako koroa 
argitasunez ikusi zitezkeen. GCL: Zelula granular geruza. ML: Geruza molekularra. SGZ: Gune 
azpigranularra. Eskala barrak 10 µm-koak dira. 
6.2.3. DMSko sortzaileek DGrenganako ekarpen espazial dibergentea 
egiten zuten 
 Hala, NSC helduak emango dituzten aitzindariak badaude DG barruan 
kokatuak jaio ondorengo aro goiztiarrean. Nolanahi, DMSa aktibo mantendu zen jaio 
ondorengo etapa honetan zehar. Hargatik DMSko sortzaileek GCLra egiten duten 
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ekarpena ikertzera pasatu ginen. SFFV-RV-mCherrya erabiliz P2 eta P5 adinetan 
DMSan injekzio erretrobiralak gauzatuz, P14n dibisioan sarturiko zelulen patu espazial 
diferentzial preferentzia aztertu genuen. 
 Bi adinetan neurona itxurako zelulak dentsitate handiagoan DGaren beso 
bentralean multzokatuak zeuden, beso dorsalean baino. SFFV-RVarekin infektaturiko 
zelulak gehienbat beso bentraleko bazterrean pilaturik aurkitzen ziren, sakabanatutako 
zelulak gainontzeko GCLean zehar ikusarazi zitezkeen bitartean (R10 A-B Figura). 
Hori gutxi balitz, beso bentraleko eta beso dorsaleko SFFV-RV zelula positiboek euren 
morfologian diferentziak aurkezten zituzten. Beso bentralekoak SGZaren eta MLaren 
artean kokaturik agertzen ziren eta gehiengoak prozesu apikal labur bat zuen, zeinetik 
dendritak berehala MLean zehar hedatzen ziren. Alderantziz, beso dorsalekoak sarri 
GCLaren behealdean kokatuak ageri ziren, prozesu luzeekin, zeinetatik dendritak 
MLean zehar hedatzen ziren (R10 A-B Figura). 
 
R10 Figura. DMSko sortzaileek DGarenganako ekarpen espazial dibergentea egiten zuten. A-B) 
Lamina-eskaner fluoreszente irudiak P2 eta P5 adinetan SFFV-RVarekin infektaturiko DMSko aitzindarien 
leinuak P14n duen distribuzio espaziala erakutsiz. Neuronak ikusarazi zitezkeen GCL guztian zehar. 
Nolanahi ere, beso dorsalean banakako, ongi separaturiko zelulek populatzen zutelarik GCLa (A’, B’), 
beso bentrala zelula multzoz beterik ageri zen (A’’, B’’). CA: Cornu ammonis. DG: Hortzdun zirkunboluzioa. 
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DMS: Hortzdun migrazio korrontea. GCL: Zelula granular geruza. LV: Bentrikulu laterala. SGZ: Gune 
azpigranularra. Eskala barra 10 µm-koa da. 
6.3. LPA1 NSC helduen markatzaile diferentzial bezala 
 Aurretiaz ezarri izan dugu jaio ondorengo aro goiztiarrean zehar dNSCak 
cD2ren menpeko prozesu bat jarraituz DGaren barruan ugaritu egiten direla. Hala, 
teorizatu genuen NSC helduek DGan populazio berri independente bat osatzen zutela. 
Hala ere, NSCen garapen dinamikak ikertzerakoan topatzen den arazo nagusietako 
bat dNSC eta NSC helduen arteko ezberdintzerako markatzaile gabezia da. Berriki, 
LPA1 hipokanpoko NSC helduen markatzaile selektibo bezala aurkeztu izan da (Walker 
et al., 2016). LPA1ek AHN eta garapen kortikalaren modulatzaile bezala jokatzen 
duenetik (Estivill-Torrús et al., 2008; Matas-Rico et al., 2008), bere espresioa LPA1-
EGFP sagu transgenikoa erabiliz jaio ondorengo aroan ikertzea proposatu genuen 
(Gong et al., 2003). 
6.3.1. NSCek jaio ondorengo aroan zehar bereganatu zuten LPA1 
espresioa 
Jaio ondorengo bost adin ezberdinetan (P4, P7, P10, P14 and P21) DGa eta 
gune neurogenikoa aztertu genituen. P4n LPA1-EGFP espresioa hilusean zehar zabal 
hedatua zegoen, GCLean arbuiagarria zen bitartean. Beranduago P7n, LPA1-EGFP 
espresioa hilus eremutik GCLrantza aldatzen hasi zen. P14 aldera, aldaketa guztiz 
nabarmena zen eta LPA1-EGFP espresioa SGZra mugatua ageri zen (R11 A Figura). 
Era interesgarrian, P4n GCLean LPA1-EGFP espresiorik ez zegoenez, Nestin 
espresioa zuten eta era erradialen orientaturiko dNSCtako batek ere ez zuen LPA1-
EGFP espresioa agertzen. Hala ere, P7 geroztik, dNSC batzuk LPA1-EGFP 
bereganatzen hasi ziren. Azpimarragarria da behin NSC populazioa heldu bilakatzen 
denean (Nicola et al., 2015), ia NSC guztiek aurkezten zutela LPA1-EGFP espresioa 
(R11 B Figura). Emaitza hauek LPA1 NSCek garapenetik helduarora egiten duten 
trantsizioa ezberdintzeko markatzaile baliagarria izan litekeela iradoki zuten. 
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R11 Figura. LPA1-EGFP espresioak diferentzialki ezberdintzen ditu dNSCak NSC helduengandik. A-
B) Konfikal irudi errepresentatiboak LPA1-EGFP  espresioa erakutsiz DGan (A) eta GCLean (B) P4n, P7n 
eta P14n. dNSCen gehiengoa LPA1-EGFP negatiboak ziren bitartean, P14n ia NSC helduen populazio 
osoak LPA1-EGFP espresatzen zuen. C) P4, P7 eta P14 adinetan LPA1-EGFP espresioa zuten 
dNSC/NSCen portzentajearen kuantifikazioa (Nestin-positibo, era erradialean bideraturiko zelula bezala 
definiturik). Garapen arotik P14ra bitartean LPA1-EGFP espresioa zuten NSCetan hazkuntza 
esanguratsua ikusarazi zen. GCL: Zelula granular geruza. ML: Geruza molekularra. SGZ: Gune 
azpigranularra. Eskala barrak 10 µm-koak dira. **p<0.005, ***p<0.001. Bide bakarreko ANOVA Holm-
Sidak post-hoc testaren bidezko binakako konparazio anizkoitzez jarraitua. Barrek batez bestekoa ± errore 
estandarra erakusten dute.Puntuek datu indibidualak erakusten dituzte. 
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6.3.2. LPA1 espezifikotasuna jaio ostetik helduarora aldatzen da 
 Ondoren hilusean kokaturiko LPA1-EGFP espresatzen zuten zelulen natura 
ebaluatu genuen, neuronak izan zitezkeelakoan euren morfologiari so eginik . Hain 
zuzen ere, emaitzek LPA1-EGFPren espresioaren zelula espezifikotasunean aldaketa 
bat jasotzen zela erakutsi zuten. P4-P7 bitartean, hiluseko LPA1-EGFP zelulen 
gehiengoa neurona helduen markatzailea den NeuNrentzako positiboak ziren (R12 A-
B Figura). Hortik aurrera aldiz, NSCak LPA1-EGFP espresatzen hasten diren 
aldiarekin bat etorriz, LPA1-EGFP espresatzen zuten zelulen ehuneko txiki bat soilik 
zen NeuN-positiboa (R12 C-D Figura). 
 Guzti hau kontuan izanik, emaitza hauek jaio ondorengo aro goiztiarretik (P4-
P7) gune neurogenikoaren formazio amaiera bitartean LPA1-EGFP espresioan 
jazotzen den aldaera espazial eta zelular baten erakusle dira. Jaio ondorengo garapen 
goiztiarrean espresioa nagusiki neuronala den arren, NSCetara mugatzen da P14tik 
aurrera. Honela, LPA1 dNSC eta NSC helduen artean ezberdintzeko baliabide bezala 
iradokitzen dugu, beharbada bien arteko igarotze honetan rolen bat jokatuz. Era 
berean, emaitza hauek NSC helduek dNSCenganik osoki ezberdina den populazio bat 
osatzen duten ideia babesten dute.  
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 Aurreko orrialdean. R12 Figura. Jaio ondorengo aro goiztiarrean DGan LPA1-EGFPren 
espresioak aldaera bat izan zuen. A-D) Irudi konfokal errepresentatiboak  jaio ondorengo adin 
ezberdinetan hilusean LPA1-EGFP eta NeuN espresatzen zuten zelulak erakutsiz. Jaio ondorengo adin 
goiztiarretan bi markatzaileak espresatzen zituzten zelula handiak ageri ziren arren, apurka LPA1-EGFP 
espresioa galtzen joan ziren. Gida-marrak SGZa zehazten du. Geziek LPA1-EGFP  eta NeuN, biak, ko-
espresatzen zituzten zelula haiek adierazten ditu. Eskala barrak 10 µm-koak dira. 
6.4. Haurdunaldiaren erdirako giza DGaren garapena ia amaiturik 
dago  
 Gure aurreko emaitzek adierazten zutenez, DGan jaio ondorengo aroan zehar 
NSC populazio independente bat sortzen da, zeinak saguaren bizitza osoan zehar 
neuronak emango dituen eta DGko eta HPFko beste eremu batzuen formazioan parte 
hartzen duten dNSCetatik desberdina den. Gure hurrengo pausua, hala, aurkikuntza 
hauek gizakira zelan aplikatu zitezkeen ikertzea izan zen. AHNaren existentziak 
eztabaidagarri darraien testuinguru batean (Moreno-Jiménez et al., 2019; Sorrells et 
al., 2018), AHNak gizakietan duen hedadura esploratzeko DGaren eta honen gune 
neurogenikoaren formazio patroien inguruan argia igortzea aberasgarria izango litzake.  
6.4.1. DMSa presente zegoen giza garapen goiztiarrean (GW14) 
 Mercedes Paredesekin kolaborazioan, UCSFetik, nork adeitasun osoz giza 
ehuna erabiltzea ahalbidetu zigun, giza DGaren garapena eta espezifikoki dNSCen 
populazio ezberdinen potentziala karakterizatzeari ekin genion. Aurretiko lanek 
ugaritze prozesuan zeuden sortzaile eta RGC neurogenikoak GW14an DMSa eratuz 
erakutsi izan dituzte (Cipriani et al., 2017, 2018; Sorrells et al., 2018). Are gehiago, hau 
da neurogenesiak bere goia erdiesten duen enbrioi garapenaren garaia (Yang et al., 
2014). Hemen, HPFa haratago karakterizatu genuen adin honetan, RGC eta sortzaile 
markatzaileak erabiliz. Adin honetan bizkarraldeko hipokanpoko formazioa (ingelesetik 
dorsal hippocampal formation, dHPF) eta sabelaldeko hipokanpoko formazioa 
(ingelesetik ventral hippocampal formazioa, vHPF) behagarriak izanagatik, sabelaldeko 
gunea da HPF helduan eboluzionatzen duena eta beraz, geure analisia oinarritu 
genuen gunea (R13 A Figura). Gainjarri egiten ziren Nestin eta GFAP positiboak ziren 
zuntzak DNetik DGra luzatzen ziren, DMSan zehar RGC aldamio bat sortuz. Nestin 
espresatzen zuten zelulak DG barruan ere bazeuden, nagusiki kanpoko beso inguruan 
eta HFaz gertu zegoen ML populatzen (R13 B Figura). Horrez gain, GFAP 
espresatzen zuten zelulek HOPXen espresioa ere agertzen zuten, zeinen tindaketak 
DGa FDJtik erdiesten zuen, GCLa HOPX barik ageri zen arren (R13 C Figura). 
Saguetan, HOPX haurdunaldi garaitik helduarora GCen aurrekarien markatzaile bezala 
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iradoki izan da (Berg et al., 2019) eta gure emaitzek gizakietan antzeko HOPX 
populazio baten existentzia planteatzeko aukera ireki zuten. 
 Sagu helduetan S100ßk astrozito helduak markatzen ditu, nahiz eta saguaren 
jaio ondorengo DGaren garapenean neurona aurrekarien markatzaile bezala ere izan 
den proposatua (Namba et al., 2005). Hemen, S100ß positiboak ziren zelulak DMS 
osoan zehar ikusi genituen, Tbr2 positiboak ziren sortzaile intermedioetatik hurbil (R13 
D Figura). Ugaritze prozesuan zeuden zelulei erreparatuta, Ki67 markatzaile mitotikoa 
erabiliz, HPF osoan zehar sakabanatuak agertzen ziren, Ki67 positibo zelulen 
presentzia sendo bat FDJ inguruan hilusera bidean ikusi zitekeen arren (R13 E 
Figura). 
 
R13 Figura. RGC eta sortzaileek DMSa eratzen zuten giza HPFaren garapen goiztiarrean. A) Lamina-
eskaner fluoreszente irudiak GW14 adineko garun baten hemisferioa erakutsiz. Gida-karratuak vHPFa 
adierazten du. B) Nestin (berdez) eta GFAP (gorriz) espresatzen zuten zelulak HPFan GW14n. GFAP 
espresatzen zuten zuntzak presente zeuden DMSan zehar, Nestin espresatzen zuten zelulak DGaren 
sortzeke dagoen MLan ere ikusarazi zitezkeen bitartean. C) Era berean, HOPX espresatzen zuten zelulak 
DMSa populatzen ageri ziren baita ere, hein handi batean GFAP positiboak ziren zuntzekin gainjarriz. D) 
S100β eta Tbr2 espresatzen zuten zelulak ere eremu honetan zehar aurki zitezkeen. E) Ki67 zelula 
positiboak DNetik DGra bidean sakabanatuak ageri ziren. CA: Cornu ammonis. Cx: Kortex. D: 
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Bizkarraldea. DG: Horzdun zirkunboluzioa. dHPF: Bizkarraldeko formazio hipokanpala. DMS: Horzdun 
migrazio korrontea. DNe: Horzdun neuroepitelioa. EC: Kortex entorrinala fi: fimbria. GCL: Zelula granular 
geruza. HNe: Hipokanpoko neuroepitelioa. L: Laterala. M: Mediala. SUB: Subiculum. V: Sabelaldea. 
vHPF: Sabelaldeko formazio hipokanpala. Eskala barrak 500 µm-koak An eta 100 µm-koak B-En dira.   
6.4.2. Patroi espazial diferentzialak DGaren garapenean zehar 
 Ondoren, HPFko aurrekoz atzerako ardatzean zehar sortzaile eta ugaritze 
markatzaileen distribuzioa deskribatzeari ekin genion. Era nabarmenean, aurreko 
HPFan Ki67 zelula positiboen gehiengoa DNe-ari eta HNe-ari elkarturik ageri zen, 
DMSa eta DGa nukleo bakar batzuek populatzen zituztelarik (R14 A Figura). Hala ere, 
posizio medialagoetan Ki67 espresatzen zuten nukleoak DMS eta hilus inguruan 
kontzentratuagoak zeuden, nahiz eta batzuk DNe-an aurki zitezkeen (R14 B Figura). 
Tendentzia hau nabariagoa bihurtu zen atzeragoko posizioetan non Ki67 espresatzen 
zuten zelulen gehiengoa DGra mugaturik zegoen, bereziki DMSak DGarekin 
konektatzen duen barruko besoaren muturrean, baina GCLtik sakabanatuak eta 
kanpoko besora iritsiz baita ere (R14 C Figura). HPFaren aurreko eta atzeko eremuen 
arteko espresio zelularraren patroi diferentzialak ez ziren ugaritze prozesuan zeuden 
zeluletara mugatu, HOPX zelula positiboak era berdintsuan sakabanaturik ageri 
zirelarik. Aurreko posizioetan DNe-ra loturik eta euren prozesuak DMSan zehar eta 
fimbriaren gainetik luzatuz ageri ziren (R14 D Figura), atzeko posizioetan DGaren 
barruan hilusera ia guztiz mugaturik ikusarazi zitezkeen bitartean (R14 E Figura). 
Aitzitik, GFAP espresatzen zuten zelulak DMSra mugatuak ageri ziren aurreko eta 
atzeko maila ezberdinetan (R14 D-E Figura). 
 Hau dena kontuan harturik, GW14n ikusiriko zelulen espresio patroiek 
sortzaileen distribuzioa enbrioi garaian eta jaio ondorengo aro goiztiarrean saguetan 
ikusi daitekeenaren antzekoa dela iradoki zuten.  Nolanahi ere, zelula populazio 
heterogeneoak ikusarazi zitezkeen kokapen espazialaren arabera, (DG barruan edo 
kanpoan) eta markatzaile espresioaren arabera. Honen ostean, populazio hauen 
garapena aztertu nahi izan genuen beranduagoko etapetan, haurdunaldi erdia eta 
gero. 
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R14 Figura. Espresio patroi diferentzialak garapen goiztiarrean aurrekoz atzerako ardatzean zehar. 
A-C) Lamina-eskaner fluoreszente irudiak ugaritze prozesuan zeuden zelulak (Ki67) aurrekoz atzerako 
ardatzean zehar maila ezberdinetan erakutsiz (esker eskuin, aurretik atzera). Aurreko partean, Ki67 
espresatzen zuten zelulak gehienbat DNe eta HNe inguruan kokaturik ageri ziren, atzeragoko parteetan 
DMS eta DG ingurura aldatzen zirelarik. D-E) HOPX espresatzen zuten zelulek patroi berbera jarraitu 
zuten. Aurreko parteetan DNe-ra eta DMSra mugatzen ziren baina atzeragoko parteetan DGaren barruan 
agertzen ziren. Aitzitik, GFAP espresioak ardatz osoan zehar patroi berdina mantentzen zuen, DMSra 
mugaturik. CA: Cornu ammonis. D: Dorsal. DG: Dentate gyrus. DMS: Dentate migratory stream. DNe: 
Dentate neuroepithelium. fi: fimbria. GCL: Granule cell layer. HNe: Hippocampal neuroepithelium L: 
Lateral. M: Medial. V: Ventral. Scale bars are 100 µm.CA: Cornu ammonis. D: Bizkarraldea. DG: Horzdun 
zirkunboluzioa. dHPF: Bizkarraldeko formazio hipokanpala. DMS: Horzdun migrazio korrontea. DNe: 
Horzdun neuroepitelioa. EC: Kortex entorrinala fi: fimbria. GCL: Zelula granular geruza. HNe: 
Neuroepitelio hipokanpala. L: Laterala. M: Mediala. SUB: Subiculum. V: Ventral. vHPF: Sabelaldeko 
formazio hipokanpala. Eskala barrak 500 µm-koak A-n eta 100 µm-koak B-E-n dira.   
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6.4.3. GW30rako DGaren formazioa GCLra mugatua dago  
 Haurdunaldi erdi eta berantiarrean zehar DG formazioan  sortzaileek duten 
bilakaera ikertzeko asmoz,  GW30 adineko enbrioiak aztertzera pasa ginen. Adin 
honetan, dHPFa ikusarazi daiteke, nahiz eta vHPFa baino txikiagoa izan. Azken hau 
aurretiaz deskribaturiko patroiak jarraituz tolesturik agertzen da (Humphrey, 1967) 
(R15 A Figura). GW14n eginiko behaketen aurrean, adin honetan Nestin espresatzen 
duten zelulak hilusa populatzen agertzen dira, euren zuntzak GCLra eta MLra luzatuz. 
Era nabarmenean, GW30an oraindik ere zuntzak ikusarazi zitezkeen norabide 
horizontalean DNe-an zehar, fimbriaren gainetik eta DMSa zeharkatuz (R15 B Figura). 
HOPX tindaketa HPF osoan zehar agertzen zen, GW14rekin alderatuz markatzailearen 
espresio zelular zabal eta ez espezifikoa iradokiz. DGan, HOPX espresatzen zuten 
zelulak euren prozesuak ML aldera luzatuz hilusean kokaturik agertzen ziren, Nestin 
espresatzen zuten zelulen antzera. Xelebrea nola DGaren barruko besoak HOPX 
espresatzen zuen zelularik ez zuen agertzen, kanpoko besoa guztiz beterik zegoelarik. 
Bestalde, DMSan zehar GFAP espresio indartsua ikusi zitekeen (R15 C Figura). Hala, 
DMSaren amaierarekin lotzen den DGaren barruko besoan S100ren espresio 
indartsua presente zegoen (R15 D Figura), HOPX espresioak jarraitzen zuen antzeko 
patroia segituz (R15 C Figura). S100ren espresioak GCLean zehar patroi 
diferentziala agertzen zuen, zelulak kanpoko besoan kokaturik ageriz barruko besoan 
baino maizago (R15 D Figura). Tbr2 espresatzen zuten sortzaile eta ugaritze 
prozesuan aurkitzen ziren zelulak hilusera mugaturik zeuden, GCLaren azpian geruza 
bat osatuz (R15 D-E Figura), GW30rako DG formazioa hein handi batean amaiturik 
dagoena adieraziz, saguaren DGaren garapeneko jaio ondorengo aro berantiarraren 
antza handia hartuz. 
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R15 Figura. GW30rako RGC eta sortzaileak hilusera mugatuak daude. A) Lamina-eskaner 
fluoreszente irudiak GW30 adineko garun baten hemisferioa erakutsiz. Gida-karratuak vHPFa adierazten 
du. B) GW30n Nestin espresatzen zuten zelulak DGaren barruan ageri ziren, kanporantz zabalduz. Hilusa 
GCLarenganako bidean gurutzatzen zuen aldamio bat eratzen zuten. C) GFAP espresioa zuten zuntzak 
DMSan zehar ageri ziren, HOPX espresatzen zuten zelulak HPF osoan zehar zeudelarik, DGa barne, non 
Nestin zuntzek sortzen zuten aldamioaren antzekoa osatzen zuten. D) S100 zelula positiboak GCLean 
eta MLean zehar sakabanaturik zeuden, nahiz eta DGaren kanpoko besoan espresioa askoz indartsuagoa 
zen barrukoan baino. Aitzitik, GCL azpialdean Tbr2 bitarteko sortzaileen markatzailearentzako positiboak 
ziren zelulek geruza zabal bat osatzen zuten. E) Era berean, ugaritze prozesuan aurkitzen ziren zelulak 
hilusera mugatuak zeuden orain, GCLaren azpialdean geruza bat osatuz. CA: Cornu ammonis. Cx: 
Kortex. D: Bizkarraldea. DG: Horzdun zirkunboluzioa. dHPF: Bizkarraldeko formazio hipokanpala. DMS: 
Horzdun migrazio korrontea. EC: Kortex entorrinala. fi: fimbria. GCL: Zelula granular geruza. L: Laterala. 
M: Mediala. SUB: Subiculum. V: Sabelaldea. vHPF: Sabelaldeko formazio hipokanpala. Eskala barrak 500 
µm-koak An eta 100 µm-koak B-En dira.    
6.4.4. Jaio ondoren eta gutxira RGC aldamio batek DGan presente zirauen  
 Nahiz eta HPFaren formazioa ia amaiturik dagoen jaio aurretik, helduaroan 
izango duen itxura jada aurkeztuz (R16 A Figura), NBen azken korronte migratzaileak 
jaio ondorengo lehen urteetan iristen dira GCLra, euren sinapsiak ezarriz eta zirkuitu 
hipokanpala osatuz (Cipriani et al., 2018; Seress et al., 2001; Sorrells et al., 2018). 
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Jaiotzetik hilabete batera, RGCek hilusa populatu zuten GCLaren azpialdean, euren 
prozesuek GCLa MLrentza zeharkatzen zutelarik. Interesgarria da Vimentin tindaketa 
GCL osoan zehar banaturik ikusi daitekeen era berean, Nestin espresioa DGaren 
barruko besora mugaturik zegoela, adin honetan geratzen den RGC populazioaren 
heterogeneitatea iradokiz (R16 B-C Figura). Baita ere, ugaritze prozesuan aurkitzen 
ziren zelula apurrak hilusean zehar sakabanaturik agertzen ziren, nahiz eta ez zuten 
SGZ hautemangarririk eratzen saguetan egiten duten antzera (R16 D Figura), 
aurretiaz Arturo Alvarez-Buylla eta bere kideek azaldu izan duten bezala (Sorrells et 
al., 2018). Hau guztia kontuan harturik, emaitzek RGC populazioa heterogeneoa dela 
adierazten dute, jaiotzaren ondoren DGan mantentzen diren azpipopulazioekin, 
ugaritze prozesuan dauden zelulak gehienbat hilusean ageri ziren arren. 
 
R16 Figura. Jaiotzetik gutxira, RGC eta ugaritze prozesuan zeuden zelulak oraindik ere DGan 
presente zeuden. A) Lamina-eskaner fluoreszente irudiak hilabete bateko garun baten HPFa erakutsiz. 
B-C) Vimentin eta Nestin zelula positiboa DGan jaio eta hilabete batera. Bi markatzaileak aurkezten 
zituzten zuntzak ageri ziren GCLa zeharkatuz, hilusetik MLra. D) Ugaritze prozesuari begira, DG barruan 
Ki67 zelula positiboak ikusarazi genituen, nahiz eta gehienbat hilusean ageri ziren, GCLean beharrean. D: 
Bizkarraldea. DG: Horzdun zirkunboluzioa. EC: Kortex entorrinala. GCL: Zelula granular geruza. L: 
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Laterala. M: Mediala. SUB: Subiculum. V: Sabelaldea. vHPF: Sabelaldeko formazio hipokanpala. Eskala 
barrak 500 µm-koak An eta 50 µm-koak B-Dn dira.    
Tesi honen lehenengo atalean lorturiko emaitzek adierazten dutenez, saguetan 
hipokanpoko NSC helduak DGaren formazioan parte hartzen duten dNSCengandik 
desberdintzen den populazio independente bat dira. Halaber, NSC helduen formazioa 
hain zuzen jaio ondoren DG barruan jazotzen da. Bestetik, gizakietan jaio aurretik 
ugaritzea DGra mugatzen da, GCLko gune neurogenikoaren formazioa amaiturik 
legokeela iradokiz. NSC eta neurogenesiaren izatearen inguruan sortu berri den 
eztabaida alde batera utziz (Moreno-Jiménez et al., 2019; Sorrells et al., 2018), NSC 
markatzaileak adierazten dituzten RGCen existentziak ez du zalantza izpirik uzten ( 
Blümcke et al., 2001; Cipriani et al., 2018; Sorrells et al., 2018) (R16 Figura). Izan ere, 
konbultsio infantilen ondoren Nestin zelula positiboak areagotzen direla deskribatu izan 
da, estimulu patologikoetan zelula hauen paper posible bat iradokiz. Saguetan, 
konbultsioen ostean hipokanpoko zelula helduak masiboki aktibatuak izaten dira, 
erreaktibo bihurtuz (Muro-García et al., 2019; Sierra et al., 2015), nahiz eta emaitza 
honetara eramaten duen mekanismoak ezezagun dirauen. Hemen,  MTLE sagu 
modelo bat erabiliz zeinetan konbultsioak KA injekzio intrahipokanpal baten bitartez 
eragiten diren (Bouilleret et al., 1999; Sierra et al., 2015), NSCen erantzun goiztiarrean 
jardun dezaketen bi posible hartzaile ikertu genituen (FGFR eta EGFR). 
6.5. FGFR ibilbideak eta MTLE egoeran HPFak ematen duen 
erantzun goiztiarrak ez dute loturarik 
FGFR seinalizazio ibilbidea, batez ere FGF2ra erantzuten duen FGFR1en 
bitartez, hazitako NSPC eta astrozitoen jarduera mitotikoaren modulatzaile dela 
demostratu izan da (Reynolds and Weiss, 1992; Tropepe et al., 1999). Izan ere, KA 
injekzio intraperitonealaren ostean FGF2ren eta bere hartzaile FGFR1en areagotzea 
ikusi izan da, bereziki zelula glial erreaktiboetan (Van Der Wal et al., 1994; Gómez-
Pinilla et al., 1995). Honela, gure ustez FGFR seinalizazio ibilbideak, eta bereziki 
FGFR1ek, rol garrantzitsu bat joka lezakete MTLE sagu modeloetan erantzun azkar 
bezala NSCek pairatzen duten aktibazio eta React-NSC transformazioan (Muro-García 
et al., 2019; Sierra et al., 2015). 
Hemen, ongi karakterizatua dagoen MTLE sagu modelo batean FGFR1en 
espresioa neurtzea izan dugu helburu (Bouilleret et al., 1999; Sierra et al., 2015). 
Horretarako, bai KA (MTLE group) zein disoluzio isotoniko (kontrol talde bezala) 1 nM 
intrahipokanpalki sagu helduetan administratu ziren eta euren hipokanpoak 
EMAITZAK 




injekzioaren ostean denbora ezberdinetan batuak izan ziren (R17 A Figura). Espero 
genuenaren kontrara, KA injekzioaren osteko lehen 72 h-etan zehar FGFR1k ez zuen 
mRNA edo proteina mailan aldaketarik pairatu, RT-qPCR eta WB bidez neurturik, 
hurrenez hurren (R17 B-C Figura). FGFR1az gain, FGFR2ren mRNA maila ere neurtu 
genuen, FGF2rekiko afinitate handiko beste hartzailea (Dionne et al., 1990; Johnson et 
al., 1990), KA administrazioaren osteko lehen 72 h-etan aldaketarik ikusi barik ezta ere 
(R17 C Figura). HPF osoaren analisiak DGan gertatu litezkeen FGFR1en alterazio 
espezifikoak ezkutatu zitzakeenaren beldurrez, IHC bitartez FGFR1en espresioa 
ehunean neurtzera pasatu ginen, KA injekzioaren ostean 24 h-tara. Gune 
neurogenikoan eman zitezkeen FGFR1en alterazio posibleak ikusarazteko 24 h 
denbora tarterik hoberena izatea kontsideratu genuen, KA administrazioaren osteko 
ugaritzea areagotzen hasten baita 24 h-tara eta 72 h-tan goia jotzen du (Sierra et al., 
2015). Hala, ondorengo erantzun osoa probokatzeko FGFR1ek 24 h-tarako areagotua 
egon behar litzatekeela kontsideratu genuen. Haatik, ez genuen diferentziarik 
antzeman kontrol eta KA animalien artean (R17 D Figura), FGFR seinalizazio 
ibilbideak MTLEren indukzioaren ostean gertatzen den erantzun azkarrarekin 
zerikusirik ez duela adieraziz. 
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R17 Figura. KA administrazioaren ostean FGFR maila ez zen aldatu. A) KA injekzioaren osteko 
hipokanpo bilketarako jarraituriko denbora-eskalaren eskema. B) WBak erakutsi bezala, KA injekzioaren 
osteko lehen 72 h-tan FGFR1 proteina maila ez zen aldatu. C) RT-qPCR analisiak FGFR1 eta FGFR2 
mRNA mailan, KA injekzioaren lehen 72 h-tan, aldaketarik ez zegoela erakutsi zuen. D) Irudi konfokal 
errepresentatiboak KA edo disoluzio isotoniko (kontrol) injekzioaren ostean GCLa eta Nestin-GFP 
espresatzen zuten zelulak erakutsiz. KA injekzioa eta 24 h-ra ez zen FGFR1 espresioaren aldaketarik 
antzeman. CTRL: Kontrol. GCL: Zelula granular geruza. KA: Azido kainikoa. Eskala barrak 20 µm-koak 
dira. Diferentzia estatistikorik ez zegoen (C)n bide bakarreko ANOVAk kontrol taldearen aurkako Holm-
Sidak post-hoc testak jarraiturik adierazi bezala. Barrek batez-bestekoa ± errore estandarra erakusten 
dute. Puntuek datu indibidualak erakusten dituzte. 
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6.6. EGFRek gune neurogenikoak MTLE indukzioaren ostean duen 
hasierako erantzunean parte hartzen du 
Honela, aurreko emaitzek FGFR gune neurogenikoak eta NSCek konbultsioen 
ostean duten erantzunaren erregulatzaile bezala albo batera uzten dute. Hortaz, 
hurrengo hautagaia ikertzera jo genuen, EGFR seinalizazio ibilbidea, NSPCen 
ugaritzean ere parte hartzen duena (Reynolds and Weiss, 1992; Tropepe et al., 1999), 
haren espresio nuklearra ugaritze prozesuan sakon murgilduriko zelulekin zuzenean 
erlazionatuta egonik (Lin et al., 2001). EGFR astrozitoentzako agente mitogeniko 
indartsua dela demostratu izan da (Simpson et al., 1982) eta glioblastomaren 
garapenarekin oso erlazionaturik dago (Lee et al., 2006; Libermann et al., 1985; 
Vivanco et al., 2012). Are gehiago, bai arratoi zein gizakietan EGFR areagotu egiten da 
zauri fokalen modelo ezberdinetan (Ferrer et al., 1996; Nieto-Sampedro et al., 1988; 
Río et al., 1995). Garrantzitsuago, ErbB familiaren espresioak (EGFR parte delarik) 
KAren administrazioaren ostean HPFan gora egiten du (Sierra et al., 2015). Hala ere, 
EGFRren konbultsioen osteko inplikazio espezifikoa ez da oraindik ezagutzen eta 
honela, MTLE sagu modeloan EGFRren alterazio posibleak ebaluatzeari ekin genion.  
6.6.1. MTLEren indukzioaren ostean, EGFR seinalizazio ibilbidearen 
aktibazio eta areagotzea jazoera azkarrak izan ziren 
Aurretik erabilitako paradigma berdina erabiliz EGFRren espresioa ebaluatzeari 
ekin genion; KAa edo disoluzio isotonikoa (kontrol taldea) intrahipokanpalki 
administratu genituen eta ondoren denbora-eskala bat jarraituz hipokanpoak bildu 
genituen (1,5 h, 12 h, 24 h eta 72 h) (R18 A Figura). RT-qPCR analisiaren bitartez 
EGFR mRNA maila neurtu genuen, 1,5 h, 24 h eta 72 h KA administrazioaren ostean 
2-3 aldiko areagotzea ikusaraziz (R18 B Figura). Hurren, KA administrazioaren ostean 
EGFR maila areagotua ageri zenez, WB bidez EGFR seinalizazio bidearen aktibazioa 
neurtzera jo genuen. Y845 EGFR fosforilazio hondakinaren maila neurtu genuen, zeina 
EGFR bitartezko mitogenesiarekin erlazionatua dagoen (Biscardi et al., 1999; Sato et 
al., 1995; Tice et al., 1999). Emaitzek EGFR totalaren artean fosforilatutako Y845 
EGFR proportzioaren areagotzea azaldu zuten, estatistikoki esanguratsua bilakatuz 24 
h-ko denbora puntua eta gero (R18 C-D Figura). 
Y845 EGFRren fosforilazioak hainbat ur beherako seinalizazio ibilbide 
aktibatzen ditu, STAT3, Akt eta ERK1/2 barne, zeinek erreaktibotasun glialean, zelula 
biziraupenean, apoptosian eta ugaritze zelularrean parte hartzen duten (Goffin and 
Zbuk, 2013; Lill and Sever, 2012; Meloche and Pouysségur, 2007; Priego et al., 2018). 
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Geure analisiek KA administratu eta 12 h-ra STAT3ren kopuru totalaren artean maila 
fosforilatuen (aktibatuen) areagotzea demostratu zuten, hortik aurrera murriztu egiten 
delarik (R18 C-E Figura). Akt seinalizazio ibilbideari erreparatuz, Akt totalaren artean 
fosforilaturiko Akt proportzioa era esanguratsuan areagotua zegoen KA administratu 
eta 24 h-tik aurrera (R18 C-F Figura). Era berean, fosforilaturiko ERK1/2a ere 
areagotua ageri zen KA asministratu eta 1,5 h-ra eta areagotze honek goraka jarraitu 
zuen aztertutako azken denbora punturaino (72 h KAren ostean). Garrantzitsua da 
esatea aldaketa hauek proteina kopuru totalaren kontingente direla, zeina era 
ezberdinetan aldatu daitekeen. Izan ere, WBak EGFRk eta STAT3k areagotzeko 
tendentzia zutela erakutsi zuen, Akt-k eta ERK1/2k gutxitzeko tendentzia agertu zuten 
artean (R18 C Figura). Edozein kasutan, MTLE induzitu eta gutxira EGFRren 
espresioa HPFan ez zen bakarrik areagotu, baizik eta gutxienez bere Y845 fosforilazio 
lekuan oso fosforilatua gertatu zen. Are gehiago, KA administratu eta gutxira EGFRren 
hainbat ur beherako seinalizazio ibilbide (STAT3, Akt eta ERK1/2) fosforilatuak izan 
ziren, konbultsio ostean jazotzen den erantzun hipokanpalean seinalizazio ibilbide 
honek rol inportante bat joka lezakeela iradokiz. 
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R18 Figura. EGFR seinalizazio ibilbidearen aktibazioa eta espresio areagotzea MTLE osteko 
gertakizun azkarrak izan ziren. A) KA injekzioaren osteko hipokanpo bilketarako jarraituriko denbora-
eskalaren eskema. B) KA administratu eta denbora-tarte ezberdinetan RT-qPCRak EGFRren mRNA 
mailaren areagotzea erakutsi zuen. C) KA administratu eta denbora-tarte ezberdinetan WBak aldaketak 
erakutsi zituen EGFR, Y845 EGFR, STAT3, Akt eta ERK1/2 proteina kopuruan eta fosforilazio mailan. D-
G) Fosforilaturiko isoformen kuantifikazioa proteina kopuru totalarekin alderatuta EGFRan eta bere ur 
beherako seinalizazio ibilbide diren STAT3an, Aktan eta ERK1/2an. Grafiko bakoitzeko datuak 
normalizatuak izan ziren kontrol taldearen batez bestekoa 1 ± errore estandarra bezala hartuta. *p<0.05, 
**p<0.01 eta ***p<0.001. Bide bakarreko ANOVA Holm-Sidak post hoc testaren bidezko kontrol taldearen 
aurkako konparazio anizkoitzez jarraitua (A)n, (D)n eta (G)n. Kruskal Wallis Dunnet post hoc testaren 
bidezko kontrol taldearen aurkako konparazio anizkoitzez jarraitua (E)n eta (F)n. Barrek batez bestekoa ± 
errore estandarra erakusten dute.Puntuek datu indibidualak erakusten dituzte. 
Behin konfirmaturik KAaren bitartez MTLEa induzitu eta berehala HPFan 
EGFRren espresioa areagoturik ageri zela eta bere hainbat ur beherako seinalizazio 
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ibilbide (STAT3, Akt eta ERK1/2) aktibaturik ageri zirela, gure hurrengo hipotesia 
EGFRa espezifikoki NSCetan areagotua egon beharko lukeela izan zen, euren 
aktibazio masibo eta transformazio erreaktiboan paper bat jokatuz. Hau aztertzeko, 
Nestin-GFP sagu transgenikoetan bai KA edo disoluzio isotoniko (kontrol taldea) 
injekzio intrahipokanpalak gauzatu genituen eta 24 h geroago EGFR espresioa gune 
neurogenikoan neurtu genuen. Horretarako, IHC eta mikroskopia konfokala konbinatu 
genituen, EGFR pixel positiboek Nestin-GFP espresatzen zuten zelulekin zuten 
gainjarpena neurtuz. 
Kontrol egoeretan, EGFR espresioa Nestin-GFP espresatzen zuten zelula 
kopuru murriztu batera estuki mugaturik ageri zen, hain zuzen ere RGC antzerako 
NSC helduak eta ANPak. Kontraste zorrotzean, KA eman eta 24 h-ra gune  
neurogenikoan eta Nestin-GFP espresatzen zuten zeluletan EGFR espresioa era 
esanguratsuan areagotu zen (R19 A Figura). Izan ere, KAren ostean EGFR positiboak 
ziren pixel kopuruaren kuantifikazioak GCLean gora egiteko tendentzia (R19 B Figura) 
eta hilusean areagotze esanguratsua ageri zituen (R19 C Figura). Are garrantzitsuago, 
KAren ostean EGFRren gainjarpena Nestin-GFP espresatzen zuten NSCekin, irizpide 
morfologikoen bitartez identifikatuak (Mignone et al., 2004), %450 batean areagotua 
ageri zen (R19 D Figura), konbultsio osteko erantzunean NSCek ematen duten 
erantzunean hartzaile honek rol bat jokatzen duela biziki iradokiz. 
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R19 Figura. KA administrazioaren ostean gune neurogenikoan eta NSCetan EGFR areagotu egin 
zen. A) Irudi konfokal errepresentatiboak KA edo disoluzio isotoniko (kontrol) injekzioen ondoren. B-D) 
DGko eremu ezberdinetan (GCL eta hilusa) EGFR espresioaren (pixeletan) eta NSCekiko gainjarpenaren 
kuantifikazioak. Grafiko bakoitzeko datuak normalizatuak izan ziren kontrol taldearen batez bestekoa 100 
± errore estandarra bezala hartuta.  GCL: Zelula granular geruza. KA: Azido kainikoa. SAL: Disoluzio 
isotonikoa. Eskala barrak 20 µm-koak dira. *p<0.05 eta ***p<0.001. Mann Whitney testa (B)n eta Student’s 
t testa (C)n eta (D)n. Barrek batez-bestekoa ± errore estandarra erakusten dute.Puntuek datu indibidualak 
erakusten dituzte. 
6.6.2. EGFRk NSPC hipokanpalen ugaritze jardueran parte hartzen zuen 
Lorturiko emaitzek konbultsioen ondoren EGFRak NSCengan izan lezakeen 
akzio potentzial bat erakusten dute, gune neurogenikoan eta NSCetan KA administratu 
ostean ematen den hartzailearen areagotzea kontuan harturik. Honela, hartzailearen 
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rola argitzea bilatuz NSPC hipokanpalak in vitro isolatu eta aberastera pasatu ginen, 
aurretiaz optimizaturiko metodoak moldatuz (Pineda et al., 2013). Planteamendu honek 
EGFRren presentzia egiaztatu eta honen seinalizazioa kanpoko gune seinaleen 
interferentzia barik (ioiak, molekulak edota zirkuituaren jarduera elektrikoa) modulatzea 
ahalbidetu zuen. 
Espero zen bezala, 2 hilabete heldu ziren saguetatik NSPCak isolatu, hazi eta 
astebetera EGFR zelula guztietan presente zegoela egiaztatu genuen (R20 A Figura). 
Hortaz, behin artifizialki ugaritzera bultzatutako NSPCetan EGFRren presentzia 
demostratuta, euren ugaritze ahalmenean EGFRren inhibizioak izan zezakeen efektua 
ebaluatzeari ekin genion. NSPCak ugaritze prozesu jarraituan izanik, EGF 
estimulazioaren bitartez EGFR seinalizazioa aktibaturik zelarik, EGFRren inhibizio 
farmakologikoaren  efektua ebaluatu genuen bere inhibitzaile itzulgarria den Gefitinib 
erabiliz, zeinak EGFRren tirosina leku guztietako fosforilazioa blokeatzen duen 
(Pedersen et al., 2005). Kasu honetan, Gefitinibek EGFRrengan duen efektua zentzu 
global batean ulertzeko helburuarekin, ez genuen soilik Y845 fosforilazio lekua aztertu, 
aurretik egin bezala, baizik eta Y1068 autofosforilazio lekua ere, zeina aski ezaguna 
den EGFRren bitartezko zelula ugaritzea kontrolatzeagatik (Downward et al., 1984). 
Haratago joanik, zelula ugaritzearekin zuzenean loturik dagoen EGFRren ur beherako 
seinalizazio ibilbidea denetik, ERK1/2 fosforilazioa ere aztertu genuen (Meloche and 
Pouysségur, 2007). WB bitartez emaitzek erakutsi zutenez, haziriko NSPCetan 
ordubetez Gefitinib 2 µM gehitzeak EGFRren Y845 eta Y1068 hondakinen fosforilazioa 
era eraginkorrean murrizten du eta baita ERK1/2ren fosforilazioa baita (Figure R20 B-
E). Honela, Gefitinibek NSPCengan duen efektua demostratu zen eta in vivo konbultsio 
ostean gertatzen den NSCen aktibazio masiboa eta React-NSC indukzioa 
alderantzikatzeko alternatiba terapeutiko potentzial bezala aurkeztu zen.  
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R20 Figura. In vitro haziriko DGko NSPCetan Gefitinibek era eraginkorrean itzaltzen du EGFR 
seinalizazioa. A) Irudi konfokal errepresentatiboak Nestin-GFP espresatzen duten haziriko NSPCetan 
EGFR espresioa erakutsiz. B) WB irudi errepresentatiboak EGFR eta ERK1/2 eta hauen aktibazioa 
EGFrekin eta FGFrekin estimulaturiko NSPCetan, baita EGFRren inhibitzaile den Gefitinibekin ere. C-E) 
Fosforilaturiko isoformen kuantifikazioa proteina kopuru totalarekin alderatuta EGFRrentzako (Y845 eta 
Y1068) eta honen ur beherako seinalizazio ibilbidea den ERK1/2rentzako. Grafiko bakoitzeko datuak 
normalizatuak izan ziren kontrol taldearen batez bestekoa 100 ± errore estandarra bezala hartuta. Eskala 
barrak 20 µm-koak dira. *p<0.05. Mann Whitney testa (C)n. Student’s t testa (D)n eta (E)n. Barrek batez 
bestekoa ± errore estandarra erakusten dute.Puntuek datu indibidualak erakusten dituzte. 
Gure emaitzek orain arte adierazi zutenez, in vitro hazitako NSPC 
hipokanpaletan EGFR presente ageri zen eta Gefitinib bere seinalizazio aktibitatea 
eteteko kapaza zen. Ondoren, EGFRek NSPCen ugaritze jardueran izan lezakeen rol 
potentzialaren gainean argia igortzea jarri genuen helburu. EGFR SVZan aktibaturiko 
NSCetan presente ageri dela demostratu egin da (Codega et al., 2014; Pastrana et al., 
2009), baina honek NSC hipokanpaletan duen rolak ezezagun dirau. Honela, gure in 
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vitro paradigma esperimentalarekin segituz, lehenbizi EGFRren espresioa NSPC 
mitotiko eta ez-mitotikoetan neurtu genuen, ondoren BrdU erabiliz ugaritze prozesuan 
zeuden NSPCen proportzioa neurtuz Gefitinibek euren gainean duen efektu funtzionala 
ikertzeko. Emaitzen arabera, mitosian zeuden NSPCetan EGFR espresioa areagotu 
egiten zen ,interfasean zeudenekin alderatuta, azken hauek DAPI tindaketaren 
disposizio kromosomikoaren bidez identifikatu zirelarik (R21 A-C Figura). Are gehiago, 
BrdUa finkatu baino ordubete lehenago bereganatzen zuten zelulak 2 µM Gefitiniben 
presentzian%37 batean gutxitu egiten ziren, ibilgailuaren (DMSO)  presentzian 
zeudenekin alderaturik (R21 D-E Figura), NSPCen ugaritzerako EGFRren garrantzia 
esentziala eta Gefitiniben bitartezko blokeo eraginkorra konfirmatuz. 
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R21 Figura. DGtik eratorritako NSPCen EGFRren bitartezko ugaritze jarduera gutxitu egiten zen 
Gefitiniben presentzian. A) Irudi konfokal errepresentatiboak NSPC mitotiko eta ez-mitotikoak erakutsiz 
(DAPI erabiliz disposizio kromosomikoaren bitartez identifikatuz), NSPC mitotikoetan EGFR intentsitate 
handiagoa dagoelarik. Geziek zelulen kokapena adierazten dute. B-C) Zelulen arean eginiko EGFR 
intentsitate kuantifikazioak (B) eta zelulen area totala NSPC mitotiko eta ez-mitotikoetan (C). D) Irudi 
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konfokal errepresentatiboak Gefitinib bitartez trataturiko zeluletan ugaritze fasean aurkitzen ziren zelulen 
(BrdU bereganatzeak adierazi bezala) murriztea erakutsiz, DMSOrekin trataturiko kontrol NSPCekin 
alderatuz. E) Kontrol taldearekin (DMSOrekin trataturiko NSPCak) alderatuz Gefitiniben presentzian BrdU 
positiboak ziren NSPCetan gertatzen zen gutxitzea erakusten duen kuantifikazioa. Grafiko bakoitzeko 
datuak normalizatuak izan ziren kontrol taldearen batez bestekoa 100 ± errore estandarra bezala hartuta. 
Eskala barra 20 µm-koa da. ***p<0.001. Mann Whitney (B)n eta (E)n. Student’s t testa (C)n. Barrek batez 
bestekoa ± errore estandarra erakusten dute.Puntuek datu indibidualak erakusten dituzte. 
Gefitinib, EGFRren inhibitzaile itzulgarria, NSPCtan ugaritzea eraginkorki 
murrizteko kapaza izanik, Afatinib EGFRren inhibitzaile ez itzulgarriak efektu 
handiagoa izan ote zezakeen probatzea erabaki genuen. Afatinibek EGFRren kinasa 
jarduera eraginkorki erreprimitzen du eta tumore pazienteek inhibitzaile itzulgarriekiko 
kinasa domeinuaren mutazioen ondorioz duten erresistentziari aurre egiteko diseinatua 
izan zen (Li et al., 2008). Gefitinib erabiliz lorturiko emaitzen kontrara, 2µM Afatinib 
inhibitzaileak heriotza zelular masiboa eragin zuen 48 h-tan, NSPC ia guztien galerak, 
geratu zirenen morfologia boroboilduarekin, tamaina txikiarekin eta DNA nuklear 
kondentsatuarekin batera adierazten zuenez (R22 A Figura). Izan ere, kuantifikazioak 
BrdU zelula positiboen murriztea erakutsi zuen Afatiniben presentzian, nahiz eta 
jazoriko heriotza zelular maila altuaren ondorioz Afatinibek mitosiaren gainean duen 
efektuari buruzko konklusio sendorik ezin den irudikatu (R22 B Figura). 
Hala, lorturiko emaitzetan oinarriturik, in vivo MTLE esperimentalean EGFR 
inhibitzeko eta inhibizo honek gune neurogenikoaren gainean duen efektua 
ebaluatzeko Gefitinib hautagai apropos bezala ikusi genuen. Afatinib erabilita in vitro 









 Aurreko orrialdean. R22 Figura. Afatiniben bidezko EGFRren blokeo itzulezinak NSPCen heriotza 
zelularra eragin zuen. A) Konfokal irudi errepresentatiboak Afatinibek NSPCetan duen efektu 
suntsitzailea erakutsiz, zelula galera masiboa ekarriz. B) Afatinibekin tratatutako zeluletan eman zen BrdU 
zelula positiboen galera erakusten duen kuantifikazioa, kontrol kondizioarekin konparatuz. Grafiko 
bakoitzeko datuak normalizatuak izan ziren kontrol taldearen batez bestekoa 100 ± errore estandarra 
bezala hartuta. Eskala barra 20 µm-koa da. ***p<0.001. Mann Whitney. Barrek batez bestekoa ± errore 
estandarra erakusten dute. Puntuek datu indibidualak erakusten dituzte. 
6.6.3. EGFRren blokeo farmakologikoak MTLE osteko NSCen erantzun 
patologikoaren hobetzea ekarri zuen 
KA administrazio hipokanpalaren ostean EGFR inhibitzeak gune neurogenikoan 
eta NSCetan duen efektua ebaluatzeko Gefitinib erabiliz jarraitzea erabaki genuen, 
Afatinibek probokatutako heriotz zelular masiboa kontuan izanik. Injekzio zuzenak sor 
zezakeen lesioa ekiditeko (KA soila injektatzean baino bolumen handiagoa baitzen); 
gizakietan aplikazio potentziala errazteko eta Gefitinibak muga hematoentzefalikoa 
(ingelesetik blood brain barrier, BBB) zeharkatzen ez duelako sudurreko administrazioa 
erabili genuen (Chen, 2013; McKillop et al., 2004). Sudurreko bidea erabilia izan da 
beste droga antiepileptiko batzuen administraziorako, hortaz bere eraginkortasuna 
frogatuz (Barakat et al., 2006). 
Aurretiaz eginiko ikerlanek adierazi dutenez KA injekzio intrahipokanpalaren 
osteko ugaritzea goiz areagotzen da (24 h) eta bere goia jotzen du 72 h-tan (Sierra et 
al., 2015). Nahiz eta Gefitinib dosi bakar batek ugaritzea 72 orduz murriztu dezakeela 
argitaratu izan den (Pedersen et al., 2005), guk 12 orduro administratu genuen MTLE 
eragin eta berehala, ugaritzeak goia jotzen duenean bere efektua maximizatzeko 
asmoz (Sierra et al., 2015) (R23 A Figura). Espero zen bezala, emaitzek KA ostean 72 
ordura Gefitiniba jaso zuten animalietan ugaritzea zeharo murriztua zegoela (hilus eta 
GCL+SGZ) adierazi zuten, kontrol taldearekin alderatuz, zeinak DMSO 
intranasalarekin soilik tratatuak izan ziren (R23 B Figura). Are gehiago, gune 
neurogenikoaren analisi espezifikoak erakutsi bezala KA ostean Gefitiniba jaso zuten 
animalietan SGZan kokaturiko Ki67 zelula positiboen dentsitatea eta Ki67 positiboak 
ziren NSCen portzentaia era esanguratsuan murrizturik zeuden (R23 C and R23 D 
Figura). Emaitza honek EGFRak konbultsio osteko gune neurogenikoan jazotzen den 
NSCen aktibazio masiboan eta ugaritze orokorrean parte hartzen duela eta are 
gehiago, Gefitiniben bidezko bere blokeoa alternatiba bat izan daitekeela NSCn 
populazioa kontserbatu eta neurogenesia epe erdi-luzera mantentzeko adierazten 
zuten. 
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R23 Figura. Gefitiniben administrazioak KA ostean gune neurogenikoan eta NSCetan ematen den 
ugaritzea murrizten du. A) Paradigma esperimentalaren eskema. KA intrahipokanpalaren 
administrazioaren ondoren, Gefitinib edo DMSO (CTRL) administratu ziren 12 orduro KA osteko 72 h-tara 
sakrifizioa egin zen arte. B) Irudi konfokal errepresentatiboak KA administrazioaren ondoren DMSO 
(CTRL) edo Gefitinibarekin trataturiko animalietan DGa erakutsiz. C-D) Kuantifikazioak SGZan Ki67 zelula 
positiboen dentsitatea erakutsiz (C) eta Ki67 positiboak ziren NSCen portzentaia erakutsiz (D) bai 
KA+CTRL zein KA+Gefitinib taldeetan. Grafiko bakoitzeko datuak normalizatuak izan ziren KA+CTRL 
taldearen batez bestekoa 100 ± errore estandarra bezala hartuta. CTRL: Kontrol. GCL: Zelula granular 
geruza. GEFI: Gefitinib. KA: Azido kainikoa. SGZ: Gune azpigranularra. Eskala barra 20 µm-koa da. 
**p>0.01, ***p<0.001. Student’s t testa. Barrek batez bestekoa ± errore estandarra erakusten dute. 
Puntuek datu indibidualak erakusten dituzte. 
SGZan emandako ugaritze orokorra eta NSCen aktibazio goiztiarra MTLEa 
eragin eta berehala Gefitinib emandakoan eragotzita, Gefitinib tratamenduak NSCak 
epe erdira babesteko balioko lukeen galdetu genion geure buruari, gunearen ahalmen 
neurogenikoaren galera dakarren React-NSC indukzioa ekidinez (Muro-García et al., 
2019; Sierra et al., 2015; Valcárcel-Martín et al., 2020). Honela, DMSO edo Gefitinib 
bidezko tratamenduak errepikatu genituen KA edo disoluzio isotoniko (kontrol taldea) 
administrazioaren osteko lehen 72 h-tan zehar, baina oraingoan Nestin-GFP saguak 
KA eman eta 14 egunera izan ziren sakrifikatuak (R24 A Figura). 
MTLE modeloan, bi eragin nagusienetarikoak GCDa eta berriki sorturiko DCX 
positibo zelula heldugabeen produkziorik eza dira (Muro-García et al., 2019; Sierra et 
al., 2015). Hemen, KArekin injektaturiko eta DMSOrekin trataturiko animalietan 
(KA+CTRL) DCX espresatzen zuten zelulen koporu totala 4 aldiz murriztua zegoela 
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aurkitu genuen, DMSOrekin trataturiko kontrol animaliekin alderatuz (CTRL+CTRL). 
Interesgarria da zelan KArekin injektaturiko eta Gefitinibekin trataturiko animalietan 
(KA+GEFI) DCX espresatzen zuten zelulen kopurua kontrol mailara berreskuratu zen, 
gogor iradokiz Gefitiniben bidezko EGFRren inhibizioa konbultsio osteko epe erdira 
gune hipokanpalaren ahalmen neurogenikoa babesteko gai dela. Kontrol kondizioetan 
Gune neurogenikoan zuen efektuaren kontrol neurri modura, Gefitinib animaliak 
disoluzio isotonikoarekin injektatu ostean administratu genuen (CTRL+GEFI). Kasu 
honetan, DCX espresatzen zuten zelulen kopurua ez zen disoluzio isotonikoarekin 
injekataturiko eta DMSOrekin trataturiko animalietan (CTRL+CTRL) zenaren 
ezberdina, Gefitiniben bitartez emandako EGFRren inhibizioak neurogenesian eraginik 
ez duela iradokiz (R24 B-C Figura). GCDa ere ebaluatu genuen (DAPI tindaketaren 
bidez bere lodiera neurtuz, hilusetik MLra) kontrol eta KArekin injektaturiko animalietan 
DMSO edo Gefitinib tratamenduen ondoren. Emaitzek erakutsi zutenez, animaliak 
KArekin injektaturik zeudenean (KA+CTRL) GCDa ageri zen, disoluzio isotonikoarekin 
injektaturiko kontrol animaliekin alderatuz (CTRL+CTRL). Aurretik DCX espresatzen 
zuten zelulekin ikusiriko tendentzia bera jarraituz, KArekin injektaturiko animaliak 
Gefitinibekin tratatuak zirenean (KA+GEFI) GCDa kontrol mailara itzularazten zen (R24 
B-D Figura). Espero bezala, DMSO (CTRL+CTRL) zein Gefitinibekin (CTRL+GEFI) 
tratatuak izan, disoluzio isotonikoarekin injektaturiko animalietan GCDa berdina zen. 
Beraz, KA administrazioaren ostean Gefitinib bitartezko EGFR inhibizioa gune 
neurogenikoa babesteko kapaza zela ondorioztatu genuen, gutxienez DCX espresioa 
zuten zelulen kopuruari eta GCDari dagokionez. Are gehiago, Gefitinib bitartez 
trataturiko KArekin injektaturiko animalietan React-NSCen indukzioak murriztua 
ematen zuen DMSOrekin trataturikoekin alderatuz (R24 B Figura), EGFRak React-
NSC indukzioan parte hartzen ote duen, hala nola bere inhibizioak Gefitinib erabiliz 
epe erdira babestu zituzkeen geure buruari galdetzera eraman gintuena. 
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 Aurreko orrialdean. R24 Figura. Gefitiniben administrazioak gune neurogenikoa babestu zuen 
KA administratu eta 14 egunera. A) Paradigma experimentalaren eskema. Disoluzio isotoniko (kontrol 
taldea) edo KAren administrazio hipokanpalaren ostean, Gefitinib edo bere ibilgailua (DMSO) 12 h-ro 
administratuak izan ziren KA eman eta 14 egunera animaliak sakrifikatuak izan ziren arte. Honela, lau 
talde ezberdin osatu ziren (CTRL+CTRL; CTRL+GEFI; KA+CTRL; KA+GEFI). B) Irudi konfokal 
errepresentatiboak DGa erakutsiz DMSO edo Gefitinib administrazioen ostean disoluzio isotonikoarekin 
edo KArekin injektaturiko animalietan. C-D) Talde bakoitzaren GCLean egindako DCX espresatzen zuten 
zelula kopuruaren kuantifikazioak (C) eta GCDaren (DAPIren bitartez neurtua) kuantifikazioa (D). CTRL: 
Kontrol. GCL: Zelula granular geruza. GEFI: Gefitinib. KA: Azido kainikoa. ML: Geruza molekularra. SGZ: 
Gune azpigranularra. Eskala barra 20 µm-koa da. *p<0.05, ***p<0.001. Bide bakarreko ANOVA Holm-
Sidak post-hoc testaren bidezko binakako konparazio anizkoitzez jarraitua (C)n eta Kruskal-Wallis 
Student-Newman-Keuls post-hoc testaren bidezko binakako konparazio anizkoitzez jarraitua (D)n. Barrek 
batez bestekoa ± errore estandarra erakusten dute. Puntuek datu indibidualak erakusten dituzte. 
Ondoren KA administrazioaren osteko React-NSC indukzioan zentratu ginen, 
hau atzera botatzeko Gefitinibek eduki lezakeen efektua ebaluatuz. Aurretik 
jarraitutako paradigma berdina jarraitu genuen, intrahipokanpalki KA edo disoluzio 
isotonikoa injektatuz eta ondorengo egunetan animaliak DMSO edo Gefitinib bitartez 
sudurretik tratatuz, lau talde ezberdin eratuz (CTRL+CTRL; CTRL+GEFI; KA+CTRL; 
KA+GEFI). NSCak epe erdira ebaluatzeko asmoz, animaliak injekzio intrahipokanpalak 
gauzatu eta 14 egunera sakrifikatu genituen (R25 A Figura). Astrozito erreaktiboen 
ezaugarrietako bat euren morfologia hipertrofiatua da, handituriko soma eta lodituriko 
prozesuekin (Sofroniew, 2009). Konbultsio ostean NSCek antzeko aldaketak pairatzen 
dituztela deskribatua izan da baita ere, React-NSCen ezaugarria izanik (Muro-García 
et al., 2019; Sierra et al., 2015). Hala, aldaketa morfologikoak neurtzeko asmoz 3D 
Sholl analisira jo genuen (Rodriguez et al., 2006), Nestin-GFP saguetan NSCen 
prozesuaren luzeera, gurutzebide puntuak eta bolumena neurtuz.  
KAren administrazio hipokanpalak, Gefitinibaren ibilgailu den DMSOren 
sudurreko administrazioaz jarraitua (KA+CTRL), NSCetan prozesu luzeeraren, 
bolumenaren eta gurutzebide puntuen areagotzea eragin zuen, kontrol taldearekin 
alderatuz (CTRL+CTRL) (R25 B-E Figura). Aurretik gune neurogenikoaren ebaluaketa 
orokorra egiterakoan erakutsi bezala (GCDa eta DCX espresatzen zuten zelulen 
kopurua), Gefitinibaren administrazioarekin KAren administrazioak eragindako Nestin-
GFP espresatzen zuten NSCen morfologia erreaktiboa atzera bota zen (KA+GEFI). 
Aipagarria da nola KA+GEFI taldeak aukeratutako irizpide morfologikoetan 
CTRL+CTRL eta CTRL+GEFI taldeekin diferentziarik erakutsi ez bazuen ere, euren 
brokoli itxurako koroa galdua zutela ikusi zitekeen, React-NSCen beste ezaugarrietako 
bat. Nolanahi ere, EGFRk React-NSCen indukzioan parte hartzen duela ondorioztatu 
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genuen, hala nola bere Gefitiniben bitartezko inhibizioak NSCen morfologia normala 
epe erdira (14 egun) kontserbatu zezakeela (R25 B-E Figura). Bestalde, disoluzio 
isotonikoarekin injektaturiko animalietan Gefitinib administrazioak (CTRL+GEFI) 
NSCetan aldaketak eragin zituen baita ere, kontrol taldearekin alderatuz 
(CTRL+CTRL) euren bolumena eta gurutzebide puntuak murriztuz (R25 D-E Figura). 
 
R25 Figura. Gefitinib administrazioak KA administrazioaren ondorioz eragindako React-NSC 
transformazioa epe erdira murrizten du. A) Paradigma esperimentalaren eskema. Disoluzio isotoniko 
(kontrol taldea) edo KA administrazio hipokanpalaren ostean, animaliak KA eman eta 14 egunera 
sakrifikatuak izan ziren arte Gefitinibarekin edo bere ibilgailuarekin (DMSO) 12 orduro administratuak izan 
ziren. Honela, lau talde ezberdin osatu ziren (CTRL+CTRL; CTRL+GEFI; KA+CTRL; KA+GEFI). B) Irudi 
konfokal errepresentatiboak talde bakoitzeko Nestin-GFP espresioa zuten zelulen morfologia erakutsiz. C-
E) 3D Sholl analisiaren bidez eginiko kuantifikazioak talde bakoitzean Nestin-GFP espresioa zuten NSCen 
prozesu luzeera (C), bolumena (D) eta gurutzebide puntuak (E) erakutsiz. Grafiko bakoitzeko datuak 
normalizatuak izan ziren CTRL+CTRL taldearen batez bestekoa 100 ± errore estandarra bezala hartuta. 
CTRL: kontrol. GCL: Zelula granular geruza. GEFI: Gefitinib. KA: Azido kainikoa. SGZ: Gune 
azpigranularra. Eskala barra 20 µm-koa da. ***p<0.001. Bide bakarreko ANOVA Holm-Sidak post-hoc 
testaren bidezko binakako konparazio anizkoitzez jarraitua. Barrek batez-bestekoa ± errore estandarra 
erakusten dute. Puntuek datu indibidualak erakusten dituzte. 
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6.7. Zn+2aren rola MTLE egoeran NSCen aktibazioan eta React-NSC 
indukzioan 
Behin EGFRren seinalizazio ibilbideak MTLE sagu modeloan gune 
neurogenikoaren eta NSCen erantzun goiztiarrean duen partaidetza demostraturik, 
bere aktibazioa eragin zezaketen mekanismo posibleak aztertzera jo genuen. Hala, 
geure begirada Zn+2aren norabidean zuzendu genuen, zeina EGFR seinalizazioa 
bultzatzen duela deskribatu den, bai era zuzenean eta baita zeharka ere, HB-EGFaren 
askapena eraginez (Samet et al., 2003; Wu et al., 2004). Are gehiago, Zn+2 
neurobabesle bezala deskribatua izan da, neurona zirkuitu orokorraren hiperaktibazioa 
ekidituz (Bancila et al., 2004; Takeda et al., 2003). Izan ere, konbultsio ostean, 
jarduera neuronala larriagotu egiten denean, Zn+2 HPFan areagotu egiten dela erakutsi 
da (Carrasco et al., 2000; Kasarskis et al., 1987; Mody and Miller, 1985). Nolanahi ere, 
zelula glialetan duen efetuak ezezagun dirau. Hala, konbultsio osteko aktibazio 
neuronalaren gainean Zn+2aren rol posible bati buruz galdetu genion geure buruari eta 
neuronengan duen efektuaz aparte EGFRren bidezko aktibazio masiboa eta React-
NSC indukzioa bultzatu zitzakeen mekanismo alternatibo bezala proposatu genuen. 
6.7.1. MTLE egoeran Zn+2 areagotu egin zen gune neurogenikoan  
Lehenik, deskribaturiko HPFan ematen den konbultsio osteko Zn+2 askapenak 
(Carrasco et al., 2000; Kasarskis et al., 1987; Mody and Miller, 1985) espezifikoki gune 
neurogenikoarengan eragiten duen ebaluatzea bilatuz, histokimikoki erreaktiboa 
(askea) zen Zn+2 maila neurtzeko asmotan Danscher tindaketara jo genuen. Danscher 
tindaketak sodio selenito injekzioa oso garai kontrolatuan behar du (sakrifizioa baino 
30 minutu lehenago) granuloen tamaina aldatu barik Zn+2a prezipitatu dadin kondizio 
guztietan (Danscher, 1981). Hala, disoluzio isotoniko edo KA administrazio 
intrahipokanpalaren ostean 72 ordutara, KA administrazioaren osteko ugaritzeak goia 
jotzen duenean (Sierra et al., 2015), GCL+SGZ zonaldean Nestin-GFP espresatzen 
zuten zelulekin gainjartzen zen Zn+2 kopurua neurtu genuen. Emaitzek disoluzio 
isotonikoarekin injektaturiko kontrol animalietan GCL+SGZ zonaldean Zn+2ik ia ez 
zegoela erakutsi zuten, hau hilusera mugaturik aurkitzen zelarik, non MFek Zn+2ez 
beteriko besikula sinaptikoak dituzten (Frederickson et al., 1983; Sindreu et al., 2003), 
eta beraz Nestin-GFP espresatzen zuten zelulekin gainjarpen oso txikia izanik. 
Kontrara, KA administrazioaren ostean Zn+2 granuluak GCL+SGZ zonaldetik 
sakabanaturik ageri ziren, Nestin-GFP espresatzen zuten NSCekin neurri batean 
gainjarriz (R26 A Figura). Izan ere, Zn+2 granuluen kuantifikazioak, pixeletan neurtua, 
behaketa hauek konfirmatu zituen. Lehenbizi Danscher tindaketa teknikaren 
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kalitatearen neurri bezala Zn+2 granuluen tamaina egiaztatu genuen, disoluzio 
isotonikoarekin eta KArekin injektaturiko animalien artean ezberdintasun estatistikorik 
antzeman gabe eta beraz teknikaren aldakortasunak sor zitzakeen desberdintasun 
posibleak baztertuz (R26 B Figura). Bestalde, KA administrazioa jasotako animalietan 
GCLean Nestin-GFP espresatzen zuten zelulekin gainjartzen zen Zn+2 granuluen 
kopuruak ia 2 aldiko areagotzea aurkeztu zuen, kontrol animaliekin alderatuz (R26 C 
Figura). Honela, KAak induzituriko Zn+2 askapena gune neurogenikoan biltzen zela 
ondorioztatu genuen, NSCetatik gertu, bien arteko interakzio posible baten ateak irekiz. 
Are gehiago, KA ostean Zn+2 kopurua HPFean eta espezifikoki gune 
neurogenikoan areagotzen zela izanik, MTen espresioa ere kondizio hauetan areagotu 
egingo zela hipotetizatu genuen. MTak Zn+2 zelulaz barneko maila gutxitzeaz 
arduratzen diren metaloproteinak dira, nerbio-sistema zentraleko (ingelesetik central 
nervous system; CNS) Zn+2 homeostasia kontrolatuz (Kägi and Schäffer, 1988; Vašák 
and Hasler, 2000). Gure hipotesia frogatzeko, aurreko esperimentuetan jarraituriko 
denbora-eskala jarraitu genuen, animaliak KA ostean denbora puntu ezberdinetan 
sakrifikatuz (1,5 h, 12 h, 24 h, 72 h) (R26 D Figura). WB bidez MT1 eta MT2 proteina 
nibelak determinatu genituen eta emaitzek MT1 eta MT2 espresioa KA administratu eta 
12 ordura igotzen hasten zela adierazi zuten, kontrol animaliekin konparatuta (R26 E 
Figura). Era berean, RT-qPCR bitartez MT1, MT2 eta baita MT3 mRNA maila ere 
determinatu genuen. Kasu honetan, KA ostean MT1 mRNA nibelak areagotu egin ziren 
24 ordutik aurrera esanguratsu bihurtuz. Gainera, nahiz eta estatistikoki esanguratsua 
ez izan, MT2rentzako tendentzia berdina ikusi zen. Ordea, MT3 nibelak KA 
administrazioaren osteko denbora-puntu guztietan aldakaitz mantendu ziren (R26 E-F 
Figura). Hau dena kontuan harturik, emaitzek KA ostean HPFan Zn+2 askapen masibo 
bat ematen dela adierazi zuten, sistema eusten saiatzen den MT nibelak areagotu 
egiten direlarik baita ere. Gainera, GCLean gertatzen den akumulazioari so eginez, 
Zn+2a NSCei eragiten egon zitekeen, euren MTLE hasierako erantzun goiztiarra 
bultzatuz. 
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a gune neurogenikoan bildu zen KA administrazioaren ostean. A) Mikroskopio 
fluoreszente irudi errepresentatiboak KA administrazio osteko 72 orduetan gune neurogenikoan gertatzen 
den Zn
+2
 igoera eta bere gainjarpena NSCekin erakutsiz. Irudiak pseudokoloreztatuak (Zn
+2 
gorriz) izan 
ziren irudikapen arrazoiengatik. B) Danscher teknikaren kalitatearen kontrol neurri modura, Zn
+2
 granuluen 
tamainaren kuantifikazioa. KA eta kontrol taldearen arteko diferentzia ezak teknikaren garapen eraginkorra 
adierazi zuen. C) Kuantifikazioa Zn
+2
 granuluek Nestin-GFP espresatzen zuten zelulekin zuten 
gainjarpenean KAren ostean zegoen areagotze esanguratsua erakutsiz. D) Denbora-eskala 
esperimentalaren eskema. Hipokanpoak KA administratu osteko denbora-puntu ezberdinetan bilduak izan 
ziren. E) KA administrazioaren ondoren denbora-puntu ezberdinetan bildutako hipokanpoen WBak KA 
eman eta 12 orduz geroztik MT1 eta MT2 espresioaren igoera erakutsi zuen. F) KA administrazioaren 
ondoren denbora-puntu ezberdinetan bildutako hipokanpoen RT-qPCRak KA administratu eta 12 orduz 
geroztik MT1 eta MT2 nibelen, baina ez MT3renak, areagotzeko tendentzia agertu zuen. Grafiko 
bakoitzeko datuak normalizatuak izan ziren CTRL+CTRL taldearen batez bestekoa 1 ± errore estandarra 
bezala hartuta. SAL: Disoluzio isotonikoa. KA: Azido kainikoa. Eskala barra 20 µm-koa da. *p<0.05, 
***p<0.001. Student’s t testa (B-C)n. Kruskal Wallis Dunnet post hoc testaren bidezko kontrol taldearen 
aurkako konparazio anizkoitzez jarraitua MT1entzako eta MT3rentzako eta bide bakarreko ANOVA 
Dunnet post hoc testaren bidezko kontrol taldearen aurkako konparazio anizkoitzez jarraitua MT2rentzako 
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(F)n. Barrek batez bestekoa ± errore estandarra erakusten dute. Puntuek datu indibidualak erakusten 
dituzte. 
6.7.2. Zn+2ak dosiaren araberako ugaritzea sustatu zuen NSPCetan 
Ondoren, Zn+2ak NSCen gainean izan zezakeen efektu posiblea ikertzeari ekin 
genion. Horretarako, NSPCetara jo genuen, ugaritze kondizioetan hauek 
manipulatzeko eta Zn+2 dosi ezberdinek eragindako efektua ebaluatzeko asmoz (0, 5, 
10 and 400 µM). 25.000 NSPC hazi genituen lamininaz gainjantzitako estalkietan, Zn+2 
dosi ezberdinekin tratatu eta finkatu baino ordubete lehenago BrdU pultsu bat eman 
genien, zelula ugaritzea determinatzeko xedez. Emaitzek erakutsi zutenez, NSPCak 5 
M Zn+2ekin tratatu eta gero BrdUa bereganatu zuten zelulak 3 aldiz areagotu ziren 
(R27 A-B Figura). Hala ere, Zn+2 dosiak igotzerakoan (10 M and 400 M) 
NSPCengan Nestin-GFP zitoplasmatikoaren galera eta heriotza zelularra iradokitzen 
zuten nukleo txiki eta argien presentzia eragin zituen efektu kaltegarri bat sortu zen 
(R27 A-B Figura). Emaitza hauek Zn+2ak dosi baxuetan NSPCen ugaritzea sustatzen 
zuela adierazi zuten, nahiz eta dosiak igotzerakoan heriotza zelularra eragiten zuen. 
Lorturiko emaitzen argitan, in vivo MTLE kondiziotan Zn+2ak NSCengan eduki 
zezakeen rol posiblearen gainean galdetu genion geure buruari. 
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administrazioak dosiaren arabera efektu desberdinak eragin zuen NSPCengan. A) 
Konfokal irudi errepresentatiboak ugaritzen ari ziren NSPCak erakutsiz. Irudiek erakutsi zuten 5 µM of Zn
+2 
eman ondoren BrdUa NSPC kopuru handiagoek bereganatzen zutela, dosi handiagoekin kopuru hau 
gutxitzen zelarik. Era berean, NSPCak 10 µMekin edo 400 µMekin tratatzen zirenean ikusitako nukleo txiki 
eta borobilduek  Zn
+2
 dosi hauek heriotza zelularra sortzen zutela adierazi zuten. B) BrdUa bereganatu 
zuten NSPCen kopuru totala kondizio esperimental bakoitzean erakusten duen kuantifikazioa. Areagotze 
esanguratsua ikusi zen zelulak 5 µM Zn
+2
ekin tratatu zirenean, kopurua murrizten joan zelarik dosia igo 
zen heinean. CTRL: Kontrol. Zn
+2
: Zinc. Eskala barra 20 µm-koa da. *p<0.05. Kruskal Wallis Dunn post 
hoc testaren bidezko kontrol taldearen aurkako konparazio anizkoitzez jarraitua. Barrek batez bestekoa ± 
errore estandarra erakusten dute. Puntuek datu indibidualak erakusten dituzte. 
6.7.3. Zn+2 administrazio intrahipokanpalak MTLEak gune neurogenikoan 
eragiten dituen alterazioen antzekoak sortu zituen 
KA administrazioaren ostean Zn+2a GCLean banatu egiten zela, Nestin-GFP 
espresatzen zuten zelulekin gainjarriz, eta in vitro hazitako NSPCetan ugaritzea 
sustatzen zuela kontuan harturik, in vivo Zn+2 administrazioaren efektua gune 
neurogenikoan ebaluatzeari ekin genion, konbultsio ostean ageri den aktibazio eta 
React-NSC indukzioan paper bat joka zezakeelakoan. Hau aztertzeko, disoluzio 
isotonikoa (kontrol taldea) edo Zn+2 dosi ezberdinak (5, 20 or 30 nM) injektatu genituen 
intrahipokanpalki eta hauen efektua gune neurogenikoaren eta NSCen gainean zazpi 
egun geroago ebaluatu genuen. Animaliak sakrifikatu baino 24 ordu lehenago BrdU 
injektatu genuen intraperitonealki, ugaritzen zeuden zelulak identifikatzeko asmoz (R28 
A Figura). Emaitzek Zn+2 5 nMko dosiarekin diferentzia esanguratsurik ez zegoela 
adierazi zuten (erakutsi gabeko datuak). Aldiz, dosi altuagoek gune neurogenikoan 
dosiaren araberako efektu gogorra eragin zuten. 20 nM eta 30 nM dosiekin GCDa, 
BrdU zelula positiboen areagotzea eta NSCen morfologia erreaktiboa eta 
desplazamendua ikusarazi zitezkeen (R28 B-D Figura), KA injekzioak eragindako 
gune neurogenikoaren erantzuna definitzen duten efektu nagusietako batzuk 
erreplikatuz. 
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 intrahipokanpalak dosiaren araberako disrupzioa sortu zuen gune neurogenikoan. 
A) Denbora-eskala esperimentalaren eskema. Nestin-GFP saguak Zn
+2
 administrazio hipokanpala egin 
eta zazpi egunera sakrifikatuak izan ziren. Sakrifizioa baino egun bat lehenago hiru BrdU injekzio 
intraperitoneal administratu ziren, hiru orduz bananduak, ugaritzen zeuden zelulak markatzeko asmoz. B-
D) Konfokal irudi errepresentatiboak disoluzio isotoniko (CTRL) (B), 20 nM Zn
+2
 (C) edo 30 nM Zn
+2
 (D) 
intrahipokanpal administrazioaren efektua erakutsiz. Zn
+2
 administrazioak gune neurogenikoan eragina 
izan zuela ikusi daiteke GCDa, BrdU zelula positiboen areagotzea eta NSCen alterazio morfologiko eta 
espazialak sortuz, azken hauek erreaktibo bilakatzen zirelarik SGZtik MLerantza alde egiten zutelarik. 
GCL: Zelula granular geruza. ML: Geruza molekularra. Zn
+2
: Zinc. Eskala barra 20 µm-koa da. 
Gure ikerketa aurrera eramateko eta Zn+2aren efektua hobeto karakterizatzeko 
gune neurogenikoan alterazioak sortu zituen Zn+2 kopururik baxuena erabiltzea erabaki 
genuen. Aurretik erabilitako denbora-eskala berdina jarraitu genuen, saguak Zn+2 
injekzio intrahipokanpala administratu eta zazpi egunera sakrifikatuz eta BrdU 
sakrifikazioa baino egun bat lehenago injektatuz (R29 A-B Figura). Hala, konbultsio 
ostean gune neurogenikoaren etetea definitzen duten karakteristika nagusietako 
batzuen errepikapena ebaluatu genuen. Lehenik DAPI tindaketan oinarrituz eta 
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GCLaren lodiera neurtuz GCDa ebaluatu genuen (Houser, 1990) eta ondoren gune 
neurogenikoan BrdUa bereganatu zuten zelula kopurua ebaluatu genuen. Emaitzek 
Zn+2 injekzioa jaso zuten animalien GCLean nukleoen dispertsio esanguratsua erakutsi 
zuten, disoluzio isotonikoa jaso zutenekin alderatuta (R29 D Figura). Are gehiago, Zn+2 
administrazioaren ostean gune neurogenikoan BrdU bereganatu zuten zelulen 
dentsitatea lau aldiz areagotu zen (R29 E Figura). Emaitza hauek Zn+2 administrazioak 
KA administrazioak gune neurogenikoan eragiten dituen efektu antzekoak sorrarazten 
dituela are gehago egiaztatu zuten. 
Ondoren Zn+2 efektua zehazki NSCen gainean ebaluatzeari ekin genion. 
GCLean zegoen NSC dentsitatea eta BrdU bereganatu zuten NSCen proportzioa bi 
talde esperimentaletan kuantifikatu genituen. Era interesgarrian, Zn+2 eman eta zazpi 
egunera NSCen dentsitateak murrizteko tendentzia aurkeztu zuen (R29 F Figura), 
nahiz eta NSC guztien artean BrdU positiboak ziren NSCen proportzioa aldaezin 
mantendu zen (R29 G Figura). Honek gune neurogenikoaren gaineko Zn+2aren 
efektua iradoki zuen, nahiz eta NSCen aktibazioan eraginik ez izan, zeina era 
diferentizialen erregulatuak egongo litekeen. Haatik, ezin genezake Zn+2 
administraziotik gutxira NSCen aktibazio iragankor bat baztertu, zeina zazpi egunera 
jada itzalia egongo litzakeen, NSCak erregulatu eta bere kontrol aktibazio mailetara 
bueltatuz. 
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 administrazio intrahipokanpalak KA administrazioaren osteko alterazio antzekoak 
sortu zituen gune neurogenikoan. A) Denbora-eskala esperimentalaren eskema. Nestin-GFP saguak 
Zn
+2
a administratu eta zazpi egunera sakrifikatuak izan ziren. Sakrifizioa baino egun bat lehenago hiru 
BrdU injekzio intraperitoneal administratu ziren, 3 orduz bananduak, ugaritzen zeuden zelulak markatzeko 
asmoz. B-C) Konfokal irudi errepresentatiboak gune neurogenikoa disoluzio isotoniko (CTRL) (B)  edo 20 
nM Zn
+2
 (C) injekzio intrahipokanpalen ostean erakutsiz. D) DAPI tindaketan oinarrituriko GCD 
kuantifikazioa. Emaitzek Zn
+2
 administrazioaren ostean GCLaren lodieran areagotze esanguratsua 
erakutsi zuten. E) Kuantifikazioa BrdU zelula positiboen areagotzea erakutsiz Zn
+2
 administrazioaren 
ostean. F) NSC dentsitatearen kuantifikazioa. Emaitzek Zn
+2
 administratu ondoren NSC dentsitatearen 
gutxitzeko tendentzia erakutsi zuten, nahiz eta ez zen esanguratsua. G) Kuantifikazioa aktibaturiko NSCen 
proportzioan aldaketarik ez zegoela erakutsiz. GCL: Zelula granular geruza. ML: Geruza molekularra. 
Zn
+2
: Zinc. Eskala barra 20 µm-koa da. ***p<0.001. Student’s t testa. Barrek batez bestekoa ± errore 
estandarra erakusten dute. Puntuek datu indibidualak erakusten dituzte. 
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6.7.4. Zn+2ak NSCengan duen efektuan EGFR bitartekari izan zitekeen 
Gure aurreko emaitzek Zn+2a KA administrazioaren ostean era masiboan 
askatzen dela aurkeztu zuten, gune neurogenikoan bilduz eta honen etetea 
sorrarazteko kapaz izanik, MTLE modelo esperimentalean gertatzen den antzera. Are 
gehiago, beste ikerlan batzuek Zn+2a EGFR seinalizazio ibilbidea estimulatzeko gai 
dela argitaratu izan dute (Samet et al., 2003; Wu et al., 2004), haien arteko 
elkarrekintzak konbultsio ostean gune neurogenikoan eta NSCetan ikusi daitekeen 
erantzunean parte har lezakeela adieraziz. Zn+2aren presentziak NSCak EGFRren 
bitartez modulatu ahal litzakeen ikusteko, NSPCetara jo genuen berriz ere. Zn+2ak 
EGFRren gainean izan zezakeen efektu potentziala ikusteko asmoz, lehenik hazkuntza 
faktoreen seinalizazioa itzali behar genuen, zeina normalean hazitako NSPCetan 
aktibo dagoen hazkuntza medioan EGFren eta FGFren erabilpenaren ondorioz. 
Helburu honetarako, hazkuntza faktoreak erantsi genituen NSPCak hazkuntza 
faktorerik gabeko medio batean haziz. Gure datu preliminarrek adierazi zutenez, 
fosforilaturiko ERK1/2ren galera esanguratsua gertatu zen hazkuntza faktoreak kendu 
eta bi ordura (erakutsi gabeko datuak). Honela, hazkuntza faktoreek eragindako EGFR 
seinalizazioaren aktibazioa itzaltzeko eta Zn+2aren bitartezko hartzailearen aktibazio 
potentziala ganoraz neurtzeko esperimentua hasi baino lehen zelulei hazkuntza 
faktoreak bi orduz erantsi zitzaizkien. 
EGFR aktibatzeko Zn+2aren ahalmena aurretiaz deskribaturiko protokolo baten 
adaptazioa erabiliz ebaluatu genuen (Wu et al., 2004). Hazkuntza faktorerik gabeko 
taldeaz gain (Stvd), 100 ng/ml EGF, EGFRren aktibazioaren kontrol neurri bezala 
(EGF), edo 200 M Zn+2 (Stvd+ Zn+2) administratu genituen. Are gehiago, NSPCak 200 
M Zn+2 administratu baino lehen 60 minutuz 2 M Gefitinibekin tratatuak izan ziren 
beste talde bat gehitu genuen (Stvd+ Zn+2+Gef). Y845 eta Y1068 EGFRan, hala nola 
EGFR totalean ere, proteina estraktuen WBa gauzatu zen, hartzailearen 
fosforilazioaren ratioa burutzeko asmoz (R30 A Figura). Interesgarria izan zen nola 
Zn+2 administrazioa  NSPCetan Y845 hondakinaren fosforilazio leuna eragiteko kapaza 
izan zen, hazkuntza faktorerik gabeko taldearekin alderatuta (Stvd), eta nola 
Gefitiniben aurretiazko tratamenduarekin fosforilazio hau guztiz blokeatua izan zen 
(R30 C Figura). Nolanahi ere, EGFren presentzian, baina ez Zn+2en presentzian, 
Y1068 hondakinaren fosforilazioa eragin zen (R30 D Figura). Hori gutxi balitz, 
EGFRren ERK1/2 ur beherako seinalizazio ibilbidea aztertu genuen, zelula 
ugaritzearekin nagusiki erlazionatua dagoena (Downward et al., 1984). Emaitzek 
erakutsi zuten Zn+2aren presentzia hazkuntza faktorerik gabe fosforilaturiko ERK1/2 
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seinalizazioa areagotzeko kapaza zela eta garrantzitsuago dena, EGFRren inhibizioak 
fosforilazio maila jaitsi zuela (R30 B; E Figura). Beraz, emaitzek adierazi zutenez Zn+2 
EGFR zuzenean aktibatzeko kapaza izan zen bere Y845 fosforilazio hondakinean eta 
honen ERK1/2 ur beherako seinalizazio ibilbidea aktibatu zezakeen baita ere, EGFR-




 NSPCetan EGFR seinalizazio ibilbidearen aktibazioa sustatzeko kapaza zen. A) 
WBak Y845 EGFR, 1068 EGFR eta EGFR totalarentzako EGFrekin estimulaturiko taldean, hazkuntza 
faktorerik gabeko taldean, Zn
+2
arekin estimulaturiko taldean eta Gefitinibarekin tratatu ondoren Zn
+2
arekin 
estimulaturiko taldean. B) WB P-ERK1/2entzako, ERK1/2 totalarentzako eta kontrol bezala ß-
Actinarentzako hazkuntza faktorerik gabeko taldean, Zn
+2
arekin estimulaturiko taldean eta Gefitinibarekin 
tratatu ondoren Zn
+2
arekin estimulaturiko taldean. C) WBaren kuantifikazioa Y845 EGFRa EGFrekin 
trataturiko NSPCtan 10 aldiz areagotua zegoela erakutsiz, hazkuntza faktorerik gabeko zelulekin 
alderatuta. Era berean, Zn
+2
a Y845 fosforilazioa era esanguratsuan areagotzeko kapaza zen eta aktibazio 
hau Gefitinib erabiliz blokeatzen zen. D) WBaren kuantifikazioa EGFrekin trataturiko NSPCetan EGFR 
totalaren arteko Y1068 EGFRa sei aldiz areagotua zegoela erakutsiz, hazkuntza faktorerik gabeko 
taldearekin alderatuta. Kasu honetan, Zn
+2
 ez zen Y1068 EGFRren aktibazioa sustatzeko gai izan, eta 
Gefitinibekin eginiko aurretiazko tratamenduak ez zuen alteraziorik eragin ezta. E) WBaren kuantifikazioa 
Zn
+2
aren presentzian ERK1/2 totalaren arteko P-ERK1/2 fosforilazioa ratioa erakutsiz, hala nola bere 
inhibizioa Gefitinibekin egindako aurretiazko tratamenduaren ondorioz.*p<0.05 eta***p<0.001. Kruskal 
Wallis Student-Newman-Keuls post hoc testaren bidezko kontrol taldearen aurkako konparazio anizkoitzez 
jarraitua (C-D)n eta bide bakarreko ANOVA Holm-Sidak post hoc testaren bidezko binakako konparazio 
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anizkoitzez jarraitua (E)n. Barrek batez bestekoa ± errore estandarra erakusten dute. Puntuek datu 
indibidualak erakusten dituzte. 
Zn+2 NSPCtan EGFR estimulatzeko gai zela ikusiz, gutxienez Y845 fosforilazio 
lekuan, ondoren in vivo Zn+2 administrazioaren ostean ikusi genuen gune 
neurogenikoaren etetea Zn+2 bidezko EGFR aktibazioaren bitartez modulatua izan 
zitekeen ebaluatzera mugitu ginen. Helburu hau betetzeko, 20 nM Zn+2 dosi bakarra 
intrahipokanpalki jaso zuten Nestin-GFP saguetan EGFR inhibizioaren efektua aztertu 
genuen. KA administratu genuen esperimentuetan jarraituriko paradigma berdinarekin, 
lehen 72 orduetan zehar Gefitinib eman genuen sudurretik (R23-R25 Figura) eta 
ugaritzen zeuden zelulak jarraitzeko sakrifikatu baino egun bat lehenago animaliek hiru 
BrdU dosi intraperitoneal jaso zituzten (R31 A Figura). Espero bezala, emaitzek Zn+2 
administrazio intrahipokanpalak gune neurogenikoan BrdUa bereganatu zuten zelulen 
dentsitatea areagotzen zuela erakutsi zuten. Gainera, Gefitiniben bidezko EGFR 
inhibizioak Zn+2ak gune neurogenikoan eragindako BrdU zelula positiboen areagotzea 
murrizten zuen, disoluzio isotonikoarekin injektaturiko animalietan aldaketarik eragiten 
ez zuen bitartean (R31 B-C Figura). Emaitza hauen bitartez EGFRk Zn+2aren eraginez 
gune neurogenikoan jazotzen den BrdU zelula positiboen areagotzean parte hartzen 
duela azaleratu zen, MTLE egoeran faktore bien arteko elkarreragitea iradokiz. 
EMAITZAK 







ek DGko gune neurogenikoan ugaritzea sustatu zuen EGFRren bitartez. A) 
Denbora-eskala esperimentalaren eskema. Nestin-GFP saguak disoluzio isotoniko (CTRL) edo Zn
+2
 
administrazioa egin eta 72 ordura sakrifikatuak izan ziren, 12 orduko tarteak utziz DMSOrekin (CTRL) edo 
Gefitinibekin sei sudurreko tratamendu jaso ostean. Sakrifizioa baino egun bat lehenago hiru BrdU injekzio 
intraperitoneal administratu ziren, 3 orduz bananduak, ugaritzen zeuden zelulak markatzeko asmoz. B) 
Konfokal irudi errepresentatiboak disoluzio isotoniko edo Zn
+2
 injekzio intrahipokanpalak eta sudurretik 
DMSO edo Gefitinib tratamendua jasotako saguen DGa erakutsiz. C) GCLean zegoen BrdU zelula 
positiboen dentsitatearen kuantifikazioa, Zn
+2
 administrazio intrahipokanpalaren ostean dentsitatearen 
areagotzea erakutsiz, disoluzio isotonikoarekin injektaturiko animaliekin konparatuz. Zn
+2 
administrazioaren ostean Gefitinib administratu zenean BrdU zelula positiboen areagotzea murriztu egin 
zen. CTRL: Kontrol. SAL: Disoluzio isotonikoa. Zn
+2
: Zinc. Eskala barra 20 µm-koa da. **p<0.01. 
***p<0.001. bide bakarreko ANOVA Holm-Sidak post hoc testaren bidezko binakako konparazio 
anizkoitzez jarraitua. Barrek batez bestekoa ± errore estandarra erakusten dute. Puntuek datu indibidualak 
erakusten dituzte. 
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6.7.5. Zn+2 kelazioak MTLE egoeran heriotza zelularra areagotu zuen 
GCLean 
KA administrazioaren ostean 72 ordura GCLeanzegoen Zn+2 presentzia 
areagotua kontuan harturik, hala nola gune neurogenikoaren gainean honek duen 
EGFRren bitartezko efektua, gune neurogenikoan KA administrazioaren ostean 
ematen diren alterazioak murrizteko  Zn+2 kelazioa estrategia baliagarria litzakeela 
espekulatu genuen. Hipotesi hau aztertzeko, disoluzio isotoniko (CTRL) edo KA 
injekzio intrahipokanpalak gauzatu genituen eta ondoren egunean birritan, zazpi 
egunez, azal azpitik 5 mg/Kg TPEN, Zn+2 kelazio agentea, edo bere ibilgailu den 
disoluzio isotonikoa (CTRL) administratu genituen aurretiaz deskribaturiko protokoloa 
jarraituz (Kim et al., 2012). TPENaren eraginkortasunaren neurri bezala GCLean 
zeuden zelula piknotikoen dentsitatea ebaluatu genuen. Emaitzek adierazi zutenez 
hiltzen zeuden zelulen kopuruak, DAPI tindaketa kondentsaketaren bitartez 
identifikatuak,  gora egiteko tendentzia zuen KA administrazioaren ostean (KA+CTRL) 
disoluzio isotonikoarekin injektaturiko animaliekin alderatuz (CTRL+CTRL). Bestalde, 
disoluzio isotoniko injekzio intrahipokanpalaren osteko TPEN administrazioak 
(CTRL+TPEN) ez zuen eraginik izan GCLean. Ustekabean, KArekin injektaturiko 
animalietan TPEN administrazioaren ostean (KA+TPEN) hildako zelulek gora egin 
zuten kontrol taldeekin alderaturik (CTRL+CTRL; CTRL+TPEN) eta gora egiteko 
tendentzia agertu zuten KArekin injektaturiko eta ibilgailuarekin trataturiko animaliekin 
alderatuz (KA+CTRL) (R32 A-B Figura). Hala, emaitza hauek argitu egin zuten Zn+2 
kelazioak heriotza zelularra areagotu egiten zuela, estrategia hau MTLEn erabiltzeko 
ikuspegi terapeutiko bezala baztertuz. 
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 kelazioak MTLEn jazotzen den heriotza zelularra areagotu egin zuen GCLean. A) 
Konfokal irudi errepresentatiboak disoluzio isotoniko edo KA injekzioen (CTRL edo KA) eta ibilgailu edo 
TPEN azal azpiko tratamenduen ostean (CTRL edo TPEN) GCLa erakutsiz. B) GCLean zeuden zelula 
apoptotikoen dentsitatearen kuantifikazioa. KA injekzioaren ostean zelula piknotikoen igoera jazo zen, 
TPEN tratamenduak areagotu zuena. CTRL: Kontrol. KA: Azido kainikoa. SAL: Disoluzio isotonikoa. 
Eskala barra 20 µm-koa da. *p<0.05. Kruskal Wallis Dunn post hoc testaren bidezko binakako konparazio 
anizkoitzez jarraitua. Barrek bateznbestekoa ± errore estandarra erakusten dute. Puntuek datu 
indibidualak erakusten dituzte. 
Lortutako emaitzek EGFRk eta Zn+2ek konbultsio ostean gune neurogenikoak 
ematen duen erantzunean parte hartzen dutela iradoki zuten. Izan ere, Zn+2 EGFRren 
fosforilazioa estimulatzeko gai zen bere Y845 tirosina lekuan, konbultsio ostean 
EGFRren aktibazioan lagunduko duen mekanismo bezala iradokiz. Era interesgarrian, 
Zn+2aren barneratze zelularrak HB-EGFa mintz zelularretik askatzea sustatzen duela 
deskribatu da, azken hau EGFRren estekatzaile potente bat izanik (Samet et al., 2003; 
Wu et al., 2004). Hala, KA administrazioaren ostean HB-EGFk EGFR aktibazioan parte 
hartu zezakeen ikertzera jo genuen. 
6.8. KA administrazioaren ostean HB-EGF DGan masiboki askatua 
izan zen  
Aurreko emaitzek KA administrazioaren ostean jazotzen den erantzunean 
EGFR eta Zn+2, bien, rol integratu bat iradokitzen zuten. Kontuan izanik Zn+2aren 
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berreskuratze zelularrak mintz zelularretik HB-EGF askatzea susta dezakeela (Samet 
et al., 2003; Wu et al., 2004), eta konbultsio ostean Zn+2 GCLean masiboki askatua 
zela, HB-EGFk MTLEn ematen zen EGFRren bitartezko efektua sustatu zezakeen 
ikertzeari ekin genion. HB-EGFk hazitako astrogliaren ugaritzearengan, 
diferentziazioarengan eta morfologiarengan eragina izan dezakela (Jia et al., 2018; 
Kornblum et al., 1999; Puschmann et al., 2014) eta KA administrazio 
intraperitonealaren ostean areagotua izaten dela deskribatu da (Opanashuk et al., 
1999). Are gehiago, HB-EGFk biziki estimulatzen du astrogliaren migrazioa (Faber-
Elman et al., 1996). Honela, NSCek EGFR espresatzen zutela aurretiaz deskribatu 
genuelarik eta KA administratu ostean 14 egunera gaizki kokaturik eta nahasirik ageri 
zirela kontuan izanik, gure KA intrahipokanpal modeloan HB-EGF aldaketak 
karakterizatzera jo genuen.  
Aurretiaz jarraituriko paradigma esperimental berdinarekin, KA administratu 
genuen intrahipokanpalki bi hilabeteko Nestin-GFP saguetan eta injektaturiko 
hipokanpoa denbora-puntu ezberdinetan bildu genuen (1.5 h, 12 h, 24 h, 72 h) (R33 A 
Figura). HPFean askaturiko HB-EGF kopurua aztertzeko HB-EGFa ehunean KA 
osteko denbora ezberdinetan ELISA teknikaren bitartez neurtu genuen eta emaitzak 
disoluzio isotonikoarekin injektatuak izan ziren (Ctrl) animaliekin konparatu genituen. 
Emaitzek KA ostean 12 ordura %25 inguruko areagotze esanguratsua erakutsi zuten 
saguak disoluzio isotonikoarekin injektatuak izan ziren kontrol egoerarekin alderatuta. 
Nolanahi ere, areagotze honek goia jo zuen 24 ordura eta azkar egin zuen behera 
hortik aurrera (R33 B Figura). ELISA teknikak gune neurogenikoan baino gehiago HPF 
guztian zegoen HB-EGF kopuruari buruzko informazioa eman zigunez gero, IHCra jo 
genuen estekatzailearen presentzia KA edo disoluzio isotonikoa administratu eta 72 
ordura DGan neurtzeko. Emaitzek erakutsi zuten HB-EGF tindaketa aberasturik ageri 
zela goialdeko ML hurbilean eta hilusean, nahiz eta GCLak ez zuen aldaketa 
esanguratsurik aurkeztu kontrol taldearekin alderatuta (R33 C Figura). Hala ere, ezin 
genezake KA administratu eta 72 ordu baino lehenago GCLean HB-EGFaren 
areagotze iragankor baten gertaera baztertu. Beraz, HB-EGFek rol bat joka lezake 
espezifikoki DGan. MLan ageri zen espresio altua eta bere deskribaturiko 
kimioerakartzaile rola kontuan izanik (Faber-Elman et al., 1996), konbultsio ostean 
NSCek MLrantz egiten duten migrazio prozesuan HB-EGFek rol bat izatea espekulatu 
genuen. 
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R33 Figura. HB-EGF azkar areagotu egin zen DGan KA administrazioaren ostean. A) Denbora-eskala 
esperimentalaren eskema. Hipokanpoak denbora-puntu ezberdinetan bilduak izan ziren KA 
administrazioaren ostean. B) ELISAren bidezko HB-EGF kopuruaren neurketa ehunean KA administratu 
eta denbora-puntu ezberdinetan. HB-EGFen pg/µg-en areagotze bat zegoen KA administratu eta 12-24 
ordura, hortik aurrera murriztu egiten zena. C) Konfokal irudi errepresentatiboak DGan HB-EGF espresioa 
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erakutsiz. Tindaketak erakutsi zuenez, HB-EGFa MLan eta hilusean areagotu egiten zen bitartean, GCLak 
alteraziorik gabe zirauen disoluzio isotonikoarekin injektaturiko animaliekin alderatuz. GCL: Zelula granular 
geruza. KA: Azido kainikoa. ML: Geruza molekularra. SAL: Disoluzio isotonikoa. Eskala barra 20 µm-koa 
da. ***p<0.001. Bide bakarreko ANOVA Holm-Sidak post hoc testaren bidezko kontrol taldearen aurkako 
konparazio anizkoitzez jarraitua. Barrek batez bestekoa ± errore estandarra erakusten dute. Puntuek datu 
indibidualak erakusten dituzte. 
KA administrazioaren ostean HB-EGF DGan askatua izaten zela kontuan 
harturik, HB-EGF askapen honetan NSCen kontribuzio potentziala ikertzeari ekin 
genion, hala nola hazitako NSPCtan EGFR eta bere ur beherako seinalizazio ibilbidean 
dagoen ERK1/2 HB-EGFren aktibatzeko ahalmena ikertzeari. 
In vitro hazitako Nestin-GFP zelulak ugaritze egoeran mantendu genituen eta 
IHC bitartez NSPCetan zegoen HB-EGF presentzia ebaluatu genuen. Emaitzek 
adierazi zutenez, nahiz eta NSPC batzuetan HB-EGF espresioa zegoen HB-EGF 
antigorputz primariorik gabeko kontrolekin konparatuta, NSPCen gehiengoak ez zuen 
HB-EGF espresiorik agertzen (R34 A Figura). Hala ere, NSPCak ugaritze egoera 
konstantean mantentzen zirela izanik, HB-EGF mintz zelularretik era konstantean 
askatua izatearen eta EGFRren estekatzaile bezala jardutearen aukera planteatu 
genuen. Hala, ELISAren bitartez HB-EGF kopurua neurtu genuen era bereizian 
NSPCetan (Pellet), euren hazkuntza medioan (Supernatant) eta emaitzak kontrol talde 
bezala NSPCrik ez zuen hazkuntza medio batekin (Media) konparatu genituen. 
Emaitzek HB-EGF kopuruaren %200 inguruko areagotze esanguratsua erakutsi zuten 
NSPCak zituen hazkuntza medioan (Supernatant) kontrol medio (Media)  eta zelula 
alearekin (Pellet) alderaturik, NSPCak ugaritze egoeran HB-EGFa zelulaz kanpoko 
ingurura askatzeko kapazak zirela demostratuz (R34 B Figura).  
Ondoren, HB-EGF EGFR seinalizazio ibilbidearen aktibazioa probokatzeko gai 
bazen ikusteko, lehenik EGFR seinalizazio ibilbidea itzaltzeko NSPCak EGF eta FGF 
barik hazi genituen. Gero, hazkuntza faktorerik gabeko NSPCak HB-EGF eta baita 
HB.EGF gehi Zn+2 erabilita estimulatu genituen, ahalik eta in vivo egoeraren antzeko 
kondiziotan EGFR NSPCetan aktibatzeko HB-EGFaren kapazitatea neurtzeko asmoz. 
Are gehiago, beste talde esperimental bat gehitu genuen zeina Gefitinib erabiliz tratatu 
zen aurretiaz eta gero HB-EGF eta Zn+2 aplikatu zitzaizkion. EGFRren aktibazioa bere 
Y845 eta Y1068 fosforilazio lekuetan neurtu genuen eta baita EGFRren ur beherako 
seinalizazio bide den ERK1/2ren fosforilazioa. Emaitzek HB-EGF EGFR bere 
aztertutako bi fosforilazio hondakinetan (Y845 eta Y1068) fosforilatzeko gai zela 
adierazi zuten. Azpimarragarria da Zn+2 estimulazioak ez zuela aparteko efekturik 
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eragin, ziurrenik gehiegizko HB-EGF mailagatik gailendua. Azkenik, Gefitinib bitartezko 
aurretiazko tratamendua Y845 eta Y1068 bi fosforilazio lekuak blokeatzeko zein 
ERK1/2 fosforilazioa murrizteko gai izan zen, baita HB-EGF eta Zn+2 elkarrekin 
administratu zirenean ere. Emaitza hauek KA administrazioaren ostean gune 
neurogenikoan jazotzen diren efektuak HB-EGFren eta EGFRren elkarreraginak 









Aurreko orrialdean. R34 Figura. HB-EGFek in vitro hazitako NSPCetan EGFRren aktibazioa 
sustatu zuen. A) Konfokal irudi errepresentatiboak in vitro hazitako NSPCak eta HB-EGF espresioa 
IHCaren ostean bai HB-EGF antigorputz primarioarekin zein antigorputz primariorik gabe erakutsiz. B) 
ELISAren bitartezko kuantifikazioa HB-EGF kopurua erakutsiz NSPCrik gabeko hazkuntza medioan 
(media), hazitako NSPCen medioan (supernatant) eta hazitako NSPCen zelula alean (pellet). Emaitzek 
areagotze esanguratsua erakutsi zuten hazitako NSPCen medioan zegoen HB-EGF kopuruan, NSPCak 
ugaritze egoeran estekatzailea askatzeko gai zirela erakutsiz. C-D) WBak areagotutako Y845 EGFR, 
Y1068 EGFR eta ur beherako seinalizazio ibilbidea den ERK1/2 maila erakutsi zuen HB-EGFrekin 
trataturiko kondizioetan. E-G) Proteina maila totalaren arteko fosforilazio mailaren kuantifikazioak 
EGFRrentzako (Y845 eta Y1068) eta bere ur beherako seinalizazio ibilbidea den ERK1/2rentzako. Grafiko 
bakoitzeko datuak normalizatuak izan ziren CTRL+CTRL taldearen batez bestekoa 100 ± errore 
estandarra bezala hartuta. Eskala barra 20 µm-koa da. *p<0.05 eta **p<0.01. Kruskal Wallis Tukey post 
hoc testaren bidezko kontrol taldearen aurkako konparazio anizkoitzez jarraitua in (B)n. Bide bakarreko 
ANOVA Holm-Sidak post hoc testaren bidezko kontrol taldearen aurkako konparazio anizkoitzez jarraitua 
(E)n, (F)n eta (G)n. Barrek batez bestekoa ± errore estandarra erakusten dute. Puntuek datu indibidualak 
erakusten dituzte. 
Tesi honen bigarren zatian lorturiko emaitzek konbultsio ostean DGan jazotzen 
den React-NSC transformazioan EGFR modulatzaile garrantzitsuetako bat bezala 
seinalatu zuten, ahalmen neurogeniko osoaren galera dakarrena. Gure lanak bide berri 
bat irekitzen du MTLEn hipokanpoak duen erantzunean EGFRren aktibazioa 
mekanismo alternatibo bezala adieraziz. Izan ere, Gefitiniben sudurreko administrazioa 
metodo baliagarria suertatu zen EGFR inhibitzeko, BBBa zeharkatuz eta konbultsioek 
hipokanpoarengan duten efektu latza leunduz (DCXen galera, GCDa eta React-NSC 
indukzioa). Horretaz gain, Zn+2, HB-EGF eta haien arteko elkarreragina EGFRren 
aktibazioaren indukzioan partehartzaile bezala proposatzen ditugu, konbultsio ostean 
masiboki zelulaz kanpoko ingurunean askatuak izaten baitira. Buruan izanda 
konbultsio osteko erantzun hipokanpalean aktore bat baino gehiagok hartuko dutela 
parte, gure emaitzek argia igortzen dute React-NSC indukzioa eta neurogenesiaren 
galera antolatzen dituen mekanismo baten gainean. Aurkikuntza hauek bidea egiten 
dute beste seinalizazio ibilbide batzuetan oinarrituriko ikerketentzako, beste ErbB 











































 1. NSC helduak jaio ondoren sortuak izaten dira 
dNSCengandik independentea den populazio berri bat osatuz, 
DGaren garapenaren hondakin bezala iraun beharrean.  
  - NSC helduak jaio ondorengo etapa goiztiarrean zehar sortuak izaten 
dira cD2ren menpeko prozesu batean. 
  - Jaio ondorengo etapa goiztiarrean DGaren barruan kokaturik dauden 
sortzaileek NSC helduen erreserbara ekarpena egiten dute, DMStik datozen 
sortzaileak zeharo neurogenikoak diren bitartean. 
  - Jaio ondorengo LPA1 espresioaren hasierak SGZan NSC helduak eta 
dNSCak ezberdintzen ditu. 
 
2. Sortzaile matrizeen sorrera jarraiak (DNe, DMS, DG) 
ezaugarri antzekoak konpartitzen ditu giza eta sagu DGaren 
garapenean zehar. 
  - Giza haurdunaldi goiztiarraren garapenean (GW14) dNSC populazio 
heterogeneoek HPFko eremu ezberdinak betetzen dituzte (DNe, DMS, DG). 
  - Gizakietan, jaio aurretik Tbr2 espresioa duten sortzaileak eta Ki67 
espresioa duten ugaritze fasean dauden zelulak hilusera mugaturik (GCLtik hurbil) 
agertzen dira. 
  - Nestin espresioa duten RGCak giza DGan mantentzen dira jaio 
ostean, nahiz eta ugaritze kapazitate arbuiagarria duten.  
 
 3. MTLEn gertatzen den aktibazio masiboa eta React-NSC 
indukzioa Zn+2ek eta HB-EGFk sustatzen duten EGFRren aktibazioak 
erregulatzen du. 
  - EGFRk, baina ez FGFRk, parte hartzen du HPFan jazotzen den KA 
administrazioaren osteko erantzun azkarrean. 
ONDORIOAK 




  - EGFRren eta bere ur beherako seinalizazio ibilbidearen (STAT3, Akt, 
ERK1/2) espresioaren eta aktibazioaren areagotzea gertaera garrantzitsua da KA 
administrazioaren ondorengo hiru egunetan. 
  - Gefitinib kapaza da EGFR eta bere ur beherako seinalizazio ibilbidea 
den ERK1/2 NSPCetan in vitro inhibitzeko, euren ugaritzea era eraginkorrean 
blokeatuz. 
  - KAren osteko sudurreko Gefitinib administrazioak GCDa eta gune 
neurogenikoko ugaritzea murrizten ditu, hala nola NSCen aktibazioa eta transformazio 
erreaktiboa. 
  - Zn+2 masiboki askatua izaten da DGan KA administrazioaren ondoren, 
GCLean eta NSCetatik gertu akumulatuz. 
  - Zn+2ek in vitro NSPCen ugaritzea estimulatu egiten du dosiaren 
arabera, dosi altuetan heriotza zelularra eraginez.  
  - Zn+2 injekzio intrahipokanpalak SGZan ugaritzea, GCDa eta NSCen 
transformazio erreaktiboa sustatzen ditu. 
  - Zn+2 administrazioak in vitro hazitako NSPCetan EGFRren fosforilazio 
zuzena eragiten du bere Y845 tirosina lekuan, baina ez Y1068 tirosina lekuan. 
  - Gefitiniben sudurreko administrazioak Zn+2 administrazio hipokanpalak 
sorrarazten duen SGZko ugaritze masiboa ekiditen du. 
  - Azal-azpiko TPEN injekzio errepikatuen bitartezko Zn+2 kelazioak KA 
administrazioak sorturiko heriotza zelularra areagotzen du, MTLE egoeran terapia 
potentzial bezala erabiltzeko edozein ideia baztertuz. 
  - KA administrazioaren ostean HB-EGF masiboki askatua izaten da 
DGan, MLan eta hilusean akumulatuz. 
  - HB-EGF administrazioak in vitro hazitako NSPCtan Y845 eta Y1068 
EGFR tirosina kinasen eta bere ur beherako seinalizazio ibilbidea den ERK1/2ren 






































Altman, J., and Bayer, S.A. (1990). Migration and distribution of two populations of 
hippocampal granule cell precursors during the perinatal and postnatal periods. J. 
Comp. Neurol. 301, 365–381. 
Altman, J., and Das, G.D. (1965). Autoradiographic and histological evidence of 
postnatal hippocampal neurogenesis in rats. J Comp Neurol 124, 319–335. 
Ansorg, A., Witte, O.W., and Urbach, A. (2012). Age-dependent kinetics of dentate 
gyrus neurogenesis in the absence of cyclin D2. BMC Neurosci. 13, 1–13. 
Arantius, J.C. (1587). De humano foetu liber. Venetiis: Apud lacobum brechtanum. 
Arnold, S.E., and Trojanowski, J.Q. (1996). Human fetal hippocampal development: I. 
Cytoarchitecture, myeloarchitecture, and neuronal morphologic features. J. Comp. 
Neurol. 367, 274–292. 
Arteaga, C.L. (2011). ERBB receptors in cancer: signaling from the inside. Breast 
Cancer Res. 13, 304. 
Bancila, V., Nikonenko, I., Dunant, Y., and Bloc, A. (2004). Zinc inhibits glutamate 
release via activation of pre-synaptic K ATP channels and reduces ischaemic damage 
in rat hippocampus. J. Neurochem. 90, 1243–1250. 
Barakat, N.S., Omar, S.A., and Ahmed, A.A.E. (2006). Carbamazepine uptake into rat 
brain following intra-olfactory transport. J. Pharm. Pharmacol. 58, 63–72. 
Berg, D.A., Su, Y., Jimenez-Cyrus, D., Patel, A., Huang, N., Morizet, D., Lee, S., Shah, 
R., Ringeling, F.R., Jain, R., et al. (2019). A Common Embryonic Origin of Stem Cells 
Drives Developmental and Adult Neurogenesis. Cell 177, 654-668.e15. 
Bessman, N.J., Freed, D.M., and Lemmon, M.A. (2014). Putting together structures of 
epidermal growth factor receptors. Curr. Opin. Struct. Biol. 29, 95–101. 
Biscardi, J.S., Maa, M.C., Tice, D.A., Cox, M.E., Leu, T.H., and Parsons, S.J. (1999). 
C-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and 
Tyr1101 is associated with modulation of receptor function. J. Biol. Chem. 274, 8335–
8343. 
BIBLIOGRAFIA 




Blümcke, I., Schewe, J.C., Normann, S., Brüstle, O., Schramm, J., Elger, C.E., and 
Wiestler, O.D. (2001). Increase of nestin-immunoreactive neural precursor cells in the 
dentate gyrus of pediatric patients with early-onset temporal lobe epilepsy. 
Hippocampus 11, 311–321. 
Bonaguidi, M.A., Wheeler, M.A., Shapiro, J.S., Stadel, R.P., Sun, G.J., Ming, G.L., and 
Song, H. (2011). In vivo clonal analysis reveals self-renewing and multipotent adult 
neural stem cell characteristics. Cell 145, 1142–1155. 
Bouilleret, V., Ridoux, V., Depaulis, A., Marescaux, C., Nehlig, A., and Le Gal La Salle, 
G. (1999). Recurrent seizures and hippocampal sclerosis following intrahippocampal 
kainate injection in adult mice: Electroencephalography, histopathology and synaptic 
reorganization similar to mesial temporal lobe epilepsy. Neuroscience 89, 717–729. 
Brunne, B., Franco, S., Bouché, E., Herz, J., Howell, B.W., Pahle, J., Müller, U., May, 
P., Frotscher, M., and Bock, H.H. (2013). Role of the postnatal erradial glial scaffold for 
the development of the dentate gyrus as revealed by Reelin signaling mutant mice. 
Glia July, 1347–1363. 
Burgoyne, L. (1999). The Mechanisms of Pyknosis: Hypercondensation and death. 
Exp. Cell Res. 248, 214–222. 
Calof, A.L. (1995). Intrinsic and extrinsic factors regulating vertebrate neurogenesis. 
Curr. Opin. Neurobiol. 5, 19–27. 
Cameron, H.A., Woolley, C.S., McEwen, B.S., and Gould, E. (1993). Differentiation of 
newly born neurons and glia in the dentate gyrus of the adult rat. Neuroscience 56, 
337–344. 
Carpenter, G., King, L., and Cohen, S. (1978). Epidermal growth factor stimulates 
phosphorylation in membrane preparations in vitro [21]. Nature 276, 409–410. 
Carrasco, J., Penkowa, M., Hadberg, H., Molinero, A., and Hidalgo, J. (2000). 
Enhanced seizures and hippocampal neurodegeneration following kainic acid-induced 
seizures in metallothionein-I + II-deficient mice. Eur. J. Neurosci. 12, 2311–2322. 
Chen, Y.M. (2013). Update of epidermal growth factor receptor-tyrosine kinase 
inhibitors in non-small-cell lung cancer. J. Chinese Med. Assoc. 76, 249–257. 
Cipriani, S., Journiac, N., Nardelli, J., Verney, C., Delezoide, A.L., Guimiot, F., 
BIBLIOGRAFIA 




Gressens, P., and Adle-Biassette, H. (2017). Dynamic Expression Patterns of 
Progenitor and Neuron Layer Markers in the Developing Human Dentate Gyrus and 
Fimbria. Cereb. Cortex 27, 358–372. 
Cipriani, S., Ferrer, I., Aronica, E., Kovacs, G.G., Verney, C., Nardelli, J., Khung, S., 
Delezoide, A.L., Milenkovic, I., Rasika, S., et al. (2018). Hippocampal erradial glial 
subtypes and their neurogenic potential in human fetuses and healthy and Alzheimer’s 
disease adults. Cereb. Cortex 28, 2458–2478. 
Codega, P., Silva-Vargas, V., Paul, A., Maldonado-Soto, A.R., DeLeo, A.M., Pastrana, 
E., and Doetsch, F. (2014). Prospective Identification and Purification of Quiescent 
Adult Neural Stem Cells from Their In Vivo Niche. Neuron 82, 545–559. 
Cooper, J.M., Gadian, D.G., Jentschke, S., Goldman, A., Munoz, M., Pitts, G., Banks, 
T., Chong, W.K., Hoskote, A., Deanfield, J., et al. (2015). Neonatal hypoxia, 
hippocampal atrophy, and memory impairment: Evidence of a causal sequence. Cereb. 
Cortex 25, 1469–1476. 
Craig, C.G., Tropepe, V., Morshead, C.M., Reynolds, B.A., Weiss, S., and Van Der 
Kooy, D. (1996). In vivo growth factor expansion of endogenous subependymal neural 
precursor cell populations in the adult mouse brain. J. Neurosci. 16, 2649–2658. 
Crespel, A., Rigau, V., Coubes, P., Rousset, M.C., De Bock, F., Okano, H., Baldy-
Moulinier, M., Bockaert, J., and Lerner-Natoli, M. (2005). Increased number of neural 
progenitors in human temporal lobe epilepsy. Neurobiol. Dis. 19, 436–450. 
Danscher, G. (1981). Histochemical demonstration of heavy metals - A revised version 
of the sulphide silver method suitable for both light and electronmicroscopy. 
Histochemistry 71, 1–16. 
Deisseroth, K., Singla, S., Toda, H., Monje, M., Palmer, T.D., and Malenka, R.C. 
(2004). Excitation-neurogenesis coupling in adult neural stem/progenitor cells. Neuron 
42, 535–552. 
Dennis, C. V., Suh, L.S., Rodriguez, M.L., Kril, J.J., and Sutherland, G.T. (2017). 
Response to: Comment on ‘Human adult neurogenesis across the ages: An 
immunohistochemical study.’ Neuropathol. Appl. Neurobiol. 43, 452–454. 
Dionne, C.A., Crumley, G., Bellot, F., Kaplow, J.M., Searfoss, G., Ruta, M., Burgess, 
BIBLIOGRAFIA 




W.H., Jaye, M., and Schlessinger, J. (1990). Cloning and expression of two distinct 
high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. 
EMBO J. 9, 2685–2692. 
Dorn, M., Lidzba, K., Bevot, A., Goelz, R., Hauser, T.K., and Wilke, M. (2014). Long-
term neurobiological consequences of early postnatal hCMV-infection in former 
preterms: A Functional MRI study. Hum. Brain Mapp. 35, 2594–2606. 
Downward, J., Parker, P., and Waterfield, M.D. (1984). Autophosphorylation sites on 
the epidermal growth factor receptor. Nature 311, 483–485. 
Eckenhoff, M.F., and Rakic, P. (1984). Erradial organization of the hippocampal 
dentate gyrus: A Golgi, ultrastructural, and immunocytochemical analysis in the 
developing rhesus monkey. J. Comp. Neurol. 223, 1–21. 
Encinas, J.M., and Enikolopov, G. (2008). Identifying and Quantitating Neural Stem 
and Progenitor Cells in the Adult Brain. Methods Cell Biol. 85, 243–272. 
Encinas, J.M., and Sierra, A. (2012). Neural stem cell deforestation as the main force 
driving the age-related decline in adult hippocampal neurogenesis. Behav. Brain Res. 
227, 433–439. 
Encinas, J.M., Vaahtokari, A., and Enikolopov, G. (2006). Fluoxetine targets early 
progenitor cells in the adult brain. Proc. Natl. Acad. Sci. U. S. A. 103, 8233–8238. 
Encinas, J.M., Michurina, T. V., Peunova, N., Park, J.H., Tordo, J., Peterson, D.A., 
Fishell, G., Koulakov, A., and Enikolopov, G. (2011). Division-coupled astrocytic 
differentiation and age-related depletion of neural stem cells in the adult hippocampus. 
Cell Stem Cell 8, 566–579. 
Estivill-Torrús, G., Llebrez-Zayas, P., Matas-Rico, E., Santín, L., Pedraza, C., De 
Diego, I., Del Arco, I., Fernández-Llebrez, P., Chun, J., and De Fonseca, F.R. (2008). 
Absence of LPA1 signaling results in defective cortical development. Cereb. Cortex 18, 
938–950. 
Faber-Elman, A., Solomon, A., Abraham, J.A., Marikovsky, M., and Schwartz, M. 
(1996). Involvement of wound-associated factors in rat brain astrocyte migratory 
response to axonal injury: In vitro simulation. J. Clin. Invest. 97, 162–171. 
Fahrner, A., Kann, G., Flubacher, A., Heinrich, C., Freiman, T.M., Zentner, J., 
BIBLIOGRAFIA 




Frotscher, M., and Haas, C.A. (2007). Granule cell dispersion is not accompanied by 
enhanced neurogenesis in temporal lobe epilepsy patients. Exp. Neurol. 203, 320–332. 
Ferrer, I., Alcántara, S., Ballabriga, J., Olivé, M., Blanco, R., Rivera, R., Carmona, M., 
Berruezo, M., Pitarch, S., and Planas, A.M. (1996). Transforming growth factor-α (TGF-
α) and epidermal growth factor-receptor (EGF-R) immunoreactivity in normal and 
pathologic brain. Prog. Neurobiol. 49, 99–119. 
Filippov, V., Kronenberg, G., Pivneva, T., Reuter, K., Steiner, B., Wang, L.P., 
Yamaguchi, M., Kettenmann, H., and Kempermann, G. (2003). Subpopulation of 
nestin-expressing progenitor cells in the adult murine hippocampus shows 
electrophysiological and morphological characteristics of astrocytes. Mol. Cell. 
Neurosci. 23, 373–382. 
Frederickson, C.J. (1989). Neurobiology of Zinc and Zinc-Containing Neurons. Int. Rev. 
Neurobiol. 31, 145–238. 
Frederickson, C.J., and Danscher, G. (1990). Zinc-containing neurons in hippocampus 
and related CNS structures. Prog. Brain Res. 83, 71–84. 
Frederickson, C.J., Klitenick, M.A., Manton, W.I., and Kirkpatrick, J.B. (1983). 
Cytoarchitectonic distribution of zinc in the hippocampus of man and the rat. Brain Res. 
273, 335–339. 
Galichet, C., Guillemot, F., and Parras, C.M. (2008). Neurogenin 2 has an essential 
role in development of the dentate gyrus. Development 135, 2031–2041. 
Gall, C. (1993). Seizure-induced changes in neurotrophin expression: implications for 
epilepsy. Exp Neurol 124, 150–166. 
Gall, C., Lauterborn, J., Bundman, M., Murray, K., and Isackson, P. (1991). Seizures 
and the regulation of neurotrophic factor and neuropeptide gene expression in brain. 
Epilepsy Res Suppl 4, 225–245. 
de Garengeot, R.C. (1742). Splanchnologie ou, L’anatomie des viscères: avec de 
figures originales tirées d’apres les cadavres, suivle d’une dissertation sur l’origine de 
la chirurgie. 
Gilley, J.A., Yang, C.P., and Kernie, S.G. (2011). Developmental profiling of postnatal 
dentate gyrus progenitors provides evidence for dynamic cell-autonomous regulation. 
BIBLIOGRAFIA 




Hippocampus 21, 33–47. 
Goffin, J.R., and Zbuk, K. (2013). Epidermal growth factor receptor: Pathway, 
therapies, and pipeline. Clin. Ther. 35, 1282–1303. 
Golgi, C. (1886). Sulla fina anatomia degli organi centrali di sistema nervoso. V. Sulla 
anatomia di grande piede d’Hippocampo. 
Gomez-Nicola, D., Riecken, K., Fehse, B., and Perry, V.H. (2014). In-vivo RGB 
marking and multicolour single-cell tracking in the adult brain. Sci. Rep. 4, 1–10. 
Gonçalves, J.T., Schafer, S.T., and Gage, F.H. (2016). Adult Neurogenesis in the 
Hippocampus: From Stem Cells to Behavior. Cell 167, 897–914. 
Gong, S., Zheng, C., Doughty, M.L., Losos, K., Didkovsky, N., Schambra, U.B., Nowak, 
N.J., Joyner, A., Leblanc, G., Hatten, M.E., et al. (2003). A gene expression atlas of the 
central nervous system based on bacterial artificial chromosomes. Nature 425, 917–
925. 
Gould, E., Cameron, H.A., Daniels, D.C., Woolley, C.S., and McEwen, B.S. (1992). 
Adrenal hormones suppress cell division in the adult rat dentate gyrus. J. Neurosci. 12, 
3642–3650. 
Gould, E., McEwen, B.S., Tanapat, P., Galea, L.A.M., and Fuchs, E. (1997). 
Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial 
stress and NMDA receptor activation. J. Neurosci. 17, 2492–2498. 
Gould, E., Reeves, A.J., Fallah, M., Tanapat, P., Gross, C.G., and Fuchs, E. (1999a). 
Hippocampal neurogenesis in adult Old World primates. Proc. Natl. Acad. Sci. U. S. A. 
96, 5263–5267. 
Gould, E., Beylin, A., Tanapat, P., Reeves, A., and Shors, T.J. (1999b). Learning 
enhances adult neurogenesis in the hippocampal formation. Nat. Neurosci. 2, 260–265. 
Gould, E., Reeves, A.J., Graziano, M.S.A., and Gross, C.G. (1999c). Neurogenesis in 
the neocortex of adult primates. Science (80-. ). 286, 548–552. 
Gray, W.P., and Sundstrom, L.E. (1998). Kainic acid increases the proliferation of 
granule cell progenitors in the dentate gyrus of the adult rat. Brain Res. 790, 52–59. 
BIBLIOGRAFIA 




Hanson, L.R., Fine, J.M., Svitak, A.L., and Faltesek, K.A. (2013). Intranasal 
administration of CNS therapeutics to awake mice. J. Vis. Exp. 2–7. 
Hattiangady, B., Rao, M.S., and Shetty, A.K. (2004). Chronic temporal lobe epilepsy is 
associated with severely declined dentate neurogenesis in the adult hippocampus. 
Neurobiol. Dis. 17, 473–490. 
Heinrich, C., Nitta, N., Flubacher, A., Müller, M., Fahrner, A., Kirsch, M., Freiman, T., 
Suzuki, F., Depaulis, A., Frotscher, M., et al. (2006). Reelin deficiency and 
displacement of mature neurons, but not neurogenesis, underlie the formation of 
granule cell dispersion in the epileptic hippocampus. J. Neurosci. 26, 4701–4713. 
Herbst, R.S. (2004). Review of epidermal growth factor receptor biology. Int. J. Radiat. 
Oncol. Biol. Phys. 59, S21–S26. 
Hochgerner, H., Zeisel, A., Lönnerberg, P., and Linnarsson, S. (2018). Conserved 
properties of dentate gyrus neurogenesis across postnatal development revealed by 
single-cell RNA sequencing. Nat. Neurosci. 21, 290–299. 
Hodge, R.D., Kowalczyk, T.D., Wolf, S.A., Encinas, J.M., Rippey, C., Enikolopov, G., 
Kempermann, G., and Hevner, R.F. (2008). Intermediate progenitors in adult 
hippocampal neurogenesis: Tbr2 expression and coordinate regulation of neuronal 
output. J. Neurosci. 28, 3707–3717. 
Hodge, R.D., Nelson, B.R., Kahoud, R.J., Yang, R., Mussar, K.E., Reiner, S.L., and 
Hevner, R.F. (2012). Tbr2 is essential for hippocampal lineage progression from neural 
stem cells to intermediate progenitors and neurons. J. Neurosci. 32, 6275–6287. 
Hodge, R.D., Garcia, A.J., Elsen, G.E., Nelson, B.R., Mussar, K.E., Reiner, S.L., 
Ramirez, J.M., and Hevner, R.F. (2013). Tbr2 expression in Cajal-Retzius cells and 
intermediate neuronal progenitors is required for morphogenesis of the dentate gyrus. 
J. Neurosci. 33, 4165–4180. 
Houser, C.R. (1990). Granule cell dispersion in the dentate gyrus of humans with 
temporal lobe epilepsy. Brain Res. 535, 195–204. 
Humphrey, T. (1967). The development of the human hippocampal fissure. J. Anat. 
101, 655–676. 
Hüttmann, K., Sadgrove, M., Wallraff, A., Hinterkeuser, S., Kirchhoff, F., Steinhäuser, 
BIBLIOGRAFIA 




C., and Gray, W.P. (2003). Seizures preferentially stimulate proliferation of erradial 
glia-like astrocytes in the adult dentate gyrus: Functional and immunocytochemical 
analysis. Eur. J. Neurosci. 18, 2769–2778. 
Iglesias, J.E., Augustinack, J.C., Nguyen, K., Player, C.M., Player, A., Wright, M., Roy, 
N., and Frosch, M.P. (2015). A computational atlas of the hippocampal formation using 
ex vivo , ultra-high resolution MRI. Neuroimage 115–137. 
Jhaveri, T.Z., Woo, J., Shang, X., Park, B.H., and Gabrielson, E. (2015). AMP-activated 
kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer. Oncotarget 6, 
14754–14765. 
Jia, M., Shi, Z., Yan, X., Xu, L., Dong, L., Li, J., Wang, Y., Yang, S., and Yuan, F. 
(2018). Insulin and heparin-binding epidermal growth factor-like growth factor 
synergistically promote astrocyte survival and proliferation in serum-free medium. J. 
Neurosci. Methods 307, 240–247. 
Jiang, M., Polepalli, J., Chen, L.Y., Zhang, B., Südhof, T.C., and Malenka, R.C. (2017). 
Conditional ablation of neuroligin-1 in CA1 pyramidal neurons blocks LTP by a cell-
autonomous NMDA receptor-independent mechanism. Mol. Psychiatry 22, 375–383. 
Johnson, D.E., Lee, P.L., Lu, J., and Williams, L.T. (1990). Diverse forms of a receptor 
for acidic and basic fibroblast growth factors. Mol. Cell. Biol. 10, 4728–4736. 
Kägi, J.H.R., and Schäffer, A. (1988). Biochemistry of Metallothionein. Biochemistry 27, 
8509–8515. 
Kambe, T., Tsuji, T., Hashimoto, A., and Itsumura, N. (2015). The physiological, 
biochemical, and molecular roles of zinc transporters in zinc homeostasis and 
metabolism. Physiol. Rev. 95, 749–784. 
Kaplan, M.S., and Bell, D.H. (1984). Mitotic neuroblasts in the 9-day-old and 11-month-
old rodent hippocampus. J. Neurosci. 4, 1429–1441. 
Kasarskis, E.J., Forrester, T.M., and Slevin, J.T. (1987). Amygdalar kindling is 
associated with elevated zinc concentration in the cortex and hippocampus of rats. 
Epilepsy Res. 1, 227–233. 
Kempermann, G., Jessberger, S., Steiner, B., and Kronenberg, G. (2004). Milestones 
of neuronal development in the adult hippocampus. Trends Neurosci. 27, 447–452. 
BIBLIOGRAFIA 




Kim, J.H., Jang, B.G., Choi, B.Y., Kwon, L.M., Sohn, M., Song, H.K., and Suh, S.W. 
(2012). Zinc Chelation Reduces Hippocampal Neurogenesis after Pilocarpine-Induced 
Seizure. PLoS One 7, 1–10. 
Knoth, R., Singec, I., Ditter, M., Pantazis, G., Capetian, P., Meyer, R.P., Horvat, V., 
Volk, B., and Kempermann, G. (2010). Murine features of neurogenesis in the human 
hippocampus across the lifespan from 0 to 100 years. PLoS One 5. 
Kornack, D.R., and Rakic, P. (1999). Continuation of neurogenesis in the hippocampus 
of the adult macaque monkey. Proc. Natl. Acad. Sci. U. S. A. 96, 5768–5773. 
Kornack, D.R., and Rakic, P. (2001). The generation, migration, and differentiation of 
olfactory neurons in the adult primate brain. Proc. Natl. Acad. Sci. U. S. A. 98, 4752–
4757. 
Kornblum, H.I., Zurcher, S.D., Werb, Z., Derynck, R., and Seroogy, K.B. (1999). 
Multiple trophic actions of heparin-binding epidermal growth factor (HB-EGF) in the 
central nervous system. Eur. J. Neurosci. 11, 3236–3246. 
Kosaka, T., and Hama, K. (1986). Three‐dimensional structure of astrocytes in the rat 
dentate gyrus. J. Comp. Neurol. 249, 242–260. 
Kovacs, E., Zorn, J.A., Huang, Y., Barros, T., and Kuriyan, J. (2015). A Structural 
Perspective on the Regulation of the Epidermal Growth Factor Receptor. Annu. Rev. 
Biochem. 84, 739–764. 
Kralic, J.E., Ledergerber, D.A., and Fritschy, J.M. (2005). Disruption of the neurogenic 
potential of the dentate gyrus in a mouse model of temporal lobe epilepsy with focal 
seizures. Eur. J. Neurosci. 22, 1916–1927. 
Kraus, M.H., Issing, W., Miki, T., Popescu, N.P., and Aaronson, S.A. (1989). Isolation 
and characterization of ERBB3, a third member of the ERBB/epidermal growth factor 
receptor family: Evidence for overexpression in a subset of human mammary tumors. 
Proc. Natl. Acad. Sci. U. S. A. 86, 9193–9197. 
Kronenberg, G., Reuter, K., Steiner, B., Brandt, M.D., Jessberger, S., Yamaguchi, M., 
and Kempermann, G. (2003). Subpopulations of Proliferating Cells of the Adult 
Hippocampus Respond Differently to Physiologic Neurogenic Stimuli. J. Comp. Neurol. 
467, 455–463. 
BIBLIOGRAFIA 




Kruglyakova, E.P., Khovryakov, A. V., Shikhanov, N.P., MacCann, G.M., Vaél’, I., 
Kruglyakov, P.P., and Sosunov, A.A. (2005). Nestin-expressing cells in the human 
hippocampus. Neurosci. Behav. Physiol. 35, 891–897. 
Kuhn, H.G., Dickinson-Anson, H., and Gage, F.H. (1996). Neurogenesis in the dentate 
gyrus of the adult rat: Age-related decrease of neuronal progenitor proliferation. J. 
Neurosci. 16, 2027–2033. 
Kuhn, H.G., Winkler, J., Kempermann, G., Thal, L.J., and Gage, F.H. (1997). Epidermal 
growth factor and fibroblast growth factor-2 have different effects on neural progenitors 
in the adult rat brain. J. Neurosci. 17, 5820–5829. 
Kuruba, R., and Shetty, A. (2007). Could hippocampal neurogenesis be a future drug 
target for treating temporal lobe epilepsy? CNS Neurol Disord Drug Targets 6, 342–
357. 
Lee, J., Auyeung, W.W., and Mattson, M.P. (2003). Interactive Effects of Excitotoxic 
Injury and Dietary Restriction on Microgliosis and Neurogenesis in the Hippocampus of 
Adult Mice. NeuroMolecular Med. 4, 179–195. 
Lee, J.C., Vivanco, I., Beroukhim, R., Huang, J.H.Y., Feng, W.L., DeBiasi, R.M., 
Yoshimoto, K., King, J.C., Nghiemphu, P., Yuza, Y., et al. (2006). Epidermal growth 
factor receptor activation in glioblastoma through novel missense mutations in the 
extracellular domain. PLoS Med. 3, 2264–2273. 
Lendahl, U., Zimmerman, L.B., and McKay, R.D.G. (1990). CNS stem cells express a 
new class of intermediate filament protein. Cell 60, 585–595. 
Levenson, C.W., and Morris, D. (2011). 22332038.Pdf. 96–100. 
Li, D., Ambrogio, L., Shimamura, T., Kubo, S., Takahashi, M., Chirieac, L.R., Padera, 
R.F., Shapiro, G.I., Baum, A., Himmelsbach, F., et al. (2008). BIBW2992, an 
irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models. 
Oncogene 27, 4702–4711. 
Li, D., Takeda, N., Jain, R., Manderfield, L.J., Liu, F., Li, L., Anderson, S.A., and 
Epstein, J.A. (2015). Hopx distinguishes hippocampal from lateral ventricle neural stem 
cells. Stem Cell Res. 15, 522–529. 
Li, G., Kataoka, H., Coughlin, S.R., and Pleasure, S.J. (2009). Identification of a 
BIBLIOGRAFIA 




transient subpial neurogenic zone in the developing dentate gyrus and its regulation by 
Cxcl12 and reelin signaling. Development 136, 327–335. 
Li, G., Fang, L., Fernández, G., and Pleasure, S.J. (2013). The ventral hippocampus is 
the embryonic origin for adult neural stem cells in the dentate gyrus. Neuron 78, 658–
672. 
Li, Z.W., Li, J.J., Wang, L., Zhang, J.P., Wu, J.J., Mao, X.Q., Shi, G.F., Wang, Q., 
Wang, F., and Zou, J. (2014). Epidermal growth factor receptor inhibitor ameliorates 
excessive astrogliosis and improves the regeneration microenvironment and functional 
recovery in adult rats following spinal cord injury. J. Neuroinflammation 11, 1–16. 
Libermann, T., Nusbaum, H., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., 
Waterfield, M., Ullrich, A., and Schlessinger, J. (1985). Am Plification and 
Overexpression of T H E Egf R Ec Epto R Gene in Primary Hum an. J Cell Sci 3, 161–
172. 
Lill, N.L., and Sever, N.I. (2012). Where EGF receptors transmit their signals. Sci. 
Signal. 5. 
Lin, S.Y., Makino, K., Xia, W., Matin, A., Wen, Y., Kwong, K.Y., Bourguignon, L., and 
Hung, M.C. (2001). Nuclear localization of EGF receptor and its potential new role as a 
transcription factor. Nat. Cell Biol. 3, 802–808. 
Liu, J.Y.W., Matarin, M., Reeves, C., McEvoy, A.W., Miserocchi, A., Thompson, P., 
Sisodiya, S.M., and Thom, M. (2018). Doublecortin-expressing cell types in temporal 
lobe epilepsy. Acta Neuropathol. Commun. 6, 60. 
López-García, C., Varea, E., Palop, J.J., Nacher, J., Ramirez, C., Ponsoda, X., and 
Molowny, A. (2002). Cytochemical techniques for zinc and heavy metals localization in 
nerve cells. Microsc. Res. Tech. 56, 318–331. 
Lorente de Nó, R. (1934). Studies on the strcuture of the cerebral cortex. II. 
Continuation of the study of the ammonic system. J Psychol Neurol 46, 113–177. 
Lugert, S., Basak, O., Knuckles, P., Haussler, U., Fabel, K., Götz, M., Haas, C.A., 
Kempermann, G., Taylor, V., and Giachino, C. (2010). Quiescent and active 
hippocampal neural stem cells with distinct morphologies respond selectively to 
physiological and pathological stimuli and aging. Cell Stem Cell 6, 445–456. 
BIBLIOGRAFIA 




Luzuriaga, J., Pineda, J.R., Irastorza, I., Uribe-Etxebarria, V., García-Gallastegui, P., 
Encinas, J.M., Chamero, P., Unda, F., and Ibarretxe, G. (2019). BDNF and NT3 
reprogram human ectomesenchymal dental pulp stem cells to neurogenic and 
gliogenic neural crest progenitors cultured in serum-free medium. Cell. Physiol. 
Biochem. 52, 1361–1380. 
Maret, W. (2017). Zinc in cellular regulation: The nature and significance of “zinc 
signals.” Int. J. Mol. Sci. 18. 
Marucci, G. (2017). Commentary on human adult neurogenesis across the ages: An 
immunohistochemical study. Neuropathol. Appl. Neurobiol. 43, 450–451. 
Maske, H. (1955). Über den topochemischen Nachweis von Zink im Ammonshorn 
verschiedener Säugetiere. Naturwissenschaften 42, 424. 
Matas-Rico, E., García-Diaz, B., Llebrez-Zayas, P., López-Barroso, D., Santín, L., 
Pedraza, C., Smith-Fernández, A., Fernández-Llebrez, P., Tellez, T., Redondo, M., et 
al. (2008). Deletion of lysophosphatidic acid receptor LPA1 reduces neurogenesis in 
the mouse dentate gyrus. Mol. Cell. Neurosci. 39, 342–355. 
Matsue, K., Minakawa, S., Kashiwagi, T., Toda, K., Sato, T., Shioda, S., and Seki, T. 
(2018). Dentate granule progenitor cell properties are rapidly altered soon after birth. 
Brain Struct. Funct. 223, 357–369. 
Matsushime, H., Ewen, M.E., Strom, D.K., Kato, J.Y., Hanks, S.K., Roussel, M.F., and 
Sherr, C.J. (1992). Identification and properties of an atypical catalytic subunit 
(p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 71, 323–334. 
McKillop, D., Hutchison, M., Partridge, E.A., Bushby, N., Cooper, C.M.F., Clarkson-
Jones, J.A., Herron, W., and Swaisland, H.C. (2004). Metabolic disposition of gefitinib, 
an epidermal growth factor receptor tyrosine kinase inhibitor, in rat, dog and man. 
Xenobiotica 34, 917–934. 
Meloche, S., and Pouysségur, J. (2007). The ERK1/2 mitogen-activated protein kinase 
pathway as a master regulator of the G1- to S-phase transition. Oncogene 26, 3227–
3239. 
Meyerson, M., and Harlow, E. (1994). Identification of G1 kinase activity for cdk6, a 
novel cyclin D partner. Mol. Cell. Biol. 14, 2077–2086. 
BIBLIOGRAFIA 




Mignone, J.L., Kukekov, V., Chiang, A.S., Steindler, D., and Enikolopov, G. (2004). 
Neural Stem and Progenitor Cells in Nestin-GFP Transgenic Mice. J. Comp. Neurol. 
469, 311–324. 
Mody, I., and Miller, J.J. (1985). Levels of hippocampal calcium and zinc following 
kindling-induced epilepsy. Can. J. Physiol. Pharmacol. 63, 159–161. 
Moreno-Jiménez, E.P., Flor-García, M., Terreros-Roncal, J., Rábano, A., Cafini, F., 
Pallas-Bazarra, N., Ávila, J., and Llorens-Martín, M. (2019). Adult hippocampal 
neurogenesis is abundant in neurologically healthy subjects and drops sharply in 
patients with Alzheimer’s disease. Nat. Med. 25, 554–560. 
Muro-García, T., Martín-Suárez, S., Espinosa, N., Valcárcel-Martín, R., Marinas, A., 
Zaldumbide, L., Galbarriatu, L., Sierra, A., Fuentealba, P., and Encinas, J.M. (2019). 
Reactive Disruption of the Hippocampal Neurogenic Niche After Induction of Seizures 
by Injection of Kainic Acid in the Amygdala. Front. Cell Dev. Biol. 7, 1–14. 
Nakahira, E., and Yuasa, S. (2005). Neuronal generation, migration, and differentiation 
in the mouse hippocampal primoridium as revealed by enhanced green fluorescent 
protein gene transfer by means of in utero electroporation. J. Comp. Neurol. 483, 329–
340. 
Namba, T., Mochizuki, H., Onodera, M., Mizuno, Y., Namiki, H., and Seki, T. (2005). 
The fate of neural progenitor cells expressing astrocytic and erradial glial markers in 
the postnatal rat dentate gyrus. Eur. J. Neurosci. 22, 1928–1941. 
Nicholson, R.I., Gee, J.M.W., and Harper, M.E. (2001). EGFR and cancer prognosis. 
Eur. J. Cancer 37, 9. 
Nicola, Z., Fabel, K., and Kempermann, G. (2015). Development of the adult 
neurogenic niche in the hippocampus of mice. Front. Neuroanat. 9, 1–13. 
Nieto-Sampedro, M., Gómez-Pinilla, F., Knauer, D.J., and Broderick, J.T. (1988). 
Epidermal growth factor receptor immunoreactivity in rat brain astrocytes. Response to 
injury. Neurosci. Lett. 91, 276–282. 
Nowakowski, R.S. (2000). New Neurons: Extraordinary Evidence or Extraordinary 
Conclusion? Science (80-. ). 288, 771a – 771. 
Opanashuk, L.A., Mark, R.J., Porter, J., Damm, D., Mattson, M.P., and Seroogy, K.B. 
BIBLIOGRAFIA 




(1999). Heparin-binding epidermal growth factor-like growth factor in hippocampus: 
Modulation of expression by seizures and anti-excitotoxic action. J. Neurosci. 19, 133–
146. 
Palmer, T.D., Ray, J., and Gage, F.H. (1995). FGF-2-responsive neuronal progenitors 
reside in proliferative and quiescent regions of the adult rodent brain. Mol. Cell. 
Neurosci. 6, 474–486. 
Pastrana, E., Cheng, L.C., and Doetsch, F. (2009). Simultaneous prospective 
purification of adult subventricular zone neural stem cells and their progeny. Proc. Natl. 
Acad. Sci. U. S. A. 106, 6387–6392. 
Pedersen, M.W., Pedersen, N., Ottesen, L.H., and Poulsen, H.S. (2005). Differential 
response to gefitinib of cells expressing normal EGFR and the mutant EGFRvIII. Br. J. 
Cancer 93, 915–923. 
Pencea, V., Bingaman, K.D., Freedman, L.J., and Luskin, M.B. (2001). Neurogenesis 
in the subventricular zone and rostral migratory stream of the neonatal and adult 
primate forebrain. Exp. Neurol. 172, 1–16. 
Pilz, G.A., Bottes, S., Betizeau, M., Jörg, D.J., Carta, S., Simons, B.D., Helmchen, F., 
and Jessberger, S. (2018). Live imaging of neurogenesis in the adult mouse 
hippocampus. Science (80-. ). 359, 658–662. 
Pineda, J.R., Daynac, M., Chicheportiche, A., Cebrian-Silla, A., Sii Felice, K., Garcia-
Verdugo, J.M., Boussin, F.D., and Mouthon, M.A. (2013). Vascular-derived TGF-β 
increases in the stem cell niche and perturbs neurogenesis during aging and following 
irradiation in the adult mouse brain. EMBO Mol. Med. 5, 548–562. 
Pleasure, S.J., Collins, A.E., and Lowenstein, D.H. (2000). Unique expression patterns 
of cell fate molecules delineate sequential stages of dentate gyrus development. J. 
Neurosci. 20, 6095–6105. 
Plowman, G.D., Whitney, G.S., Neubauer, M.G., Green, J.M., McDonald, V.L., Todaro, 
G.J., and Shoyab, M. (1990). Molecular cloning and expression of an additional 
epidermal growth factor receptor-related gene. Proc. Natl. Acad. Sci. U. S. A. 87, 
4905–4909. 
Priego, N., Zhu, L., Monteiro, C., Mulders, M., Wasilewski, D., Bindeman, W., Doglio, 
BIBLIOGRAFIA 




L., Martínez, L., Martínez-Saez, E., Cajal, S.R.Y., et al. (2018). STAT3 labels a 
subpopulation of reactive astrocytes required for brain metastasis article. Nat. Med. 24, 
1024–1035. 
Puschmann, T.B., Zandén, C., Lebkuechner, I., Philippot, C., De Pablo, Y., Liu, J., and 
Pekny, M. (2014). HB-EGF affects astrocyte morphology, proliferation, differentiation, 
and the expression of intermediate filament proteins. J. Neurochem. 128, 878–889. 
Qu, W. sheng, Tian, D. shi, Guo, Z. bao, Fang, J., Zhang, Q., Yu, Z. yuan, Xie, M. jie, 
Zhang, H. qiu, Lü, J. gao, and Wang, W. (2012). Inhibition of EGFR/MAPK signaling 
reduces microglial inflammatory response and the associated secondary damage in 
rats after spinal cord injury. J. Neuroinflammation 9, 1–14. 
Ramón y Cajal, S. (1893). Estructura del asta de Ammon. Anal Soc. Español Hist. Nat. 
22. 
Ramón y Cajal, S. (1911). Histologie du système nerveux de l’homme et des vertébrés. 
Rees, S., and Inder, T. (2005). Fetal and neonatal origins of altered brain development. 
Early Hum. Dev. 81, 753–761. 
Reynolds, B.A., and Weiss, S. (1992). Generation of neurons and astrocytes from 
isolated cells of the adult mammalian central nervous system. Science (80-. ). 255, 
1707–1710. 
Reynolds, B.A., Tetzlaff, W., and Weiss, S. (1992). A multipotent EGF-responsive 
striatal embryonic progenitor cell produces neurons and astrocytes. J. Neurosci. 12, 
4565–4574. 
Rickmann, M., Amaral, D.G., and Cowan, W.M. (1987). Organization of erradial glial 
cells during the development of the rat dentate gyrus. J. Comp. Neurol. 264, 449–479. 
Riese, D.J., and Stern, D.F. (1998). Specificity within the EGF family/ErbB receptor 
family signaling network. BioEssays 20, 41–48. 
Río, C., Pérez‐Cerdá, F., Matute, C., and Nieto‐Sampedro, M. (1995). Preparation of a 
monoclonal antibody to a glycidic epitope of the epidermal growth factor receptor that 
recognizes inhibitors of astrocyte proliferation and reactive microglia. J. Neurosci. Res. 
40, 776–786. 
BIBLIOGRAFIA 




Rodriguez, A., Ehlenberger, D.B., Hof, P.R., and Wearne, S.L. (2006). Rayburst 
sampling, an algorithm for automated three-dimensional shape analysis from laser 
scanning microscopy images. Nat. Protoc. 1, 2152–2161. 
Salomon, D.S., Brandt, R., Ciardiello, F., and Normanno, N. (1995). Epidermal growth 
factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. 
Hematol. 19, 183–232. 
Samet, J.M., Dewar, B.J., Wu, W., and Graves, L.M. (2003). Mechanisms of Zn2+-
induced signal initiation through the epidermal growth factor receptor. Toxicol. Appl. 
Pharmacol. 191, 86–93. 
Sandstead, H.H. (2012). Subclinical zinc deficiency impairs human brain function. J. 
Trace Elem. Med. Biol. 26, 70–73. 
Sandstead, H.H., Frederickson, C.J., and Penland, J.G. (2000). History of Zinc as 
Related to Brain Function. J. Nutr. 130, 496S-502S. 
Sasaki, H., Shimizu, S., Okuda, K., Kawano, O., Yukiue, H., Yano, M., and Fujii, Y. 
(2009). Epidermal growth factor receptor gene amplification in surgical resected 
Japanese lung cancer. Lung Cancer 64, 295–300. 
Sato, K.I., Sato, A., Aoto, M., and Fukami, Y. (1995). c-SRC phosphorylates epidermal 
growth factor receptor on tyrosine 845. Biochem. Biophys. Res. Commun. 215, 1078–
1087. 
Segi-Nishida, E., Warner-Schmidt, J.L., and Duman, R.S. (2008). Electroconvulsive 
seizure and VEGF increase the proliferation of neural stem-like cells in rat 
hippocampus. Proc. Natl. Acad. Sci. U. S. A. 105, 11352–11357. 
Seki, T., and Arai, Y. (1993). Highly polysialylated neural cell adhesion molecule 
(NCAM-H) is expressed by newly generated granule cells in the dentate gyrus of the 
adult rat. J. Neurosci. 13, 2351–2358. 
Seki, T., Sato, T., Toda, K., Osumi, N., Imura, T., and Shioda, S. (2014). Distinctive 
population of Gfap-expressing neural progenitors arising around the dentate notch 
migrate and form the granule cell layer in the developing hippocampus. J. Comp. 
Neurol. 522, 261–283. 
Seki, T., Hori, T., Miyata, H., Maehara, M., and Namba, T. (2019). Analysis of 
BIBLIOGRAFIA 




proliferating neuronal progenitors and immature neurons in the human hippocampus 
surgically removed from control and epileptic patients. Sci. Rep. 9, 1–14. 
Semba, K., Toyoshima, K., and Yamamoto, T. (1985). c-erbB-1/epidermal growth 
factor-receptor. 82, 6497–6501. 
Seress, L. (1988). Interspecies comparison of the hippocampal formation shows 
increased emphasis on the regio superior in the Ammon’s horn of the human brain. J 
Hirnforsch 29, 335–340. 
Seress, L., Gulyás, A.I., and Freund, T.F. (1992). Pyramidal neurons are 
immunoreactive for calbindin D28k in the CA1 subfield of the human hippocampus. 
Neurosci. Lett. 138, 257–260. 
Seress, L., Ábrahám, H., Tornóczky, T., and Kosztolányi, G. (2001). Cell formation in 
the human hippocampal formation from mid-gestation to the late postnatal period. 
Neuroscience 105, 831–843. 
Seri, B., García-Verdugo, J.M., McEwen, B.S., and Alvarez-Buylla, A. (2001). 
Astrocytes give rise to new neurons in the adult mammalian hippocampus. J. Neurosci. 
21, 7153–7160. 
Sharma, S. V., Bell, D.W., Settleman, J., and Haber, D.A. (2007). Epidermal growth 
factor receptor mutations in lung cancer. Nat. Rev. Cancer 7, 169–181. 
Sherr, C.J. (1995). Mammalian G1 cyclins and cell cycle progression. Proc. Assoc. Am. 
Physicians 107, 181–186. 
Shin, J., Berg, D.A., Zhu, Y., Shin, J.Y., Song, J., Bonaguidi, M.A., Enikolopov, G., 
Nauen, D.W., Christian, K.M., Ming, G.L., et al. (2015). Single-Cell RNA-Seq with 
Waterfall Reveals Molecular Cascades underlying Adult Neurogenesis. Cell Stem Cell 
17, 360–372. 
Sierra, A., Martín-Suárez, S., Valcárcel-Martín, R., Pascual-Brazo, J., Aelvoet, S.A., 
Abiega, O., Deudero, J.J., Brewster, A.L., Bernales, I., Anderson, A.E., et al. (2015). 
Neuronal hyperactivity accelerates depletion of neural stem cells and impairs 
hippocampal neurogenesis. Cell Stem Cell 16, 488–503. 
Silvestre, F., Fissore, R.A., Tosti, E., and Boni, R. (2012). [Ca2+]i rise at in vitro 
maturation in bovine cumulus-oocyte complexes. Mol. Reprod. Dev. 79, 369–379. 
BIBLIOGRAFIA 




Simpson, D.L., Morrison, R., de Vellis, J., and Herschman, H.R. (1982). Epidermal 
growth factor binding and mitogenic activity on purified populations of cells from the 
central nervous system. J. Neurosci. Res. 8, 453–462. 
Sindreu, C.B., Varoqui, H., Erickson, J.D., and Pérez-Clausell, J. (2003). Boutons 
containing vesicular zinc define a subpopulation of synapses with low AMPAR content 
in rat hippocampus. Cereb. Cortex 13, 823–829. 
Slomianka, L. (1992). Neurons of origin of zinc-containing pathways and the 
distribution of zinc-containing boutons in the hippocampal region of the rat. 
Neuroscience 48, 325–352. 
Sofroniew, M. V. (2009). Molecular dissection of reactive astrogliosis and glial scar 
formation. Trends Neurosci. 32, 638–647. 
Sorrells, S.F., Paredes, M.F., Cebrian-Silla, A., Sandoval, K., Qi, D., Kelley, K.W., 
James, D., Mayer, S., Chang, J., Auguste, K.I., et al. (2018). Human hippocampal 
neurogenesis drops sharply in children to undetectable levels in adults. Nature 555, 
377–381. 
Sugiyama, T., Osumi, N., and Katsuyama, Y. (2013). The germinal matrices in the 
developing dentate gyrus are composed of neuronal progenitors at distinct 
differentiation stages. Dev. Dyn. 242, 1442–1453. 
Takeda, A., and Tamano, H. (2009). Insight into zinc signaling from dietary zinc 
deficiency. Brain Res. Rev. 62, 33–44. 
Takeda, A., Minami, A., Seki, Y., and Oku, N. (2003). Inhibitory function of zinc against 
excitation of hippocampal glutamatergic neurons. Epilepsy Res. 57, 169–174. 
Tice, D.A., Biscardi, J.S., Nickles, A.L., and Parsons, S.J. (1999). Mechanism of 
biological synergy between cellular Src and epidermal growth factor receptor. Proc. 
Natl. Acad. Sci. U. S. A. 96, 1415–1420. 
Tropepe, V., Sibilia, M., Ciruna, B.G., Rossant, J., Wagner, E.F., and Van Der Kooy, D. 
(1999). Distinct neural stem cells proliferate in response to EGF and FGF in the 
developing mouse telencephalon. Dev. Biol. 208, 166–188. 
Ullrich, A., Coussens, L., Hayflick, J.S., Dull, T.J., Gray, A., Tam, A.W., Lee, J., Yarden, 
Y., Libermann, T.A., Schlessinger, J., et al. (1984). Human epidermal growth factor 
BIBLIOGRAFIA 




receptor cDNA sequence and aberrant expression of the amplified gene in A431 
epidermoid carcinoma cells. Nature 309, 418–425. 
Valcárcel-Martín, R., Martín-Suárez, S., Muro-García, T., Pastor-Alonso, O., Rodríguez 
de Fonseca, F., Estivill-Torrús, G., and Encinas, J.M. (2020). Lysophosphatidic acid 
receptor 1 specifically labels seizure-induced hippocampal reactive neural stem cells 
and controls their division. Front. Neurosci. - Neurogenes. August. 
Vašák, M., and Hasler, D.W. (2000). Metallothioneins: New functional and structural 
insights. Curr. Opin. Chem. Biol. 4, 177–183. 
Verwer, R.W.H., Sluiter, A.A., Balesar, R.A., Baaijen, J.C., De Witt Hamer, P.C., 
Speijer, D., Li, Y., and Swaab, D.F. (2015). Injury Response of Resected Human Brain 
Tissue in Vitro. Brain Pathol. 25, 454–468. 
Vivanco, I., Ian Robins, H., Rohle, D., Campos, C., Grommes, C., Nghiemphu, P.L., 
Kubek, S., Oldrini, B., Chheda, M.G., Yannuzzi, N., et al. (2012). Differential sensitivity 
of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. 
Cancer Discov. 2, 458–471. 
Wakeling, A.E., Guy, S.P., Woodburn, J.R., Ashton, S.E., Curry, B.J., Barker, A.J., and 
Gibson, K.H. (2002). ZD1839 (Iressa): An orally active inhibitor of epidermal growth 
factor signaling with potential for cancer therapy. Cancer Res. 62, 5749–5754. 
Van Der Wal, E.A., Gómez-Pinilla, F., and Cotman, C.W. (1994). Seizure-associated 
induction of basic fibroblast growth factor and its receptor in the rat brain. Neuroscience 
60, 311–323. 
Walker, T.L., Overall, R.W., Vogler, S., Sykes, A.M., Ruhwald, S., Lasse, D., Ichwan, 
M., Fabel, K., and Kempermann, G. (2016). Lysophosphatidic Acid Receptor Is a 
Functional Marker of Adult Hippocampal Precursor Cells. Stem Cell Reports 6, 552–
565. 
Watanabe, M., Oizumi, S., Kiuchi, S., Yamada, N., Yokouchi, H., Fukumoto, S., and 
Harada, M. (2018). The effectiveness of afatinib in a patient with advanced lung 
adenocarcinoma harboring rare G719X and S768I mutations. Intern. Med. 57, 993–
996. 
Weber, K., Thomaschewski, M., Benten, D., and Fehse, B. (2012). RGB marking with 
BIBLIOGRAFIA 




lentiviral vectors for multicolor clonal cell tracking. Nat. Protoc. 7, 839–849. 
Wu, W., Samet, J.M., Silbajoris, R., Dailey, L.A., Sheppard, D., Bromberg, P.A., and 
Graves, L.M. (2004). Heparin-binding epidermal growth factor cleavage mediates zinc-
induced epidermal growth factor receptor phosphorylation. Am. J. Respir. Cell Mol. 
Biol. 30, 540–547. 
Xu, W., Morishita, W., Buckmaster, P.S., Pang, Z.P., Malenka, R.C., and Südhof, T.C. 
(2012). Distinct Neuronal Coding Schemes in Memory Revealed by Selective Erasure 
of Fast Synchronous Synaptic Transmission. Neuron 73, 990–1001. 
Yamaguchi, M., Saito, H., Suzuki, M., and Mori, K. (2000). Visualization of 
neurogenesis in the central nervous system using nestin promoter-GFP transgenic 
mice. Neuroreport 11, 1991–1996. 
Yang, J.C.H., Sequist, L. V., Geater, S.L., Tsai, C.M., Mok, T.S.K., Schuler, M., 
Yamamoto, N., Yu, C.J., Ou, S.H.I., Zhou, C., et al. (2015). Clinical activity of afatinib in 
patients with advanced non-small-cell lung cancer harbouring uncommon EGFR 
mutations: A combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 
6. Lancet Oncol. 16, 830–838. 
Yang, P., Zhang, J., Shi, H., Zhang, J., Xu, X., Xiao, X., and Liu, Y. (2014). 
Developmental profile of neurogenesis in prenatal human hippocampus: An 
immunohistochemical study. Int. J. Dev. Neurosci. 38, 1–9. 
Yarden, Y., and Sliwkowski, M.X. (2001). Untangling the ErbB signalling network. Nat. 
Rev. Mol. Cell Biol. 2, 127–137. 
BIBLIOGRAFIA 
Hipokanpoko NSCak: Garapenetik Patologiara 
158 
